data_2mn5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mn5 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.16 176.62 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.529 3.486 . . . . 0.0 111.921 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 m -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.186 0.594 . . . . 0.0 109.828 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.39 132.43 22.97 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.24 -10.72 1.69 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.907 0.483 . . . . 0.0 111.988 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.28 13.43 61.86 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 123.656 0.646 . . . . 0.0 112.427 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.53 -17.16 64.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.875 0.838 . . . . 0.0 112.643 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.4 m -94.46 3.33 55.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.081 0.4 . . . . 0.0 111.742 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.32 -29.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-N 118.19 0.45 . . . . 0.0 111.476 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 t -156.12 -26.41 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -79.49 -20.01 48.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.085 -0.384 . . . . 0.0 111.817 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.86 172.48 48.38 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.809 0.719 . . . . 0.0 112.99 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.13 -28.65 69.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.94 0.496 . . . . 0.0 110.852 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -63.07 -33.7 76.0 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.064 -0.398 . . . . 0.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.21 -33.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.6 t -69.73 -30.89 68.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -79.04 -31.26 44.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.888 0.475 . . . . 0.0 110.744 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.56 -30.64 52.76 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.072 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -76.73 -34.42 58.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.841 0.291 . . . . 0.0 110.609 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.7 m -74.39 -24.31 59.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.326 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -89.3 -8.78 52.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.321 0.51 . . . . 0.0 111.397 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -102.99 165.43 11.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 109.303 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.77 125.07 25.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -142.71 169.53 17.41 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.838 0.455 . . . . 0.0 109.997 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpt85 -73.97 126.8 31.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.247 0.219 . . . . 0.0 110.737 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.76 -159.97 33.85 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -82.54 -21.3 35.4 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.94 -10.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.682 0.393 . . . . 0.0 111.74 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.48 171.79 44.52 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.0 m -73.8 142.49 46.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.89 0.845 . . . . 0.0 111.423 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.36 167.86 3.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.409 1.083 . . . . 0.0 110.205 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -136.24 149.88 48.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.61 -173.1 2.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.888 0.475 . . . . 0.0 111.648 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -98.53 -36.89 9.77 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.03 -174.81 4.99 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.043 -0.41 . . . . 0.0 109.993 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.67 167.15 31.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.866 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.46 163.67 39.84 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.012 0.925 . . . . 0.0 109.146 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.7 m -94.98 143.65 26.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -135.9 -179.34 5.6 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.902 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.48 173.41 25.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -69.74 -19.77 63.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.974 0.51 . . . . 0.0 111.755 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.78 14.01 4.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.209 0.604 . . . . 0.0 111.177 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 15.31 78.61 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.6 p -82.82 13.57 3.79 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.883 0.873 . . . . 0.0 113.094 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -130.88 150.18 52.16 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.906 -0.496 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.9 t -107.18 143.78 34.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.915 0.886 . . . . 0.0 109.422 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.4 m -144.3 145.96 32.31 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.063 0.545 . . . . 0.0 109.941 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.16 163.94 12.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.783 0.433 . . . . 0.0 111.631 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.91 134.86 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.595 0.758 . . . . 0.0 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -70.02 159.62 83.58 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.017 0.527 . . . . 0.0 110.799 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -64.9 162.82 64.19 Favored 'Cis proline' 0 N--CA 1.459 -0.509 0 CA-C-N 118.692 0.568 . . . . 0.0 113.259 -2.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 96.7 m -140.82 69.46 29.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 110.265 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.11 168.83 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.158 3.239 . . . . 0.0 112.041 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.26 164.25 23.2 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.898 0.479 . . . . 0.0 111.444 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.586 178.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.506 0.193 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.64 177.68 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.053 3.169 . . . . 0.0 110.345 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -125.85 128.86 48.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.549 0.34 . . . . 0.0 110.13 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -141.14 134.74 30.05 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.885 0.874 . . . . 0.0 109.143 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -138.78 163.08 33.13 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.7 0.8 . . . . 0.0 109.213 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 15.87 76.65 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.17 -25.26 63.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.435 0.617 . . . . 0.0 111.409 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -76.28 2.61 12.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.884 0.474 . . . . 0.0 111.715 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -124.84 -24.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 122.869 0.468 . . . . 0.0 111.238 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -98.9 -21.14 16.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -146.71 -22.05 0.42 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -178.02 26.0 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -58.82 -28.01 65.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.185 0.594 . . . . 0.0 111.68 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.6 m -61.34 -34.85 75.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.025 -0.422 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.52 -31.99 28.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.848 0.294 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.1 t -67.22 -31.85 72.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -79.17 -36.65 40.02 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.187 -0.321 . . . . 0.0 110.768 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -69.99 -22.6 63.12 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.913 -0.089 . . . . 0.0 110.976 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -82.17 -35.83 27.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.671 0.214 . . . . 0.0 110.832 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.11 -24.61 54.96 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.455 0.302 . . . . 0.0 111.616 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.04 6.34 22.46 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.377 0.671 . . . . 0.0 111.226 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -133.29 169.8 16.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.84 131.82 39.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -145.11 171.13 14.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.71 0.404 . . . . 0.0 110.364 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -78.35 137.1 37.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.16 -170.9 17.12 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -88.69 -11.42 45.25 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.3 t -129.83 -16.46 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.031 0.532 . . . . 0.0 111.081 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.11 44.6 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.5 m -82.24 139.55 34.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.203 -0.587 . . . . 0.0 111.058 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.31 168.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.274 0.63 . . . . 0.0 111.639 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -139.06 143.24 38.28 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -127.2 -175.32 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.499 0.591 . . . . 0.0 112.289 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -100.59 -35.03 9.65 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -154.46 -175.11 5.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.82 167.35 30.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.26 165.18 37.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.964 0.906 . . . . 0.0 109.356 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.7 m -95.35 143.53 26.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.3 p -135.8 179.57 6.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.117 0.567 . . . . 0.0 111.105 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.56 179.68 49.77 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.8 136.87 57.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.4 mt 52.22 16.66 0.6 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.921 0.888 . . . . 0.0 113.229 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.7 75.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.972 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -74.81 3.1 8.64 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.193 0.997 . . . . 0.0 113.613 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 48.6 m -121.8 155.71 34.73 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.538 0.608 . . . . 0.0 110.256 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.4 t -112.49 139.3 48.19 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.577 0.751 . . . . 0.0 109.959 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.7 m -142.41 146.1 34.52 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.346 0.658 . . . . 0.0 109.846 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.02 165.02 11.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.986 0.514 . . . . 0.0 111.48 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.75 145.32 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 110.408 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -70.4 156.06 92.48 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.915 0.486 . . . . 0.0 110.852 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.97 162.64 91.82 Favored 'Cis proline' 0 N--CA 1.454 -0.847 0 CA-C-N 118.274 0.419 . . . . 0.0 111.146 -2.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.8 m -137.65 68.99 52.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 109.942 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.83 167.44 13.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.936 3.091 . . . . 0.0 112.094 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.37 164.2 26.72 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.293 0.637 . . . . 0.0 111.802 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.991 176.334 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.318 0.104 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.77 171.47 18.16 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.975 3.117 . . . . 0.0 109.955 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.2 m -118.59 120.74 38.36 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -136.09 137.16 40.79 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 123.796 0.838 . . . . 0.0 109.407 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -139.94 162.49 35.05 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.09 17.31 78.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.51 -24.24 63.48 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.484 0.642 . . . . 0.0 111.918 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.4 m -76.53 2.87 12.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.075 0.55 . . . . 0.0 111.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.73 -25.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 122.737 0.415 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -95.21 -21.16 18.65 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.017 -0.427 . . . . 0.0 111.968 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -146.27 -21.84 0.44 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -177.43 25.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.31 -29.26 65.75 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 m -62.59 -34.22 76.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 111.141 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.59 -30.39 32.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.94 -0.475 . . . . 0.0 110.583 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.86 -30.77 69.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -81.0 -30.24 35.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.489 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.62 -22.29 43.84 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.505 -0.122 . . . . 0.0 111.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.55 -35.95 24.37 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.252 -0.28 . . . . 0.0 110.782 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.4 m -73.98 -26.14 60.3 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.462 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -88.61 8.98 25.73 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.959 0.345 . . . . 0.0 111.494 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -127.97 164.93 21.25 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.888 0.875 . . . . 0.0 108.993 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.6 t -69.7 127.09 31.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -143.49 168.16 20.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.792 0.437 . . . . 0.0 110.538 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.54 133.8 37.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.567 0.347 . . . . 0.0 111.037 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.86 -163.48 23.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -86.84 -11.36 51.06 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.77 -11.92 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.627 0.371 . . . . 0.0 111.893 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.75 177.57 47.46 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.0 m -86.94 139.91 30.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.663 0.731 . . . . 0.0 111.45 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.31 166.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.377 0.671 . . . . 0.0 110.611 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -135.01 148.3 49.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.8 m -126.88 -174.01 3.03 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.971 0.351 . . . . 0.0 111.755 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -100.5 -33.39 10.36 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.28 -175.14 5.28 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.46 167.62 29.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.61 164.99 37.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.981 0.912 . . . . 0.0 109.501 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.8 142.6 27.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.4 p -137.26 -177.88 4.97 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.732 0.813 . . . . 0.0 110.981 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.76 -175.91 53.16 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.8 134.27 56.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 51.18 18.89 0.64 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.102 0.961 . . . . 0.0 113.275 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 22.23 77.25 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.334 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -75.42 7.61 3.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -125.31 153.23 43.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.423 0.556 . . . . 0.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.9 t -108.9 138.94 44.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.538 0.735 . . . . 0.0 110.146 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.0 m -141.0 147.17 38.27 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 123.008 0.523 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -100.87 162.88 12.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.121 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.71 141.01 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.793 0.837 . . . . 0.0 110.035 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -68.86 155.35 93.52 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.159 0.583 . . . . 0.0 111.088 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.52 164.49 87.09 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 118.23 0.403 . . . . 0.0 111.351 -1.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.2 m -139.11 68.32 41.03 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.509 0.724 . . . . 0.0 110.192 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.77 164.08 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.675 2.916 . . . . 0.0 111.874 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.54 160.77 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.896 0.478 . . . . 0.0 111.43 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.702 -178.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.17 178.34 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.921 3.081 . . . . 0.0 110.731 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -122.6 128.57 50.86 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.846 0.458 . . . . 0.0 110.157 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -143.62 144.91 32.11 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.699 0.799 . . . . 0.0 109.16 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.6 mmm180 -133.27 -23.88 1.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 17.4 58.63 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.75 0.69 . . . . 0.0 113.604 -173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.72 -25.76 63.25 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.971 0.886 . . . . 0.0 112.623 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.9 m -79.53 4.65 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 111.936 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.63 -25.41 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.111 0.565 . . . . 0.0 111.181 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.5 p -89.11 -15.58 33.56 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -154.73 -36.61 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.689 0.396 . . . . 0.0 111.384 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -165.36 13.03 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.4 -27.6 67.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.479 -0.424 . . . . 0.0 111.751 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -62.81 -39.63 94.88 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.772 -0.58 . . . . 0.0 111.0 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -28.77 48.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.181 0.446 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.33 -32.83 70.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -78.56 -31.99 47.59 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.443 0.297 . . . . 0.0 110.8 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -77.14 -20.17 55.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.483 -0.136 . . . . 0.0 110.838 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -86.24 -31.43 21.69 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.638 0.375 . . . . 0.0 110.875 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.4 m -80.16 -29.89 38.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.259 -0.401 . . . . 0.0 111.925 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.51 -15.71 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.54 0.609 . . . . 0.0 111.036 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -102.99 169.64 8.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -77.69 141.44 39.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -146.54 171.97 14.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.132 0.973 . . . . 0.0 109.609 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -73.43 139.36 45.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.589 0.233 . . . . 0.0 111.271 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.5 -169.34 15.27 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.908 0.766 . . . . 0.0 111.199 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.68 -14.82 36.41 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.771 0.429 . . . . 0.0 112.015 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.2 -8.12 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 122.813 0.445 . . . . 0.0 111.616 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.93 179.26 42.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.72 140.31 34.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.579 0.69 . . . . 0.0 110.881 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.84 163.41 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.497 0.719 . . . . 0.0 110.989 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -133.68 147.34 51.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.22 -173.27 2.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.79 0.436 . . . . 0.0 111.568 -172.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -99.97 -35.75 9.62 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -154.13 -174.5 4.99 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.48 26.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.38 165.12 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.474 1.11 . . . . 0.0 109.508 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 100.0 m -99.03 144.8 27.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -136.95 -178.88 5.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.953 0.901 . . . . 0.0 111.106 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.65 -178.45 25.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.01 -22.89 67.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.047 0.539 . . . . 0.0 112.014 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -144.36 20.8 1.72 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.815 0.279 . . . . 0.0 111.676 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.68 17.78 79.57 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -81.29 7.1 12.28 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.4 m -128.02 153.27 46.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.811 0.444 . . . . 0.0 110.273 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 t -105.39 141.88 36.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.335 0.654 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 m -142.4 146.04 34.46 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.195 0.598 . . . . 0.0 110.101 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.94 162.96 12.52 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.886 0.474 . . . . 0.0 111.256 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -111.69 138.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.426 0.69 . . . . 0.0 110.007 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -67.46 156.1 89.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.22 0.608 . . . . 0.0 111.027 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.71 167.95 78.77 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 O-C-N 121.97 0.458 . . . . 0.0 111.382 -1.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 88.5 m -139.97 67.64 34.49 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.627 0.771 . . . . 0.0 110.063 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.61 170.88 14.17 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.317 3.345 . . . . 0.0 112.082 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -66.11 169.74 6.6 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.597 0.759 . . . . 0.0 110.715 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.17 -1.395 . . . . 0.0 111.363 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.275 0.083 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.52 173.11 15.06 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.428 2.752 . . . . 0.0 110.162 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.3 m -120.51 123.92 44.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.5 0.32 . . . . 0.0 110.197 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -143.77 138.63 28.91 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -138.87 -15.0 1.18 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.202 0.601 . . . . 0.0 111.716 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.1 13.21 62.05 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.554 0.597 . . . . 0.0 112.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.06 -17.35 63.29 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.683 0.741 . . . . 0.0 112.499 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.42 2.69 52.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.152 0.433 . . . . 0.0 111.95 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.11 -30.08 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 118.226 0.467 . . . . 0.0 111.603 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -155.45 -26.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -79.98 -19.75 47.13 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.137 -0.352 . . . . 0.0 111.591 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.69 171.34 47.65 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.942 0.782 . . . . 0.0 112.609 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.57 -28.25 68.32 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.831 0.452 . . . . 0.0 111.097 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -62.46 -33.08 74.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.865 0.302 . . . . 0.0 110.564 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -33.58 42.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.031 -0.418 . . . . 0.0 110.384 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.86 -29.67 68.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -79.43 -30.83 42.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.716 0.407 . . . . 0.0 111.079 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -77.53 -19.27 56.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.092 0.157 . . . . 0.0 111.128 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -87.43 -31.61 19.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.581 0.352 . . . . 0.0 111.108 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.7 m -80.37 -23.84 40.21 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -88.05 9.49 22.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.845 0.293 . . . . 0.0 111.117 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -132.8 170.53 15.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.222 1.009 . . . . 0.0 108.449 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.8 133.5 43.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.769 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -146.88 169.24 19.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.409 0.684 . . . . 0.0 110.019 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -75.08 139.48 42.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.058 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.48 -170.82 16.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.73 -13.27 54.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.02 -18.13 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 122.695 0.398 . . . . 0.0 111.25 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.94 179.58 47.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -82.95 141.56 32.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.915 0.857 . . . . 0.0 111.242 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -146.94 170.01 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.449 0.7 . . . . 0.0 110.829 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -136.15 146.02 46.45 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -126.29 -172.24 2.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.09 0.405 . . . . 0.0 112.062 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 t -103.37 -36.93 7.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.75 -174.87 4.99 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.89 167.85 28.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.19 164.85 37.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.418 1.087 . . . . 0.0 109.206 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.86 145.01 26.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -139.29 -178.52 5.4 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.526 0.73 . . . . 0.0 111.176 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.77 174.28 41.96 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.37 143.44 57.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 tp 54.5 11.73 0.45 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.72 0.808 . . . . 0.0 112.53 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.12 76.31 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.37 -0.684 . . . . 0.0 112.924 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -76.19 9.88 2.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.589 1.194 . . . . 0.0 114.184 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.3 m -127.37 152.31 47.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.65 0.659 . . . . 0.0 110.671 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 t -111.27 139.61 46.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.5 m -140.54 148.34 40.88 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 123.659 0.784 . . . . 0.0 109.783 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.54 164.46 11.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.821 0.448 . . . . 0.0 111.652 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.75 142.99 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 123.906 0.883 . . . . 0.0 110.113 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.11 156.48 91.74 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 122.898 0.479 . . . . 0.0 110.964 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.57 163.03 90.74 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 O-C-N 121.901 0.422 . . . . 0.0 111.347 -1.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.15 68.85 48.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.767 0.827 . . . . 0.0 110.38 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -62.6 159.97 34.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.464 2.776 . . . . 0.0 111.614 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -74.57 159.44 32.16 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.883 0.473 . . . . 0.0 112.025 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.259 -1.353 . . . . 0.0 109.952 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.83 -0.063 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.79 174.33 12.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.699 2.932 . . . . 0.0 110.392 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 m -122.06 134.63 54.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.337 0.025 0 C-N-CA 123.379 0.672 . . . . 0.0 110.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -143.31 162.44 35.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.639 1.176 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.11 13.84 70.42 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.777 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.5 mt -58.62 -26.33 63.6 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 117.83 0.815 . . . . 0.0 111.974 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -85.75 7.31 24.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.4 -24.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 122.843 0.457 . . . . 0.0 110.978 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -103.62 -18.79 14.59 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 m -143.07 -19.76 0.64 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.35 -176.65 32.93 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 tp -59.14 -27.35 65.55 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.297 0.639 . . . . 0.0 111.791 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.166 -0.334 . . . . 0.0 111.214 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.46 31.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.057 -0.402 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -69.47 -31.58 69.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -78.27 -36.3 46.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.555 0.342 . . . . 0.0 110.87 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.83 -23.93 61.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.899 0.124 . . . . 0.0 110.783 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -81.31 -34.72 31.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.881 0.31 . . . . 0.0 110.656 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -77.49 -28.09 52.07 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.561 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -85.83 4.24 38.02 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.793 0.437 . . . . 0.0 111.462 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -123.98 165.7 16.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -72.22 134.09 45.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.001 -0.437 . . . . 0.0 110.034 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.04 170.18 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.187 0.595 . . . . 0.0 110.449 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -72.57 137.36 46.16 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.44 -163.24 22.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.02 -17.43 25.08 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.42 -0.459 . . . . 0.0 112.135 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.79 -4.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.93 0.492 . . . . 0.0 111.898 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.71 -147.11 5.83 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.0 m -125.92 140.88 52.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.132 0.466 . . . . 0.0 110.797 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.47 170.26 6.32 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.049 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.38 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.84 150.4 45.97 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 124.841 1.256 . . . . 0.0 107.83 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -127.82 -174.09 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.181 0.446 . . . . 0.0 111.506 -175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -105.96 -28.15 10.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -156.94 -178.06 7.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.656 0.662 . . . . 0.0 109.772 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.64 168.37 25.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.35 170.15 21.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.423 1.089 . . . . 0.0 108.721 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.1 m -109.02 145.69 35.16 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.9 p -133.47 -178.25 4.91 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.381 0.672 . . . . 0.0 110.979 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.73 -176.65 26.33 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -66.61 -22.02 66.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.899 0.479 . . . . 0.0 112.23 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -144.44 20.74 1.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.853 0.297 . . . . 0.0 111.306 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.07 19.75 79.69 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 121.971 -0.456 . . . . 0.0 112.177 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -82.03 3.0 28.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.802 0.801 . . . . 0.0 112.973 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.8 m -119.15 153.21 35.23 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.092 0.557 . . . . 0.0 109.777 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.6 t -110.17 136.86 48.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.007 0.523 . . . . 0.0 110.33 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -139.94 147.23 40.23 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 109.861 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.86 164.95 11.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.584 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.0 mm -112.88 145.48 18.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 123.907 0.883 . . . . 0.0 110.292 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -72.94 155.64 90.35 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.866 0.466 . . . . 0.0 110.825 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.19 164.58 87.41 Favored 'Cis proline' 0 N--CA 1.455 -0.769 0 CA-C-N 118.321 0.436 . . . . 0.0 111.42 -1.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -137.42 69.66 54.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 123.505 0.722 . . . . 0.0 110.329 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.3 163.39 26.58 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.901 3.067 . . . . 0.0 111.76 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -74.76 160.58 30.54 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.498 0.719 . . . . 0.0 111.672 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.859 179.527 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.02 177.67 8.45 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.315 3.343 . . . . 0.0 110.915 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -118.19 137.59 52.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -142.39 147.31 36.0 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.657 0.383 . . . . 0.0 110.902 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -141.9 163.42 32.94 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.802 1.241 . . . . 0.0 109.047 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.85 16.79 72.72 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.395 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.54 -28.41 68.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.884 0.842 . . . . 0.0 111.462 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.1 m -81.31 5.56 16.92 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.21 -13.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.768 0.427 . . . . 0.0 111.54 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -126.19 -16.58 5.46 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 m -140.39 -19.15 0.87 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.55 -175.94 39.44 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.95 -27.83 65.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.055 0.542 . . . . 0.0 112.003 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -61.11 -36.49 79.85 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.873 0.306 . . . . 0.0 111.143 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.04 -29.22 35.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.995 0.361 . . . . 0.0 110.648 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 t -70.22 -31.03 68.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -80.64 -33.52 35.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.552 0.341 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.8 -28.81 61.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -78.21 -33.34 50.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.709 0.231 . . . . 0.0 110.855 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.97 -28.4 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.534 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.81 -20.18 36.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.56 0.618 . . . . 0.0 111.105 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 m -90.85 163.49 14.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.61 134.55 42.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -144.04 169.83 17.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.055 0.542 . . . . 0.0 110.042 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -73.77 140.16 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.343 0.257 . . . . 0.0 111.192 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.77 -166.48 14.77 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.94 -17.27 31.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.781 0.432 . . . . 0.0 112.156 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.81 -10.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.754 0.422 . . . . 0.0 111.685 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.08 47.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.3 m -83.86 140.78 31.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.674 0.737 . . . . 0.0 111.286 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -145.15 169.65 7.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -140.77 154.01 46.09 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -127.36 -173.81 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.889 0.476 . . . . 0.0 111.44 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -98.33 -39.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -150.18 -175.06 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.592 0.757 . . . . 0.0 110.201 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.92 167.54 30.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 112.059 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.47 164.22 38.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.959 0.904 . . . . 0.0 109.216 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.9 m -94.57 142.2 27.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -135.2 -176.34 4.23 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.443 0.697 . . . . 0.0 111.027 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.21 -177.27 28.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -67.42 -21.88 65.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.736 0.414 . . . . 0.0 112.093 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -145.17 22.97 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.68 17.59 80.05 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.885 -0.509 . . . . 0.0 111.978 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 p -81.64 6.62 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.8 m -126.98 158.15 37.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.94 0.496 . . . . 0.0 109.952 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.6 t -115.36 138.17 51.27 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.313 0.645 . . . . 0.0 109.977 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.0 m -140.53 146.24 37.86 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.559 0.744 . . . . 0.0 109.981 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -98.7 164.79 12.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.844 0.458 . . . . 0.0 111.388 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.28 146.06 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.231 1.013 . . . . 0.0 109.937 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -76.27 155.34 84.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.39 0.276 . . . . 0.0 111.056 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.43 165.26 86.2 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 CA-C-N 118.257 0.413 . . . . 0.0 111.649 -0.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 76.2 m -135.9 70.46 64.18 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.674 0.79 . . . . 0.0 109.96 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.41 162.44 27.28 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.841 3.027 . . . . 0.0 111.877 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -74.15 160.14 31.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.878 0.471 . . . . 0.0 111.625 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.316 -1.326 . . . . 0.0 109.723 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 175.21 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.112 3.208 . . . . 0.0 111.183 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -118.61 119.96 36.03 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -144.71 135.81 25.08 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.403 0.681 . . . . 0.0 109.279 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -131.99 -14.92 3.04 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.202 0.601 . . . . 0.0 111.225 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.75 11.16 67.37 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.632 0.634 . . . . 0.0 112.531 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.99 -25.63 65.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.719 0.76 . . . . 0.0 112.288 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.82 3.6 16.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.567 0.347 . . . . 0.0 111.908 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.75 -25.63 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 122.99 0.516 . . . . 0.0 110.835 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -89.96 -15.25 32.37 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -155.04 -37.91 0.09 Allowed 'General case' 0 C--O 1.23 0.079 0 C-N-CA 122.53 0.332 . . . . 0.0 111.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.16 -165.65 13.64 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.02 -26.95 66.5 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.735 0.414 . . . . 0.0 111.591 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -62.67 -39.19 93.17 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 121.913 -0.492 . . . . 0.0 111.277 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.45 -29.98 42.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.328 0.513 . . . . 0.0 110.863 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.74 -32.35 72.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -78.49 -35.9 45.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.196 -0.315 . . . . 0.0 110.653 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.38 -17.02 62.43 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.72 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -90.71 -30.78 16.89 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.186 0.594 . . . . 0.0 111.258 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.33 -21.37 39.24 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.035 -0.416 . . . . 0.0 110.749 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -86.13 4.08 39.9 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.511 0.724 . . . . 0.0 111.35 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.2 p -131.62 169.61 15.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.088 0.955 . . . . 0.0 108.841 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -75.15 134.67 41.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.58 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -145.73 169.99 17.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.837 0.855 . . . . 0.0 109.891 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -73.32 139.54 46.11 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 122.44 -0.163 . . . . 0.0 111.16 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.8 -166.8 14.38 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.367 0.984 . . . . 0.0 111.031 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.25 -13.05 53.65 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.0 -10.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.645 0.378 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.05 179.98 45.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -80.92 142.52 33.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.616 0.708 . . . . 0.0 111.279 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 m -145.08 169.27 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.843 0.857 . . . . 0.0 110.8 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.97 151.76 49.38 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -130.91 -175.25 3.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 112.024 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.9 p -97.07 -36.91 10.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -154.45 -174.78 5.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.023 0.529 . . . . 0.0 109.609 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 166.94 30.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.426 0.632 . . . . 0.0 112.518 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.25 165.82 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.9 0.88 . . . . 0.0 109.246 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.39 143.9 29.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -137.15 -178.64 5.3 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.881 0.872 . . . . 0.0 111.212 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.94 -176.7 23.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.05 -23.02 66.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.144 0.578 . . . . 0.0 111.854 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.96 20.9 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.26 -0.275 . . . . 0.0 111.24 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.39 17.82 80.08 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.7 p -82.62 7.9 13.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.7 m -127.78 151.5 48.94 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.838 0.455 . . . . 0.0 110.381 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -104.35 140.21 38.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.525 0.73 . . . . 0.0 110.655 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -141.45 147.76 38.42 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.686 0.795 . . . . 0.0 110.046 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.98 162.97 12.5 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.874 0.369 . . . . 0.0 111.247 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.2 147.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.698 0.799 . . . . 0.0 110.315 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -75.42 154.5 85.9 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.794 0.438 . . . . 0.0 111.109 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.74 164.47 88.13 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 O-C-N 121.819 0.378 . . . . 0.0 111.715 -1.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 63.5 m -136.48 70.8 60.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.736 0.815 . . . . 0.0 110.192 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.19 160.65 29.72 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.649 2.9 . . . . 0.0 111.438 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.08 160.38 29.1 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.895 0.478 . . . . 0.0 111.95 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.188 -179.638 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.87 175.59 10.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.518 3.479 . . . . 0.0 111.523 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -112.86 121.95 46.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.132 0.573 . . . . 0.0 110.004 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -139.97 137.62 34.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.079 0.952 . . . . 0.0 109.315 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.92 -11.87 1.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.397 0.679 . . . . 0.0 111.352 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.43 10.4 74.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.416 0.531 . . . . 0.0 112.482 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.04 -24.9 64.92 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 117.431 0.615 . . . . 0.0 112.39 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.1 m -77.35 2.34 16.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.37 -23.74 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 122.827 0.451 . . . . 0.0 111.394 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.1 p -97.27 -21.36 17.3 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.322 0.51 . . . . 0.0 112.207 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.4 m -145.93 -22.18 0.45 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 -177.46 25.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.46 -29.51 69.09 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.177 0.591 . . . . 0.0 111.665 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -62.02 -34.93 77.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.004 -0.435 . . . . 0.0 111.142 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -30.51 38.99 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.072 -0.393 . . . . 0.0 110.13 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.7 t -68.78 -31.67 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -78.9 -32.36 45.73 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.896 0.478 . . . . 0.0 111.035 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -78.03 -24.13 47.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.246 0.218 . . . . 0.0 111.353 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -81.71 -35.86 29.3 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 122.185 -0.322 . . . . 0.0 110.896 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.8 m -74.92 -24.18 58.46 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.734 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.62 13.99 14.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.891 0.476 . . . . 0.0 111.167 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -134.01 168.36 18.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.824 0.85 . . . . 0.0 109.098 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -73.31 123.22 23.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -140.2 164.36 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.049 0.54 . . . . 0.0 109.859 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -73.54 134.99 43.93 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.269 -0.269 . . . . 0.0 110.583 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.0 -152.78 25.0 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.02 -19.24 27.43 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.89 -10.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.969 0.508 . . . . 0.0 112.112 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.19 173.04 45.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.4 m -79.81 141.26 36.39 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 117.582 0.691 . . . . 0.0 111.458 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.62 169.05 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 110.163 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -136.87 151.6 49.28 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.649 1.18 . . . . 0.0 108.088 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.7 m -128.04 -173.44 2.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.993 0.361 . . . . 0.0 111.83 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 t -99.01 -36.43 9.72 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.9 -175.22 5.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.54 167.14 31.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.931 0.396 . . . . 0.0 111.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.47 165.33 36.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.787 0.835 . . . . 0.0 109.667 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -99.1 140.7 32.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.6 p -137.68 -178.41 5.23 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.652 0.781 . . . . 0.0 110.752 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.76 -172.65 16.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -66.81 -23.03 66.0 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 111.781 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -146.78 21.71 1.28 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 111.294 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.83 79.13 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 112.085 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -81.65 7.03 13.35 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -129.83 145.57 51.58 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.689 0.677 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -95.37 141.74 28.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.652 0.781 . . . . 0.0 110.291 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.7 m -143.63 145.19 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.212 0.605 . . . . 0.0 109.991 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.87 164.61 12.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 111.422 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.24 136.48 53.07 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.061 0 C-N-CA 123.964 0.905 . . . . 0.0 109.763 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.81 159.01 86.74 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 122.989 0.516 . . . . 0.0 111.185 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.57 161.57 65.89 Favored 'Cis proline' 0 N--CA 1.459 -0.535 0 CA-C-N 118.741 0.586 . . . . 0.0 113.073 -2.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.82 71.33 36.21 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.54 165.06 23.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.62 2.88 . . . . 0.0 111.583 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.47 164.65 25.25 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.072 -178.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 178.09 7.93 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.288 3.325 . . . . 0.0 110.619 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -123.01 122.87 39.57 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.759 0.424 . . . . 0.0 110.151 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.58 130.65 20.65 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.474 0.709 . . . . 0.0 109.233 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -126.76 -15.11 5.53 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.373 0.669 . . . . 0.0 111.452 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.52 11.1 59.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.733 0.683 . . . . 0.0 112.839 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 -17.33 64.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.527 0.664 . . . . 0.0 112.177 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.3 m -96.96 2.36 51.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.16 0.436 . . . . 0.0 112.046 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.54 -29.92 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.06 0.391 . . . . 0.0 111.478 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -154.48 -26.95 0.12 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -80.09 -20.42 45.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.199 -0.313 . . . . 0.0 111.766 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.05 171.9 48.29 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.12 0.867 . . . . 0.0 112.386 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.57 -28.74 68.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.164 0.585 . . . . 0.0 111.147 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -61.7 -33.8 74.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.153 -0.342 . . . . 0.0 110.722 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.75 -31.26 40.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.232 -0.293 . . . . 0.0 110.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.9 t -71.34 -29.66 65.25 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -79.23 -33.48 43.66 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 122.194 -0.316 . . . . 0.0 110.935 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -22.88 59.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.207 0.203 . . . . 0.0 110.76 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -82.76 -32.51 27.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.893 0.477 . . . . 0.0 110.743 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -80.38 -25.17 39.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.431 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -86.15 9.36 17.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.783 0.433 . . . . 0.0 111.059 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -131.13 170.26 14.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.1 m -78.13 132.69 37.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -145.02 170.63 15.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.583 0.753 . . . . 0.0 109.726 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -74.48 140.07 44.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.166 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.69 -169.55 15.24 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -86.37 -12.5 49.08 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.16 -10.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.811 0.445 . . . . 0.0 111.854 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.1 44.08 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.72 140.84 34.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.496 0.648 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.7 168.62 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.101 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -138.48 148.77 44.72 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 107.703 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -128.58 -171.68 2.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.038 0.381 . . . . 0.0 111.906 -172.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.2 t -103.46 -39.4 6.77 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -146.67 -175.43 4.79 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.574 0.75 . . . . 0.0 110.416 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 168.09 28.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.83 165.54 35.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.323 1.049 . . . . 0.0 109.539 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.25 143.01 30.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.5 p -138.62 -176.64 4.55 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.681 0.792 . . . . 0.0 110.943 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.93 178.18 25.58 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.65 -20.57 66.02 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.11 0.564 . . . . 0.0 111.968 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -141.54 18.38 2.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.661 0.267 . . . . 0.0 111.329 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.67 80.61 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.1 p -83.21 10.46 8.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.982 0.913 . . . . 0.0 113.09 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 m -126.14 151.77 46.83 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.368 0.531 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -108.71 140.19 42.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.501 0.72 . . . . 0.0 109.769 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.5 m -140.89 147.19 38.51 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.297 0.639 . . . . 0.0 110.071 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.59 165.97 10.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mm -116.8 142.3 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 124.202 1.001 . . . . 0.0 110.516 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -67.76 156.43 89.17 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 122.894 0.477 . . . . 0.0 111.224 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 162.43 91.73 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 O-C-N 121.761 0.348 . . . . 0.0 111.337 -1.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -137.51 68.9 53.61 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.826 0.851 . . . . 0.0 110.499 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.91 164.66 21.13 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.718 2.945 . . . . 0.0 111.189 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.17 167.07 22.38 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.462 0.649 . . . . 0.0 112.085 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.087 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.6 177.21 8.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.219 3.279 . . . . 0.0 111.497 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -115.89 130.98 57.06 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 109.825 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.07 142.28 31.5 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.7 mmm180 -131.13 -23.53 2.43 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.73 17.0 58.07 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.358 0.504 . . . . 0.0 113.59 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.04 -24.71 59.44 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.884 0.842 . . . . 0.0 112.747 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.83 6.92 19.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.393 0.542 . . . . 0.0 111.843 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.32 -25.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.514 0.726 . . . . 0.0 110.374 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -89.05 -15.49 33.9 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.97 -0.457 . . . . 0.0 111.423 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -153.61 -38.91 0.1 Allowed 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.632 0.253 . . . . 0.0 111.062 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.81 -167.92 15.12 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.82 -27.15 66.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.635 0.374 . . . . 0.0 111.327 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -60.91 -41.24 95.75 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 122.07 -0.394 . . . . 0.0 111.283 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.75 -28.62 44.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.998 -0.439 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.1 -32.69 72.27 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -79.13 -36.25 40.84 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 122.369 0.268 . . . . 0.0 110.776 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -73.3 -17.73 61.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.0 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -89.79 -30.99 17.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.601 0.361 . . . . 0.0 111.108 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.3 m -77.87 -25.14 48.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.545 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -88.93 8.32 29.98 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.949 0.5 . . . . 0.0 111.351 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p -130.58 169.28 15.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 108.593 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.5 m -74.82 131.62 40.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.754 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.58 167.07 23.41 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.985 0.914 . . . . 0.0 109.162 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.53 124.31 26.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 -158.29 34.4 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.11 -21.18 36.85 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.59 -10.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.794 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 173.61 45.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -76.06 140.24 41.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.042 0.921 . . . . 0.0 111.482 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.93 169.7 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 124.233 1.013 . . . . 0.0 110.691 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -137.68 149.96 46.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.7 m -129.22 -172.31 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.159 0.436 . . . . 0.0 111.501 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -103.3 -37.52 7.62 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -151.15 -176.13 5.43 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.17 168.34 26.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.87 168.58 25.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.915 1.286 . . . . 0.0 108.657 173.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.17 148.6 25.58 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.193 -0.317 . . . . 0.0 110.622 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -135.12 179.96 5.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.548 0.739 . . . . 0.0 110.796 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 177.22 29.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.03 -19.69 63.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.746 0.419 . . . . 0.0 111.947 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.42 13.93 3.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.066 0.546 . . . . 0.0 111.658 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.06 16.23 78.5 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.287 -0.325 . . . . 0.0 112.287 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.6 p -80.49 6.13 13.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.681 0.792 . . . . 0.0 113.072 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.6 m -122.81 154.39 38.29 Favored 'General case' 0 CA--C 1.526 0.022 0 C-N-CA 122.95 0.5 . . . . 0.0 110.139 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.7 t -107.35 141.39 38.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.585 0.754 . . . . 0.0 110.566 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -142.34 147.15 35.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.395 0.678 . . . . 0.0 109.971 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.6 m -101.53 164.55 11.7 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.872 0.368 . . . . 0.0 111.512 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.98 143.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -70.23 156.28 92.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 122.92 0.488 . . . . 0.0 110.868 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.84 162.87 91.26 Favored 'Cis proline' 0 N--CA 1.451 -1.012 0 O-C-N 121.959 0.452 . . . . 0.0 111.378 -1.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.8 m -136.94 69.25 57.83 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.562 0.745 . . . . 0.0 110.367 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.09 162.96 24.25 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.587 2.858 . . . . 0.0 111.623 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -76.61 159.98 29.81 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.869 0.468 . . . . 0.0 111.592 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.99 178.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 p . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.9 174.22 12.71 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.872 3.048 . . . . 0.0 110.962 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.8 m -115.87 121.47 42.47 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.0 138.78 30.27 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 123.741 0.816 . . . . 0.0 109.211 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.19 -16.18 1.08 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.673 0.389 . . . . 0.0 111.7 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.24 11.45 71.01 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.586 0.613 . . . . 0.0 112.491 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.0 -27.05 63.16 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.53 0.665 . . . . 0.0 112.395 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.0 t -74.94 -6.09 47.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.666 0.386 . . . . 0.0 111.536 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.01 -22.76 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.166 -0.334 . . . . 0.0 111.319 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 p -98.69 -21.16 16.56 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -144.93 -22.66 0.5 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.56 179.68 23.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.92 -27.84 68.49 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.221 0.608 . . . . 0.0 111.787 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -63.09 -33.79 76.2 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.976 -0.453 . . . . 0.0 110.857 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.09 -30.25 43.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.891 -0.506 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.69 -31.0 67.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.48 -29.07 46.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.344 0.258 . . . . 0.0 110.959 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.71 -16.48 51.06 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.067 0.147 . . . . 0.0 111.005 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -87.39 -33.59 19.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.074 -0.391 . . . . 0.0 110.967 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.59 -26.36 45.42 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.195 -0.316 . . . . 0.0 111.815 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -87.16 9.75 19.01 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.116 0.416 . . . . 0.0 111.28 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -133.18 166.78 21.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.484 1.113 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.8 m -72.48 133.45 44.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.551 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -145.64 169.63 18.07 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.591 0.756 . . . . 0.0 109.766 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -74.3 136.72 42.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.217 0.207 . . . . 0.0 111.079 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 -159.61 19.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.123 0.868 . . . . 0.0 111.098 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.79 -18.32 33.27 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.28 -11.37 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 122.569 0.348 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.99 178.61 48.61 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -81.48 142.84 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.64 0.72 . . . . 0.0 111.328 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -146.48 169.48 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.698 0.799 . . . . 0.0 110.418 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.7 150.27 47.19 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.1 m -130.16 -174.61 3.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.059 0.391 . . . . 0.0 111.462 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 -27.54 11.95 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.05 -177.31 6.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.693 0.678 . . . . 0.0 109.814 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.08 169.5 22.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.64 168.95 24.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.665 1.186 . . . . 0.0 109.037 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.7 t -110.93 142.56 42.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -132.42 173.15 11.59 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.026 -175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.82 177.77 15.31 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -72.2 -20.61 61.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.877 0.339 . . . . 0.0 111.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.12 9.94 3.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.082 0.953 . . . . 0.0 110.709 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.12 83.87 0.24 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -140.29 4.91 2.04 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.2 m -132.81 147.68 52.31 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.314 0.506 . . . . 0.0 110.323 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.3 t -94.01 137.95 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.084 0.554 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -138.01 145.17 41.53 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.414 0.686 . . . . 0.0 109.555 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.42 162.7 12.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 143.86 18.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.726 0.81 . . . . 0.0 110.049 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -72.7 155.16 91.1 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 122.888 0.475 . . . . 0.0 110.99 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.61 165.43 85.62 Favored 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.605 0.538 . . . . 0.0 111.249 -0.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.61 69.8 38.13 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.051 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.8 161.67 28.07 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.785 2.99 . . . . 0.0 111.322 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -76.5 161.42 28.64 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.851 0.358 . . . . 0.0 111.642 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.283 -1.342 . . . . 0.0 109.916 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 177.14 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 124.786 3.657 . . . . 0.0 111.487 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m -108.62 125.86 52.32 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.379 0.672 . . . . 0.0 109.576 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -138.88 133.31 31.77 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.45 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -130.88 -16.97 3.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.5 67.82 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.339 0.495 . . . . 0.0 112.879 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.16 -27.46 68.41 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 117.564 0.682 . . . . 0.0 112.01 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.7 m -80.24 5.33 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.09 -24.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 122.613 0.365 . . . . 0.0 111.497 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -100.09 -15.65 18.12 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.7 t -149.86 -35.07 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.04 -164.53 12.03 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.97 -27.15 66.59 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.948 0.499 . . . . 0.0 111.794 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 m -62.39 -40.76 97.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.86 -0.525 . . . . 0.0 111.125 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.09 46.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.411 0.55 . . . . 0.0 110.626 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -68.0 -33.28 74.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -78.7 -35.93 44.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.261 0.224 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -72.43 -17.47 61.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.942 -0.117 . . . . 0.0 111.17 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -90.05 -32.04 16.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.578 0.351 . . . . 0.0 110.79 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.39 -25.65 42.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.574 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -85.89 5.2 34.0 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.3 0.5 . . . . 0.0 111.249 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.9 m -127.73 165.97 19.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.57 1.148 . . . . 0.0 107.946 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.43 137.33 39.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.806 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -146.18 167.92 22.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.351 1.06 . . . . 0.0 108.834 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -73.87 134.31 43.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.154 -0.342 . . . . 0.0 110.635 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.69 -152.24 24.94 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -88.64 -17.95 29.0 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.766 0.427 . . . . 0.0 112.135 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.75 -12.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.687 0.395 . . . . 0.0 112.051 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 175.37 47.59 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -78.03 142.58 38.13 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.425 0.612 . . . . 0.0 111.602 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.09 165.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 124.006 0.922 . . . . 0.0 110.621 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -132.96 144.51 50.17 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 124.763 1.225 . . . . 0.0 107.946 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.53 -172.47 2.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.613 0.365 . . . . 0.0 111.335 -172.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 t -103.48 -36.6 7.92 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.41 -177.3 5.99 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.24 167.95 28.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -154.25 164.53 38.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.083 0.953 . . . . 0.0 109.548 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.7 m -96.44 143.26 27.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -137.89 -177.4 4.8 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.662 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.29 -179.07 48.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -65.7 138.92 58.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.533 . . . . 0.0 109.946 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp 52.92 17.21 0.83 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.078 0.951 . . . . 0.0 112.483 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.87 77.35 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.92 -0.488 . . . . 0.0 112.164 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -76.19 10.06 2.19 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 153.29 48.46 Favored 'General case' 0 C--O 1.228 -0.069 0 CA-C-N 118.501 0.591 . . . . 0.0 110.355 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 t -108.98 141.37 41.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.684 0.794 . . . . 0.0 110.021 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.6 m -142.42 146.76 35.2 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.158 0.583 . . . . 0.0 109.727 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.1 m -100.46 164.41 11.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.787 0.435 . . . . 0.0 111.327 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.41 142.53 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.172 0.989 . . . . 0.0 110.237 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -70.78 155.77 92.92 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.215 0.606 . . . . 0.0 111.267 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.09 165.33 86.2 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 118.176 0.384 . . . . 0.0 111.529 -1.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.59 67.76 44.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.762 0.825 . . . . 0.0 110.388 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.66 167.66 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.013 3.142 . . . . 0.0 111.286 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -78.47 172.69 13.28 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.882 0.473 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.241 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.588 0.232 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 174.01 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.132 3.221 . . . . 0.0 111.328 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -111.43 126.72 55.24 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.897 0.479 . . . . 0.0 109.868 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -139.82 135.23 32.78 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -140.25 161.87 36.64 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.686 0.795 . . . . 0.0 109.433 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.89 15.35 78.26 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.436 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.98 -23.27 63.48 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 117.665 0.733 . . . . 0.0 111.687 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.1 m -74.43 0.72 13.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.811 0.444 . . . . 0.0 111.831 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 -23.19 2.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.042 0.383 . . . . 0.0 111.416 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -97.94 -20.1 17.65 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -149.94 -24.1 0.26 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.09 178.51 22.07 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.31 -28.05 67.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.661 0.385 . . . . 0.0 111.857 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -61.46 -33.29 73.5 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.881 -0.512 . . . . 0.0 110.88 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.15 -30.4 49.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.959 -0.463 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.43 -29.07 46.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.402 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.16 -34.06 72.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -74.4 -28.95 61.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.255 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -78.81 -35.02 44.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.1 m -75.49 -30.59 59.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.642 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -81.68 -15.99 52.72 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.493 0.588 . . . . 0.0 111.623 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -99.83 170.49 8.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -80.18 139.38 36.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.192 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -147.37 170.19 17.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.146 0.578 . . . . 0.0 109.923 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 tpt85 -74.27 122.05 22.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.72 -160.89 36.96 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.01 -17.44 37.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.928 0.364 . . . . 0.0 111.918 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.7 -11.56 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.39 177.22 48.37 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.09 137.34 35.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.666 0.733 . . . . 0.0 111.82 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.07 166.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 C-N-CA 123.708 0.803 . . . . 0.0 110.562 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -134.07 149.48 51.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.3 -170.12 2.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.084 0.554 . . . . 0.0 111.23 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -104.67 -35.73 7.7 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.68 -175.14 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.8 163.77 39.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.938 -0.476 . . . . 0.0 111.868 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -151.64 160.36 43.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.673 0.789 . . . . 0.0 109.545 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -91.1 140.71 29.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -131.52 178.8 6.46 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.939 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.78 173.49 30.6 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.07 -18.97 61.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.277 -0.543 . . . . 0.0 111.987 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 14.03 3.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.417 0.687 . . . . 0.0 111.352 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 16.01 78.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 122.037 -0.414 . . . . 0.0 112.072 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -78.38 4.83 11.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.48 0.712 . . . . 0.0 112.554 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 m -133.85 162.59 31.6 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t -130.17 158.12 40.57 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.183 -0.323 . . . . 0.0 110.892 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -143.03 136.57 28.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.727 0.811 . . . . 0.0 109.361 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -87.37 159.43 18.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.749 0.309 . . . . 0.0 110.351 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -106.75 140.15 25.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.372 0.669 . . . . 0.0 110.32 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -68.08 155.37 92.19 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.469 0.708 . . . . 0.0 110.928 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.95 166.09 83.83 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 -0.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 72.4 m -138.04 66.88 47.65 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 110.372 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.81 165.91 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.887 3.058 . . . . 0.0 111.504 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -75.71 167.88 21.05 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.937 0.495 . . . . 0.0 110.564 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.16 -1.4 . . . . 0.0 111.562 -178.669 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 177.58 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.36 3.373 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -118.36 135.7 54.17 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -140.71 146.51 37.89 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.086 0.554 . . . . 0.0 110.1 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -142.09 161.97 36.66 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.701 1.2 . . . . 0.0 108.815 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.67 14.31 72.44 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.749 -0.473 . . . . 0.0 112.98 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.9 -26.18 61.83 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.823 0.811 . . . . 0.0 111.604 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.2 t -75.67 -4.18 38.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.648 0.379 . . . . 0.0 111.88 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.29 -27.24 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.565 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.91 -21.09 20.78 Favored 'General case' 0 N--CA 1.458 -0.048 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -145.86 -22.4 0.46 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.03 178.96 24.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.11 -27.94 64.17 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.023 0.529 . . . . 0.0 111.704 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -62.32 -32.71 73.5 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.022 -0.424 . . . . 0.0 111.246 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.18 -29.77 34.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.952 -0.467 . . . . 0.0 110.717 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.0 -31.84 69.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -78.17 -31.32 49.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.806 0.443 . . . . 0.0 111.098 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.19 -23.02 44.15 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.301 0.241 . . . . 0.0 111.238 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -82.29 -33.01 29.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.933 0.333 . . . . 0.0 111.245 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.6 m -76.91 -23.42 52.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.448 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.17 5.85 42.8 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.791 0.436 . . . . 0.0 111.69 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -126.99 166.76 16.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.8 m -72.66 131.82 42.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.102 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -142.95 170.14 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 109.464 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -75.1 139.28 42.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.369 -0.207 . . . . 0.0 111.193 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.74 -168.08 15.79 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -17.44 37.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.828 0.451 . . . . 0.0 112.206 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.5 -10.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.86 0.464 . . . . 0.0 111.708 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.09 178.76 45.2 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.5 m -80.99 142.29 33.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.88 168.54 7.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.524 0.73 . . . . 0.0 110.773 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.09 150.65 45.95 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.7 m -127.53 -173.81 3.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.184 0.447 . . . . 0.0 111.487 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 m -104.92 -30.55 9.75 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -155.19 -177.36 6.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.449 0.568 . . . . 0.0 109.6 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.95 170.18 21.03 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.139 0.495 . . . . 0.0 112.257 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -151.84 166.36 31.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.34 1.056 . . . . 0.0 109.213 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.3 t -106.5 139.75 40.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -137.08 -171.53 2.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.809 0.844 . . . . 0.0 111.03 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.37 173.74 26.11 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.75 -21.02 63.48 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.973 0.509 . . . . 0.0 111.772 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -144.9 24.81 1.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.684 0.22 . . . . 0.0 111.393 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.68 32.38 57.38 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.7 p -101.29 12.21 37.88 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -133.05 154.02 50.94 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.517 0.327 . . . . 0.0 110.762 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -116.9 139.43 50.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.795 0.838 . . . . 0.0 109.489 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -139.34 143.98 38.03 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.126 0.57 . . . . 0.0 109.783 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -100.86 164.68 11.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.659 0.384 . . . . 0.0 111.515 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.31 145.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.791 0.836 . . . . 0.0 110.399 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.42 155.74 89.4 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.973 0.509 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.9 162.96 91.12 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 118.49 0.497 . . . . 0.0 111.687 -1.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.3 m -136.56 69.8 60.08 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.698 0.799 . . . . 0.0 109.976 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.62 162.82 26.47 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.054 3.17 . . . . 0.0 111.507 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -75.38 161.33 29.35 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.966 0.506 . . . . 0.0 111.471 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.013 179.561 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.34 174.41 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 124.357 3.371 . . . . 0.0 111.792 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -113.36 135.43 53.87 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -142.99 147.62 35.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 122.212 0.205 . . . . 0.0 110.717 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -142.31 164.47 30.07 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 124.801 1.24 . . . . 0.0 109.504 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.78 16.85 74.66 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.969 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.9 -29.03 68.08 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.036 0.918 . . . . 0.0 111.152 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.4 m -81.92 6.08 17.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.097 0.559 . . . . 0.0 112.092 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.61 -15.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.684 0.394 . . . . 0.0 111.923 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -123.29 -18.39 6.29 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 m -139.12 -18.27 1.02 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -177.49 39.63 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.7 tp -58.41 -27.57 64.41 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.21 0.604 . . . . 0.0 111.825 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -61.66 -34.21 75.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.238 -0.289 . . . . 0.0 111.246 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.77 -28.2 30.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.226 0.466 . . . . 0.0 110.981 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.16 -31.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -78.8 -33.51 46.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -77.57 -22.44 50.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.312 0.245 . . . . 0.0 111.334 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -84.43 -32.78 23.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.845 0.293 . . . . 0.0 111.179 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.8 m -77.79 -22.63 49.85 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.411 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.34 6.07 42.17 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.866 0.467 . . . . 0.0 111.821 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.5 p -127.86 165.45 20.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.29 131.08 42.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.139 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -142.78 167.13 22.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.678 0.791 . . . . 0.0 109.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.68 123.69 26.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.2 -160.15 36.24 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.61 -14.4 45.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.01 -11.82 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 122.594 0.358 . . . . 0.0 111.881 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.89 45.54 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -76.59 140.22 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.082 0.941 . . . . 0.0 111.55 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.96 169.23 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.516 0.726 . . . . 0.0 110.733 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -138.29 151.05 47.24 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.95 -172.41 2.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.326 0.512 . . . . 0.0 111.635 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -102.48 -35.95 8.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -153.95 -175.92 5.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.98 168.43 26.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 112.078 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.96 163.83 39.75 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.894 0.878 . . . . 0.0 109.539 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.8 m -93.72 142.41 27.39 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.2 p -137.67 -178.52 5.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.458 0.703 . . . . 0.0 111.008 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 -176.97 52.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.01 134.24 56.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt 50.86 20.13 0.73 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.981 0.912 . . . . 0.0 113.229 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.38 76.64 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.229 0.468 . . . . 0.0 112.345 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.9 p -75.53 8.76 2.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 155.84 42.0 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.588 0.631 . . . . 0.0 110.085 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.7 t -112.52 138.83 48.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.303 0.641 . . . . 0.0 110.159 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 m -141.32 145.8 35.92 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.008 0.523 . . . . 0.0 110.025 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.914 0.388 . . . . 0.0 111.42 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mm -112.4 143.18 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.798 0.839 . . . . 0.0 110.047 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -71.01 156.06 92.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 0.0 111.068 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 162.83 91.44 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 O-C-N 121.883 0.412 . . . . 0.0 111.387 -1.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.7 m -136.08 69.69 63.35 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.591 0.757 . . . . 0.0 109.772 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.66 161.77 30.74 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.383 2.722 . . . . 0.0 111.074 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.17 161.37 28.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.693 0.397 . . . . 0.0 111.681 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.62 -1.181 . . . . 0.0 110.146 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.94 178.46 7.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.365 3.377 . . . . 0.0 111.231 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -117.41 133.38 56.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.563 0.745 . . . . 0.0 109.246 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -142.79 142.82 31.96 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.657 0.383 . . . . 0.0 110.043 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -142.81 164.76 29.23 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.386 1.074 . . . . 0.0 109.207 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.79 18.7 77.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.489 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.28 -14.41 55.74 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.522 0.661 . . . . 0.0 112.332 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.04 -3.25 41.74 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.062 0.392 . . . . 0.0 111.635 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.24 -27.62 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 O-C-N 121.909 -0.494 . . . . 0.0 111.549 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -154.44 -26.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -83.8 -20.38 33.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.151 0.432 . . . . 0.0 111.992 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.22 170.44 45.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.104 0.859 . . . . 0.0 112.408 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.6 -28.17 68.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.846 0.459 . . . . 0.0 111.078 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -62.0 -32.5 72.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.212 -0.305 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.35 45.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.068 -0.395 . . . . 0.0 110.501 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.2 t -74.05 -30.9 62.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -77.44 -28.96 52.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.615 0.366 . . . . 0.0 111.051 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.56 -30.66 41.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.999 0.187 . . . . 0.0 110.899 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -76.34 -32.5 58.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.756 0.253 . . . . 0.0 111.187 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 98.9 m -76.48 -28.48 56.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.322 -0.371 . . . . 0.0 111.575 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -85.17 -20.53 30.09 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.365 0.529 . . . . 0.0 111.769 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -94.34 166.19 12.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.8 m -75.95 136.55 40.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.581 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -144.61 170.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -75.19 140.61 43.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.135 0.174 . . . . 0.0 111.407 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.63 -170.58 16.68 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.58 -14.42 48.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.53 -18.38 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.867 0.467 . . . . 0.0 111.149 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.99 176.8 44.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -75.17 144.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.612 0.706 . . . . 0.0 111.548 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.79 171.7 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.25 1.02 . . . . 0.0 110.463 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -141.66 153.07 44.47 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.7 m -123.83 -175.26 3.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 111.491 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -103.81 -29.58 10.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -155.92 -177.51 6.63 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.446 0.566 . . . . 0.0 109.756 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.0 170.03 22.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.273 0.558 . . . . 0.0 111.785 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.65 165.76 34.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.399 1.08 . . . . 0.0 109.028 173.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.0 t -107.99 141.51 39.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -130.6 179.73 5.77 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.586 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 168.63 45.06 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.83 132.09 47.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.47 -0.429 . . . . 0.0 110.295 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt 52.53 14.71 0.42 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.427 1.091 . . . . 0.0 112.749 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.73 102.0 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.99 0.805 . . . . 0.0 111.521 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 p -144.82 4.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.877 0.471 . . . . 0.0 111.551 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.3 m -134.05 152.25 51.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.603 0.361 . . . . 0.0 110.216 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.78 138.13 47.56 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.171 0.589 . . . . 0.0 110.271 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.1 m -139.45 140.96 37.45 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.88 164.12 12.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.377 0.271 . . . . 0.0 111.043 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.84 143.03 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 124.055 0.942 . . . . 0.0 110.448 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -73.55 157.05 88.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 122.939 0.496 . . . . 0.0 111.105 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.72 164.01 88.44 Favored 'Cis proline' 0 N--CA 1.455 -0.784 0 O-C-N 121.87 0.405 . . . . 0.0 111.575 -2.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 95.1 m -134.67 70.63 71.5 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 124.1 0.96 . . . . 0.0 109.906 177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.73 167.28 15.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.248 3.299 . . . . 0.0 112.018 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -69.45 163.25 25.71 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.276 0.63 . . . . 0.0 111.557 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.525 175.735 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.34 -179.08 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.428 3.418 . . . . 0.0 110.581 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -125.32 122.41 36.77 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 122.804 0.441 . . . . 0.0 110.15 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -144.74 139.02 27.6 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.963 0.905 . . . . 0.0 109.431 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -137.77 -12.08 1.52 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.687 0.395 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.55 12.22 70.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.584 0.611 . . . . 0.0 112.581 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.77 -25.61 63.22 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.668 0.734 . . . . 0.0 112.609 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.9 t -86.39 10.14 15.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.16 0.436 . . . . 0.0 111.811 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -17.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 123.024 0.529 . . . . 0.0 111.252 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.3 p -120.59 -17.11 8.15 Favored 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 m -140.51 -19.51 0.85 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 -173.68 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.344 0.497 . . . . 0.0 112.069 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.38 -26.6 68.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.161 0.584 . . . . 0.0 111.751 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -63.45 -36.17 82.86 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.759 -0.588 . . . . 0.0 110.664 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.6 36.3 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.002 0.365 . . . . 0.0 110.703 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 t -68.62 -30.86 69.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -79.08 -35.46 42.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.259 -0.276 . . . . 0.0 110.691 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -19.57 60.92 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.918 0.136 . . . . 0.0 111.031 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.49 -33.35 21.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.447 0.299 . . . . 0.0 110.675 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.36 -26.49 46.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.554 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -87.13 8.02 25.57 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 122.865 0.466 . . . . 0.0 111.305 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -130.89 167.23 19.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.539 1.136 . . . . 0.0 108.347 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.3 m -73.2 133.82 44.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.047 -0.408 . . . . 0.0 110.41 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.95 170.91 15.66 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.887 0.875 . . . . 0.0 109.554 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -73.54 140.38 46.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.234 0.214 . . . . 0.0 111.14 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.81 -168.1 14.76 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -86.63 -17.09 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.86 -16.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.852 0.461 . . . . 0.0 110.907 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.79 48.07 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.6 m -80.29 142.18 34.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.833 0.816 . . . . 0.0 110.895 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.22 169.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.782 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -138.44 150.5 46.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.422 1.089 . . . . 0.0 108.16 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.9 m -128.18 -172.49 2.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.242 0.617 . . . . 0.0 111.212 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.2 m -107.54 -29.85 8.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -154.16 -178.97 7.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.729 0.695 . . . . 0.0 109.799 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 168.1 26.97 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.281 0.562 . . . . 0.0 112.348 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.93 168.09 27.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.992 1.317 . . . . 0.0 108.757 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.4 m -105.0 146.29 29.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -132.79 179.59 6.07 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.476 0.71 . . . . 0.0 111.0 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 176.37 28.6 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -68.89 -18.01 64.06 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.37 13.3 3.51 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.074 0.55 . . . . 0.0 111.667 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.68 17.7 78.27 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.909 -0.477 . . . . 0.0 111.909 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.6 p -83.15 9.55 10.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 113.009 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.9 m -125.65 150.82 47.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.0 t -102.66 141.69 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.484 0.714 . . . . 0.0 110.125 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.5 m -143.66 147.36 34.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.719 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -101.22 164.45 11.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.97 143.97 20.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.065 0.946 . . . . 0.0 109.632 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -72.46 156.09 90.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 122.832 0.453 . . . . 0.0 110.691 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.66 166.08 83.91 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 122.041 0.495 . . . . 0.0 111.441 -1.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.58 70.31 45.17 Favored Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 123.491 0.716 . . . . 0.0 110.069 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.9 163.43 22.18 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.798 2.998 . . . . 0.0 111.733 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -76.35 161.99 28.25 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.07 179.711 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.11 174.91 11.64 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 124.232 3.288 . . . . 0.0 111.57 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -111.15 134.63 52.6 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.306 0.642 . . . . 0.0 109.696 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -143.95 142.75 30.91 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.958 0.503 . . . . 0.0 110.023 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -142.09 163.69 32.18 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.062 0.945 . . . . 0.0 109.512 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.68 17.95 75.36 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.389 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.41 -27.31 67.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.754 0.777 . . . . 0.0 111.405 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.63 4.37 16.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.047 0.539 . . . . 0.0 112.192 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -14.8 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 122.889 0.476 . . . . 0.0 111.62 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -121.48 -19.6 6.88 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 m -140.71 -19.36 0.83 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.34 -173.47 34.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.565 0.602 . . . . 0.0 111.761 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -59.82 -28.08 67.17 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.014 0.526 . . . . 0.0 111.933 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -60.7 -36.2 78.22 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 122.052 -0.405 . . . . 0.0 110.988 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.1 27.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.067 0.394 . . . . 0.0 110.792 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.5 t -68.05 -31.47 71.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -80.12 -36.96 34.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.231 -0.293 . . . . 0.0 110.999 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.74 -18.65 61.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.927 0.142 . . . . 0.0 111.325 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -87.64 -35.69 17.88 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 117.871 0.305 . . . . 0.0 110.574 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.5 m -75.48 -28.4 59.2 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.84 3.26 34.5 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.391 . . . . 0.0 111.97 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -126.01 163.73 22.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.9 m -71.12 133.3 46.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.137 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -145.08 167.33 22.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 124.78 28.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.379 -0.201 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.79 -158.55 34.51 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 123.752 0.692 . . . . 0.0 111.389 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.67 -20.25 31.56 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.496 -0.414 . . . . 0.0 112.093 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.32 -12.39 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.58 0.352 . . . . 0.0 111.651 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.8 175.4 46.51 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.5 m -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.019 0.909 . . . . 0.0 111.875 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -142.9 167.86 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.032 0.933 . . . . 0.0 110.745 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -139.71 144.1 37.37 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.4 -173.69 2.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.133 0.424 . . . . 0.0 111.47 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -103.4 -35.85 8.22 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -152.7 -176.36 5.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.47 168.25 27.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 111.647 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -153.62 163.39 40.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.876 0.87 . . . . 0.0 109.321 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.54 142.57 27.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.4 p -132.34 -179.71 5.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 111.122 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.92 177.06 30.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.37 -18.78 63.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 112.002 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.35 14.52 3.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.069 0.547 . . . . 0.0 111.387 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.13 15.69 78.63 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -80.62 8.33 8.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.6 m -125.26 155.34 40.29 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 122.914 0.486 . . . . 0.0 110.075 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -114.34 139.36 49.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.584 0.754 . . . . 0.0 110.063 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -142.95 144.5 32.39 Favored 'General case' 0 C--O 1.228 -0.058 0 C-N-CA 122.921 0.488 . . . . 0.0 109.919 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.27 162.23 13.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.964 0.412 . . . . 0.0 111.274 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.64 145.62 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 123.918 0.887 . . . . 0.0 110.127 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -73.59 156.18 88.79 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.061 0.544 . . . . 0.0 111.609 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.57 165.37 85.84 Favored 'Cis proline' 0 N--CA 1.451 -1.004 0 CA-C-N 118.188 0.388 . . . . 0.0 111.288 -2.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.0 m -137.14 67.45 55.16 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.729 0.812 . . . . 0.0 110.287 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.69 168.84 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.961 3.107 . . . . 0.0 112.052 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -70.64 165.01 23.77 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.549 0.739 . . . . 0.0 111.661 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 176.88 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.93 175.48 11.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.842 3.028 . . . . 0.0 111.098 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -117.23 127.8 54.45 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -141.52 146.01 35.85 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.266 0.627 . . . . 0.0 110.157 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -143.14 165.52 27.2 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 109.354 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.71 17.33 74.91 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.594 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.21 -23.19 65.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.555 0.678 . . . . 0.0 112.033 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.64 3.67 15.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.723 0.409 . . . . 0.0 111.594 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.6 -27.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 122.879 0.472 . . . . 0.0 111.088 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.5 p -87.63 -15.18 38.01 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 122.09 -0.381 . . . . 0.0 111.789 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -154.21 -40.25 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.352 0.261 . . . . 0.0 111.283 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.15 -167.73 16.41 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.96 -27.88 65.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.874 0.47 . . . . 0.0 111.715 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 m -61.7 -40.43 95.0 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.288 -0.257 . . . . 0.0 111.291 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -28.05 41.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.895 -0.503 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.7 -32.53 71.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -80.03 -36.18 36.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.16 -0.337 . . . . 0.0 110.949 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -71.6 -21.78 61.81 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.167 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -87.51 -31.88 19.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.633 0.373 . . . . 0.0 111.315 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.02 -27.5 54.6 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.584 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -83.96 -14.76 50.05 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.541 0.609 . . . . 0.0 111.652 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.8 p -101.02 168.44 9.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -78.38 139.51 38.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.611 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -145.8 170.58 16.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 109.394 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -72.91 139.27 46.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.465 0.174 . . . . 0.0 111.001 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.92 -172.79 16.4 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.176 0.893 . . . . 0.0 111.0 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -83.69 -12.68 55.56 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.87 -17.68 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 110.987 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.06 -179.77 45.2 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.4 m -78.02 141.59 38.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.739 0.769 . . . . 0.0 111.041 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.06 163.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.759 0.823 . . . . 0.0 110.8 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -135.43 147.24 48.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.91 -174.3 2.67 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.995 0.518 . . . . 0.0 111.117 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 -30.24 10.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.77 -177.97 6.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.289 0.495 . . . . 0.0 109.856 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 168.46 26.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 111.842 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.18 165.83 34.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.788 0.835 . . . . 0.0 109.434 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.3 m -98.64 143.03 29.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -131.99 179.46 6.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.714 0.806 . . . . 0.0 110.801 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.17 176.05 30.35 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -69.48 -18.15 63.68 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.805 0.442 . . . . 0.0 112.05 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.33 13.45 3.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.011 0.524 . . . . 0.0 111.451 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.07 16.68 78.47 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -81.26 7.96 10.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.6 m -125.79 154.16 42.98 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 122.896 0.478 . . . . 0.0 110.304 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 t -111.71 140.57 46.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.484 0.713 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.8 m -143.51 143.74 31.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.433 0.693 . . . . 0.0 109.582 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.9 162.82 13.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.033 0.445 . . . . 0.0 111.189 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -107.34 142.0 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 123.714 0.806 . . . . 0.0 109.801 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.25 156.03 89.52 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 122.59 0.356 . . . . 0.0 110.974 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.03 168.61 76.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 118.265 0.416 . . . . 0.0 111.739 -1.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.74 69.11 37.31 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.641 0.777 . . . . 0.0 109.725 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.77 171.7 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.064 3.176 . . . . 0.0 112.268 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -66.75 169.82 7.38 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.666 0.786 . . . . 0.0 110.529 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.222 -1.37 . . . . 0.0 111.655 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -78.84 -6.01 54.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.589 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.4 p -149.43 74.53 9.69 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.802 0.841 . . . . 0.0 110.006 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.16 176.62 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.529 3.486 . . . . 0.0 111.921 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 m -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.186 0.594 . . . . 0.0 109.828 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.39 132.43 22.97 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.24 -10.72 1.69 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.907 0.483 . . . . 0.0 111.988 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.28 13.43 61.86 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 123.656 0.646 . . . . 0.0 112.427 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.53 -17.16 64.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.875 0.838 . . . . 0.0 112.643 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.4 m -94.46 3.33 55.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.081 0.4 . . . . 0.0 111.742 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.32 -29.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-N 118.19 0.45 . . . . 0.0 111.476 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 t -156.12 -26.41 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -79.49 -20.01 48.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.085 -0.384 . . . . 0.0 111.817 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.86 172.48 48.38 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.809 0.719 . . . . 0.0 112.99 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.13 -28.65 69.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.94 0.496 . . . . 0.0 110.852 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -63.07 -33.7 76.0 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.064 -0.398 . . . . 0.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.21 -33.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.6 t -69.73 -30.89 68.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -79.04 -31.26 44.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.888 0.475 . . . . 0.0 110.744 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.56 -30.64 52.76 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.072 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -76.73 -34.42 58.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.841 0.291 . . . . 0.0 110.609 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.7 m -74.39 -24.31 59.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.326 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -89.3 -8.78 52.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.321 0.51 . . . . 0.0 111.397 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -102.99 165.43 11.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 109.303 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.77 125.07 25.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -142.71 169.53 17.41 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.838 0.455 . . . . 0.0 109.997 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpt85 -73.97 126.8 31.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.247 0.219 . . . . 0.0 110.737 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.76 -159.97 33.85 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -82.54 -21.3 35.4 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.94 -10.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.682 0.393 . . . . 0.0 111.74 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.48 171.79 44.52 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.0 m -73.8 142.49 46.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.89 0.845 . . . . 0.0 111.423 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.36 167.86 3.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.409 1.083 . . . . 0.0 110.205 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -136.24 149.88 48.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.61 -173.1 2.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.888 0.475 . . . . 0.0 111.648 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -98.53 -36.89 9.77 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.03 -174.81 4.99 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.043 -0.41 . . . . 0.0 109.993 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.67 167.15 31.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.866 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.46 163.67 39.84 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.012 0.925 . . . . 0.0 109.146 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.7 m -94.98 143.65 26.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -135.9 -179.34 5.6 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.902 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.48 173.41 25.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -69.74 -19.77 63.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.974 0.51 . . . . 0.0 111.755 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.78 14.01 4.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.209 0.604 . . . . 0.0 111.177 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 15.31 78.61 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.6 p -82.82 13.57 3.79 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.883 0.873 . . . . 0.0 113.094 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -130.88 150.18 52.16 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.906 -0.496 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.9 t -107.18 143.78 34.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.915 0.886 . . . . 0.0 109.422 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.4 m -144.3 145.96 32.31 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.063 0.545 . . . . 0.0 109.941 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.16 163.94 12.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.783 0.433 . . . . 0.0 111.631 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.91 134.86 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.595 0.758 . . . . 0.0 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -70.02 159.62 83.58 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.017 0.527 . . . . 0.0 110.799 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -64.9 162.82 64.19 Favored 'Cis proline' 0 N--CA 1.459 -0.509 0 CA-C-N 118.692 0.568 . . . . 0.0 113.259 -2.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 96.7 m -140.82 69.46 29.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 110.265 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.11 168.83 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.158 3.239 . . . . 0.0 112.041 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.26 164.25 23.2 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.898 0.479 . . . . 0.0 111.444 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.586 178.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.9 12.99 2.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.072 0.549 . . . . 0.0 111.399 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.21 87.63 4.91 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.225 0.61 . . . . 0.0 110.614 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.64 177.68 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.053 3.169 . . . . 0.0 110.345 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -125.85 128.86 48.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.549 0.34 . . . . 0.0 110.13 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -141.14 134.74 30.05 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.885 0.874 . . . . 0.0 109.143 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -138.78 163.08 33.13 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.7 0.8 . . . . 0.0 109.213 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 15.87 76.65 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.17 -25.26 63.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.435 0.617 . . . . 0.0 111.409 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -76.28 2.61 12.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.884 0.474 . . . . 0.0 111.715 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -124.84 -24.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 122.869 0.468 . . . . 0.0 111.238 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -98.9 -21.14 16.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -146.71 -22.05 0.42 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -178.02 26.0 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -58.82 -28.01 65.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.185 0.594 . . . . 0.0 111.68 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.6 m -61.34 -34.85 75.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.025 -0.422 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.52 -31.99 28.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.848 0.294 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.1 t -67.22 -31.85 72.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -79.17 -36.65 40.02 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.187 -0.321 . . . . 0.0 110.768 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -69.99 -22.6 63.12 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.913 -0.089 . . . . 0.0 110.976 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -82.17 -35.83 27.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.671 0.214 . . . . 0.0 110.832 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.11 -24.61 54.96 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.455 0.302 . . . . 0.0 111.616 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.04 6.34 22.46 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.377 0.671 . . . . 0.0 111.226 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -133.29 169.8 16.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.84 131.82 39.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -145.11 171.13 14.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.71 0.404 . . . . 0.0 110.364 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -78.35 137.1 37.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.16 -170.9 17.12 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -88.69 -11.42 45.25 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.3 t -129.83 -16.46 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.031 0.532 . . . . 0.0 111.081 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.11 44.6 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.5 m -82.24 139.55 34.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.203 -0.587 . . . . 0.0 111.058 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.31 168.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.274 0.63 . . . . 0.0 111.639 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -139.06 143.24 38.28 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -127.2 -175.32 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.499 0.591 . . . . 0.0 112.289 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -100.59 -35.03 9.65 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -154.46 -175.11 5.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.82 167.35 30.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.26 165.18 37.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.964 0.906 . . . . 0.0 109.356 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.7 m -95.35 143.53 26.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.3 p -135.8 179.57 6.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.117 0.567 . . . . 0.0 111.105 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.56 179.68 49.77 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.8 136.87 57.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.4 mt 52.22 16.66 0.6 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.921 0.888 . . . . 0.0 113.229 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.7 75.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.972 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -74.81 3.1 8.64 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.193 0.997 . . . . 0.0 113.613 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 48.6 m -121.8 155.71 34.73 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.538 0.608 . . . . 0.0 110.256 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.4 t -112.49 139.3 48.19 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.577 0.751 . . . . 0.0 109.959 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.7 m -142.41 146.1 34.52 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.346 0.658 . . . . 0.0 109.846 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.02 165.02 11.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.986 0.514 . . . . 0.0 111.48 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.75 145.32 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 110.408 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -70.4 156.06 92.48 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.915 0.486 . . . . 0.0 110.852 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.97 162.64 91.82 Favored 'Cis proline' 0 N--CA 1.454 -0.847 0 CA-C-N 118.274 0.419 . . . . 0.0 111.146 -2.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.8 m -137.65 68.99 52.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 109.942 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.83 167.44 13.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.936 3.091 . . . . 0.0 112.094 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.37 164.2 26.72 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.293 0.637 . . . . 0.0 111.802 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.991 176.334 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 111.114 0.042 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -139.44 17.31 2.56 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.574 0.75 . . . . 0.0 111.266 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p -147.16 93.41 4.72 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 122.667 0.387 . . . . 0.0 110.84 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.77 171.47 18.16 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.975 3.117 . . . . 0.0 109.955 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.2 m -118.59 120.74 38.36 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -136.09 137.16 40.79 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 123.796 0.838 . . . . 0.0 109.407 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -139.94 162.49 35.05 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.09 17.31 78.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.51 -24.24 63.48 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.484 0.642 . . . . 0.0 111.918 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.4 m -76.53 2.87 12.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.075 0.55 . . . . 0.0 111.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.73 -25.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 122.737 0.415 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -95.21 -21.16 18.65 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.017 -0.427 . . . . 0.0 111.968 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -146.27 -21.84 0.44 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -177.43 25.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.31 -29.26 65.75 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 m -62.59 -34.22 76.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 111.141 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.59 -30.39 32.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.94 -0.475 . . . . 0.0 110.583 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.86 -30.77 69.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -81.0 -30.24 35.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.489 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.62 -22.29 43.84 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.505 -0.122 . . . . 0.0 111.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.55 -35.95 24.37 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.252 -0.28 . . . . 0.0 110.782 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.4 m -73.98 -26.14 60.3 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.462 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -88.61 8.98 25.73 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.959 0.345 . . . . 0.0 111.494 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -127.97 164.93 21.25 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.888 0.875 . . . . 0.0 108.993 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.6 t -69.7 127.09 31.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -143.49 168.16 20.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.792 0.437 . . . . 0.0 110.538 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.54 133.8 37.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.567 0.347 . . . . 0.0 111.037 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.86 -163.48 23.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -86.84 -11.36 51.06 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.77 -11.92 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.627 0.371 . . . . 0.0 111.893 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.75 177.57 47.46 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.0 m -86.94 139.91 30.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.663 0.731 . . . . 0.0 111.45 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.31 166.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.377 0.671 . . . . 0.0 110.611 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -135.01 148.3 49.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.8 m -126.88 -174.01 3.03 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.971 0.351 . . . . 0.0 111.755 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -100.5 -33.39 10.36 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.28 -175.14 5.28 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.46 167.62 29.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.61 164.99 37.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.981 0.912 . . . . 0.0 109.501 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.8 142.6 27.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.4 p -137.26 -177.88 4.97 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.732 0.813 . . . . 0.0 110.981 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.76 -175.91 53.16 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.8 134.27 56.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 51.18 18.89 0.64 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.102 0.961 . . . . 0.0 113.275 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 22.23 77.25 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.334 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -75.42 7.61 3.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -125.31 153.23 43.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.423 0.556 . . . . 0.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.9 t -108.9 138.94 44.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.538 0.735 . . . . 0.0 110.146 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.0 m -141.0 147.17 38.27 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 123.008 0.523 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -100.87 162.88 12.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.121 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.71 141.01 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.793 0.837 . . . . 0.0 110.035 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -68.86 155.35 93.52 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.159 0.583 . . . . 0.0 111.088 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.52 164.49 87.09 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 118.23 0.403 . . . . 0.0 111.351 -1.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.2 m -139.11 68.32 41.03 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.509 0.724 . . . . 0.0 110.192 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.77 164.08 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.675 2.916 . . . . 0.0 111.874 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.54 160.77 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.896 0.478 . . . . 0.0 111.43 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.702 -178.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -80.12 6.98 10.16 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.128 0.571 . . . . 0.0 110.826 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p -150.59 84.68 5.48 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 123.682 0.793 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.17 178.34 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.921 3.081 . . . . 0.0 110.731 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -122.6 128.57 50.86 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.846 0.458 . . . . 0.0 110.157 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -143.62 144.91 32.11 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.699 0.799 . . . . 0.0 109.16 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.6 mmm180 -133.27 -23.88 1.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 17.4 58.63 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.75 0.69 . . . . 0.0 113.604 -173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.72 -25.76 63.25 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.971 0.886 . . . . 0.0 112.623 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.9 m -79.53 4.65 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 111.936 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.63 -25.41 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.111 0.565 . . . . 0.0 111.181 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.5 p -89.11 -15.58 33.56 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -154.73 -36.61 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.689 0.396 . . . . 0.0 111.384 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -165.36 13.03 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.4 -27.6 67.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.479 -0.424 . . . . 0.0 111.751 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -62.81 -39.63 94.88 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.772 -0.58 . . . . 0.0 111.0 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -28.77 48.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.181 0.446 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.33 -32.83 70.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -78.56 -31.99 47.59 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.443 0.297 . . . . 0.0 110.8 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -77.14 -20.17 55.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.483 -0.136 . . . . 0.0 110.838 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -86.24 -31.43 21.69 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.638 0.375 . . . . 0.0 110.875 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.4 m -80.16 -29.89 38.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.259 -0.401 . . . . 0.0 111.925 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.51 -15.71 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.54 0.609 . . . . 0.0 111.036 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -102.99 169.64 8.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -77.69 141.44 39.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -146.54 171.97 14.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.132 0.973 . . . . 0.0 109.609 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -73.43 139.36 45.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.589 0.233 . . . . 0.0 111.271 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.5 -169.34 15.27 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.908 0.766 . . . . 0.0 111.199 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.68 -14.82 36.41 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.771 0.429 . . . . 0.0 112.015 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.2 -8.12 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 122.813 0.445 . . . . 0.0 111.616 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.93 179.26 42.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.72 140.31 34.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.579 0.69 . . . . 0.0 110.881 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.84 163.41 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.497 0.719 . . . . 0.0 110.989 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -133.68 147.34 51.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.22 -173.27 2.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.79 0.436 . . . . 0.0 111.568 -172.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -99.97 -35.75 9.62 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -154.13 -174.5 4.99 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.48 26.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.38 165.12 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.474 1.11 . . . . 0.0 109.508 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 100.0 m -99.03 144.8 27.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -136.95 -178.88 5.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.953 0.901 . . . . 0.0 111.106 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.65 -178.45 25.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.01 -22.89 67.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.047 0.539 . . . . 0.0 112.014 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -144.36 20.8 1.72 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.815 0.279 . . . . 0.0 111.676 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.68 17.78 79.57 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -81.29 7.1 12.28 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.4 m -128.02 153.27 46.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.811 0.444 . . . . 0.0 110.273 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 t -105.39 141.88 36.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.335 0.654 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 m -142.4 146.04 34.46 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.195 0.598 . . . . 0.0 110.101 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.94 162.96 12.52 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.886 0.474 . . . . 0.0 111.256 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -111.69 138.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.426 0.69 . . . . 0.0 110.007 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -67.46 156.1 89.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.22 0.608 . . . . 0.0 111.027 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.71 167.95 78.77 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 O-C-N 121.97 0.458 . . . . 0.0 111.382 -1.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 88.5 m -139.97 67.64 34.49 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.627 0.771 . . . . 0.0 110.063 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.61 170.88 14.17 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.317 3.345 . . . . 0.0 112.082 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -66.11 169.74 6.6 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.597 0.759 . . . . 0.0 110.715 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.17 -1.395 . . . . 0.0 111.363 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.63 10.84 6.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.23 0.612 . . . . 0.0 111.705 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 p -154.13 93.25 2.96 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.063 0.545 . . . . 0.0 110.957 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.52 173.11 15.06 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.428 2.752 . . . . 0.0 110.162 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.3 m -120.51 123.92 44.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.5 0.32 . . . . 0.0 110.197 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -143.77 138.63 28.91 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -138.87 -15.0 1.18 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.202 0.601 . . . . 0.0 111.716 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.1 13.21 62.05 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.554 0.597 . . . . 0.0 112.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.06 -17.35 63.29 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.683 0.741 . . . . 0.0 112.499 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.42 2.69 52.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.152 0.433 . . . . 0.0 111.95 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.11 -30.08 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 118.226 0.467 . . . . 0.0 111.603 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -155.45 -26.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -79.98 -19.75 47.13 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.137 -0.352 . . . . 0.0 111.591 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.69 171.34 47.65 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.942 0.782 . . . . 0.0 112.609 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.57 -28.25 68.32 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.831 0.452 . . . . 0.0 111.097 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -62.46 -33.08 74.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.865 0.302 . . . . 0.0 110.564 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -33.58 42.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.031 -0.418 . . . . 0.0 110.384 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.86 -29.67 68.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -79.43 -30.83 42.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.716 0.407 . . . . 0.0 111.079 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -77.53 -19.27 56.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.092 0.157 . . . . 0.0 111.128 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -87.43 -31.61 19.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.581 0.352 . . . . 0.0 111.108 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.7 m -80.37 -23.84 40.21 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -88.05 9.49 22.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.845 0.293 . . . . 0.0 111.117 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -132.8 170.53 15.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.222 1.009 . . . . 0.0 108.449 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.8 133.5 43.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.769 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -146.88 169.24 19.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.409 0.684 . . . . 0.0 110.019 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -75.08 139.48 42.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.058 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.48 -170.82 16.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.73 -13.27 54.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.02 -18.13 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 122.695 0.398 . . . . 0.0 111.25 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.94 179.58 47.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -82.95 141.56 32.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.915 0.857 . . . . 0.0 111.242 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -146.94 170.01 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.449 0.7 . . . . 0.0 110.829 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -136.15 146.02 46.45 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -126.29 -172.24 2.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.09 0.405 . . . . 0.0 112.062 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 t -103.37 -36.93 7.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.75 -174.87 4.99 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.89 167.85 28.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.19 164.85 37.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.418 1.087 . . . . 0.0 109.206 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.86 145.01 26.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -139.29 -178.52 5.4 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.526 0.73 . . . . 0.0 111.176 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.77 174.28 41.96 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.37 143.44 57.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 tp 54.5 11.73 0.45 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.72 0.808 . . . . 0.0 112.53 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.12 76.31 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.37 -0.684 . . . . 0.0 112.924 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -76.19 9.88 2.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.589 1.194 . . . . 0.0 114.184 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.3 m -127.37 152.31 47.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.65 0.659 . . . . 0.0 110.671 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 t -111.27 139.61 46.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.5 m -140.54 148.34 40.88 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 123.659 0.784 . . . . 0.0 109.783 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.54 164.46 11.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.821 0.448 . . . . 0.0 111.652 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.75 142.99 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 123.906 0.883 . . . . 0.0 110.113 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.11 156.48 91.74 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 122.898 0.479 . . . . 0.0 110.964 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.57 163.03 90.74 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 O-C-N 121.901 0.422 . . . . 0.0 111.347 -1.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.15 68.85 48.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.767 0.827 . . . . 0.0 110.38 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -62.6 159.97 34.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.464 2.776 . . . . 0.0 111.614 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -74.57 159.44 32.16 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.883 0.473 . . . . 0.0 112.025 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.259 -1.353 . . . . 0.0 109.952 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -70.6 -22.2 62.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.2 p -160.07 88.56 1.88 Allowed Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 122.486 0.314 . . . . 0.0 110.83 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.79 174.33 12.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.699 2.932 . . . . 0.0 110.392 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 m -122.06 134.63 54.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.337 0.025 0 C-N-CA 123.379 0.672 . . . . 0.0 110.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -143.31 162.44 35.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.639 1.176 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.11 13.84 70.42 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.777 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.5 mt -58.62 -26.33 63.6 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 117.83 0.815 . . . . 0.0 111.974 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -85.75 7.31 24.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.4 -24.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 122.843 0.457 . . . . 0.0 110.978 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -103.62 -18.79 14.59 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 m -143.07 -19.76 0.64 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.35 -176.65 32.93 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 tp -59.14 -27.35 65.55 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.297 0.639 . . . . 0.0 111.791 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.166 -0.334 . . . . 0.0 111.214 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.46 31.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.057 -0.402 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -69.47 -31.58 69.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -78.27 -36.3 46.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.555 0.342 . . . . 0.0 110.87 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.83 -23.93 61.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.899 0.124 . . . . 0.0 110.783 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -81.31 -34.72 31.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.881 0.31 . . . . 0.0 110.656 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -77.49 -28.09 52.07 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.561 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -85.83 4.24 38.02 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.793 0.437 . . . . 0.0 111.462 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -123.98 165.7 16.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -72.22 134.09 45.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.001 -0.437 . . . . 0.0 110.034 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.04 170.18 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.187 0.595 . . . . 0.0 110.449 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -72.57 137.36 46.16 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.44 -163.24 22.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.02 -17.43 25.08 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.42 -0.459 . . . . 0.0 112.135 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.79 -4.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.93 0.492 . . . . 0.0 111.898 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.71 -147.11 5.83 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.0 m -125.92 140.88 52.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.132 0.466 . . . . 0.0 110.797 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.47 170.26 6.32 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.049 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.38 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.84 150.4 45.97 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 124.841 1.256 . . . . 0.0 107.83 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -127.82 -174.09 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.181 0.446 . . . . 0.0 111.506 -175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -105.96 -28.15 10.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -156.94 -178.06 7.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.656 0.662 . . . . 0.0 109.772 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.64 168.37 25.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.35 170.15 21.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.423 1.089 . . . . 0.0 108.721 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.1 m -109.02 145.69 35.16 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.9 p -133.47 -178.25 4.91 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.381 0.672 . . . . 0.0 110.979 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.73 -176.65 26.33 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -66.61 -22.02 66.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.899 0.479 . . . . 0.0 112.23 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -144.44 20.74 1.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.853 0.297 . . . . 0.0 111.306 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.07 19.75 79.69 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 121.971 -0.456 . . . . 0.0 112.177 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -82.03 3.0 28.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.802 0.801 . . . . 0.0 112.973 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.8 m -119.15 153.21 35.23 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.092 0.557 . . . . 0.0 109.777 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.6 t -110.17 136.86 48.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.007 0.523 . . . . 0.0 110.33 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -139.94 147.23 40.23 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 109.861 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.86 164.95 11.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.584 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.0 mm -112.88 145.48 18.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 123.907 0.883 . . . . 0.0 110.292 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -72.94 155.64 90.35 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.866 0.466 . . . . 0.0 110.825 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.19 164.58 87.41 Favored 'Cis proline' 0 N--CA 1.455 -0.769 0 CA-C-N 118.321 0.436 . . . . 0.0 111.42 -1.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -137.42 69.66 54.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 123.505 0.722 . . . . 0.0 110.329 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.3 163.39 26.58 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.901 3.067 . . . . 0.0 111.76 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -74.76 160.58 30.54 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.498 0.719 . . . . 0.0 111.672 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.859 179.527 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -82.83 10.48 7.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.946 0.498 . . . . 0.0 110.876 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 p -148.15 84.64 6.71 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.009 0.523 . . . . 0.0 110.365 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.02 177.67 8.45 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.315 3.343 . . . . 0.0 110.915 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -118.19 137.59 52.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -142.39 147.31 36.0 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.657 0.383 . . . . 0.0 110.902 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -141.9 163.42 32.94 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.802 1.241 . . . . 0.0 109.047 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.85 16.79 72.72 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.395 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.54 -28.41 68.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.884 0.842 . . . . 0.0 111.462 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.1 m -81.31 5.56 16.92 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.21 -13.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.768 0.427 . . . . 0.0 111.54 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -126.19 -16.58 5.46 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 m -140.39 -19.15 0.87 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.55 -175.94 39.44 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.95 -27.83 65.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.055 0.542 . . . . 0.0 112.003 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -61.11 -36.49 79.85 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.873 0.306 . . . . 0.0 111.143 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.04 -29.22 35.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.995 0.361 . . . . 0.0 110.648 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 t -70.22 -31.03 68.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -80.64 -33.52 35.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.552 0.341 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.8 -28.81 61.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -78.21 -33.34 50.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.709 0.231 . . . . 0.0 110.855 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.97 -28.4 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.534 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.81 -20.18 36.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.56 0.618 . . . . 0.0 111.105 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 m -90.85 163.49 14.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.61 134.55 42.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -144.04 169.83 17.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.055 0.542 . . . . 0.0 110.042 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -73.77 140.16 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.343 0.257 . . . . 0.0 111.192 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.77 -166.48 14.77 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.94 -17.27 31.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.781 0.432 . . . . 0.0 112.156 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.81 -10.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.754 0.422 . . . . 0.0 111.685 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.08 47.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.3 m -83.86 140.78 31.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.674 0.737 . . . . 0.0 111.286 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -145.15 169.65 7.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -140.77 154.01 46.09 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -127.36 -173.81 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.889 0.476 . . . . 0.0 111.44 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -98.33 -39.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -150.18 -175.06 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.592 0.757 . . . . 0.0 110.201 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.92 167.54 30.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 112.059 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.47 164.22 38.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.959 0.904 . . . . 0.0 109.216 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.9 m -94.57 142.2 27.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -135.2 -176.34 4.23 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.443 0.697 . . . . 0.0 111.027 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.21 -177.27 28.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -67.42 -21.88 65.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.736 0.414 . . . . 0.0 112.093 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -145.17 22.97 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.68 17.59 80.05 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.885 -0.509 . . . . 0.0 111.978 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 p -81.64 6.62 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.8 m -126.98 158.15 37.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.94 0.496 . . . . 0.0 109.952 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.6 t -115.36 138.17 51.27 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.313 0.645 . . . . 0.0 109.977 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.0 m -140.53 146.24 37.86 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.559 0.744 . . . . 0.0 109.981 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -98.7 164.79 12.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.844 0.458 . . . . 0.0 111.388 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.28 146.06 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.231 1.013 . . . . 0.0 109.937 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -76.27 155.34 84.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.39 0.276 . . . . 0.0 111.056 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.43 165.26 86.2 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 CA-C-N 118.257 0.413 . . . . 0.0 111.649 -0.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 76.2 m -135.9 70.46 64.18 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.674 0.79 . . . . 0.0 109.96 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.41 162.44 27.28 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.841 3.027 . . . . 0.0 111.877 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -74.15 160.14 31.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.878 0.471 . . . . 0.0 111.625 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.316 -1.326 . . . . 0.0 109.723 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -79.58 8.59 6.17 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.759 0.424 . . . . 0.0 111.174 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.0 84.88 5.24 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.555 0.742 . . . . 0.0 110.436 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 175.21 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.112 3.208 . . . . 0.0 111.183 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -118.61 119.96 36.03 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -144.71 135.81 25.08 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.403 0.681 . . . . 0.0 109.279 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -131.99 -14.92 3.04 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.202 0.601 . . . . 0.0 111.225 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.75 11.16 67.37 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.632 0.634 . . . . 0.0 112.531 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.99 -25.63 65.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.719 0.76 . . . . 0.0 112.288 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.82 3.6 16.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.567 0.347 . . . . 0.0 111.908 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.75 -25.63 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 122.99 0.516 . . . . 0.0 110.835 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -89.96 -15.25 32.37 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -155.04 -37.91 0.09 Allowed 'General case' 0 C--O 1.23 0.079 0 C-N-CA 122.53 0.332 . . . . 0.0 111.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.16 -165.65 13.64 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.02 -26.95 66.5 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.735 0.414 . . . . 0.0 111.591 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -62.67 -39.19 93.17 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 121.913 -0.492 . . . . 0.0 111.277 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.45 -29.98 42.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.328 0.513 . . . . 0.0 110.863 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.74 -32.35 72.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -78.49 -35.9 45.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.196 -0.315 . . . . 0.0 110.653 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.38 -17.02 62.43 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.72 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -90.71 -30.78 16.89 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.186 0.594 . . . . 0.0 111.258 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.33 -21.37 39.24 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.035 -0.416 . . . . 0.0 110.749 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -86.13 4.08 39.9 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.511 0.724 . . . . 0.0 111.35 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.2 p -131.62 169.61 15.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.088 0.955 . . . . 0.0 108.841 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -75.15 134.67 41.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.58 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -145.73 169.99 17.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.837 0.855 . . . . 0.0 109.891 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -73.32 139.54 46.11 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 122.44 -0.163 . . . . 0.0 111.16 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.8 -166.8 14.38 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.367 0.984 . . . . 0.0 111.031 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.25 -13.05 53.65 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.0 -10.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.645 0.378 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.05 179.98 45.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -80.92 142.52 33.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.616 0.708 . . . . 0.0 111.279 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 m -145.08 169.27 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.843 0.857 . . . . 0.0 110.8 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.97 151.76 49.38 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -130.91 -175.25 3.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 112.024 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.9 p -97.07 -36.91 10.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -154.45 -174.78 5.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.023 0.529 . . . . 0.0 109.609 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 166.94 30.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.426 0.632 . . . . 0.0 112.518 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.25 165.82 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.9 0.88 . . . . 0.0 109.246 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.39 143.9 29.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -137.15 -178.64 5.3 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.881 0.872 . . . . 0.0 111.212 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.94 -176.7 23.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.05 -23.02 66.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.144 0.578 . . . . 0.0 111.854 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.96 20.9 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.26 -0.275 . . . . 0.0 111.24 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.39 17.82 80.08 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.7 p -82.62 7.9 13.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.7 m -127.78 151.5 48.94 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.838 0.455 . . . . 0.0 110.381 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -104.35 140.21 38.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.525 0.73 . . . . 0.0 110.655 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -141.45 147.76 38.42 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.686 0.795 . . . . 0.0 110.046 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.98 162.97 12.5 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.874 0.369 . . . . 0.0 111.247 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.2 147.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.698 0.799 . . . . 0.0 110.315 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -75.42 154.5 85.9 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.794 0.438 . . . . 0.0 111.109 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.74 164.47 88.13 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 O-C-N 121.819 0.378 . . . . 0.0 111.715 -1.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 63.5 m -136.48 70.8 60.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.736 0.815 . . . . 0.0 110.192 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.19 160.65 29.72 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.649 2.9 . . . . 0.0 111.438 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.08 160.38 29.1 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.895 0.478 . . . . 0.0 111.95 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.188 -179.638 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -143.54 154.37 43.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.819 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -147.63 80.68 8.9 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 122.985 0.514 . . . . 0.0 110.07 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.87 175.59 10.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.518 3.479 . . . . 0.0 111.523 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -112.86 121.95 46.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.132 0.573 . . . . 0.0 110.004 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -139.97 137.62 34.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.079 0.952 . . . . 0.0 109.315 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.92 -11.87 1.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.397 0.679 . . . . 0.0 111.352 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.43 10.4 74.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.416 0.531 . . . . 0.0 112.482 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.04 -24.9 64.92 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 117.431 0.615 . . . . 0.0 112.39 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.1 m -77.35 2.34 16.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.37 -23.74 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 122.827 0.451 . . . . 0.0 111.394 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.1 p -97.27 -21.36 17.3 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.322 0.51 . . . . 0.0 112.207 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.4 m -145.93 -22.18 0.45 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 -177.46 25.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.46 -29.51 69.09 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.177 0.591 . . . . 0.0 111.665 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -62.02 -34.93 77.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.004 -0.435 . . . . 0.0 111.142 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -30.51 38.99 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.072 -0.393 . . . . 0.0 110.13 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.7 t -68.78 -31.67 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -78.9 -32.36 45.73 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.896 0.478 . . . . 0.0 111.035 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -78.03 -24.13 47.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.246 0.218 . . . . 0.0 111.353 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -81.71 -35.86 29.3 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 122.185 -0.322 . . . . 0.0 110.896 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.8 m -74.92 -24.18 58.46 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.734 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.62 13.99 14.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.891 0.476 . . . . 0.0 111.167 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -134.01 168.36 18.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.824 0.85 . . . . 0.0 109.098 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -73.31 123.22 23.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -140.2 164.36 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.049 0.54 . . . . 0.0 109.859 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -73.54 134.99 43.93 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.269 -0.269 . . . . 0.0 110.583 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.0 -152.78 25.0 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.02 -19.24 27.43 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.89 -10.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.969 0.508 . . . . 0.0 112.112 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.19 173.04 45.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.4 m -79.81 141.26 36.39 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 117.582 0.691 . . . . 0.0 111.458 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.62 169.05 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 110.163 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -136.87 151.6 49.28 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.649 1.18 . . . . 0.0 108.088 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.7 m -128.04 -173.44 2.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.993 0.361 . . . . 0.0 111.83 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 t -99.01 -36.43 9.72 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.9 -175.22 5.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.54 167.14 31.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.931 0.396 . . . . 0.0 111.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.47 165.33 36.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.787 0.835 . . . . 0.0 109.667 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -99.1 140.7 32.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.6 p -137.68 -178.41 5.23 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.652 0.781 . . . . 0.0 110.752 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.76 -172.65 16.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -66.81 -23.03 66.0 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 111.781 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -146.78 21.71 1.28 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 111.294 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.83 79.13 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 112.085 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -81.65 7.03 13.35 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -129.83 145.57 51.58 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.689 0.677 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -95.37 141.74 28.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.652 0.781 . . . . 0.0 110.291 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.7 m -143.63 145.19 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.212 0.605 . . . . 0.0 109.991 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.87 164.61 12.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 111.422 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.24 136.48 53.07 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.061 0 C-N-CA 123.964 0.905 . . . . 0.0 109.763 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.81 159.01 86.74 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 122.989 0.516 . . . . 0.0 111.185 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.57 161.57 65.89 Favored 'Cis proline' 0 N--CA 1.459 -0.535 0 CA-C-N 118.741 0.586 . . . . 0.0 113.073 -2.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.82 71.33 36.21 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.54 165.06 23.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.62 2.88 . . . . 0.0 111.583 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.47 164.65 25.25 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.072 -178.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.31 6.91 7.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.618 0.367 . . . . 0.0 110.883 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.05 87.3 4.33 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 123.284 0.633 . . . . 0.0 110.482 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 178.09 7.93 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.288 3.325 . . . . 0.0 110.619 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -123.01 122.87 39.57 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.759 0.424 . . . . 0.0 110.151 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.58 130.65 20.65 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.474 0.709 . . . . 0.0 109.233 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -126.76 -15.11 5.53 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.373 0.669 . . . . 0.0 111.452 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.52 11.1 59.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.733 0.683 . . . . 0.0 112.839 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 -17.33 64.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.527 0.664 . . . . 0.0 112.177 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.3 m -96.96 2.36 51.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.16 0.436 . . . . 0.0 112.046 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.54 -29.92 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.06 0.391 . . . . 0.0 111.478 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -154.48 -26.95 0.12 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -80.09 -20.42 45.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.199 -0.313 . . . . 0.0 111.766 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.05 171.9 48.29 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.12 0.867 . . . . 0.0 112.386 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.57 -28.74 68.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.164 0.585 . . . . 0.0 111.147 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -61.7 -33.8 74.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.153 -0.342 . . . . 0.0 110.722 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.75 -31.26 40.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.232 -0.293 . . . . 0.0 110.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.9 t -71.34 -29.66 65.25 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -79.23 -33.48 43.66 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 122.194 -0.316 . . . . 0.0 110.935 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -22.88 59.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.207 0.203 . . . . 0.0 110.76 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -82.76 -32.51 27.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.893 0.477 . . . . 0.0 110.743 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -80.38 -25.17 39.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.431 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -86.15 9.36 17.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.783 0.433 . . . . 0.0 111.059 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -131.13 170.26 14.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.1 m -78.13 132.69 37.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -145.02 170.63 15.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.583 0.753 . . . . 0.0 109.726 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -74.48 140.07 44.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.166 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.69 -169.55 15.24 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -86.37 -12.5 49.08 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.16 -10.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.811 0.445 . . . . 0.0 111.854 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.1 44.08 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.72 140.84 34.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.496 0.648 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.7 168.62 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.101 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -138.48 148.77 44.72 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 107.703 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -128.58 -171.68 2.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.038 0.381 . . . . 0.0 111.906 -172.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.2 t -103.46 -39.4 6.77 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -146.67 -175.43 4.79 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.574 0.75 . . . . 0.0 110.416 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 168.09 28.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.83 165.54 35.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.323 1.049 . . . . 0.0 109.539 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.25 143.01 30.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.5 p -138.62 -176.64 4.55 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.681 0.792 . . . . 0.0 110.943 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.93 178.18 25.58 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.65 -20.57 66.02 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.11 0.564 . . . . 0.0 111.968 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -141.54 18.38 2.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.661 0.267 . . . . 0.0 111.329 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.67 80.61 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.1 p -83.21 10.46 8.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.982 0.913 . . . . 0.0 113.09 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 m -126.14 151.77 46.83 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.368 0.531 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -108.71 140.19 42.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.501 0.72 . . . . 0.0 109.769 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.5 m -140.89 147.19 38.51 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.297 0.639 . . . . 0.0 110.071 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.59 165.97 10.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mm -116.8 142.3 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 124.202 1.001 . . . . 0.0 110.516 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -67.76 156.43 89.17 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 122.894 0.477 . . . . 0.0 111.224 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 162.43 91.73 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 O-C-N 121.761 0.348 . . . . 0.0 111.337 -1.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -137.51 68.9 53.61 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.826 0.851 . . . . 0.0 110.499 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.91 164.66 21.13 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.718 2.945 . . . . 0.0 111.189 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.17 167.07 22.38 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.462 0.649 . . . . 0.0 112.085 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.087 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -143.47 157.66 44.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.826 0.85 . . . . 0.0 109.825 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.1 p -145.8 79.59 11.04 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.185 0.594 . . . . 0.0 110.232 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.6 177.21 8.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.219 3.279 . . . . 0.0 111.497 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -115.89 130.98 57.06 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 109.825 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.07 142.28 31.5 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.7 mmm180 -131.13 -23.53 2.43 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.73 17.0 58.07 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.358 0.504 . . . . 0.0 113.59 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.04 -24.71 59.44 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.884 0.842 . . . . 0.0 112.747 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.83 6.92 19.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.393 0.542 . . . . 0.0 111.843 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.32 -25.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.514 0.726 . . . . 0.0 110.374 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -89.05 -15.49 33.9 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.97 -0.457 . . . . 0.0 111.423 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -153.61 -38.91 0.1 Allowed 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.632 0.253 . . . . 0.0 111.062 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.81 -167.92 15.12 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.82 -27.15 66.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.635 0.374 . . . . 0.0 111.327 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -60.91 -41.24 95.75 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 122.07 -0.394 . . . . 0.0 111.283 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.75 -28.62 44.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.998 -0.439 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.1 -32.69 72.27 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -79.13 -36.25 40.84 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 122.369 0.268 . . . . 0.0 110.776 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -73.3 -17.73 61.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.0 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -89.79 -30.99 17.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.601 0.361 . . . . 0.0 111.108 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.3 m -77.87 -25.14 48.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.545 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -88.93 8.32 29.98 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.949 0.5 . . . . 0.0 111.351 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p -130.58 169.28 15.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 108.593 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.5 m -74.82 131.62 40.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.754 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.58 167.07 23.41 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.985 0.914 . . . . 0.0 109.162 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.53 124.31 26.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 -158.29 34.4 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.11 -21.18 36.85 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.59 -10.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.794 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 173.61 45.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -76.06 140.24 41.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.042 0.921 . . . . 0.0 111.482 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.93 169.7 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 124.233 1.013 . . . . 0.0 110.691 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -137.68 149.96 46.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.7 m -129.22 -172.31 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.159 0.436 . . . . 0.0 111.501 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -103.3 -37.52 7.62 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -151.15 -176.13 5.43 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.17 168.34 26.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.87 168.58 25.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.915 1.286 . . . . 0.0 108.657 173.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.17 148.6 25.58 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.193 -0.317 . . . . 0.0 110.622 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -135.12 179.96 5.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.548 0.739 . . . . 0.0 110.796 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 177.22 29.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.03 -19.69 63.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.746 0.419 . . . . 0.0 111.947 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.42 13.93 3.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.066 0.546 . . . . 0.0 111.658 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.06 16.23 78.5 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.287 -0.325 . . . . 0.0 112.287 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.6 p -80.49 6.13 13.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.681 0.792 . . . . 0.0 113.072 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.6 m -122.81 154.39 38.29 Favored 'General case' 0 CA--C 1.526 0.022 0 C-N-CA 122.95 0.5 . . . . 0.0 110.139 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.7 t -107.35 141.39 38.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.585 0.754 . . . . 0.0 110.566 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -142.34 147.15 35.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.395 0.678 . . . . 0.0 109.971 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.6 m -101.53 164.55 11.7 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.872 0.368 . . . . 0.0 111.512 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.98 143.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -70.23 156.28 92.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 122.92 0.488 . . . . 0.0 110.868 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.84 162.87 91.26 Favored 'Cis proline' 0 N--CA 1.451 -1.012 0 O-C-N 121.959 0.452 . . . . 0.0 111.378 -1.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.8 m -136.94 69.25 57.83 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.562 0.745 . . . . 0.0 110.367 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.09 162.96 24.25 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.587 2.858 . . . . 0.0 111.623 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -76.61 159.98 29.81 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.869 0.468 . . . . 0.0 111.592 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.99 178.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -80.79 5.66 15.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.125 0.57 . . . . 0.0 111.246 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 p -150.18 84.92 5.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.189 0.596 . . . . 0.0 110.11 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.9 174.22 12.71 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.872 3.048 . . . . 0.0 110.962 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.8 m -115.87 121.47 42.47 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.0 138.78 30.27 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 123.741 0.816 . . . . 0.0 109.211 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.19 -16.18 1.08 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.673 0.389 . . . . 0.0 111.7 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.24 11.45 71.01 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.586 0.613 . . . . 0.0 112.491 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.0 -27.05 63.16 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.53 0.665 . . . . 0.0 112.395 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.0 t -74.94 -6.09 47.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.666 0.386 . . . . 0.0 111.536 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.01 -22.76 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.166 -0.334 . . . . 0.0 111.319 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 p -98.69 -21.16 16.56 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -144.93 -22.66 0.5 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.56 179.68 23.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.92 -27.84 68.49 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.221 0.608 . . . . 0.0 111.787 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -63.09 -33.79 76.2 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.976 -0.453 . . . . 0.0 110.857 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.09 -30.25 43.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.891 -0.506 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.69 -31.0 67.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.48 -29.07 46.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.344 0.258 . . . . 0.0 110.959 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.71 -16.48 51.06 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.067 0.147 . . . . 0.0 111.005 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -87.39 -33.59 19.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.074 -0.391 . . . . 0.0 110.967 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.59 -26.36 45.42 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.195 -0.316 . . . . 0.0 111.815 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -87.16 9.75 19.01 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.116 0.416 . . . . 0.0 111.28 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -133.18 166.78 21.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.484 1.113 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.8 m -72.48 133.45 44.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.551 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -145.64 169.63 18.07 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.591 0.756 . . . . 0.0 109.766 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -74.3 136.72 42.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.217 0.207 . . . . 0.0 111.079 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 -159.61 19.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.123 0.868 . . . . 0.0 111.098 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.79 -18.32 33.27 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.28 -11.37 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 122.569 0.348 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.99 178.61 48.61 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -81.48 142.84 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.64 0.72 . . . . 0.0 111.328 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -146.48 169.48 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.698 0.799 . . . . 0.0 110.418 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.7 150.27 47.19 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.1 m -130.16 -174.61 3.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.059 0.391 . . . . 0.0 111.462 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 -27.54 11.95 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.05 -177.31 6.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.693 0.678 . . . . 0.0 109.814 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.08 169.5 22.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.64 168.95 24.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.665 1.186 . . . . 0.0 109.037 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.7 t -110.93 142.56 42.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -132.42 173.15 11.59 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.026 -175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.82 177.77 15.31 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -72.2 -20.61 61.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.877 0.339 . . . . 0.0 111.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.12 9.94 3.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.082 0.953 . . . . 0.0 110.709 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.12 83.87 0.24 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -140.29 4.91 2.04 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.2 m -132.81 147.68 52.31 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.314 0.506 . . . . 0.0 110.323 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.3 t -94.01 137.95 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.084 0.554 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -138.01 145.17 41.53 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.414 0.686 . . . . 0.0 109.555 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.42 162.7 12.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 143.86 18.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.726 0.81 . . . . 0.0 110.049 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -72.7 155.16 91.1 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 122.888 0.475 . . . . 0.0 110.99 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.61 165.43 85.62 Favored 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.605 0.538 . . . . 0.0 111.249 -0.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.61 69.8 38.13 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.051 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.8 161.67 28.07 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.785 2.99 . . . . 0.0 111.322 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -76.5 161.42 28.64 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.851 0.358 . . . . 0.0 111.642 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.283 -1.342 . . . . 0.0 109.916 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -80.27 7.55 9.27 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.032 0.533 . . . . 0.0 110.709 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.5 p -145.56 72.32 14.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.701 0.8 . . . . 0.0 109.958 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 177.14 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 124.786 3.657 . . . . 0.0 111.487 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m -108.62 125.86 52.32 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.379 0.672 . . . . 0.0 109.576 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -138.88 133.31 31.77 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.45 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -130.88 -16.97 3.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.5 67.82 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.339 0.495 . . . . 0.0 112.879 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.16 -27.46 68.41 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 117.564 0.682 . . . . 0.0 112.01 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.7 m -80.24 5.33 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.09 -24.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 122.613 0.365 . . . . 0.0 111.497 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -100.09 -15.65 18.12 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.7 t -149.86 -35.07 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.04 -164.53 12.03 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.97 -27.15 66.59 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.948 0.499 . . . . 0.0 111.794 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 m -62.39 -40.76 97.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.86 -0.525 . . . . 0.0 111.125 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.09 46.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.411 0.55 . . . . 0.0 110.626 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -68.0 -33.28 74.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -78.7 -35.93 44.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.261 0.224 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -72.43 -17.47 61.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.942 -0.117 . . . . 0.0 111.17 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -90.05 -32.04 16.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.578 0.351 . . . . 0.0 110.79 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.39 -25.65 42.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.574 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -85.89 5.2 34.0 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.3 0.5 . . . . 0.0 111.249 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.9 m -127.73 165.97 19.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.57 1.148 . . . . 0.0 107.946 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.43 137.33 39.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.806 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -146.18 167.92 22.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.351 1.06 . . . . 0.0 108.834 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -73.87 134.31 43.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.154 -0.342 . . . . 0.0 110.635 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.69 -152.24 24.94 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -88.64 -17.95 29.0 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.766 0.427 . . . . 0.0 112.135 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.75 -12.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.687 0.395 . . . . 0.0 112.051 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 175.37 47.59 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -78.03 142.58 38.13 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.425 0.612 . . . . 0.0 111.602 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.09 165.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 124.006 0.922 . . . . 0.0 110.621 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -132.96 144.51 50.17 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 124.763 1.225 . . . . 0.0 107.946 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.53 -172.47 2.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.613 0.365 . . . . 0.0 111.335 -172.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 t -103.48 -36.6 7.92 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.41 -177.3 5.99 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.24 167.95 28.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -154.25 164.53 38.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.083 0.953 . . . . 0.0 109.548 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.7 m -96.44 143.26 27.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -137.89 -177.4 4.8 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.662 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.29 -179.07 48.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -65.7 138.92 58.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.533 . . . . 0.0 109.946 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp 52.92 17.21 0.83 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.078 0.951 . . . . 0.0 112.483 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.87 77.35 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.92 -0.488 . . . . 0.0 112.164 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -76.19 10.06 2.19 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 153.29 48.46 Favored 'General case' 0 C--O 1.228 -0.069 0 CA-C-N 118.501 0.591 . . . . 0.0 110.355 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 t -108.98 141.37 41.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.684 0.794 . . . . 0.0 110.021 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.6 m -142.42 146.76 35.2 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.158 0.583 . . . . 0.0 109.727 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.1 m -100.46 164.41 11.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.787 0.435 . . . . 0.0 111.327 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.41 142.53 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.172 0.989 . . . . 0.0 110.237 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -70.78 155.77 92.92 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.215 0.606 . . . . 0.0 111.267 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.09 165.33 86.2 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 118.176 0.384 . . . . 0.0 111.529 -1.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.59 67.76 44.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.762 0.825 . . . . 0.0 110.388 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.66 167.66 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.013 3.142 . . . . 0.0 111.286 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -78.47 172.69 13.28 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.882 0.473 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.241 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . 0.445 ' C ' ' H ' ' A' ' 3' ' ' CYS . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 59.15 0.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.079 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.445 ' H ' ' C ' ' A' ' 1' ' ' PCA . 15.0 p -152.35 74.08 7.46 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.546 0.739 . . . . 0.0 110.606 175.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 174.01 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.132 3.221 . . . . 0.0 111.328 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -111.43 126.72 55.24 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.897 0.479 . . . . 0.0 109.868 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -139.82 135.23 32.78 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -140.25 161.87 36.64 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.686 0.795 . . . . 0.0 109.433 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.89 15.35 78.26 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.436 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.98 -23.27 63.48 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 117.665 0.733 . . . . 0.0 111.687 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.1 m -74.43 0.72 13.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.811 0.444 . . . . 0.0 111.831 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 -23.19 2.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.042 0.383 . . . . 0.0 111.416 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -97.94 -20.1 17.65 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -149.94 -24.1 0.26 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.09 178.51 22.07 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.31 -28.05 67.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.661 0.385 . . . . 0.0 111.857 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -61.46 -33.29 73.5 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.881 -0.512 . . . . 0.0 110.88 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.15 -30.4 49.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.959 -0.463 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.43 -29.07 46.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.402 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.16 -34.06 72.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -74.4 -28.95 61.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.255 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -78.81 -35.02 44.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.1 m -75.49 -30.59 59.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.642 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -81.68 -15.99 52.72 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.493 0.588 . . . . 0.0 111.623 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -99.83 170.49 8.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -80.18 139.38 36.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.192 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -147.37 170.19 17.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.146 0.578 . . . . 0.0 109.923 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 tpt85 -74.27 122.05 22.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.72 -160.89 36.96 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.01 -17.44 37.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.928 0.364 . . . . 0.0 111.918 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.7 -11.56 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.39 177.22 48.37 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.09 137.34 35.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.666 0.733 . . . . 0.0 111.82 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.07 166.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 C-N-CA 123.708 0.803 . . . . 0.0 110.562 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -134.07 149.48 51.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.3 -170.12 2.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.084 0.554 . . . . 0.0 111.23 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -104.67 -35.73 7.7 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.68 -175.14 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.8 163.77 39.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.938 -0.476 . . . . 0.0 111.868 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -151.64 160.36 43.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.673 0.789 . . . . 0.0 109.545 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -91.1 140.71 29.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -131.52 178.8 6.46 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.939 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.78 173.49 30.6 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.07 -18.97 61.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.277 -0.543 . . . . 0.0 111.987 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 14.03 3.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.417 0.687 . . . . 0.0 111.352 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 16.01 78.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 122.037 -0.414 . . . . 0.0 112.072 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -78.38 4.83 11.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.48 0.712 . . . . 0.0 112.554 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 m -133.85 162.59 31.6 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t -130.17 158.12 40.57 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.183 -0.323 . . . . 0.0 110.892 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -143.03 136.57 28.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.727 0.811 . . . . 0.0 109.361 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -87.37 159.43 18.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.749 0.309 . . . . 0.0 110.351 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -106.75 140.15 25.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.372 0.669 . . . . 0.0 110.32 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -68.08 155.37 92.19 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.469 0.708 . . . . 0.0 110.928 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.95 166.09 83.83 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 -0.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 72.4 m -138.04 66.88 47.65 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 110.372 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.81 165.91 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.887 3.058 . . . . 0.0 111.504 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -75.71 167.88 21.05 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.937 0.495 . . . . 0.0 110.564 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.16 -1.4 . . . . 0.0 111.562 -178.669 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -78.19 -0.88 30.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.874 0.47 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p -146.14 83.27 8.64 Favored Pre-proline 0 N--CA 1.454 -0.241 0 C-N-CA 123.433 0.693 . . . . 0.0 110.324 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 177.58 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.36 3.373 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -118.36 135.7 54.17 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -140.71 146.51 37.89 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.086 0.554 . . . . 0.0 110.1 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -142.09 161.97 36.66 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.701 1.2 . . . . 0.0 108.815 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.67 14.31 72.44 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.749 -0.473 . . . . 0.0 112.98 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.9 -26.18 61.83 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.823 0.811 . . . . 0.0 111.604 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.2 t -75.67 -4.18 38.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.648 0.379 . . . . 0.0 111.88 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.29 -27.24 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.565 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.91 -21.09 20.78 Favored 'General case' 0 N--CA 1.458 -0.048 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -145.86 -22.4 0.46 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.03 178.96 24.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.11 -27.94 64.17 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.023 0.529 . . . . 0.0 111.704 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -62.32 -32.71 73.5 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.022 -0.424 . . . . 0.0 111.246 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.18 -29.77 34.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.952 -0.467 . . . . 0.0 110.717 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.0 -31.84 69.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -78.17 -31.32 49.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.806 0.443 . . . . 0.0 111.098 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.19 -23.02 44.15 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.301 0.241 . . . . 0.0 111.238 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -82.29 -33.01 29.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.933 0.333 . . . . 0.0 111.245 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.6 m -76.91 -23.42 52.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.448 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.17 5.85 42.8 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.791 0.436 . . . . 0.0 111.69 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -126.99 166.76 16.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.8 m -72.66 131.82 42.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.102 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -142.95 170.14 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 109.464 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -75.1 139.28 42.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.369 -0.207 . . . . 0.0 111.193 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.74 -168.08 15.79 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -17.44 37.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.828 0.451 . . . . 0.0 112.206 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.5 -10.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.86 0.464 . . . . 0.0 111.708 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.09 178.76 45.2 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.5 m -80.99 142.29 33.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.88 168.54 7.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.524 0.73 . . . . 0.0 110.773 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.09 150.65 45.95 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.7 m -127.53 -173.81 3.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.184 0.447 . . . . 0.0 111.487 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 m -104.92 -30.55 9.75 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -155.19 -177.36 6.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.449 0.568 . . . . 0.0 109.6 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.95 170.18 21.03 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.139 0.495 . . . . 0.0 112.257 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -151.84 166.36 31.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.34 1.056 . . . . 0.0 109.213 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.3 t -106.5 139.75 40.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -137.08 -171.53 2.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.809 0.844 . . . . 0.0 111.03 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.37 173.74 26.11 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.75 -21.02 63.48 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.973 0.509 . . . . 0.0 111.772 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -144.9 24.81 1.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.684 0.22 . . . . 0.0 111.393 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.68 32.38 57.38 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.7 p -101.29 12.21 37.88 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -133.05 154.02 50.94 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.517 0.327 . . . . 0.0 110.762 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -116.9 139.43 50.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.795 0.838 . . . . 0.0 109.489 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -139.34 143.98 38.03 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.126 0.57 . . . . 0.0 109.783 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -100.86 164.68 11.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.659 0.384 . . . . 0.0 111.515 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.31 145.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.791 0.836 . . . . 0.0 110.399 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.42 155.74 89.4 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.973 0.509 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.9 162.96 91.12 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 118.49 0.497 . . . . 0.0 111.687 -1.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.3 m -136.56 69.8 60.08 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.698 0.799 . . . . 0.0 109.976 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.62 162.82 26.47 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.054 3.17 . . . . 0.0 111.507 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -75.38 161.33 29.35 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.966 0.506 . . . . 0.0 111.471 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.013 179.561 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -75.91 1.06 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.13 0.572 . . . . 0.0 110.889 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p -149.5 80.27 7.71 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 123.613 0.765 . . . . 0.0 109.928 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.34 174.41 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 124.357 3.371 . . . . 0.0 111.792 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -113.36 135.43 53.87 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -142.99 147.62 35.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 122.212 0.205 . . . . 0.0 110.717 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -142.31 164.47 30.07 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 124.801 1.24 . . . . 0.0 109.504 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.78 16.85 74.66 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.969 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.9 -29.03 68.08 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.036 0.918 . . . . 0.0 111.152 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.4 m -81.92 6.08 17.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.097 0.559 . . . . 0.0 112.092 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.61 -15.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.684 0.394 . . . . 0.0 111.923 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -123.29 -18.39 6.29 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 m -139.12 -18.27 1.02 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -177.49 39.63 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.7 tp -58.41 -27.57 64.41 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.21 0.604 . . . . 0.0 111.825 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -61.66 -34.21 75.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.238 -0.289 . . . . 0.0 111.246 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.77 -28.2 30.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.226 0.466 . . . . 0.0 110.981 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.16 -31.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -78.8 -33.51 46.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -77.57 -22.44 50.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.312 0.245 . . . . 0.0 111.334 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -84.43 -32.78 23.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.845 0.293 . . . . 0.0 111.179 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.8 m -77.79 -22.63 49.85 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.411 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.34 6.07 42.17 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.866 0.467 . . . . 0.0 111.821 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.5 p -127.86 165.45 20.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.29 131.08 42.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.139 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -142.78 167.13 22.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.678 0.791 . . . . 0.0 109.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.68 123.69 26.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.2 -160.15 36.24 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.61 -14.4 45.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.01 -11.82 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 122.594 0.358 . . . . 0.0 111.881 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.89 45.54 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -76.59 140.22 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.082 0.941 . . . . 0.0 111.55 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.96 169.23 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.516 0.726 . . . . 0.0 110.733 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -138.29 151.05 47.24 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.95 -172.41 2.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.326 0.512 . . . . 0.0 111.635 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -102.48 -35.95 8.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -153.95 -175.92 5.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.98 168.43 26.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 112.078 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.96 163.83 39.75 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.894 0.878 . . . . 0.0 109.539 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.8 m -93.72 142.41 27.39 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.2 p -137.67 -178.52 5.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.458 0.703 . . . . 0.0 111.008 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 -176.97 52.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.01 134.24 56.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt 50.86 20.13 0.73 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.981 0.912 . . . . 0.0 113.229 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.38 76.64 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.229 0.468 . . . . 0.0 112.345 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.9 p -75.53 8.76 2.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 155.84 42.0 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.588 0.631 . . . . 0.0 110.085 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.7 t -112.52 138.83 48.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.303 0.641 . . . . 0.0 110.159 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 m -141.32 145.8 35.92 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.008 0.523 . . . . 0.0 110.025 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.914 0.388 . . . . 0.0 111.42 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mm -112.4 143.18 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.798 0.839 . . . . 0.0 110.047 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -71.01 156.06 92.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 0.0 111.068 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 162.83 91.44 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 O-C-N 121.883 0.412 . . . . 0.0 111.387 -1.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.7 m -136.08 69.69 63.35 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.591 0.757 . . . . 0.0 109.772 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.66 161.77 30.74 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.383 2.722 . . . . 0.0 111.074 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.17 161.37 28.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.693 0.397 . . . . 0.0 111.681 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.62 -1.181 . . . . 0.0 110.146 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -142.99 157.54 44.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.525 0.73 . . . . 0.0 109.991 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.07 81.87 9.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.357 0.663 . . . . 0.0 110.217 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.94 178.46 7.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.365 3.377 . . . . 0.0 111.231 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -117.41 133.38 56.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.563 0.745 . . . . 0.0 109.246 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -142.79 142.82 31.96 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.657 0.383 . . . . 0.0 110.043 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -142.81 164.76 29.23 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.386 1.074 . . . . 0.0 109.207 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.79 18.7 77.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.489 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.28 -14.41 55.74 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.522 0.661 . . . . 0.0 112.332 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.04 -3.25 41.74 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.062 0.392 . . . . 0.0 111.635 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.24 -27.62 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 O-C-N 121.909 -0.494 . . . . 0.0 111.549 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -154.44 -26.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -83.8 -20.38 33.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.151 0.432 . . . . 0.0 111.992 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.22 170.44 45.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.104 0.859 . . . . 0.0 112.408 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.6 -28.17 68.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.846 0.459 . . . . 0.0 111.078 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -62.0 -32.5 72.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.212 -0.305 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.35 45.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.068 -0.395 . . . . 0.0 110.501 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.2 t -74.05 -30.9 62.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -77.44 -28.96 52.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.615 0.366 . . . . 0.0 111.051 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.56 -30.66 41.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.999 0.187 . . . . 0.0 110.899 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -76.34 -32.5 58.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.756 0.253 . . . . 0.0 111.187 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 98.9 m -76.48 -28.48 56.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.322 -0.371 . . . . 0.0 111.575 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -85.17 -20.53 30.09 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.365 0.529 . . . . 0.0 111.769 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -94.34 166.19 12.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.8 m -75.95 136.55 40.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.581 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -144.61 170.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -75.19 140.61 43.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.135 0.174 . . . . 0.0 111.407 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.63 -170.58 16.68 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.58 -14.42 48.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.53 -18.38 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.867 0.467 . . . . 0.0 111.149 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.99 176.8 44.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -75.17 144.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.612 0.706 . . . . 0.0 111.548 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.79 171.7 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.25 1.02 . . . . 0.0 110.463 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -141.66 153.07 44.47 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.7 m -123.83 -175.26 3.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 111.491 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -103.81 -29.58 10.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -155.92 -177.51 6.63 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.446 0.566 . . . . 0.0 109.756 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.0 170.03 22.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.273 0.558 . . . . 0.0 111.785 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.65 165.76 34.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.399 1.08 . . . . 0.0 109.028 173.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.0 t -107.99 141.51 39.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -130.6 179.73 5.77 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.586 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 168.63 45.06 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.83 132.09 47.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.47 -0.429 . . . . 0.0 110.295 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt 52.53 14.71 0.42 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.427 1.091 . . . . 0.0 112.749 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.73 102.0 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.99 0.805 . . . . 0.0 111.521 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 p -144.82 4.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.877 0.471 . . . . 0.0 111.551 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.3 m -134.05 152.25 51.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.603 0.361 . . . . 0.0 110.216 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.78 138.13 47.56 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.171 0.589 . . . . 0.0 110.271 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.1 m -139.45 140.96 37.45 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.88 164.12 12.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.377 0.271 . . . . 0.0 111.043 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.84 143.03 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 124.055 0.942 . . . . 0.0 110.448 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -73.55 157.05 88.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 122.939 0.496 . . . . 0.0 111.105 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.72 164.01 88.44 Favored 'Cis proline' 0 N--CA 1.455 -0.784 0 O-C-N 121.87 0.405 . . . . 0.0 111.575 -2.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 95.1 m -134.67 70.63 71.5 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 124.1 0.96 . . . . 0.0 109.906 177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.73 167.28 15.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.248 3.299 . . . . 0.0 112.018 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -69.45 163.25 25.71 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.276 0.63 . . . . 0.0 111.557 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.525 175.735 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.043 0.449 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -77.3 1.2 19.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.928 0.491 . . . . 0.0 110.813 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.1 p -152.7 86.84 4.18 Favored Pre-proline 0 N--CA 1.452 -0.342 0 C-N-CA 123.337 0.655 . . . . 0.0 110.469 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.34 -179.08 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.428 3.418 . . . . 0.0 110.581 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -125.32 122.41 36.77 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 122.804 0.441 . . . . 0.0 110.15 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -144.74 139.02 27.6 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.963 0.905 . . . . 0.0 109.431 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -137.77 -12.08 1.52 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.687 0.395 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.55 12.22 70.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.584 0.611 . . . . 0.0 112.581 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.77 -25.61 63.22 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.668 0.734 . . . . 0.0 112.609 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.9 t -86.39 10.14 15.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.16 0.436 . . . . 0.0 111.811 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -17.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 123.024 0.529 . . . . 0.0 111.252 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.3 p -120.59 -17.11 8.15 Favored 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 m -140.51 -19.51 0.85 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 -173.68 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.344 0.497 . . . . 0.0 112.069 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.38 -26.6 68.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.161 0.584 . . . . 0.0 111.751 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -63.45 -36.17 82.86 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.759 -0.588 . . . . 0.0 110.664 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.6 36.3 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.002 0.365 . . . . 0.0 110.703 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 t -68.62 -30.86 69.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -79.08 -35.46 42.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.259 -0.276 . . . . 0.0 110.691 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -19.57 60.92 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.918 0.136 . . . . 0.0 111.031 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.49 -33.35 21.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.447 0.299 . . . . 0.0 110.675 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.36 -26.49 46.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.554 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -87.13 8.02 25.57 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 122.865 0.466 . . . . 0.0 111.305 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -130.89 167.23 19.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.539 1.136 . . . . 0.0 108.347 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.3 m -73.2 133.82 44.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.047 -0.408 . . . . 0.0 110.41 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.95 170.91 15.66 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.887 0.875 . . . . 0.0 109.554 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -73.54 140.38 46.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.234 0.214 . . . . 0.0 111.14 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.81 -168.1 14.76 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -86.63 -17.09 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.86 -16.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.852 0.461 . . . . 0.0 110.907 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.79 48.07 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.6 m -80.29 142.18 34.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.833 0.816 . . . . 0.0 110.895 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.22 169.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.782 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -138.44 150.5 46.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.422 1.089 . . . . 0.0 108.16 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.9 m -128.18 -172.49 2.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.242 0.617 . . . . 0.0 111.212 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.2 m -107.54 -29.85 8.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -154.16 -178.97 7.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.729 0.695 . . . . 0.0 109.799 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 168.1 26.97 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.281 0.562 . . . . 0.0 112.348 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.93 168.09 27.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.992 1.317 . . . . 0.0 108.757 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.4 m -105.0 146.29 29.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -132.79 179.59 6.07 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.476 0.71 . . . . 0.0 111.0 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 176.37 28.6 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -68.89 -18.01 64.06 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.37 13.3 3.51 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.074 0.55 . . . . 0.0 111.667 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.68 17.7 78.27 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.909 -0.477 . . . . 0.0 111.909 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.6 p -83.15 9.55 10.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 113.009 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.9 m -125.65 150.82 47.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.0 t -102.66 141.69 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.484 0.714 . . . . 0.0 110.125 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.5 m -143.66 147.36 34.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.719 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -101.22 164.45 11.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.97 143.97 20.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.065 0.946 . . . . 0.0 109.632 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -72.46 156.09 90.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 122.832 0.453 . . . . 0.0 110.691 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.66 166.08 83.91 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 122.041 0.495 . . . . 0.0 111.441 -1.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.58 70.31 45.17 Favored Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 123.491 0.716 . . . . 0.0 110.069 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.9 163.43 22.18 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.798 2.998 . . . . 0.0 111.733 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -76.35 161.99 28.25 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.07 179.711 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.116 0.484 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -150.01 157.54 43.25 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.517 0.727 . . . . 0.0 110.275 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p -149.07 77.56 9.1 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.11 174.91 11.64 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 124.232 3.288 . . . . 0.0 111.57 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -111.15 134.63 52.6 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.306 0.642 . . . . 0.0 109.696 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -143.95 142.75 30.91 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.958 0.503 . . . . 0.0 110.023 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -142.09 163.69 32.18 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.062 0.945 . . . . 0.0 109.512 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.68 17.95 75.36 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.389 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.41 -27.31 67.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.754 0.777 . . . . 0.0 111.405 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.63 4.37 16.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.047 0.539 . . . . 0.0 112.192 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -14.8 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 122.889 0.476 . . . . 0.0 111.62 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -121.48 -19.6 6.88 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 m -140.71 -19.36 0.83 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.34 -173.47 34.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.565 0.602 . . . . 0.0 111.761 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -59.82 -28.08 67.17 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.014 0.526 . . . . 0.0 111.933 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -60.7 -36.2 78.22 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 122.052 -0.405 . . . . 0.0 110.988 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.1 27.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.067 0.394 . . . . 0.0 110.792 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.5 t -68.05 -31.47 71.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -80.12 -36.96 34.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.231 -0.293 . . . . 0.0 110.999 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.74 -18.65 61.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.927 0.142 . . . . 0.0 111.325 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -87.64 -35.69 17.88 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 117.871 0.305 . . . . 0.0 110.574 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.5 m -75.48 -28.4 59.2 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.84 3.26 34.5 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.391 . . . . 0.0 111.97 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -126.01 163.73 22.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.9 m -71.12 133.3 46.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.137 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -145.08 167.33 22.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 124.78 28.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.379 -0.201 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.79 -158.55 34.51 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 123.752 0.692 . . . . 0.0 111.389 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.67 -20.25 31.56 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.496 -0.414 . . . . 0.0 112.093 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.32 -12.39 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.58 0.352 . . . . 0.0 111.651 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.8 175.4 46.51 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.5 m -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.019 0.909 . . . . 0.0 111.875 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -142.9 167.86 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.032 0.933 . . . . 0.0 110.745 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -139.71 144.1 37.37 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.4 -173.69 2.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.133 0.424 . . . . 0.0 111.47 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -103.4 -35.85 8.22 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -152.7 -176.36 5.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.47 168.25 27.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 111.647 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -153.62 163.39 40.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.876 0.87 . . . . 0.0 109.321 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.54 142.57 27.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.4 p -132.34 -179.71 5.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 111.122 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.92 177.06 30.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.37 -18.78 63.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 112.002 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.35 14.52 3.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.069 0.547 . . . . 0.0 111.387 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.13 15.69 78.63 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -80.62 8.33 8.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.6 m -125.26 155.34 40.29 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 122.914 0.486 . . . . 0.0 110.075 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -114.34 139.36 49.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.584 0.754 . . . . 0.0 110.063 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -142.95 144.5 32.39 Favored 'General case' 0 C--O 1.228 -0.058 0 C-N-CA 122.921 0.488 . . . . 0.0 109.919 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.27 162.23 13.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.964 0.412 . . . . 0.0 111.274 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.64 145.62 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 123.918 0.887 . . . . 0.0 110.127 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -73.59 156.18 88.79 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.061 0.544 . . . . 0.0 111.609 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.57 165.37 85.84 Favored 'Cis proline' 0 N--CA 1.451 -1.004 0 CA-C-N 118.188 0.388 . . . . 0.0 111.288 -2.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.0 m -137.14 67.45 55.16 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.729 0.812 . . . . 0.0 110.287 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.69 168.84 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.961 3.107 . . . . 0.0 112.052 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -70.64 165.01 23.77 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.549 0.739 . . . . 0.0 111.661 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 176.88 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.77 2.61 19.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.183 0.593 . . . . 0.0 111.019 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.87 83.76 6.13 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.323 0.649 . . . . 0.0 110.534 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.93 175.48 11.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.842 3.028 . . . . 0.0 111.098 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -117.23 127.8 54.45 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -141.52 146.01 35.85 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.266 0.627 . . . . 0.0 110.157 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -143.14 165.52 27.2 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 109.354 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.71 17.33 74.91 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.594 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.21 -23.19 65.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.555 0.678 . . . . 0.0 112.033 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.64 3.67 15.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.723 0.409 . . . . 0.0 111.594 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.6 -27.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 122.879 0.472 . . . . 0.0 111.088 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.5 p -87.63 -15.18 38.01 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 122.09 -0.381 . . . . 0.0 111.789 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -154.21 -40.25 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.352 0.261 . . . . 0.0 111.283 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.15 -167.73 16.41 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.96 -27.88 65.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.874 0.47 . . . . 0.0 111.715 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 m -61.7 -40.43 95.0 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.288 -0.257 . . . . 0.0 111.291 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -28.05 41.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.895 -0.503 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.7 -32.53 71.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -80.03 -36.18 36.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.16 -0.337 . . . . 0.0 110.949 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -71.6 -21.78 61.81 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.167 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -87.51 -31.88 19.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.633 0.373 . . . . 0.0 111.315 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.02 -27.5 54.6 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.584 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -83.96 -14.76 50.05 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.541 0.609 . . . . 0.0 111.652 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.8 p -101.02 168.44 9.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -78.38 139.51 38.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.611 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -145.8 170.58 16.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 109.394 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -72.91 139.27 46.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.465 0.174 . . . . 0.0 111.001 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.92 -172.79 16.4 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.176 0.893 . . . . 0.0 111.0 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -83.69 -12.68 55.56 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.87 -17.68 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 110.987 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.06 -179.77 45.2 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.4 m -78.02 141.59 38.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.739 0.769 . . . . 0.0 111.041 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.06 163.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.759 0.823 . . . . 0.0 110.8 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -135.43 147.24 48.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.91 -174.3 2.67 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.995 0.518 . . . . 0.0 111.117 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 -30.24 10.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.77 -177.97 6.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.289 0.495 . . . . 0.0 109.856 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 168.46 26.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 111.842 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.18 165.83 34.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.788 0.835 . . . . 0.0 109.434 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.3 m -98.64 143.03 29.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -131.99 179.46 6.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.714 0.806 . . . . 0.0 110.801 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.17 176.05 30.35 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -69.48 -18.15 63.68 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.805 0.442 . . . . 0.0 112.05 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.33 13.45 3.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.011 0.524 . . . . 0.0 111.451 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.07 16.68 78.47 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -81.26 7.96 10.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.6 m -125.79 154.16 42.98 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 122.896 0.478 . . . . 0.0 110.304 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 t -111.71 140.57 46.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.484 0.713 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.8 m -143.51 143.74 31.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.433 0.693 . . . . 0.0 109.582 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.9 162.82 13.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.033 0.445 . . . . 0.0 111.189 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -107.34 142.0 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 123.714 0.806 . . . . 0.0 109.801 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.25 156.03 89.52 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 122.59 0.356 . . . . 0.0 110.974 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.03 168.61 76.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 118.265 0.416 . . . . 0.0 111.739 -1.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.74 69.11 37.31 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.641 0.777 . . . . 0.0 109.725 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.77 171.7 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.064 3.176 . . . . 0.0 112.268 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -66.75 169.82 7.38 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.666 0.786 . . . . 0.0 110.529 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.222 -1.37 . . . . 0.0 111.655 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.16 176.62 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.529 3.486 . . . . 0.0 111.921 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 m -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.186 0.594 . . . . 0.0 109.828 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.39 132.43 22.97 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.24 -10.72 1.69 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.907 0.483 . . . . 0.0 111.988 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.28 13.43 61.86 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 123.656 0.646 . . . . 0.0 112.427 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.53 -17.16 64.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.875 0.838 . . . . 0.0 112.643 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.4 m -94.46 3.33 55.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.081 0.4 . . . . 0.0 111.742 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.32 -29.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-N 118.19 0.45 . . . . 0.0 111.476 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 t -156.12 -26.41 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -79.49 -20.01 48.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.085 -0.384 . . . . 0.0 111.817 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.86 172.48 48.38 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.809 0.719 . . . . 0.0 112.99 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.13 -28.65 69.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.94 0.496 . . . . 0.0 110.852 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -63.07 -33.7 76.0 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.064 -0.398 . . . . 0.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.21 -33.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.6 t -69.73 -30.89 68.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -79.04 -31.26 44.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.888 0.475 . . . . 0.0 110.744 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.56 -30.64 52.76 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.072 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -76.73 -34.42 58.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.841 0.291 . . . . 0.0 110.609 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.7 m -74.39 -24.31 59.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.326 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -89.3 -8.78 52.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.321 0.51 . . . . 0.0 111.397 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -102.99 165.43 11.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 109.303 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.77 125.07 25.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -142.71 169.53 17.41 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.838 0.455 . . . . 0.0 109.997 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpt85 -73.97 126.8 31.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.247 0.219 . . . . 0.0 110.737 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.76 -159.97 33.85 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -82.54 -21.3 35.4 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.94 -10.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.682 0.393 . . . . 0.0 111.74 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.48 171.79 44.52 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.0 m -73.8 142.49 46.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.89 0.845 . . . . 0.0 111.423 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.36 167.86 3.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.409 1.083 . . . . 0.0 110.205 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -136.24 149.88 48.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.61 -173.1 2.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.888 0.475 . . . . 0.0 111.648 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -98.53 -36.89 9.77 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.03 -174.81 4.99 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.043 -0.41 . . . . 0.0 109.993 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.67 167.15 31.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.866 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.46 163.67 39.84 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.012 0.925 . . . . 0.0 109.146 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.7 m -94.98 143.65 26.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -135.9 -179.34 5.6 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.902 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.48 173.41 25.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -69.74 -19.77 63.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.974 0.51 . . . . 0.0 111.755 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.78 14.01 4.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.209 0.604 . . . . 0.0 111.177 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 15.31 78.61 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.6 p -82.82 13.57 3.79 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.883 0.873 . . . . 0.0 113.094 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -130.88 150.18 52.16 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.906 -0.496 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.9 t -107.18 143.78 34.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.915 0.886 . . . . 0.0 109.422 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.4 m -144.3 145.96 32.31 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.063 0.545 . . . . 0.0 109.941 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.16 163.94 12.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.783 0.433 . . . . 0.0 111.631 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.91 134.86 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.595 0.758 . . . . 0.0 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -70.02 159.62 83.58 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.017 0.527 . . . . 0.0 110.799 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -64.9 162.82 64.19 Favored 'Cis proline' 0 N--CA 1.459 -0.509 0 CA-C-N 118.692 0.568 . . . . 0.0 113.259 -2.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 96.7 m -140.82 69.46 29.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 110.265 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.11 168.83 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.158 3.239 . . . . 0.0 112.041 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.26 164.25 23.2 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.898 0.479 . . . . 0.0 111.444 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.586 178.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.506 0.193 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.64 177.68 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.053 3.169 . . . . 0.0 110.345 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -125.85 128.86 48.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.549 0.34 . . . . 0.0 110.13 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -141.14 134.74 30.05 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.885 0.874 . . . . 0.0 109.143 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -138.78 163.08 33.13 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.7 0.8 . . . . 0.0 109.213 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 15.87 76.65 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.17 -25.26 63.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.435 0.617 . . . . 0.0 111.409 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -76.28 2.61 12.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.884 0.474 . . . . 0.0 111.715 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -124.84 -24.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 122.869 0.468 . . . . 0.0 111.238 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -98.9 -21.14 16.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -146.71 -22.05 0.42 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -178.02 26.0 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -58.82 -28.01 65.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.185 0.594 . . . . 0.0 111.68 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.6 m -61.34 -34.85 75.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.025 -0.422 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.52 -31.99 28.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.848 0.294 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.1 t -67.22 -31.85 72.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -79.17 -36.65 40.02 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.187 -0.321 . . . . 0.0 110.768 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -69.99 -22.6 63.12 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.913 -0.089 . . . . 0.0 110.976 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -82.17 -35.83 27.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.671 0.214 . . . . 0.0 110.832 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.11 -24.61 54.96 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.455 0.302 . . . . 0.0 111.616 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.04 6.34 22.46 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.377 0.671 . . . . 0.0 111.226 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -133.29 169.8 16.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.84 131.82 39.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -145.11 171.13 14.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.71 0.404 . . . . 0.0 110.364 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -78.35 137.1 37.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.16 -170.9 17.12 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -88.69 -11.42 45.25 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.3 t -129.83 -16.46 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.031 0.532 . . . . 0.0 111.081 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.11 44.6 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.5 m -82.24 139.55 34.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.203 -0.587 . . . . 0.0 111.058 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.31 168.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.274 0.63 . . . . 0.0 111.639 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -139.06 143.24 38.28 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -127.2 -175.32 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.499 0.591 . . . . 0.0 112.289 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -100.59 -35.03 9.65 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -154.46 -175.11 5.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.82 167.35 30.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.26 165.18 37.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.964 0.906 . . . . 0.0 109.356 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.7 m -95.35 143.53 26.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.3 p -135.8 179.57 6.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.117 0.567 . . . . 0.0 111.105 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.56 179.68 49.77 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.8 136.87 57.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.4 mt 52.22 16.66 0.6 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.921 0.888 . . . . 0.0 113.229 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.7 75.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.972 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -74.81 3.1 8.64 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.193 0.997 . . . . 0.0 113.613 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 48.6 m -121.8 155.71 34.73 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.538 0.608 . . . . 0.0 110.256 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.4 t -112.49 139.3 48.19 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.577 0.751 . . . . 0.0 109.959 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.7 m -142.41 146.1 34.52 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.346 0.658 . . . . 0.0 109.846 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.02 165.02 11.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.986 0.514 . . . . 0.0 111.48 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.75 145.32 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 110.408 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -70.4 156.06 92.48 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.915 0.486 . . . . 0.0 110.852 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.97 162.64 91.82 Favored 'Cis proline' 0 N--CA 1.454 -0.847 0 CA-C-N 118.274 0.419 . . . . 0.0 111.146 -2.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.8 m -137.65 68.99 52.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 109.942 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.83 167.44 13.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.936 3.091 . . . . 0.0 112.094 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.37 164.2 26.72 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.293 0.637 . . . . 0.0 111.802 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.991 176.334 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.318 0.104 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.77 171.47 18.16 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.975 3.117 . . . . 0.0 109.955 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.2 m -118.59 120.74 38.36 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -136.09 137.16 40.79 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 123.796 0.838 . . . . 0.0 109.407 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -139.94 162.49 35.05 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.09 17.31 78.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.51 -24.24 63.48 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.484 0.642 . . . . 0.0 111.918 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.4 m -76.53 2.87 12.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.075 0.55 . . . . 0.0 111.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.73 -25.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 122.737 0.415 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -95.21 -21.16 18.65 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.017 -0.427 . . . . 0.0 111.968 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -146.27 -21.84 0.44 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -177.43 25.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.31 -29.26 65.75 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 m -62.59 -34.22 76.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 111.141 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.59 -30.39 32.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.94 -0.475 . . . . 0.0 110.583 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.86 -30.77 69.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -81.0 -30.24 35.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.489 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.62 -22.29 43.84 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.505 -0.122 . . . . 0.0 111.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.55 -35.95 24.37 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.252 -0.28 . . . . 0.0 110.782 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.4 m -73.98 -26.14 60.3 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.462 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -88.61 8.98 25.73 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.959 0.345 . . . . 0.0 111.494 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -127.97 164.93 21.25 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.888 0.875 . . . . 0.0 108.993 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.6 t -69.7 127.09 31.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -143.49 168.16 20.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.792 0.437 . . . . 0.0 110.538 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.54 133.8 37.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.567 0.347 . . . . 0.0 111.037 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.86 -163.48 23.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -86.84 -11.36 51.06 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.77 -11.92 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.627 0.371 . . . . 0.0 111.893 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.75 177.57 47.46 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.0 m -86.94 139.91 30.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.663 0.731 . . . . 0.0 111.45 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.31 166.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.377 0.671 . . . . 0.0 110.611 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -135.01 148.3 49.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.8 m -126.88 -174.01 3.03 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.971 0.351 . . . . 0.0 111.755 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -100.5 -33.39 10.36 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.28 -175.14 5.28 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.46 167.62 29.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.61 164.99 37.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.981 0.912 . . . . 0.0 109.501 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.8 142.6 27.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.4 p -137.26 -177.88 4.97 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.732 0.813 . . . . 0.0 110.981 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.76 -175.91 53.16 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.8 134.27 56.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 51.18 18.89 0.64 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.102 0.961 . . . . 0.0 113.275 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 22.23 77.25 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.334 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -75.42 7.61 3.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -125.31 153.23 43.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.423 0.556 . . . . 0.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.9 t -108.9 138.94 44.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.538 0.735 . . . . 0.0 110.146 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.0 m -141.0 147.17 38.27 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 123.008 0.523 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -100.87 162.88 12.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.121 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.71 141.01 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.793 0.837 . . . . 0.0 110.035 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -68.86 155.35 93.52 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.159 0.583 . . . . 0.0 111.088 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.52 164.49 87.09 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 118.23 0.403 . . . . 0.0 111.351 -1.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.2 m -139.11 68.32 41.03 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.509 0.724 . . . . 0.0 110.192 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.77 164.08 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.675 2.916 . . . . 0.0 111.874 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.54 160.77 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.896 0.478 . . . . 0.0 111.43 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.702 -178.785 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.17 178.34 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.921 3.081 . . . . 0.0 110.731 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -122.6 128.57 50.86 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.846 0.458 . . . . 0.0 110.157 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -143.62 144.91 32.11 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.699 0.799 . . . . 0.0 109.16 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.6 mmm180 -133.27 -23.88 1.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 17.4 58.63 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.75 0.69 . . . . 0.0 113.604 -173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.72 -25.76 63.25 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.971 0.886 . . . . 0.0 112.623 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.9 m -79.53 4.65 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 111.936 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.63 -25.41 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.111 0.565 . . . . 0.0 111.181 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.5 p -89.11 -15.58 33.56 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -154.73 -36.61 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.689 0.396 . . . . 0.0 111.384 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -165.36 13.03 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.4 -27.6 67.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.479 -0.424 . . . . 0.0 111.751 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -62.81 -39.63 94.88 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.772 -0.58 . . . . 0.0 111.0 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -28.77 48.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.181 0.446 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.33 -32.83 70.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -78.56 -31.99 47.59 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.443 0.297 . . . . 0.0 110.8 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -77.14 -20.17 55.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.483 -0.136 . . . . 0.0 110.838 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -86.24 -31.43 21.69 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.638 0.375 . . . . 0.0 110.875 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.4 m -80.16 -29.89 38.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.259 -0.401 . . . . 0.0 111.925 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.51 -15.71 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.54 0.609 . . . . 0.0 111.036 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -102.99 169.64 8.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -77.69 141.44 39.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -146.54 171.97 14.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.132 0.973 . . . . 0.0 109.609 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -73.43 139.36 45.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.589 0.233 . . . . 0.0 111.271 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.5 -169.34 15.27 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.908 0.766 . . . . 0.0 111.199 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.68 -14.82 36.41 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.771 0.429 . . . . 0.0 112.015 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.2 -8.12 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 122.813 0.445 . . . . 0.0 111.616 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.93 179.26 42.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.72 140.31 34.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.579 0.69 . . . . 0.0 110.881 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.84 163.41 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.497 0.719 . . . . 0.0 110.989 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -133.68 147.34 51.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.22 -173.27 2.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.79 0.436 . . . . 0.0 111.568 -172.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -99.97 -35.75 9.62 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -154.13 -174.5 4.99 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.48 26.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.38 165.12 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.474 1.11 . . . . 0.0 109.508 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 100.0 m -99.03 144.8 27.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -136.95 -178.88 5.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.953 0.901 . . . . 0.0 111.106 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.65 -178.45 25.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.01 -22.89 67.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.047 0.539 . . . . 0.0 112.014 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -144.36 20.8 1.72 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.815 0.279 . . . . 0.0 111.676 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.68 17.78 79.57 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -81.29 7.1 12.28 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.4 m -128.02 153.27 46.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.811 0.444 . . . . 0.0 110.273 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 t -105.39 141.88 36.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.335 0.654 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 m -142.4 146.04 34.46 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.195 0.598 . . . . 0.0 110.101 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.94 162.96 12.52 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.886 0.474 . . . . 0.0 111.256 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -111.69 138.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.426 0.69 . . . . 0.0 110.007 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -67.46 156.1 89.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.22 0.608 . . . . 0.0 111.027 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.71 167.95 78.77 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 O-C-N 121.97 0.458 . . . . 0.0 111.382 -1.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 88.5 m -139.97 67.64 34.49 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.627 0.771 . . . . 0.0 110.063 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.61 170.88 14.17 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.317 3.345 . . . . 0.0 112.082 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -66.11 169.74 6.6 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.597 0.759 . . . . 0.0 110.715 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.17 -1.395 . . . . 0.0 111.363 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.275 0.083 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.52 173.11 15.06 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.428 2.752 . . . . 0.0 110.162 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.3 m -120.51 123.92 44.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.5 0.32 . . . . 0.0 110.197 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -143.77 138.63 28.91 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -138.87 -15.0 1.18 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.202 0.601 . . . . 0.0 111.716 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.1 13.21 62.05 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.554 0.597 . . . . 0.0 112.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.06 -17.35 63.29 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.683 0.741 . . . . 0.0 112.499 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.42 2.69 52.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.152 0.433 . . . . 0.0 111.95 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.11 -30.08 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 118.226 0.467 . . . . 0.0 111.603 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -155.45 -26.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -79.98 -19.75 47.13 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.137 -0.352 . . . . 0.0 111.591 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.69 171.34 47.65 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.942 0.782 . . . . 0.0 112.609 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.57 -28.25 68.32 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.831 0.452 . . . . 0.0 111.097 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -62.46 -33.08 74.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.865 0.302 . . . . 0.0 110.564 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -33.58 42.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.031 -0.418 . . . . 0.0 110.384 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.86 -29.67 68.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -79.43 -30.83 42.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.716 0.407 . . . . 0.0 111.079 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -77.53 -19.27 56.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.092 0.157 . . . . 0.0 111.128 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -87.43 -31.61 19.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.581 0.352 . . . . 0.0 111.108 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.7 m -80.37 -23.84 40.21 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -88.05 9.49 22.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.845 0.293 . . . . 0.0 111.117 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -132.8 170.53 15.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.222 1.009 . . . . 0.0 108.449 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.8 133.5 43.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.769 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -146.88 169.24 19.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.409 0.684 . . . . 0.0 110.019 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -75.08 139.48 42.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.058 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.48 -170.82 16.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.73 -13.27 54.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.02 -18.13 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 122.695 0.398 . . . . 0.0 111.25 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.94 179.58 47.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -82.95 141.56 32.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.915 0.857 . . . . 0.0 111.242 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -146.94 170.01 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.449 0.7 . . . . 0.0 110.829 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -136.15 146.02 46.45 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -126.29 -172.24 2.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.09 0.405 . . . . 0.0 112.062 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 t -103.37 -36.93 7.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.75 -174.87 4.99 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.89 167.85 28.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.19 164.85 37.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.418 1.087 . . . . 0.0 109.206 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.86 145.01 26.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -139.29 -178.52 5.4 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.526 0.73 . . . . 0.0 111.176 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.77 174.28 41.96 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.37 143.44 57.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 tp 54.5 11.73 0.45 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.72 0.808 . . . . 0.0 112.53 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.12 76.31 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.37 -0.684 . . . . 0.0 112.924 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -76.19 9.88 2.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.589 1.194 . . . . 0.0 114.184 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.3 m -127.37 152.31 47.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.65 0.659 . . . . 0.0 110.671 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 t -111.27 139.61 46.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.5 m -140.54 148.34 40.88 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 123.659 0.784 . . . . 0.0 109.783 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.54 164.46 11.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.821 0.448 . . . . 0.0 111.652 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.75 142.99 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 123.906 0.883 . . . . 0.0 110.113 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.11 156.48 91.74 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 122.898 0.479 . . . . 0.0 110.964 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.57 163.03 90.74 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 O-C-N 121.901 0.422 . . . . 0.0 111.347 -1.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.15 68.85 48.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.767 0.827 . . . . 0.0 110.38 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -62.6 159.97 34.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.464 2.776 . . . . 0.0 111.614 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -74.57 159.44 32.16 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.883 0.473 . . . . 0.0 112.025 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.259 -1.353 . . . . 0.0 109.952 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.83 -0.063 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.79 174.33 12.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.699 2.932 . . . . 0.0 110.392 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 m -122.06 134.63 54.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.337 0.025 0 C-N-CA 123.379 0.672 . . . . 0.0 110.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -143.31 162.44 35.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.639 1.176 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.11 13.84 70.42 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.777 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.5 mt -58.62 -26.33 63.6 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 117.83 0.815 . . . . 0.0 111.974 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -85.75 7.31 24.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.4 -24.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 122.843 0.457 . . . . 0.0 110.978 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -103.62 -18.79 14.59 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 m -143.07 -19.76 0.64 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.35 -176.65 32.93 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 tp -59.14 -27.35 65.55 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.297 0.639 . . . . 0.0 111.791 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.166 -0.334 . . . . 0.0 111.214 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.46 31.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.057 -0.402 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -69.47 -31.58 69.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -78.27 -36.3 46.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.555 0.342 . . . . 0.0 110.87 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.83 -23.93 61.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.899 0.124 . . . . 0.0 110.783 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -81.31 -34.72 31.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.881 0.31 . . . . 0.0 110.656 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -77.49 -28.09 52.07 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.561 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -85.83 4.24 38.02 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.793 0.437 . . . . 0.0 111.462 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -123.98 165.7 16.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -72.22 134.09 45.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.001 -0.437 . . . . 0.0 110.034 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.04 170.18 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.187 0.595 . . . . 0.0 110.449 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -72.57 137.36 46.16 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.44 -163.24 22.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.02 -17.43 25.08 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.42 -0.459 . . . . 0.0 112.135 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.79 -4.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.93 0.492 . . . . 0.0 111.898 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.71 -147.11 5.83 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.0 m -125.92 140.88 52.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.132 0.466 . . . . 0.0 110.797 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.47 170.26 6.32 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.049 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.38 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.84 150.4 45.97 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 124.841 1.256 . . . . 0.0 107.83 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -127.82 -174.09 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.181 0.446 . . . . 0.0 111.506 -175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -105.96 -28.15 10.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -156.94 -178.06 7.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.656 0.662 . . . . 0.0 109.772 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.64 168.37 25.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -153.35 170.15 21.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.423 1.089 . . . . 0.0 108.721 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.1 m -109.02 145.69 35.16 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.9 p -133.47 -178.25 4.91 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.381 0.672 . . . . 0.0 110.979 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.73 -176.65 26.33 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -66.61 -22.02 66.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.899 0.479 . . . . 0.0 112.23 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -144.44 20.74 1.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.853 0.297 . . . . 0.0 111.306 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.07 19.75 79.69 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 121.971 -0.456 . . . . 0.0 112.177 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -82.03 3.0 28.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.802 0.801 . . . . 0.0 112.973 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.8 m -119.15 153.21 35.23 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.092 0.557 . . . . 0.0 109.777 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.6 t -110.17 136.86 48.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.007 0.523 . . . . 0.0 110.33 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -139.94 147.23 40.23 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 109.861 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.86 164.95 11.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.584 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.0 mm -112.88 145.48 18.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 123.907 0.883 . . . . 0.0 110.292 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -72.94 155.64 90.35 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.866 0.466 . . . . 0.0 110.825 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.19 164.58 87.41 Favored 'Cis proline' 0 N--CA 1.455 -0.769 0 CA-C-N 118.321 0.436 . . . . 0.0 111.42 -1.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -137.42 69.66 54.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 123.505 0.722 . . . . 0.0 110.329 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.3 163.39 26.58 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.901 3.067 . . . . 0.0 111.76 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -74.76 160.58 30.54 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.498 0.719 . . . . 0.0 111.672 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.859 179.527 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.02 177.67 8.45 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.315 3.343 . . . . 0.0 110.915 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -118.19 137.59 52.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -142.39 147.31 36.0 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.657 0.383 . . . . 0.0 110.902 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -141.9 163.42 32.94 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.802 1.241 . . . . 0.0 109.047 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.85 16.79 72.72 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.395 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.54 -28.41 68.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.884 0.842 . . . . 0.0 111.462 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.1 m -81.31 5.56 16.92 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.21 -13.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.768 0.427 . . . . 0.0 111.54 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -126.19 -16.58 5.46 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 m -140.39 -19.15 0.87 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.55 -175.94 39.44 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.95 -27.83 65.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.055 0.542 . . . . 0.0 112.003 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -61.11 -36.49 79.85 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.873 0.306 . . . . 0.0 111.143 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.04 -29.22 35.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.995 0.361 . . . . 0.0 110.648 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 t -70.22 -31.03 68.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -80.64 -33.52 35.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.552 0.341 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.8 -28.81 61.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -78.21 -33.34 50.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.709 0.231 . . . . 0.0 110.855 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.97 -28.4 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.534 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.81 -20.18 36.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.56 0.618 . . . . 0.0 111.105 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 m -90.85 163.49 14.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.61 134.55 42.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -144.04 169.83 17.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.055 0.542 . . . . 0.0 110.042 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -73.77 140.16 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.343 0.257 . . . . 0.0 111.192 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.77 -166.48 14.77 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.94 -17.27 31.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.781 0.432 . . . . 0.0 112.156 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.81 -10.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.754 0.422 . . . . 0.0 111.685 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.08 47.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.3 m -83.86 140.78 31.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.674 0.737 . . . . 0.0 111.286 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -145.15 169.65 7.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -140.77 154.01 46.09 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -127.36 -173.81 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.889 0.476 . . . . 0.0 111.44 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -98.33 -39.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -150.18 -175.06 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.592 0.757 . . . . 0.0 110.201 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.92 167.54 30.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 112.059 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.47 164.22 38.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.959 0.904 . . . . 0.0 109.216 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.9 m -94.57 142.2 27.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -135.2 -176.34 4.23 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.443 0.697 . . . . 0.0 111.027 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.21 -177.27 28.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -67.42 -21.88 65.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.736 0.414 . . . . 0.0 112.093 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -145.17 22.97 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.68 17.59 80.05 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.885 -0.509 . . . . 0.0 111.978 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 p -81.64 6.62 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.8 m -126.98 158.15 37.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.94 0.496 . . . . 0.0 109.952 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.6 t -115.36 138.17 51.27 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.313 0.645 . . . . 0.0 109.977 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.0 m -140.53 146.24 37.86 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.559 0.744 . . . . 0.0 109.981 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -98.7 164.79 12.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.844 0.458 . . . . 0.0 111.388 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.28 146.06 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.231 1.013 . . . . 0.0 109.937 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -76.27 155.34 84.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.39 0.276 . . . . 0.0 111.056 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.43 165.26 86.2 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 CA-C-N 118.257 0.413 . . . . 0.0 111.649 -0.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 76.2 m -135.9 70.46 64.18 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.674 0.79 . . . . 0.0 109.96 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.41 162.44 27.28 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.841 3.027 . . . . 0.0 111.877 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -74.15 160.14 31.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.878 0.471 . . . . 0.0 111.625 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.316 -1.326 . . . . 0.0 109.723 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 175.21 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.112 3.208 . . . . 0.0 111.183 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -118.61 119.96 36.03 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -144.71 135.81 25.08 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.403 0.681 . . . . 0.0 109.279 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -131.99 -14.92 3.04 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.202 0.601 . . . . 0.0 111.225 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.75 11.16 67.37 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.632 0.634 . . . . 0.0 112.531 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.99 -25.63 65.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.719 0.76 . . . . 0.0 112.288 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.82 3.6 16.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.567 0.347 . . . . 0.0 111.908 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.75 -25.63 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 122.99 0.516 . . . . 0.0 110.835 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -89.96 -15.25 32.37 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -155.04 -37.91 0.09 Allowed 'General case' 0 C--O 1.23 0.079 0 C-N-CA 122.53 0.332 . . . . 0.0 111.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.16 -165.65 13.64 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.02 -26.95 66.5 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.735 0.414 . . . . 0.0 111.591 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -62.67 -39.19 93.17 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 121.913 -0.492 . . . . 0.0 111.277 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.45 -29.98 42.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.328 0.513 . . . . 0.0 110.863 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.74 -32.35 72.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -78.49 -35.9 45.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.196 -0.315 . . . . 0.0 110.653 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.38 -17.02 62.43 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.72 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -90.71 -30.78 16.89 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.186 0.594 . . . . 0.0 111.258 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.33 -21.37 39.24 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.035 -0.416 . . . . 0.0 110.749 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -86.13 4.08 39.9 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.511 0.724 . . . . 0.0 111.35 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.2 p -131.62 169.61 15.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.088 0.955 . . . . 0.0 108.841 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -75.15 134.67 41.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.58 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -145.73 169.99 17.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.837 0.855 . . . . 0.0 109.891 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -73.32 139.54 46.11 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 122.44 -0.163 . . . . 0.0 111.16 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.8 -166.8 14.38 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.367 0.984 . . . . 0.0 111.031 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.25 -13.05 53.65 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.0 -10.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.645 0.378 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.05 179.98 45.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -80.92 142.52 33.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.616 0.708 . . . . 0.0 111.279 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 m -145.08 169.27 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.843 0.857 . . . . 0.0 110.8 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.97 151.76 49.38 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -130.91 -175.25 3.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 112.024 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.9 p -97.07 -36.91 10.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -154.45 -174.78 5.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.023 0.529 . . . . 0.0 109.609 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 166.94 30.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.426 0.632 . . . . 0.0 112.518 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.25 165.82 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.9 0.88 . . . . 0.0 109.246 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.39 143.9 29.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -137.15 -178.64 5.3 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.881 0.872 . . . . 0.0 111.212 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.94 -176.7 23.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.05 -23.02 66.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.144 0.578 . . . . 0.0 111.854 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.96 20.9 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.26 -0.275 . . . . 0.0 111.24 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.39 17.82 80.08 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.7 p -82.62 7.9 13.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.7 m -127.78 151.5 48.94 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.838 0.455 . . . . 0.0 110.381 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -104.35 140.21 38.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.525 0.73 . . . . 0.0 110.655 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -141.45 147.76 38.42 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.686 0.795 . . . . 0.0 110.046 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.98 162.97 12.5 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.874 0.369 . . . . 0.0 111.247 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.2 147.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.698 0.799 . . . . 0.0 110.315 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -75.42 154.5 85.9 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.794 0.438 . . . . 0.0 111.109 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.74 164.47 88.13 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 O-C-N 121.819 0.378 . . . . 0.0 111.715 -1.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 63.5 m -136.48 70.8 60.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.736 0.815 . . . . 0.0 110.192 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.19 160.65 29.72 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.649 2.9 . . . . 0.0 111.438 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.08 160.38 29.1 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.895 0.478 . . . . 0.0 111.95 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.188 -179.638 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.87 175.59 10.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.518 3.479 . . . . 0.0 111.523 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -112.86 121.95 46.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.132 0.573 . . . . 0.0 110.004 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -139.97 137.62 34.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.079 0.952 . . . . 0.0 109.315 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.92 -11.87 1.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.397 0.679 . . . . 0.0 111.352 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.43 10.4 74.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.416 0.531 . . . . 0.0 112.482 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.04 -24.9 64.92 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 117.431 0.615 . . . . 0.0 112.39 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.1 m -77.35 2.34 16.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.37 -23.74 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 122.827 0.451 . . . . 0.0 111.394 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.1 p -97.27 -21.36 17.3 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.322 0.51 . . . . 0.0 112.207 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.4 m -145.93 -22.18 0.45 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 -177.46 25.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.46 -29.51 69.09 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.177 0.591 . . . . 0.0 111.665 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -62.02 -34.93 77.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.004 -0.435 . . . . 0.0 111.142 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -30.51 38.99 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.072 -0.393 . . . . 0.0 110.13 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.7 t -68.78 -31.67 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -78.9 -32.36 45.73 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.896 0.478 . . . . 0.0 111.035 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -78.03 -24.13 47.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.246 0.218 . . . . 0.0 111.353 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -81.71 -35.86 29.3 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 122.185 -0.322 . . . . 0.0 110.896 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.8 m -74.92 -24.18 58.46 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.734 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.62 13.99 14.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.891 0.476 . . . . 0.0 111.167 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -134.01 168.36 18.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.824 0.85 . . . . 0.0 109.098 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -73.31 123.22 23.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -140.2 164.36 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.049 0.54 . . . . 0.0 109.859 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -73.54 134.99 43.93 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.269 -0.269 . . . . 0.0 110.583 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.0 -152.78 25.0 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.02 -19.24 27.43 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.89 -10.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.969 0.508 . . . . 0.0 112.112 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.19 173.04 45.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.4 m -79.81 141.26 36.39 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 117.582 0.691 . . . . 0.0 111.458 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.62 169.05 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 110.163 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -136.87 151.6 49.28 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.649 1.18 . . . . 0.0 108.088 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.7 m -128.04 -173.44 2.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.993 0.361 . . . . 0.0 111.83 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 t -99.01 -36.43 9.72 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.9 -175.22 5.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.54 167.14 31.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.931 0.396 . . . . 0.0 111.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.47 165.33 36.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.787 0.835 . . . . 0.0 109.667 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -99.1 140.7 32.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.6 p -137.68 -178.41 5.23 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.652 0.781 . . . . 0.0 110.752 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.76 -172.65 16.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -66.81 -23.03 66.0 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 111.781 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -146.78 21.71 1.28 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 111.294 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.83 79.13 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 112.085 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -81.65 7.03 13.35 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -129.83 145.57 51.58 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.689 0.677 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -95.37 141.74 28.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.652 0.781 . . . . 0.0 110.291 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.7 m -143.63 145.19 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.212 0.605 . . . . 0.0 109.991 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.87 164.61 12.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 111.422 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.24 136.48 53.07 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.061 0 C-N-CA 123.964 0.905 . . . . 0.0 109.763 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.81 159.01 86.74 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 122.989 0.516 . . . . 0.0 111.185 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.57 161.57 65.89 Favored 'Cis proline' 0 N--CA 1.459 -0.535 0 CA-C-N 118.741 0.586 . . . . 0.0 113.073 -2.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.82 71.33 36.21 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.54 165.06 23.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.62 2.88 . . . . 0.0 111.583 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.47 164.65 25.25 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.072 -178.844 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 178.09 7.93 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.288 3.325 . . . . 0.0 110.619 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -123.01 122.87 39.57 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.759 0.424 . . . . 0.0 110.151 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.58 130.65 20.65 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.474 0.709 . . . . 0.0 109.233 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -126.76 -15.11 5.53 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.373 0.669 . . . . 0.0 111.452 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.52 11.1 59.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.733 0.683 . . . . 0.0 112.839 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 -17.33 64.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.527 0.664 . . . . 0.0 112.177 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.3 m -96.96 2.36 51.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.16 0.436 . . . . 0.0 112.046 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.54 -29.92 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.06 0.391 . . . . 0.0 111.478 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -154.48 -26.95 0.12 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -80.09 -20.42 45.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.199 -0.313 . . . . 0.0 111.766 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.05 171.9 48.29 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.12 0.867 . . . . 0.0 112.386 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.57 -28.74 68.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.164 0.585 . . . . 0.0 111.147 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -61.7 -33.8 74.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.153 -0.342 . . . . 0.0 110.722 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.75 -31.26 40.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.232 -0.293 . . . . 0.0 110.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.9 t -71.34 -29.66 65.25 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -79.23 -33.48 43.66 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 122.194 -0.316 . . . . 0.0 110.935 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -22.88 59.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.207 0.203 . . . . 0.0 110.76 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -82.76 -32.51 27.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.893 0.477 . . . . 0.0 110.743 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -80.38 -25.17 39.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.431 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -86.15 9.36 17.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.783 0.433 . . . . 0.0 111.059 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -131.13 170.26 14.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.1 m -78.13 132.69 37.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -145.02 170.63 15.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.583 0.753 . . . . 0.0 109.726 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -74.48 140.07 44.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.166 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.69 -169.55 15.24 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -86.37 -12.5 49.08 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.16 -10.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.811 0.445 . . . . 0.0 111.854 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.1 44.08 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.72 140.84 34.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.496 0.648 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.7 168.62 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.101 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -138.48 148.77 44.72 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 107.703 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -128.58 -171.68 2.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.038 0.381 . . . . 0.0 111.906 -172.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.2 t -103.46 -39.4 6.77 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -146.67 -175.43 4.79 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.574 0.75 . . . . 0.0 110.416 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 168.09 28.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.83 165.54 35.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.323 1.049 . . . . 0.0 109.539 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.25 143.01 30.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.5 p -138.62 -176.64 4.55 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.681 0.792 . . . . 0.0 110.943 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.93 178.18 25.58 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.65 -20.57 66.02 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.11 0.564 . . . . 0.0 111.968 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -141.54 18.38 2.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.661 0.267 . . . . 0.0 111.329 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.67 80.61 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.1 p -83.21 10.46 8.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.982 0.913 . . . . 0.0 113.09 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 m -126.14 151.77 46.83 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.368 0.531 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -108.71 140.19 42.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.501 0.72 . . . . 0.0 109.769 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.5 m -140.89 147.19 38.51 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.297 0.639 . . . . 0.0 110.071 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.59 165.97 10.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mm -116.8 142.3 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 124.202 1.001 . . . . 0.0 110.516 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -67.76 156.43 89.17 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 122.894 0.477 . . . . 0.0 111.224 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 162.43 91.73 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 O-C-N 121.761 0.348 . . . . 0.0 111.337 -1.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -137.51 68.9 53.61 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.826 0.851 . . . . 0.0 110.499 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.91 164.66 21.13 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.718 2.945 . . . . 0.0 111.189 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.17 167.07 22.38 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.462 0.649 . . . . 0.0 112.085 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.087 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.6 177.21 8.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.219 3.279 . . . . 0.0 111.497 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -115.89 130.98 57.06 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 109.825 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.07 142.28 31.5 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.7 mmm180 -131.13 -23.53 2.43 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.73 17.0 58.07 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.358 0.504 . . . . 0.0 113.59 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.04 -24.71 59.44 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.884 0.842 . . . . 0.0 112.747 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.83 6.92 19.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.393 0.542 . . . . 0.0 111.843 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.32 -25.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.514 0.726 . . . . 0.0 110.374 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -89.05 -15.49 33.9 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.97 -0.457 . . . . 0.0 111.423 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -153.61 -38.91 0.1 Allowed 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.632 0.253 . . . . 0.0 111.062 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.81 -167.92 15.12 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.82 -27.15 66.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.635 0.374 . . . . 0.0 111.327 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -60.91 -41.24 95.75 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 122.07 -0.394 . . . . 0.0 111.283 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.75 -28.62 44.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.998 -0.439 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.1 -32.69 72.27 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -79.13 -36.25 40.84 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 122.369 0.268 . . . . 0.0 110.776 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -73.3 -17.73 61.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.0 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -89.79 -30.99 17.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.601 0.361 . . . . 0.0 111.108 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.3 m -77.87 -25.14 48.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.545 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -88.93 8.32 29.98 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.949 0.5 . . . . 0.0 111.351 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p -130.58 169.28 15.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 108.593 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.5 m -74.82 131.62 40.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.754 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.58 167.07 23.41 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.985 0.914 . . . . 0.0 109.162 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.53 124.31 26.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 -158.29 34.4 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.11 -21.18 36.85 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.59 -10.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.794 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 173.61 45.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -76.06 140.24 41.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.042 0.921 . . . . 0.0 111.482 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.93 169.7 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 124.233 1.013 . . . . 0.0 110.691 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -137.68 149.96 46.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.7 m -129.22 -172.31 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.159 0.436 . . . . 0.0 111.501 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -103.3 -37.52 7.62 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -151.15 -176.13 5.43 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.17 168.34 26.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -153.87 168.58 25.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.915 1.286 . . . . 0.0 108.657 173.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.17 148.6 25.58 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.193 -0.317 . . . . 0.0 110.622 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -135.12 179.96 5.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.548 0.739 . . . . 0.0 110.796 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 177.22 29.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.03 -19.69 63.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.746 0.419 . . . . 0.0 111.947 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.42 13.93 3.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.066 0.546 . . . . 0.0 111.658 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.06 16.23 78.5 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.287 -0.325 . . . . 0.0 112.287 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.6 p -80.49 6.13 13.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.681 0.792 . . . . 0.0 113.072 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.6 m -122.81 154.39 38.29 Favored 'General case' 0 CA--C 1.526 0.022 0 C-N-CA 122.95 0.5 . . . . 0.0 110.139 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.7 t -107.35 141.39 38.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.585 0.754 . . . . 0.0 110.566 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -142.34 147.15 35.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.395 0.678 . . . . 0.0 109.971 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.6 m -101.53 164.55 11.7 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.872 0.368 . . . . 0.0 111.512 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.98 143.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -70.23 156.28 92.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 122.92 0.488 . . . . 0.0 110.868 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.84 162.87 91.26 Favored 'Cis proline' 0 N--CA 1.451 -1.012 0 O-C-N 121.959 0.452 . . . . 0.0 111.378 -1.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.8 m -136.94 69.25 57.83 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.562 0.745 . . . . 0.0 110.367 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.09 162.96 24.25 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.587 2.858 . . . . 0.0 111.623 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -76.61 159.98 29.81 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.869 0.468 . . . . 0.0 111.592 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.99 178.895 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 p . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.9 174.22 12.71 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.872 3.048 . . . . 0.0 110.962 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.8 m -115.87 121.47 42.47 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.0 138.78 30.27 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 123.741 0.816 . . . . 0.0 109.211 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.19 -16.18 1.08 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.673 0.389 . . . . 0.0 111.7 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.24 11.45 71.01 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.586 0.613 . . . . 0.0 112.491 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.0 -27.05 63.16 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.53 0.665 . . . . 0.0 112.395 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.0 t -74.94 -6.09 47.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.666 0.386 . . . . 0.0 111.536 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.01 -22.76 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.166 -0.334 . . . . 0.0 111.319 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 p -98.69 -21.16 16.56 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -144.93 -22.66 0.5 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.56 179.68 23.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.92 -27.84 68.49 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.221 0.608 . . . . 0.0 111.787 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -63.09 -33.79 76.2 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.976 -0.453 . . . . 0.0 110.857 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.09 -30.25 43.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.891 -0.506 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.69 -31.0 67.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.48 -29.07 46.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.344 0.258 . . . . 0.0 110.959 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.71 -16.48 51.06 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.067 0.147 . . . . 0.0 111.005 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -87.39 -33.59 19.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.074 -0.391 . . . . 0.0 110.967 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.59 -26.36 45.42 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.195 -0.316 . . . . 0.0 111.815 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -87.16 9.75 19.01 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.116 0.416 . . . . 0.0 111.28 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -133.18 166.78 21.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.484 1.113 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.8 m -72.48 133.45 44.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.551 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -145.64 169.63 18.07 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.591 0.756 . . . . 0.0 109.766 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -74.3 136.72 42.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.217 0.207 . . . . 0.0 111.079 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 -159.61 19.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.123 0.868 . . . . 0.0 111.098 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.79 -18.32 33.27 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.28 -11.37 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 122.569 0.348 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.99 178.61 48.61 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -81.48 142.84 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.64 0.72 . . . . 0.0 111.328 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -146.48 169.48 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.698 0.799 . . . . 0.0 110.418 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.7 150.27 47.19 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.1 m -130.16 -174.61 3.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.059 0.391 . . . . 0.0 111.462 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 -27.54 11.95 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.05 -177.31 6.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.693 0.678 . . . . 0.0 109.814 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.08 169.5 22.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.64 168.95 24.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.665 1.186 . . . . 0.0 109.037 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.7 t -110.93 142.56 42.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -132.42 173.15 11.59 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.026 -175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.82 177.77 15.31 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -72.2 -20.61 61.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.877 0.339 . . . . 0.0 111.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.12 9.94 3.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.082 0.953 . . . . 0.0 110.709 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.12 83.87 0.24 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -140.29 4.91 2.04 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.2 m -132.81 147.68 52.31 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.314 0.506 . . . . 0.0 110.323 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.3 t -94.01 137.95 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.084 0.554 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -138.01 145.17 41.53 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.414 0.686 . . . . 0.0 109.555 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.42 162.7 12.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 143.86 18.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.726 0.81 . . . . 0.0 110.049 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -72.7 155.16 91.1 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 122.888 0.475 . . . . 0.0 110.99 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.61 165.43 85.62 Favored 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.605 0.538 . . . . 0.0 111.249 -0.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.61 69.8 38.13 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.051 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.8 161.67 28.07 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.785 2.99 . . . . 0.0 111.322 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -76.5 161.42 28.64 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.851 0.358 . . . . 0.0 111.642 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.283 -1.342 . . . . 0.0 109.916 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 177.14 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 124.786 3.657 . . . . 0.0 111.487 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m -108.62 125.86 52.32 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.379 0.672 . . . . 0.0 109.576 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -138.88 133.31 31.77 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.45 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -130.88 -16.97 3.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.5 67.82 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.339 0.495 . . . . 0.0 112.879 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.16 -27.46 68.41 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 117.564 0.682 . . . . 0.0 112.01 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.7 m -80.24 5.33 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.09 -24.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 122.613 0.365 . . . . 0.0 111.497 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -100.09 -15.65 18.12 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.7 t -149.86 -35.07 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.04 -164.53 12.03 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.97 -27.15 66.59 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.948 0.499 . . . . 0.0 111.794 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 m -62.39 -40.76 97.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.86 -0.525 . . . . 0.0 111.125 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.09 46.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.411 0.55 . . . . 0.0 110.626 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -68.0 -33.28 74.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -78.7 -35.93 44.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.261 0.224 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -72.43 -17.47 61.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.942 -0.117 . . . . 0.0 111.17 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -90.05 -32.04 16.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.578 0.351 . . . . 0.0 110.79 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.39 -25.65 42.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.574 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -85.89 5.2 34.0 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.3 0.5 . . . . 0.0 111.249 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.9 m -127.73 165.97 19.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.57 1.148 . . . . 0.0 107.946 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.43 137.33 39.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.806 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -146.18 167.92 22.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.351 1.06 . . . . 0.0 108.834 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -73.87 134.31 43.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.154 -0.342 . . . . 0.0 110.635 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.69 -152.24 24.94 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -88.64 -17.95 29.0 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.766 0.427 . . . . 0.0 112.135 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.75 -12.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.687 0.395 . . . . 0.0 112.051 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 175.37 47.59 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -78.03 142.58 38.13 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.425 0.612 . . . . 0.0 111.602 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.09 165.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 124.006 0.922 . . . . 0.0 110.621 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -132.96 144.51 50.17 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 124.763 1.225 . . . . 0.0 107.946 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.53 -172.47 2.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.613 0.365 . . . . 0.0 111.335 -172.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 t -103.48 -36.6 7.92 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.41 -177.3 5.99 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.24 167.95 28.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -154.25 164.53 38.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.083 0.953 . . . . 0.0 109.548 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.7 m -96.44 143.26 27.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -137.89 -177.4 4.8 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.662 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.29 -179.07 48.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -65.7 138.92 58.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.533 . . . . 0.0 109.946 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp 52.92 17.21 0.83 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.078 0.951 . . . . 0.0 112.483 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.87 77.35 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.92 -0.488 . . . . 0.0 112.164 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -76.19 10.06 2.19 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 153.29 48.46 Favored 'General case' 0 C--O 1.228 -0.069 0 CA-C-N 118.501 0.591 . . . . 0.0 110.355 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 t -108.98 141.37 41.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.684 0.794 . . . . 0.0 110.021 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.6 m -142.42 146.76 35.2 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.158 0.583 . . . . 0.0 109.727 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.1 m -100.46 164.41 11.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.787 0.435 . . . . 0.0 111.327 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.41 142.53 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.172 0.989 . . . . 0.0 110.237 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -70.78 155.77 92.92 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.215 0.606 . . . . 0.0 111.267 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.09 165.33 86.2 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 118.176 0.384 . . . . 0.0 111.529 -1.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.59 67.76 44.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.762 0.825 . . . . 0.0 110.388 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.66 167.66 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.013 3.142 . . . . 0.0 111.286 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -78.47 172.69 13.28 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.882 0.473 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.241 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.588 0.232 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 174.01 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.132 3.221 . . . . 0.0 111.328 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -111.43 126.72 55.24 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.897 0.479 . . . . 0.0 109.868 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -139.82 135.23 32.78 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -140.25 161.87 36.64 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.686 0.795 . . . . 0.0 109.433 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.89 15.35 78.26 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.436 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.98 -23.27 63.48 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 117.665 0.733 . . . . 0.0 111.687 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.1 m -74.43 0.72 13.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.811 0.444 . . . . 0.0 111.831 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 -23.19 2.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.042 0.383 . . . . 0.0 111.416 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -97.94 -20.1 17.65 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -149.94 -24.1 0.26 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.09 178.51 22.07 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.31 -28.05 67.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.661 0.385 . . . . 0.0 111.857 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -61.46 -33.29 73.5 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.881 -0.512 . . . . 0.0 110.88 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.15 -30.4 49.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.959 -0.463 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.43 -29.07 46.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.402 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.16 -34.06 72.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -74.4 -28.95 61.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.255 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -78.81 -35.02 44.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.1 m -75.49 -30.59 59.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.642 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -81.68 -15.99 52.72 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.493 0.588 . . . . 0.0 111.623 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -99.83 170.49 8.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -80.18 139.38 36.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.192 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -147.37 170.19 17.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.146 0.578 . . . . 0.0 109.923 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 tpt85 -74.27 122.05 22.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.72 -160.89 36.96 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.01 -17.44 37.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.928 0.364 . . . . 0.0 111.918 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.7 -11.56 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.39 177.22 48.37 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.09 137.34 35.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.666 0.733 . . . . 0.0 111.82 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.07 166.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 C-N-CA 123.708 0.803 . . . . 0.0 110.562 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -134.07 149.48 51.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.3 -170.12 2.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.084 0.554 . . . . 0.0 111.23 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -104.67 -35.73 7.7 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.68 -175.14 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.8 163.77 39.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.938 -0.476 . . . . 0.0 111.868 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -151.64 160.36 43.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.673 0.789 . . . . 0.0 109.545 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -91.1 140.71 29.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -131.52 178.8 6.46 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.939 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.78 173.49 30.6 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.07 -18.97 61.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.277 -0.543 . . . . 0.0 111.987 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 14.03 3.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.417 0.687 . . . . 0.0 111.352 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 16.01 78.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 122.037 -0.414 . . . . 0.0 112.072 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -78.38 4.83 11.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.48 0.712 . . . . 0.0 112.554 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 m -133.85 162.59 31.6 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t -130.17 158.12 40.57 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.183 -0.323 . . . . 0.0 110.892 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -143.03 136.57 28.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.727 0.811 . . . . 0.0 109.361 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -87.37 159.43 18.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.749 0.309 . . . . 0.0 110.351 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -106.75 140.15 25.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.372 0.669 . . . . 0.0 110.32 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -68.08 155.37 92.19 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.469 0.708 . . . . 0.0 110.928 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.95 166.09 83.83 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 -0.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 72.4 m -138.04 66.88 47.65 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 110.372 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.81 165.91 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.887 3.058 . . . . 0.0 111.504 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -75.71 167.88 21.05 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.937 0.495 . . . . 0.0 110.564 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.16 -1.4 . . . . 0.0 111.562 -178.669 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 177.58 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.36 3.373 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -118.36 135.7 54.17 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -140.71 146.51 37.89 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.086 0.554 . . . . 0.0 110.1 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -142.09 161.97 36.66 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.701 1.2 . . . . 0.0 108.815 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.67 14.31 72.44 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.749 -0.473 . . . . 0.0 112.98 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.9 -26.18 61.83 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.823 0.811 . . . . 0.0 111.604 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.2 t -75.67 -4.18 38.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.648 0.379 . . . . 0.0 111.88 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.29 -27.24 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.565 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.91 -21.09 20.78 Favored 'General case' 0 N--CA 1.458 -0.048 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -145.86 -22.4 0.46 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.03 178.96 24.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.11 -27.94 64.17 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.023 0.529 . . . . 0.0 111.704 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -62.32 -32.71 73.5 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.022 -0.424 . . . . 0.0 111.246 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.18 -29.77 34.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.952 -0.467 . . . . 0.0 110.717 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.0 -31.84 69.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -78.17 -31.32 49.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.806 0.443 . . . . 0.0 111.098 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.19 -23.02 44.15 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.301 0.241 . . . . 0.0 111.238 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -82.29 -33.01 29.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.933 0.333 . . . . 0.0 111.245 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.6 m -76.91 -23.42 52.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.448 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.17 5.85 42.8 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.791 0.436 . . . . 0.0 111.69 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -126.99 166.76 16.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.8 m -72.66 131.82 42.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.102 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -142.95 170.14 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 109.464 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -75.1 139.28 42.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.369 -0.207 . . . . 0.0 111.193 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.74 -168.08 15.79 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -17.44 37.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.828 0.451 . . . . 0.0 112.206 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.5 -10.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.86 0.464 . . . . 0.0 111.708 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.09 178.76 45.2 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.5 m -80.99 142.29 33.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.88 168.54 7.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.524 0.73 . . . . 0.0 110.773 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.09 150.65 45.95 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.7 m -127.53 -173.81 3.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.184 0.447 . . . . 0.0 111.487 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 m -104.92 -30.55 9.75 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -155.19 -177.36 6.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.449 0.568 . . . . 0.0 109.6 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.95 170.18 21.03 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.139 0.495 . . . . 0.0 112.257 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -151.84 166.36 31.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.34 1.056 . . . . 0.0 109.213 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.3 t -106.5 139.75 40.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -137.08 -171.53 2.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.809 0.844 . . . . 0.0 111.03 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.37 173.74 26.11 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.75 -21.02 63.48 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.973 0.509 . . . . 0.0 111.772 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -144.9 24.81 1.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.684 0.22 . . . . 0.0 111.393 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.68 32.38 57.38 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.7 p -101.29 12.21 37.88 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -133.05 154.02 50.94 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.517 0.327 . . . . 0.0 110.762 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -116.9 139.43 50.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.795 0.838 . . . . 0.0 109.489 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -139.34 143.98 38.03 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.126 0.57 . . . . 0.0 109.783 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -100.86 164.68 11.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.659 0.384 . . . . 0.0 111.515 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.31 145.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.791 0.836 . . . . 0.0 110.399 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.42 155.74 89.4 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.973 0.509 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.9 162.96 91.12 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 118.49 0.497 . . . . 0.0 111.687 -1.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.3 m -136.56 69.8 60.08 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.698 0.799 . . . . 0.0 109.976 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.62 162.82 26.47 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.054 3.17 . . . . 0.0 111.507 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -75.38 161.33 29.35 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.966 0.506 . . . . 0.0 111.471 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.013 179.561 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.34 174.41 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 124.357 3.371 . . . . 0.0 111.792 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -113.36 135.43 53.87 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -142.99 147.62 35.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 122.212 0.205 . . . . 0.0 110.717 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -142.31 164.47 30.07 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 124.801 1.24 . . . . 0.0 109.504 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.78 16.85 74.66 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.969 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.9 -29.03 68.08 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.036 0.918 . . . . 0.0 111.152 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.4 m -81.92 6.08 17.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.097 0.559 . . . . 0.0 112.092 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.61 -15.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.684 0.394 . . . . 0.0 111.923 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -123.29 -18.39 6.29 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 m -139.12 -18.27 1.02 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -177.49 39.63 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.7 tp -58.41 -27.57 64.41 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.21 0.604 . . . . 0.0 111.825 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -61.66 -34.21 75.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.238 -0.289 . . . . 0.0 111.246 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.77 -28.2 30.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.226 0.466 . . . . 0.0 110.981 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.16 -31.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -78.8 -33.51 46.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -77.57 -22.44 50.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.312 0.245 . . . . 0.0 111.334 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -84.43 -32.78 23.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.845 0.293 . . . . 0.0 111.179 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.8 m -77.79 -22.63 49.85 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.411 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.34 6.07 42.17 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.866 0.467 . . . . 0.0 111.821 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.5 p -127.86 165.45 20.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.29 131.08 42.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.139 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -142.78 167.13 22.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.678 0.791 . . . . 0.0 109.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.68 123.69 26.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.2 -160.15 36.24 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.61 -14.4 45.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.01 -11.82 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 122.594 0.358 . . . . 0.0 111.881 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.89 45.54 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -76.59 140.22 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.082 0.941 . . . . 0.0 111.55 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.96 169.23 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.516 0.726 . . . . 0.0 110.733 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -138.29 151.05 47.24 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.95 -172.41 2.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.326 0.512 . . . . 0.0 111.635 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -102.48 -35.95 8.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -153.95 -175.92 5.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.98 168.43 26.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 112.078 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.96 163.83 39.75 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.894 0.878 . . . . 0.0 109.539 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.8 m -93.72 142.41 27.39 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.2 p -137.67 -178.52 5.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.458 0.703 . . . . 0.0 111.008 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 -176.97 52.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.01 134.24 56.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt 50.86 20.13 0.73 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.981 0.912 . . . . 0.0 113.229 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.38 76.64 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.229 0.468 . . . . 0.0 112.345 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.9 p -75.53 8.76 2.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 155.84 42.0 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.588 0.631 . . . . 0.0 110.085 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.7 t -112.52 138.83 48.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.303 0.641 . . . . 0.0 110.159 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 m -141.32 145.8 35.92 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.008 0.523 . . . . 0.0 110.025 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.914 0.388 . . . . 0.0 111.42 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mm -112.4 143.18 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.798 0.839 . . . . 0.0 110.047 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -71.01 156.06 92.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 0.0 111.068 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 162.83 91.44 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 O-C-N 121.883 0.412 . . . . 0.0 111.387 -1.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.7 m -136.08 69.69 63.35 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.591 0.757 . . . . 0.0 109.772 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.66 161.77 30.74 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.383 2.722 . . . . 0.0 111.074 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.17 161.37 28.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.693 0.397 . . . . 0.0 111.681 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.62 -1.181 . . . . 0.0 110.146 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.94 178.46 7.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.365 3.377 . . . . 0.0 111.231 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -117.41 133.38 56.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.563 0.745 . . . . 0.0 109.246 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -142.79 142.82 31.96 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.657 0.383 . . . . 0.0 110.043 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -142.81 164.76 29.23 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.386 1.074 . . . . 0.0 109.207 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.79 18.7 77.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.489 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.28 -14.41 55.74 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.522 0.661 . . . . 0.0 112.332 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.04 -3.25 41.74 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.062 0.392 . . . . 0.0 111.635 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.24 -27.62 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 O-C-N 121.909 -0.494 . . . . 0.0 111.549 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -154.44 -26.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -83.8 -20.38 33.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.151 0.432 . . . . 0.0 111.992 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.22 170.44 45.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.104 0.859 . . . . 0.0 112.408 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.6 -28.17 68.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.846 0.459 . . . . 0.0 111.078 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -62.0 -32.5 72.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.212 -0.305 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.35 45.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.068 -0.395 . . . . 0.0 110.501 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.2 t -74.05 -30.9 62.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -77.44 -28.96 52.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.615 0.366 . . . . 0.0 111.051 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.56 -30.66 41.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.999 0.187 . . . . 0.0 110.899 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -76.34 -32.5 58.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.756 0.253 . . . . 0.0 111.187 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 98.9 m -76.48 -28.48 56.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.322 -0.371 . . . . 0.0 111.575 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -85.17 -20.53 30.09 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.365 0.529 . . . . 0.0 111.769 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -94.34 166.19 12.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.8 m -75.95 136.55 40.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.581 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -144.61 170.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -75.19 140.61 43.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.135 0.174 . . . . 0.0 111.407 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.63 -170.58 16.68 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.58 -14.42 48.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.53 -18.38 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.867 0.467 . . . . 0.0 111.149 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.99 176.8 44.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -75.17 144.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.612 0.706 . . . . 0.0 111.548 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.79 171.7 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.25 1.02 . . . . 0.0 110.463 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -141.66 153.07 44.47 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.7 m -123.83 -175.26 3.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 111.491 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -103.81 -29.58 10.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -155.92 -177.51 6.63 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.446 0.566 . . . . 0.0 109.756 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.0 170.03 22.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.273 0.558 . . . . 0.0 111.785 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -152.65 165.76 34.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.399 1.08 . . . . 0.0 109.028 173.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.0 t -107.99 141.51 39.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -130.6 179.73 5.77 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.586 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 168.63 45.06 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.83 132.09 47.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.47 -0.429 . . . . 0.0 110.295 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt 52.53 14.71 0.42 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.427 1.091 . . . . 0.0 112.749 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.73 102.0 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.99 0.805 . . . . 0.0 111.521 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 p -144.82 4.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.877 0.471 . . . . 0.0 111.551 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.3 m -134.05 152.25 51.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.603 0.361 . . . . 0.0 110.216 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.78 138.13 47.56 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.171 0.589 . . . . 0.0 110.271 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.1 m -139.45 140.96 37.45 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.88 164.12 12.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.377 0.271 . . . . 0.0 111.043 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.84 143.03 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 124.055 0.942 . . . . 0.0 110.448 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -73.55 157.05 88.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 122.939 0.496 . . . . 0.0 111.105 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.72 164.01 88.44 Favored 'Cis proline' 0 N--CA 1.455 -0.784 0 O-C-N 121.87 0.405 . . . . 0.0 111.575 -2.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 95.1 m -134.67 70.63 71.5 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 124.1 0.96 . . . . 0.0 109.906 177.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.73 167.28 15.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.248 3.299 . . . . 0.0 112.018 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -69.45 163.25 25.71 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.276 0.63 . . . . 0.0 111.557 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.525 175.735 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.34 -179.08 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.428 3.418 . . . . 0.0 110.581 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -125.32 122.41 36.77 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 122.804 0.441 . . . . 0.0 110.15 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -144.74 139.02 27.6 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.963 0.905 . . . . 0.0 109.431 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -137.77 -12.08 1.52 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.687 0.395 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.55 12.22 70.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.584 0.611 . . . . 0.0 112.581 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.77 -25.61 63.22 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.668 0.734 . . . . 0.0 112.609 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.9 t -86.39 10.14 15.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.16 0.436 . . . . 0.0 111.811 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -17.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 123.024 0.529 . . . . 0.0 111.252 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.3 p -120.59 -17.11 8.15 Favored 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 m -140.51 -19.51 0.85 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 -173.68 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.344 0.497 . . . . 0.0 112.069 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.38 -26.6 68.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.161 0.584 . . . . 0.0 111.751 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -63.45 -36.17 82.86 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.759 -0.588 . . . . 0.0 110.664 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.6 36.3 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.002 0.365 . . . . 0.0 110.703 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 t -68.62 -30.86 69.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -79.08 -35.46 42.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.259 -0.276 . . . . 0.0 110.691 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -19.57 60.92 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.918 0.136 . . . . 0.0 111.031 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.49 -33.35 21.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.447 0.299 . . . . 0.0 110.675 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.36 -26.49 46.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.554 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -87.13 8.02 25.57 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 122.865 0.466 . . . . 0.0 111.305 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -130.89 167.23 19.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.539 1.136 . . . . 0.0 108.347 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.3 m -73.2 133.82 44.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.047 -0.408 . . . . 0.0 110.41 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.95 170.91 15.66 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.887 0.875 . . . . 0.0 109.554 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -73.54 140.38 46.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.234 0.214 . . . . 0.0 111.14 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.81 -168.1 14.76 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -86.63 -17.09 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.86 -16.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.852 0.461 . . . . 0.0 110.907 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.79 48.07 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.6 m -80.29 142.18 34.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.833 0.816 . . . . 0.0 110.895 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.22 169.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.782 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -138.44 150.5 46.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.422 1.089 . . . . 0.0 108.16 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.9 m -128.18 -172.49 2.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.242 0.617 . . . . 0.0 111.212 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.2 m -107.54 -29.85 8.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -154.16 -178.97 7.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.729 0.695 . . . . 0.0 109.799 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 168.1 26.97 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.281 0.562 . . . . 0.0 112.348 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -153.93 168.09 27.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.992 1.317 . . . . 0.0 108.757 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.4 m -105.0 146.29 29.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -132.79 179.59 6.07 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.476 0.71 . . . . 0.0 111.0 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 176.37 28.6 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -68.89 -18.01 64.06 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.37 13.3 3.51 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.074 0.55 . . . . 0.0 111.667 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.68 17.7 78.27 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.909 -0.477 . . . . 0.0 111.909 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.6 p -83.15 9.55 10.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 113.009 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.9 m -125.65 150.82 47.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.0 t -102.66 141.69 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.484 0.714 . . . . 0.0 110.125 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.5 m -143.66 147.36 34.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.719 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -101.22 164.45 11.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.97 143.97 20.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.065 0.946 . . . . 0.0 109.632 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -72.46 156.09 90.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 122.832 0.453 . . . . 0.0 110.691 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.66 166.08 83.91 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 122.041 0.495 . . . . 0.0 111.441 -1.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.58 70.31 45.17 Favored Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 123.491 0.716 . . . . 0.0 110.069 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.9 163.43 22.18 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.798 2.998 . . . . 0.0 111.733 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -76.35 161.99 28.25 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.07 179.711 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.11 174.91 11.64 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 124.232 3.288 . . . . 0.0 111.57 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -111.15 134.63 52.6 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.306 0.642 . . . . 0.0 109.696 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -143.95 142.75 30.91 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.958 0.503 . . . . 0.0 110.023 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -142.09 163.69 32.18 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.062 0.945 . . . . 0.0 109.512 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.68 17.95 75.36 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.389 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.41 -27.31 67.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.754 0.777 . . . . 0.0 111.405 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.63 4.37 16.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.047 0.539 . . . . 0.0 112.192 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -14.8 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 122.889 0.476 . . . . 0.0 111.62 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -121.48 -19.6 6.88 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 m -140.71 -19.36 0.83 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.34 -173.47 34.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.565 0.602 . . . . 0.0 111.761 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -59.82 -28.08 67.17 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.014 0.526 . . . . 0.0 111.933 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -60.7 -36.2 78.22 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 122.052 -0.405 . . . . 0.0 110.988 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.1 27.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.067 0.394 . . . . 0.0 110.792 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.5 t -68.05 -31.47 71.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -80.12 -36.96 34.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.231 -0.293 . . . . 0.0 110.999 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.74 -18.65 61.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.927 0.142 . . . . 0.0 111.325 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -87.64 -35.69 17.88 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 117.871 0.305 . . . . 0.0 110.574 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.5 m -75.48 -28.4 59.2 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.84 3.26 34.5 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.391 . . . . 0.0 111.97 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -126.01 163.73 22.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.9 m -71.12 133.3 46.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.137 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -145.08 167.33 22.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 124.78 28.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.379 -0.201 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.79 -158.55 34.51 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 123.752 0.692 . . . . 0.0 111.389 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.67 -20.25 31.56 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.496 -0.414 . . . . 0.0 112.093 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.32 -12.39 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.58 0.352 . . . . 0.0 111.651 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.8 175.4 46.51 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.5 m -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.019 0.909 . . . . 0.0 111.875 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -142.9 167.86 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.032 0.933 . . . . 0.0 110.745 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -139.71 144.1 37.37 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.4 -173.69 2.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.133 0.424 . . . . 0.0 111.47 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -103.4 -35.85 8.22 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -152.7 -176.36 5.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.47 168.25 27.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 111.647 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -153.62 163.39 40.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.876 0.87 . . . . 0.0 109.321 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.54 142.57 27.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.4 p -132.34 -179.71 5.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 111.122 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.92 177.06 30.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.37 -18.78 63.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 112.002 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.35 14.52 3.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.069 0.547 . . . . 0.0 111.387 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.13 15.69 78.63 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -80.62 8.33 8.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.6 m -125.26 155.34 40.29 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 122.914 0.486 . . . . 0.0 110.075 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -114.34 139.36 49.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.584 0.754 . . . . 0.0 110.063 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -142.95 144.5 32.39 Favored 'General case' 0 C--O 1.228 -0.058 0 C-N-CA 122.921 0.488 . . . . 0.0 109.919 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.27 162.23 13.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.964 0.412 . . . . 0.0 111.274 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.64 145.62 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 123.918 0.887 . . . . 0.0 110.127 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -73.59 156.18 88.79 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.061 0.544 . . . . 0.0 111.609 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.57 165.37 85.84 Favored 'Cis proline' 0 N--CA 1.451 -1.004 0 CA-C-N 118.188 0.388 . . . . 0.0 111.288 -2.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.0 m -137.14 67.45 55.16 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.729 0.812 . . . . 0.0 110.287 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.69 168.84 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.961 3.107 . . . . 0.0 112.052 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -70.64 165.01 23.77 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.549 0.739 . . . . 0.0 111.661 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 176.88 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.93 175.48 11.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.842 3.028 . . . . 0.0 111.098 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -117.23 127.8 54.45 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -141.52 146.01 35.85 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.266 0.627 . . . . 0.0 110.157 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -143.14 165.52 27.2 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 109.354 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.71 17.33 74.91 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.594 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.21 -23.19 65.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.555 0.678 . . . . 0.0 112.033 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.64 3.67 15.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.723 0.409 . . . . 0.0 111.594 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.6 -27.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 122.879 0.472 . . . . 0.0 111.088 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.5 p -87.63 -15.18 38.01 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 122.09 -0.381 . . . . 0.0 111.789 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -154.21 -40.25 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.352 0.261 . . . . 0.0 111.283 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.15 -167.73 16.41 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.96 -27.88 65.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.874 0.47 . . . . 0.0 111.715 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 m -61.7 -40.43 95.0 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.288 -0.257 . . . . 0.0 111.291 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -28.05 41.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.895 -0.503 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.7 -32.53 71.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -80.03 -36.18 36.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.16 -0.337 . . . . 0.0 110.949 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -71.6 -21.78 61.81 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.167 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -87.51 -31.88 19.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.633 0.373 . . . . 0.0 111.315 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.02 -27.5 54.6 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.584 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -83.96 -14.76 50.05 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.541 0.609 . . . . 0.0 111.652 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.8 p -101.02 168.44 9.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -78.38 139.51 38.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.611 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -145.8 170.58 16.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 109.394 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -72.91 139.27 46.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.465 0.174 . . . . 0.0 111.001 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.92 -172.79 16.4 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.176 0.893 . . . . 0.0 111.0 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -83.69 -12.68 55.56 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.87 -17.68 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 110.987 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.06 -179.77 45.2 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.4 m -78.02 141.59 38.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.739 0.769 . . . . 0.0 111.041 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.06 163.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.759 0.823 . . . . 0.0 110.8 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -135.43 147.24 48.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.91 -174.3 2.67 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.995 0.518 . . . . 0.0 111.117 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 -30.24 10.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.77 -177.97 6.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.289 0.495 . . . . 0.0 109.856 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 168.46 26.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 111.842 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -153.18 165.83 34.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.788 0.835 . . . . 0.0 109.434 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.3 m -98.64 143.03 29.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -131.99 179.46 6.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.714 0.806 . . . . 0.0 110.801 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.17 176.05 30.35 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -69.48 -18.15 63.68 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.805 0.442 . . . . 0.0 112.05 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.33 13.45 3.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.011 0.524 . . . . 0.0 111.451 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.07 16.68 78.47 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -81.26 7.96 10.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.6 m -125.79 154.16 42.98 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 122.896 0.478 . . . . 0.0 110.304 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 t -111.71 140.57 46.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.484 0.713 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.8 m -143.51 143.74 31.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.433 0.693 . . . . 0.0 109.582 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.9 162.82 13.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.033 0.445 . . . . 0.0 111.189 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -107.34 142.0 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 123.714 0.806 . . . . 0.0 109.801 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.25 156.03 89.52 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 122.59 0.356 . . . . 0.0 110.974 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.03 168.61 76.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 118.265 0.416 . . . . 0.0 111.739 -1.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.74 69.11 37.31 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.641 0.777 . . . . 0.0 109.725 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.77 171.7 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.064 3.176 . . . . 0.0 112.268 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -66.75 169.82 7.38 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.666 0.786 . . . . 0.0 110.529 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.222 -1.37 . . . . 0.0 111.655 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -78.84 -6.01 54.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.589 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.4 p -149.43 74.53 9.69 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.802 0.841 . . . . 0.0 110.006 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.16 176.62 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.529 3.486 . . . . 0.0 111.921 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 m -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.186 0.594 . . . . 0.0 109.828 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.39 132.43 22.97 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.24 -10.72 1.69 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.907 0.483 . . . . 0.0 111.988 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.28 13.43 61.86 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 123.656 0.646 . . . . 0.0 112.427 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.53 -17.16 64.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.875 0.838 . . . . 0.0 112.643 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.4 m -94.46 3.33 55.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.081 0.4 . . . . 0.0 111.742 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.32 -29.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-N 118.19 0.45 . . . . 0.0 111.476 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 t -156.12 -26.41 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -79.49 -20.01 48.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.085 -0.384 . . . . 0.0 111.817 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.86 172.48 48.38 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.809 0.719 . . . . 0.0 112.99 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.13 -28.65 69.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.94 0.496 . . . . 0.0 110.852 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -63.07 -33.7 76.0 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.064 -0.398 . . . . 0.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.21 -33.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.6 t -69.73 -30.89 68.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -79.04 -31.26 44.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.888 0.475 . . . . 0.0 110.744 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.56 -30.64 52.76 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.072 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -76.73 -34.42 58.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.841 0.291 . . . . 0.0 110.609 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.7 m -74.39 -24.31 59.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.326 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -89.3 -8.78 52.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.321 0.51 . . . . 0.0 111.397 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -102.99 165.43 11.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 109.303 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.77 125.07 25.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -142.71 169.53 17.41 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.838 0.455 . . . . 0.0 109.997 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpt85 -73.97 126.8 31.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.247 0.219 . . . . 0.0 110.737 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.76 -159.97 33.85 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -82.54 -21.3 35.4 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.94 -10.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.682 0.393 . . . . 0.0 111.74 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.48 171.79 44.52 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.0 m -73.8 142.49 46.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.89 0.845 . . . . 0.0 111.423 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.36 167.86 3.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.409 1.083 . . . . 0.0 110.205 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -136.24 149.88 48.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.61 -173.1 2.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.888 0.475 . . . . 0.0 111.648 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -98.53 -36.89 9.77 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.03 -174.81 4.99 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.043 -0.41 . . . . 0.0 109.993 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.67 167.15 31.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.866 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.46 163.67 39.84 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.012 0.925 . . . . 0.0 109.146 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.7 m -94.98 143.65 26.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -135.9 -179.34 5.6 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.902 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.48 173.41 25.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -69.74 -19.77 63.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.974 0.51 . . . . 0.0 111.755 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.78 14.01 4.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.209 0.604 . . . . 0.0 111.177 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 15.31 78.61 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.6 p -82.82 13.57 3.79 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.883 0.873 . . . . 0.0 113.094 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -130.88 150.18 52.16 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.906 -0.496 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.9 t -107.18 143.78 34.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.915 0.886 . . . . 0.0 109.422 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.4 m -144.3 145.96 32.31 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.063 0.545 . . . . 0.0 109.941 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.16 163.94 12.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.783 0.433 . . . . 0.0 111.631 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.91 134.86 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.595 0.758 . . . . 0.0 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -70.02 159.62 83.58 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.017 0.527 . . . . 0.0 110.799 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -64.9 162.82 64.19 Favored 'Cis proline' 0 N--CA 1.459 -0.509 0 CA-C-N 118.692 0.568 . . . . 0.0 113.259 -2.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 96.7 m -140.82 69.46 29.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 110.265 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.11 168.83 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.158 3.239 . . . . 0.0 112.041 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.26 164.25 23.2 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.898 0.479 . . . . 0.0 111.444 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.586 178.777 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.9 12.99 2.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.072 0.549 . . . . 0.0 111.399 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.21 87.63 4.91 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.225 0.61 . . . . 0.0 110.614 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.64 177.68 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.053 3.169 . . . . 0.0 110.345 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -125.85 128.86 48.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.549 0.34 . . . . 0.0 110.13 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -141.14 134.74 30.05 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.885 0.874 . . . . 0.0 109.143 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -138.78 163.08 33.13 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.7 0.8 . . . . 0.0 109.213 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 15.87 76.65 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.17 -25.26 63.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.435 0.617 . . . . 0.0 111.409 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -76.28 2.61 12.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.884 0.474 . . . . 0.0 111.715 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -124.84 -24.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 122.869 0.468 . . . . 0.0 111.238 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -98.9 -21.14 16.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -146.71 -22.05 0.42 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -178.02 26.0 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -58.82 -28.01 65.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.185 0.594 . . . . 0.0 111.68 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.6 m -61.34 -34.85 75.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.025 -0.422 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.52 -31.99 28.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.848 0.294 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.1 t -67.22 -31.85 72.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -79.17 -36.65 40.02 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.187 -0.321 . . . . 0.0 110.768 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -69.99 -22.6 63.12 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.913 -0.089 . . . . 0.0 110.976 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -82.17 -35.83 27.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.671 0.214 . . . . 0.0 110.832 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.11 -24.61 54.96 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.455 0.302 . . . . 0.0 111.616 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.04 6.34 22.46 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.377 0.671 . . . . 0.0 111.226 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -133.29 169.8 16.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.84 131.82 39.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -145.11 171.13 14.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.71 0.404 . . . . 0.0 110.364 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -78.35 137.1 37.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.16 -170.9 17.12 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -88.69 -11.42 45.25 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.3 t -129.83 -16.46 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.031 0.532 . . . . 0.0 111.081 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.11 44.6 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.5 m -82.24 139.55 34.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.203 -0.587 . . . . 0.0 111.058 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.31 168.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.274 0.63 . . . . 0.0 111.639 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -139.06 143.24 38.28 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -127.2 -175.32 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.499 0.591 . . . . 0.0 112.289 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -100.59 -35.03 9.65 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -154.46 -175.11 5.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.82 167.35 30.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.26 165.18 37.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.964 0.906 . . . . 0.0 109.356 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.7 m -95.35 143.53 26.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.3 p -135.8 179.57 6.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.117 0.567 . . . . 0.0 111.105 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.56 179.68 49.77 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.8 136.87 57.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.4 mt 52.22 16.66 0.6 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.921 0.888 . . . . 0.0 113.229 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.7 75.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.972 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -74.81 3.1 8.64 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.193 0.997 . . . . 0.0 113.613 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 48.6 m -121.8 155.71 34.73 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.538 0.608 . . . . 0.0 110.256 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.4 t -112.49 139.3 48.19 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.577 0.751 . . . . 0.0 109.959 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.7 m -142.41 146.1 34.52 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.346 0.658 . . . . 0.0 109.846 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.02 165.02 11.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.986 0.514 . . . . 0.0 111.48 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.75 145.32 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 110.408 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -70.4 156.06 92.48 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.915 0.486 . . . . 0.0 110.852 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.97 162.64 91.82 Favored 'Cis proline' 0 N--CA 1.454 -0.847 0 CA-C-N 118.274 0.419 . . . . 0.0 111.146 -2.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.8 m -137.65 68.99 52.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 109.942 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.83 167.44 13.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.936 3.091 . . . . 0.0 112.094 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.37 164.2 26.72 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.293 0.637 . . . . 0.0 111.802 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.991 176.334 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 111.114 0.042 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -139.44 17.31 2.56 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.574 0.75 . . . . 0.0 111.266 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p -147.16 93.41 4.72 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 122.667 0.387 . . . . 0.0 110.84 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.77 171.47 18.16 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.975 3.117 . . . . 0.0 109.955 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.2 m -118.59 120.74 38.36 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -136.09 137.16 40.79 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 123.796 0.838 . . . . 0.0 109.407 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -139.94 162.49 35.05 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.09 17.31 78.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.51 -24.24 63.48 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.484 0.642 . . . . 0.0 111.918 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.4 m -76.53 2.87 12.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.075 0.55 . . . . 0.0 111.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.73 -25.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 122.737 0.415 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -95.21 -21.16 18.65 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.017 -0.427 . . . . 0.0 111.968 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -146.27 -21.84 0.44 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -177.43 25.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.31 -29.26 65.75 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 m -62.59 -34.22 76.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 111.141 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.59 -30.39 32.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.94 -0.475 . . . . 0.0 110.583 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.86 -30.77 69.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -81.0 -30.24 35.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.489 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.62 -22.29 43.84 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.505 -0.122 . . . . 0.0 111.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.55 -35.95 24.37 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.252 -0.28 . . . . 0.0 110.782 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.4 m -73.98 -26.14 60.3 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.462 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -88.61 8.98 25.73 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.959 0.345 . . . . 0.0 111.494 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -127.97 164.93 21.25 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.888 0.875 . . . . 0.0 108.993 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.6 t -69.7 127.09 31.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -143.49 168.16 20.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.792 0.437 . . . . 0.0 110.538 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.54 133.8 37.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.567 0.347 . . . . 0.0 111.037 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.86 -163.48 23.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -86.84 -11.36 51.06 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.77 -11.92 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.627 0.371 . . . . 0.0 111.893 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.75 177.57 47.46 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.0 m -86.94 139.91 30.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.663 0.731 . . . . 0.0 111.45 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.31 166.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.377 0.671 . . . . 0.0 110.611 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -135.01 148.3 49.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.8 m -126.88 -174.01 3.03 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.971 0.351 . . . . 0.0 111.755 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -100.5 -33.39 10.36 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.28 -175.14 5.28 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.46 167.62 29.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.61 164.99 37.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.981 0.912 . . . . 0.0 109.501 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.8 142.6 27.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.4 p -137.26 -177.88 4.97 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.732 0.813 . . . . 0.0 110.981 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.76 -175.91 53.16 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.8 134.27 56.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 51.18 18.89 0.64 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.102 0.961 . . . . 0.0 113.275 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 22.23 77.25 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.334 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -75.42 7.61 3.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -125.31 153.23 43.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.423 0.556 . . . . 0.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.9 t -108.9 138.94 44.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.538 0.735 . . . . 0.0 110.146 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.0 m -141.0 147.17 38.27 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 123.008 0.523 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -100.87 162.88 12.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.121 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.71 141.01 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.793 0.837 . . . . 0.0 110.035 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -68.86 155.35 93.52 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.159 0.583 . . . . 0.0 111.088 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.52 164.49 87.09 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 118.23 0.403 . . . . 0.0 111.351 -1.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.2 m -139.11 68.32 41.03 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.509 0.724 . . . . 0.0 110.192 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.77 164.08 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.675 2.916 . . . . 0.0 111.874 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.54 160.77 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.896 0.478 . . . . 0.0 111.43 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.702 -178.785 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -80.12 6.98 10.16 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.128 0.571 . . . . 0.0 110.826 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p -150.59 84.68 5.48 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 123.682 0.793 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.17 178.34 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.921 3.081 . . . . 0.0 110.731 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -122.6 128.57 50.86 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.846 0.458 . . . . 0.0 110.157 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -143.62 144.91 32.11 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.699 0.799 . . . . 0.0 109.16 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.6 mmm180 -133.27 -23.88 1.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 17.4 58.63 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.75 0.69 . . . . 0.0 113.604 -173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.72 -25.76 63.25 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.971 0.886 . . . . 0.0 112.623 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.9 m -79.53 4.65 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 111.936 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.63 -25.41 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.111 0.565 . . . . 0.0 111.181 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.5 p -89.11 -15.58 33.56 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -154.73 -36.61 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.689 0.396 . . . . 0.0 111.384 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -165.36 13.03 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.4 -27.6 67.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.479 -0.424 . . . . 0.0 111.751 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -62.81 -39.63 94.88 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.772 -0.58 . . . . 0.0 111.0 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -28.77 48.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.181 0.446 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.33 -32.83 70.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -78.56 -31.99 47.59 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.443 0.297 . . . . 0.0 110.8 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -77.14 -20.17 55.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.483 -0.136 . . . . 0.0 110.838 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -86.24 -31.43 21.69 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.638 0.375 . . . . 0.0 110.875 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.4 m -80.16 -29.89 38.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.259 -0.401 . . . . 0.0 111.925 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.51 -15.71 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.54 0.609 . . . . 0.0 111.036 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -102.99 169.64 8.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -77.69 141.44 39.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -146.54 171.97 14.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.132 0.973 . . . . 0.0 109.609 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -73.43 139.36 45.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.589 0.233 . . . . 0.0 111.271 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.5 -169.34 15.27 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.908 0.766 . . . . 0.0 111.199 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.68 -14.82 36.41 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.771 0.429 . . . . 0.0 112.015 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.2 -8.12 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 122.813 0.445 . . . . 0.0 111.616 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.93 179.26 42.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.72 140.31 34.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.579 0.69 . . . . 0.0 110.881 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.84 163.41 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.497 0.719 . . . . 0.0 110.989 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -133.68 147.34 51.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.22 -173.27 2.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.79 0.436 . . . . 0.0 111.568 -172.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -99.97 -35.75 9.62 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -154.13 -174.5 4.99 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.48 26.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.38 165.12 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.474 1.11 . . . . 0.0 109.508 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 100.0 m -99.03 144.8 27.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -136.95 -178.88 5.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.953 0.901 . . . . 0.0 111.106 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.65 -178.45 25.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.01 -22.89 67.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.047 0.539 . . . . 0.0 112.014 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -144.36 20.8 1.72 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.815 0.279 . . . . 0.0 111.676 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.68 17.78 79.57 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -81.29 7.1 12.28 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.4 m -128.02 153.27 46.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.811 0.444 . . . . 0.0 110.273 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 t -105.39 141.88 36.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.335 0.654 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 m -142.4 146.04 34.46 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.195 0.598 . . . . 0.0 110.101 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.94 162.96 12.52 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.886 0.474 . . . . 0.0 111.256 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -111.69 138.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.426 0.69 . . . . 0.0 110.007 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -67.46 156.1 89.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.22 0.608 . . . . 0.0 111.027 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.71 167.95 78.77 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 O-C-N 121.97 0.458 . . . . 0.0 111.382 -1.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 88.5 m -139.97 67.64 34.49 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.627 0.771 . . . . 0.0 110.063 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.61 170.88 14.17 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.317 3.345 . . . . 0.0 112.082 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -66.11 169.74 6.6 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.597 0.759 . . . . 0.0 110.715 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.17 -1.395 . . . . 0.0 111.363 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.63 10.84 6.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.23 0.612 . . . . 0.0 111.705 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 p -154.13 93.25 2.96 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.063 0.545 . . . . 0.0 110.957 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.52 173.11 15.06 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.428 2.752 . . . . 0.0 110.162 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.3 m -120.51 123.92 44.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.5 0.32 . . . . 0.0 110.197 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -143.77 138.63 28.91 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -138.87 -15.0 1.18 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.202 0.601 . . . . 0.0 111.716 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.1 13.21 62.05 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.554 0.597 . . . . 0.0 112.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.06 -17.35 63.29 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.683 0.741 . . . . 0.0 112.499 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.42 2.69 52.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.152 0.433 . . . . 0.0 111.95 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.11 -30.08 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 118.226 0.467 . . . . 0.0 111.603 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -155.45 -26.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -79.98 -19.75 47.13 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.137 -0.352 . . . . 0.0 111.591 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.69 171.34 47.65 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.942 0.782 . . . . 0.0 112.609 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.57 -28.25 68.32 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.831 0.452 . . . . 0.0 111.097 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -62.46 -33.08 74.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.865 0.302 . . . . 0.0 110.564 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -33.58 42.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.031 -0.418 . . . . 0.0 110.384 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.86 -29.67 68.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -79.43 -30.83 42.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.716 0.407 . . . . 0.0 111.079 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -77.53 -19.27 56.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.092 0.157 . . . . 0.0 111.128 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -87.43 -31.61 19.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.581 0.352 . . . . 0.0 111.108 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.7 m -80.37 -23.84 40.21 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -88.05 9.49 22.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.845 0.293 . . . . 0.0 111.117 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -132.8 170.53 15.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.222 1.009 . . . . 0.0 108.449 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.8 133.5 43.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.769 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -146.88 169.24 19.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.409 0.684 . . . . 0.0 110.019 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -75.08 139.48 42.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.058 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.48 -170.82 16.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.73 -13.27 54.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.02 -18.13 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 122.695 0.398 . . . . 0.0 111.25 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.94 179.58 47.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -82.95 141.56 32.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.915 0.857 . . . . 0.0 111.242 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -146.94 170.01 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.449 0.7 . . . . 0.0 110.829 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -136.15 146.02 46.45 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -126.29 -172.24 2.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.09 0.405 . . . . 0.0 112.062 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 t -103.37 -36.93 7.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.75 -174.87 4.99 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.89 167.85 28.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.19 164.85 37.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.418 1.087 . . . . 0.0 109.206 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.86 145.01 26.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -139.29 -178.52 5.4 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.526 0.73 . . . . 0.0 111.176 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.77 174.28 41.96 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.37 143.44 57.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 tp 54.5 11.73 0.45 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.72 0.808 . . . . 0.0 112.53 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.12 76.31 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.37 -0.684 . . . . 0.0 112.924 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -76.19 9.88 2.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.589 1.194 . . . . 0.0 114.184 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.3 m -127.37 152.31 47.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.65 0.659 . . . . 0.0 110.671 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 t -111.27 139.61 46.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.5 m -140.54 148.34 40.88 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 123.659 0.784 . . . . 0.0 109.783 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.54 164.46 11.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.821 0.448 . . . . 0.0 111.652 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.75 142.99 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 123.906 0.883 . . . . 0.0 110.113 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.11 156.48 91.74 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 122.898 0.479 . . . . 0.0 110.964 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.57 163.03 90.74 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 O-C-N 121.901 0.422 . . . . 0.0 111.347 -1.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.15 68.85 48.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.767 0.827 . . . . 0.0 110.38 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -62.6 159.97 34.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.464 2.776 . . . . 0.0 111.614 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -74.57 159.44 32.16 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.883 0.473 . . . . 0.0 112.025 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.259 -1.353 . . . . 0.0 109.952 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -70.6 -22.2 62.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.2 p -160.07 88.56 1.88 Allowed Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 122.486 0.314 . . . . 0.0 110.83 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.79 174.33 12.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.699 2.932 . . . . 0.0 110.392 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 m -122.06 134.63 54.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.337 0.025 0 C-N-CA 123.379 0.672 . . . . 0.0 110.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -143.31 162.44 35.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.639 1.176 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.11 13.84 70.42 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.777 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.5 mt -58.62 -26.33 63.6 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 117.83 0.815 . . . . 0.0 111.974 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -85.75 7.31 24.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.4 -24.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 122.843 0.457 . . . . 0.0 110.978 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -103.62 -18.79 14.59 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 m -143.07 -19.76 0.64 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.35 -176.65 32.93 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 tp -59.14 -27.35 65.55 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.297 0.639 . . . . 0.0 111.791 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.166 -0.334 . . . . 0.0 111.214 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.46 31.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.057 -0.402 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -69.47 -31.58 69.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -78.27 -36.3 46.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.555 0.342 . . . . 0.0 110.87 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.83 -23.93 61.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.899 0.124 . . . . 0.0 110.783 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -81.31 -34.72 31.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.881 0.31 . . . . 0.0 110.656 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -77.49 -28.09 52.07 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.561 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -85.83 4.24 38.02 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.793 0.437 . . . . 0.0 111.462 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -123.98 165.7 16.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -72.22 134.09 45.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.001 -0.437 . . . . 0.0 110.034 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.04 170.18 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.187 0.595 . . . . 0.0 110.449 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -72.57 137.36 46.16 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.44 -163.24 22.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.02 -17.43 25.08 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.42 -0.459 . . . . 0.0 112.135 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.79 -4.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.93 0.492 . . . . 0.0 111.898 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.71 -147.11 5.83 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.0 m -125.92 140.88 52.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.132 0.466 . . . . 0.0 110.797 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.47 170.26 6.32 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.049 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.38 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.84 150.4 45.97 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 124.841 1.256 . . . . 0.0 107.83 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -127.82 -174.09 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.181 0.446 . . . . 0.0 111.506 -175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -105.96 -28.15 10.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -156.94 -178.06 7.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.656 0.662 . . . . 0.0 109.772 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.64 168.37 25.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -153.35 170.15 21.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.423 1.089 . . . . 0.0 108.721 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.1 m -109.02 145.69 35.16 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.9 p -133.47 -178.25 4.91 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.381 0.672 . . . . 0.0 110.979 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.73 -176.65 26.33 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -66.61 -22.02 66.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.899 0.479 . . . . 0.0 112.23 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -144.44 20.74 1.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.853 0.297 . . . . 0.0 111.306 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.07 19.75 79.69 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 121.971 -0.456 . . . . 0.0 112.177 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -82.03 3.0 28.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.802 0.801 . . . . 0.0 112.973 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.8 m -119.15 153.21 35.23 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.092 0.557 . . . . 0.0 109.777 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.6 t -110.17 136.86 48.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.007 0.523 . . . . 0.0 110.33 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -139.94 147.23 40.23 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 109.861 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.86 164.95 11.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.584 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.0 mm -112.88 145.48 18.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 123.907 0.883 . . . . 0.0 110.292 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -72.94 155.64 90.35 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.866 0.466 . . . . 0.0 110.825 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.19 164.58 87.41 Favored 'Cis proline' 0 N--CA 1.455 -0.769 0 CA-C-N 118.321 0.436 . . . . 0.0 111.42 -1.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -137.42 69.66 54.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 123.505 0.722 . . . . 0.0 110.329 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.3 163.39 26.58 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.901 3.067 . . . . 0.0 111.76 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -74.76 160.58 30.54 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.498 0.719 . . . . 0.0 111.672 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.859 179.527 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -82.83 10.48 7.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.946 0.498 . . . . 0.0 110.876 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 p -148.15 84.64 6.71 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.009 0.523 . . . . 0.0 110.365 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.02 177.67 8.45 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.315 3.343 . . . . 0.0 110.915 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -118.19 137.59 52.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -142.39 147.31 36.0 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.657 0.383 . . . . 0.0 110.902 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -141.9 163.42 32.94 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.802 1.241 . . . . 0.0 109.047 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.85 16.79 72.72 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.395 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.54 -28.41 68.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.884 0.842 . . . . 0.0 111.462 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.1 m -81.31 5.56 16.92 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.21 -13.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.768 0.427 . . . . 0.0 111.54 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -126.19 -16.58 5.46 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 m -140.39 -19.15 0.87 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.55 -175.94 39.44 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.95 -27.83 65.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.055 0.542 . . . . 0.0 112.003 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -61.11 -36.49 79.85 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.873 0.306 . . . . 0.0 111.143 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.04 -29.22 35.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.995 0.361 . . . . 0.0 110.648 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 t -70.22 -31.03 68.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -80.64 -33.52 35.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.552 0.341 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.8 -28.81 61.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -78.21 -33.34 50.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.709 0.231 . . . . 0.0 110.855 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.97 -28.4 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.534 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.81 -20.18 36.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.56 0.618 . . . . 0.0 111.105 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 m -90.85 163.49 14.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.61 134.55 42.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -144.04 169.83 17.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.055 0.542 . . . . 0.0 110.042 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -73.77 140.16 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.343 0.257 . . . . 0.0 111.192 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.77 -166.48 14.77 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.94 -17.27 31.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.781 0.432 . . . . 0.0 112.156 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.81 -10.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.754 0.422 . . . . 0.0 111.685 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.08 47.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.3 m -83.86 140.78 31.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.674 0.737 . . . . 0.0 111.286 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -145.15 169.65 7.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -140.77 154.01 46.09 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -127.36 -173.81 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.889 0.476 . . . . 0.0 111.44 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -98.33 -39.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -150.18 -175.06 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.592 0.757 . . . . 0.0 110.201 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.92 167.54 30.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 112.059 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.47 164.22 38.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.959 0.904 . . . . 0.0 109.216 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.9 m -94.57 142.2 27.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -135.2 -176.34 4.23 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.443 0.697 . . . . 0.0 111.027 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.21 -177.27 28.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -67.42 -21.88 65.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.736 0.414 . . . . 0.0 112.093 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -145.17 22.97 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.68 17.59 80.05 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.885 -0.509 . . . . 0.0 111.978 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 p -81.64 6.62 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.8 m -126.98 158.15 37.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.94 0.496 . . . . 0.0 109.952 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.6 t -115.36 138.17 51.27 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.313 0.645 . . . . 0.0 109.977 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.0 m -140.53 146.24 37.86 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.559 0.744 . . . . 0.0 109.981 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -98.7 164.79 12.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.844 0.458 . . . . 0.0 111.388 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.28 146.06 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.231 1.013 . . . . 0.0 109.937 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -76.27 155.34 84.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.39 0.276 . . . . 0.0 111.056 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.43 165.26 86.2 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 CA-C-N 118.257 0.413 . . . . 0.0 111.649 -0.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 76.2 m -135.9 70.46 64.18 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.674 0.79 . . . . 0.0 109.96 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.41 162.44 27.28 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.841 3.027 . . . . 0.0 111.877 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -74.15 160.14 31.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.878 0.471 . . . . 0.0 111.625 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.316 -1.326 . . . . 0.0 109.723 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -79.58 8.59 6.17 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.759 0.424 . . . . 0.0 111.174 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.0 84.88 5.24 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.555 0.742 . . . . 0.0 110.436 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 175.21 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.112 3.208 . . . . 0.0 111.183 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -118.61 119.96 36.03 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -144.71 135.81 25.08 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.403 0.681 . . . . 0.0 109.279 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -131.99 -14.92 3.04 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.202 0.601 . . . . 0.0 111.225 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.75 11.16 67.37 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.632 0.634 . . . . 0.0 112.531 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.99 -25.63 65.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.719 0.76 . . . . 0.0 112.288 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.82 3.6 16.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.567 0.347 . . . . 0.0 111.908 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.75 -25.63 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 122.99 0.516 . . . . 0.0 110.835 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -89.96 -15.25 32.37 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -155.04 -37.91 0.09 Allowed 'General case' 0 C--O 1.23 0.079 0 C-N-CA 122.53 0.332 . . . . 0.0 111.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.16 -165.65 13.64 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.02 -26.95 66.5 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.735 0.414 . . . . 0.0 111.591 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -62.67 -39.19 93.17 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 121.913 -0.492 . . . . 0.0 111.277 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.45 -29.98 42.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.328 0.513 . . . . 0.0 110.863 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.74 -32.35 72.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -78.49 -35.9 45.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.196 -0.315 . . . . 0.0 110.653 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.38 -17.02 62.43 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.72 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -90.71 -30.78 16.89 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.186 0.594 . . . . 0.0 111.258 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.33 -21.37 39.24 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.035 -0.416 . . . . 0.0 110.749 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -86.13 4.08 39.9 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.511 0.724 . . . . 0.0 111.35 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.2 p -131.62 169.61 15.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.088 0.955 . . . . 0.0 108.841 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -75.15 134.67 41.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.58 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -145.73 169.99 17.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.837 0.855 . . . . 0.0 109.891 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -73.32 139.54 46.11 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 122.44 -0.163 . . . . 0.0 111.16 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.8 -166.8 14.38 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.367 0.984 . . . . 0.0 111.031 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.25 -13.05 53.65 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.0 -10.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.645 0.378 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.05 179.98 45.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -80.92 142.52 33.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.616 0.708 . . . . 0.0 111.279 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 m -145.08 169.27 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.843 0.857 . . . . 0.0 110.8 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.97 151.76 49.38 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -130.91 -175.25 3.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 112.024 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.9 p -97.07 -36.91 10.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -154.45 -174.78 5.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.023 0.529 . . . . 0.0 109.609 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 166.94 30.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.426 0.632 . . . . 0.0 112.518 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.25 165.82 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.9 0.88 . . . . 0.0 109.246 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.39 143.9 29.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -137.15 -178.64 5.3 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.881 0.872 . . . . 0.0 111.212 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.94 -176.7 23.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.05 -23.02 66.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.144 0.578 . . . . 0.0 111.854 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.96 20.9 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.26 -0.275 . . . . 0.0 111.24 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.39 17.82 80.08 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.7 p -82.62 7.9 13.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.7 m -127.78 151.5 48.94 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.838 0.455 . . . . 0.0 110.381 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -104.35 140.21 38.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.525 0.73 . . . . 0.0 110.655 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -141.45 147.76 38.42 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.686 0.795 . . . . 0.0 110.046 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.98 162.97 12.5 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.874 0.369 . . . . 0.0 111.247 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.2 147.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.698 0.799 . . . . 0.0 110.315 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -75.42 154.5 85.9 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.794 0.438 . . . . 0.0 111.109 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.74 164.47 88.13 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 O-C-N 121.819 0.378 . . . . 0.0 111.715 -1.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 63.5 m -136.48 70.8 60.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.736 0.815 . . . . 0.0 110.192 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.19 160.65 29.72 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.649 2.9 . . . . 0.0 111.438 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.08 160.38 29.1 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.895 0.478 . . . . 0.0 111.95 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.188 -179.638 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -143.54 154.37 43.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.819 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -147.63 80.68 8.9 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 122.985 0.514 . . . . 0.0 110.07 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.87 175.59 10.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.518 3.479 . . . . 0.0 111.523 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -112.86 121.95 46.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.132 0.573 . . . . 0.0 110.004 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -139.97 137.62 34.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.079 0.952 . . . . 0.0 109.315 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.92 -11.87 1.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.397 0.679 . . . . 0.0 111.352 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.43 10.4 74.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.416 0.531 . . . . 0.0 112.482 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.04 -24.9 64.92 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 117.431 0.615 . . . . 0.0 112.39 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.1 m -77.35 2.34 16.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.37 -23.74 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 122.827 0.451 . . . . 0.0 111.394 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.1 p -97.27 -21.36 17.3 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.322 0.51 . . . . 0.0 112.207 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.4 m -145.93 -22.18 0.45 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 -177.46 25.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.46 -29.51 69.09 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.177 0.591 . . . . 0.0 111.665 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -62.02 -34.93 77.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.004 -0.435 . . . . 0.0 111.142 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -30.51 38.99 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.072 -0.393 . . . . 0.0 110.13 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.7 t -68.78 -31.67 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -78.9 -32.36 45.73 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.896 0.478 . . . . 0.0 111.035 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -78.03 -24.13 47.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.246 0.218 . . . . 0.0 111.353 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -81.71 -35.86 29.3 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 122.185 -0.322 . . . . 0.0 110.896 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.8 m -74.92 -24.18 58.46 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.734 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.62 13.99 14.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.891 0.476 . . . . 0.0 111.167 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -134.01 168.36 18.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.824 0.85 . . . . 0.0 109.098 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -73.31 123.22 23.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -140.2 164.36 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.049 0.54 . . . . 0.0 109.859 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -73.54 134.99 43.93 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.269 -0.269 . . . . 0.0 110.583 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.0 -152.78 25.0 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.02 -19.24 27.43 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.89 -10.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.969 0.508 . . . . 0.0 112.112 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.19 173.04 45.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.4 m -79.81 141.26 36.39 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 117.582 0.691 . . . . 0.0 111.458 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.62 169.05 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 110.163 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -136.87 151.6 49.28 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.649 1.18 . . . . 0.0 108.088 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.7 m -128.04 -173.44 2.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.993 0.361 . . . . 0.0 111.83 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 t -99.01 -36.43 9.72 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.9 -175.22 5.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.54 167.14 31.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.931 0.396 . . . . 0.0 111.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.47 165.33 36.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.787 0.835 . . . . 0.0 109.667 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -99.1 140.7 32.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.6 p -137.68 -178.41 5.23 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.652 0.781 . . . . 0.0 110.752 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.76 -172.65 16.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -66.81 -23.03 66.0 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 111.781 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -146.78 21.71 1.28 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 111.294 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.83 79.13 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 112.085 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -81.65 7.03 13.35 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -129.83 145.57 51.58 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.689 0.677 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -95.37 141.74 28.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.652 0.781 . . . . 0.0 110.291 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.7 m -143.63 145.19 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.212 0.605 . . . . 0.0 109.991 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.87 164.61 12.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 111.422 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.24 136.48 53.07 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.061 0 C-N-CA 123.964 0.905 . . . . 0.0 109.763 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.81 159.01 86.74 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 122.989 0.516 . . . . 0.0 111.185 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.57 161.57 65.89 Favored 'Cis proline' 0 N--CA 1.459 -0.535 0 CA-C-N 118.741 0.586 . . . . 0.0 113.073 -2.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.82 71.33 36.21 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.54 165.06 23.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.62 2.88 . . . . 0.0 111.583 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.47 164.65 25.25 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.072 -178.844 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.31 6.91 7.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.618 0.367 . . . . 0.0 110.883 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.05 87.3 4.33 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 123.284 0.633 . . . . 0.0 110.482 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 178.09 7.93 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.288 3.325 . . . . 0.0 110.619 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -123.01 122.87 39.57 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.759 0.424 . . . . 0.0 110.151 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.58 130.65 20.65 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.474 0.709 . . . . 0.0 109.233 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -126.76 -15.11 5.53 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.373 0.669 . . . . 0.0 111.452 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.52 11.1 59.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.733 0.683 . . . . 0.0 112.839 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 -17.33 64.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.527 0.664 . . . . 0.0 112.177 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.3 m -96.96 2.36 51.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.16 0.436 . . . . 0.0 112.046 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.54 -29.92 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.06 0.391 . . . . 0.0 111.478 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -154.48 -26.95 0.12 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -80.09 -20.42 45.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.199 -0.313 . . . . 0.0 111.766 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.05 171.9 48.29 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.12 0.867 . . . . 0.0 112.386 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.57 -28.74 68.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.164 0.585 . . . . 0.0 111.147 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -61.7 -33.8 74.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.153 -0.342 . . . . 0.0 110.722 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.75 -31.26 40.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.232 -0.293 . . . . 0.0 110.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.9 t -71.34 -29.66 65.25 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -79.23 -33.48 43.66 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 122.194 -0.316 . . . . 0.0 110.935 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -22.88 59.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.207 0.203 . . . . 0.0 110.76 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -82.76 -32.51 27.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.893 0.477 . . . . 0.0 110.743 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -80.38 -25.17 39.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.431 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -86.15 9.36 17.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.783 0.433 . . . . 0.0 111.059 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -131.13 170.26 14.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.1 m -78.13 132.69 37.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -145.02 170.63 15.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.583 0.753 . . . . 0.0 109.726 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -74.48 140.07 44.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.166 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.69 -169.55 15.24 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -86.37 -12.5 49.08 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.16 -10.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.811 0.445 . . . . 0.0 111.854 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.1 44.08 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.72 140.84 34.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.496 0.648 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.7 168.62 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.101 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -138.48 148.77 44.72 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 107.703 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -128.58 -171.68 2.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.038 0.381 . . . . 0.0 111.906 -172.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.2 t -103.46 -39.4 6.77 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -146.67 -175.43 4.79 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.574 0.75 . . . . 0.0 110.416 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 168.09 28.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.83 165.54 35.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.323 1.049 . . . . 0.0 109.539 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.25 143.01 30.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.5 p -138.62 -176.64 4.55 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.681 0.792 . . . . 0.0 110.943 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.93 178.18 25.58 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.65 -20.57 66.02 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.11 0.564 . . . . 0.0 111.968 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -141.54 18.38 2.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.661 0.267 . . . . 0.0 111.329 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.67 80.61 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.1 p -83.21 10.46 8.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.982 0.913 . . . . 0.0 113.09 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 m -126.14 151.77 46.83 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.368 0.531 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -108.71 140.19 42.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.501 0.72 . . . . 0.0 109.769 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.5 m -140.89 147.19 38.51 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.297 0.639 . . . . 0.0 110.071 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.59 165.97 10.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mm -116.8 142.3 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 124.202 1.001 . . . . 0.0 110.516 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -67.76 156.43 89.17 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 122.894 0.477 . . . . 0.0 111.224 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 162.43 91.73 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 O-C-N 121.761 0.348 . . . . 0.0 111.337 -1.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -137.51 68.9 53.61 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.826 0.851 . . . . 0.0 110.499 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.91 164.66 21.13 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.718 2.945 . . . . 0.0 111.189 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.17 167.07 22.38 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.462 0.649 . . . . 0.0 112.085 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.087 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -143.47 157.66 44.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.826 0.85 . . . . 0.0 109.825 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.1 p -145.8 79.59 11.04 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.185 0.594 . . . . 0.0 110.232 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.6 177.21 8.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.219 3.279 . . . . 0.0 111.497 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -115.89 130.98 57.06 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 109.825 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.07 142.28 31.5 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.7 mmm180 -131.13 -23.53 2.43 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.73 17.0 58.07 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.358 0.504 . . . . 0.0 113.59 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.04 -24.71 59.44 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.884 0.842 . . . . 0.0 112.747 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.83 6.92 19.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.393 0.542 . . . . 0.0 111.843 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.32 -25.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.514 0.726 . . . . 0.0 110.374 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -89.05 -15.49 33.9 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.97 -0.457 . . . . 0.0 111.423 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -153.61 -38.91 0.1 Allowed 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.632 0.253 . . . . 0.0 111.062 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.81 -167.92 15.12 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.82 -27.15 66.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.635 0.374 . . . . 0.0 111.327 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -60.91 -41.24 95.75 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 122.07 -0.394 . . . . 0.0 111.283 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.75 -28.62 44.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.998 -0.439 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.1 -32.69 72.27 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -79.13 -36.25 40.84 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 122.369 0.268 . . . . 0.0 110.776 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -73.3 -17.73 61.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.0 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -89.79 -30.99 17.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.601 0.361 . . . . 0.0 111.108 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.3 m -77.87 -25.14 48.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.545 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -88.93 8.32 29.98 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.949 0.5 . . . . 0.0 111.351 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p -130.58 169.28 15.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 108.593 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.5 m -74.82 131.62 40.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.754 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.58 167.07 23.41 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.985 0.914 . . . . 0.0 109.162 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.53 124.31 26.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 -158.29 34.4 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.11 -21.18 36.85 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.59 -10.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.794 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 173.61 45.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -76.06 140.24 41.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.042 0.921 . . . . 0.0 111.482 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.93 169.7 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 124.233 1.013 . . . . 0.0 110.691 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -137.68 149.96 46.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.7 m -129.22 -172.31 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.159 0.436 . . . . 0.0 111.501 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -103.3 -37.52 7.62 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -151.15 -176.13 5.43 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.17 168.34 26.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -153.87 168.58 25.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.915 1.286 . . . . 0.0 108.657 173.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.17 148.6 25.58 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.193 -0.317 . . . . 0.0 110.622 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -135.12 179.96 5.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.548 0.739 . . . . 0.0 110.796 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 177.22 29.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.03 -19.69 63.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.746 0.419 . . . . 0.0 111.947 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.42 13.93 3.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.066 0.546 . . . . 0.0 111.658 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.06 16.23 78.5 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.287 -0.325 . . . . 0.0 112.287 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.6 p -80.49 6.13 13.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.681 0.792 . . . . 0.0 113.072 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.6 m -122.81 154.39 38.29 Favored 'General case' 0 CA--C 1.526 0.022 0 C-N-CA 122.95 0.5 . . . . 0.0 110.139 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.7 t -107.35 141.39 38.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.585 0.754 . . . . 0.0 110.566 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -142.34 147.15 35.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.395 0.678 . . . . 0.0 109.971 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.6 m -101.53 164.55 11.7 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.872 0.368 . . . . 0.0 111.512 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.98 143.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -70.23 156.28 92.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 122.92 0.488 . . . . 0.0 110.868 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.84 162.87 91.26 Favored 'Cis proline' 0 N--CA 1.451 -1.012 0 O-C-N 121.959 0.452 . . . . 0.0 111.378 -1.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.8 m -136.94 69.25 57.83 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.562 0.745 . . . . 0.0 110.367 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.09 162.96 24.25 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.587 2.858 . . . . 0.0 111.623 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -76.61 159.98 29.81 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.869 0.468 . . . . 0.0 111.592 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.99 178.895 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -80.79 5.66 15.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.125 0.57 . . . . 0.0 111.246 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 p -150.18 84.92 5.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.189 0.596 . . . . 0.0 110.11 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.9 174.22 12.71 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.872 3.048 . . . . 0.0 110.962 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.8 m -115.87 121.47 42.47 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.0 138.78 30.27 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 123.741 0.816 . . . . 0.0 109.211 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.19 -16.18 1.08 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.673 0.389 . . . . 0.0 111.7 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.24 11.45 71.01 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.586 0.613 . . . . 0.0 112.491 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.0 -27.05 63.16 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.53 0.665 . . . . 0.0 112.395 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.0 t -74.94 -6.09 47.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.666 0.386 . . . . 0.0 111.536 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.01 -22.76 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.166 -0.334 . . . . 0.0 111.319 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 p -98.69 -21.16 16.56 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -144.93 -22.66 0.5 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.56 179.68 23.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.92 -27.84 68.49 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.221 0.608 . . . . 0.0 111.787 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -63.09 -33.79 76.2 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.976 -0.453 . . . . 0.0 110.857 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.09 -30.25 43.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.891 -0.506 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.69 -31.0 67.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.48 -29.07 46.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.344 0.258 . . . . 0.0 110.959 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.71 -16.48 51.06 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.067 0.147 . . . . 0.0 111.005 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -87.39 -33.59 19.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.074 -0.391 . . . . 0.0 110.967 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.59 -26.36 45.42 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.195 -0.316 . . . . 0.0 111.815 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -87.16 9.75 19.01 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.116 0.416 . . . . 0.0 111.28 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -133.18 166.78 21.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.484 1.113 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.8 m -72.48 133.45 44.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.551 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -145.64 169.63 18.07 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.591 0.756 . . . . 0.0 109.766 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -74.3 136.72 42.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.217 0.207 . . . . 0.0 111.079 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 -159.61 19.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.123 0.868 . . . . 0.0 111.098 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.79 -18.32 33.27 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.28 -11.37 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 122.569 0.348 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.99 178.61 48.61 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -81.48 142.84 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.64 0.72 . . . . 0.0 111.328 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -146.48 169.48 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.698 0.799 . . . . 0.0 110.418 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.7 150.27 47.19 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.1 m -130.16 -174.61 3.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.059 0.391 . . . . 0.0 111.462 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 -27.54 11.95 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.05 -177.31 6.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.693 0.678 . . . . 0.0 109.814 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.08 169.5 22.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.64 168.95 24.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.665 1.186 . . . . 0.0 109.037 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.7 t -110.93 142.56 42.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -132.42 173.15 11.59 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.026 -175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.82 177.77 15.31 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -72.2 -20.61 61.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.877 0.339 . . . . 0.0 111.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.12 9.94 3.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.082 0.953 . . . . 0.0 110.709 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.12 83.87 0.24 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -140.29 4.91 2.04 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.2 m -132.81 147.68 52.31 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.314 0.506 . . . . 0.0 110.323 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.3 t -94.01 137.95 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.084 0.554 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -138.01 145.17 41.53 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.414 0.686 . . . . 0.0 109.555 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.42 162.7 12.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 143.86 18.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.726 0.81 . . . . 0.0 110.049 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -72.7 155.16 91.1 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 122.888 0.475 . . . . 0.0 110.99 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.61 165.43 85.62 Favored 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.605 0.538 . . . . 0.0 111.249 -0.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.61 69.8 38.13 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.051 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.8 161.67 28.07 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.785 2.99 . . . . 0.0 111.322 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -76.5 161.42 28.64 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.851 0.358 . . . . 0.0 111.642 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.283 -1.342 . . . . 0.0 109.916 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -80.27 7.55 9.27 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.032 0.533 . . . . 0.0 110.709 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.5 p -145.56 72.32 14.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.701 0.8 . . . . 0.0 109.958 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 177.14 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 124.786 3.657 . . . . 0.0 111.487 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m -108.62 125.86 52.32 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.379 0.672 . . . . 0.0 109.576 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -138.88 133.31 31.77 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.45 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -130.88 -16.97 3.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.5 67.82 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.339 0.495 . . . . 0.0 112.879 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.16 -27.46 68.41 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 117.564 0.682 . . . . 0.0 112.01 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.7 m -80.24 5.33 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.09 -24.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 122.613 0.365 . . . . 0.0 111.497 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -100.09 -15.65 18.12 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.7 t -149.86 -35.07 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.04 -164.53 12.03 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.97 -27.15 66.59 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.948 0.499 . . . . 0.0 111.794 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 m -62.39 -40.76 97.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.86 -0.525 . . . . 0.0 111.125 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.09 46.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.411 0.55 . . . . 0.0 110.626 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -68.0 -33.28 74.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -78.7 -35.93 44.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.261 0.224 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -72.43 -17.47 61.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.942 -0.117 . . . . 0.0 111.17 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -90.05 -32.04 16.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.578 0.351 . . . . 0.0 110.79 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.39 -25.65 42.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.574 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -85.89 5.2 34.0 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.3 0.5 . . . . 0.0 111.249 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.9 m -127.73 165.97 19.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.57 1.148 . . . . 0.0 107.946 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.43 137.33 39.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.806 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -146.18 167.92 22.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.351 1.06 . . . . 0.0 108.834 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -73.87 134.31 43.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.154 -0.342 . . . . 0.0 110.635 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.69 -152.24 24.94 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -88.64 -17.95 29.0 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.766 0.427 . . . . 0.0 112.135 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.75 -12.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.687 0.395 . . . . 0.0 112.051 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 175.37 47.59 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -78.03 142.58 38.13 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.425 0.612 . . . . 0.0 111.602 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.09 165.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 124.006 0.922 . . . . 0.0 110.621 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -132.96 144.51 50.17 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 124.763 1.225 . . . . 0.0 107.946 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.53 -172.47 2.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.613 0.365 . . . . 0.0 111.335 -172.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 t -103.48 -36.6 7.92 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.41 -177.3 5.99 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.24 167.95 28.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -154.25 164.53 38.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.083 0.953 . . . . 0.0 109.548 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.7 m -96.44 143.26 27.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -137.89 -177.4 4.8 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.662 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.29 -179.07 48.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -65.7 138.92 58.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.533 . . . . 0.0 109.946 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp 52.92 17.21 0.83 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.078 0.951 . . . . 0.0 112.483 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.87 77.35 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.92 -0.488 . . . . 0.0 112.164 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -76.19 10.06 2.19 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 153.29 48.46 Favored 'General case' 0 C--O 1.228 -0.069 0 CA-C-N 118.501 0.591 . . . . 0.0 110.355 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 t -108.98 141.37 41.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.684 0.794 . . . . 0.0 110.021 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.6 m -142.42 146.76 35.2 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.158 0.583 . . . . 0.0 109.727 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.1 m -100.46 164.41 11.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.787 0.435 . . . . 0.0 111.327 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.41 142.53 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.172 0.989 . . . . 0.0 110.237 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -70.78 155.77 92.92 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.215 0.606 . . . . 0.0 111.267 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.09 165.33 86.2 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 118.176 0.384 . . . . 0.0 111.529 -1.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.59 67.76 44.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.762 0.825 . . . . 0.0 110.388 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.66 167.66 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.013 3.142 . . . . 0.0 111.286 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -78.47 172.69 13.28 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.882 0.473 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.241 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 59.15 0.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.079 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.35 74.08 7.46 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.546 0.739 . . . . 0.0 110.606 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 174.01 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.132 3.221 . . . . 0.0 111.328 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -111.43 126.72 55.24 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.897 0.479 . . . . 0.0 109.868 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -139.82 135.23 32.78 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -140.25 161.87 36.64 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.686 0.795 . . . . 0.0 109.433 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.89 15.35 78.26 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.436 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.98 -23.27 63.48 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 117.665 0.733 . . . . 0.0 111.687 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.1 m -74.43 0.72 13.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.811 0.444 . . . . 0.0 111.831 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 -23.19 2.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.042 0.383 . . . . 0.0 111.416 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -97.94 -20.1 17.65 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -149.94 -24.1 0.26 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.09 178.51 22.07 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.31 -28.05 67.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.661 0.385 . . . . 0.0 111.857 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -61.46 -33.29 73.5 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.881 -0.512 . . . . 0.0 110.88 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.15 -30.4 49.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.959 -0.463 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.43 -29.07 46.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.402 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.16 -34.06 72.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -74.4 -28.95 61.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.255 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -78.81 -35.02 44.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.1 m -75.49 -30.59 59.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.642 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -81.68 -15.99 52.72 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.493 0.588 . . . . 0.0 111.623 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -99.83 170.49 8.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -80.18 139.38 36.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.192 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -147.37 170.19 17.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.146 0.578 . . . . 0.0 109.923 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 tpt85 -74.27 122.05 22.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.72 -160.89 36.96 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.01 -17.44 37.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.928 0.364 . . . . 0.0 111.918 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.7 -11.56 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.39 177.22 48.37 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.09 137.34 35.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.666 0.733 . . . . 0.0 111.82 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.07 166.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 C-N-CA 123.708 0.803 . . . . 0.0 110.562 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -134.07 149.48 51.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.3 -170.12 2.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.084 0.554 . . . . 0.0 111.23 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -104.67 -35.73 7.7 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.68 -175.14 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.8 163.77 39.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.938 -0.476 . . . . 0.0 111.868 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -151.64 160.36 43.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.673 0.789 . . . . 0.0 109.545 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -91.1 140.71 29.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -131.52 178.8 6.46 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.939 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.78 173.49 30.6 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.07 -18.97 61.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.277 -0.543 . . . . 0.0 111.987 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 14.03 3.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.417 0.687 . . . . 0.0 111.352 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 16.01 78.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 122.037 -0.414 . . . . 0.0 112.072 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -78.38 4.83 11.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.48 0.712 . . . . 0.0 112.554 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 m -133.85 162.59 31.6 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t -130.17 158.12 40.57 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.183 -0.323 . . . . 0.0 110.892 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -143.03 136.57 28.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.727 0.811 . . . . 0.0 109.361 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -87.37 159.43 18.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.749 0.309 . . . . 0.0 110.351 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -106.75 140.15 25.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.372 0.669 . . . . 0.0 110.32 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -68.08 155.37 92.19 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.469 0.708 . . . . 0.0 110.928 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.95 166.09 83.83 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 -0.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 72.4 m -138.04 66.88 47.65 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 110.372 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.81 165.91 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.887 3.058 . . . . 0.0 111.504 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -75.71 167.88 21.05 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.937 0.495 . . . . 0.0 110.564 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.16 -1.4 . . . . 0.0 111.562 -178.669 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -78.19 -0.88 30.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.874 0.47 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p -146.14 83.27 8.64 Favored Pre-proline 0 N--CA 1.454 -0.241 0 C-N-CA 123.433 0.693 . . . . 0.0 110.324 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 177.58 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.36 3.373 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -118.36 135.7 54.17 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -140.71 146.51 37.89 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.086 0.554 . . . . 0.0 110.1 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -142.09 161.97 36.66 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.701 1.2 . . . . 0.0 108.815 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.67 14.31 72.44 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.749 -0.473 . . . . 0.0 112.98 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.9 -26.18 61.83 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.823 0.811 . . . . 0.0 111.604 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.2 t -75.67 -4.18 38.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.648 0.379 . . . . 0.0 111.88 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.29 -27.24 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.565 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.91 -21.09 20.78 Favored 'General case' 0 N--CA 1.458 -0.048 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -145.86 -22.4 0.46 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.03 178.96 24.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.11 -27.94 64.17 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.023 0.529 . . . . 0.0 111.704 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -62.32 -32.71 73.5 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.022 -0.424 . . . . 0.0 111.246 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.18 -29.77 34.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.952 -0.467 . . . . 0.0 110.717 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.0 -31.84 69.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -78.17 -31.32 49.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.806 0.443 . . . . 0.0 111.098 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.19 -23.02 44.15 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.301 0.241 . . . . 0.0 111.238 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -82.29 -33.01 29.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.933 0.333 . . . . 0.0 111.245 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.6 m -76.91 -23.42 52.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.448 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.17 5.85 42.8 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.791 0.436 . . . . 0.0 111.69 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -126.99 166.76 16.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.8 m -72.66 131.82 42.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.102 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -142.95 170.14 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 109.464 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -75.1 139.28 42.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.369 -0.207 . . . . 0.0 111.193 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.74 -168.08 15.79 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -17.44 37.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.828 0.451 . . . . 0.0 112.206 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.5 -10.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.86 0.464 . . . . 0.0 111.708 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.09 178.76 45.2 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.5 m -80.99 142.29 33.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.88 168.54 7.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.524 0.73 . . . . 0.0 110.773 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.09 150.65 45.95 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.7 m -127.53 -173.81 3.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.184 0.447 . . . . 0.0 111.487 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 m -104.92 -30.55 9.75 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -155.19 -177.36 6.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.449 0.568 . . . . 0.0 109.6 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.95 170.18 21.03 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.139 0.495 . . . . 0.0 112.257 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -151.84 166.36 31.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.34 1.056 . . . . 0.0 109.213 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.3 t -106.5 139.75 40.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -137.08 -171.53 2.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.809 0.844 . . . . 0.0 111.03 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.37 173.74 26.11 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.75 -21.02 63.48 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.973 0.509 . . . . 0.0 111.772 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -144.9 24.81 1.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.684 0.22 . . . . 0.0 111.393 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.68 32.38 57.38 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.7 p -101.29 12.21 37.88 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -133.05 154.02 50.94 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.517 0.327 . . . . 0.0 110.762 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -116.9 139.43 50.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.795 0.838 . . . . 0.0 109.489 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -139.34 143.98 38.03 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.126 0.57 . . . . 0.0 109.783 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -100.86 164.68 11.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.659 0.384 . . . . 0.0 111.515 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.31 145.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.791 0.836 . . . . 0.0 110.399 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.42 155.74 89.4 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.973 0.509 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.9 162.96 91.12 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 118.49 0.497 . . . . 0.0 111.687 -1.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.3 m -136.56 69.8 60.08 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.698 0.799 . . . . 0.0 109.976 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.62 162.82 26.47 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.054 3.17 . . . . 0.0 111.507 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -75.38 161.33 29.35 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.966 0.506 . . . . 0.0 111.471 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.013 179.561 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -75.91 1.06 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.13 0.572 . . . . 0.0 110.889 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p -149.5 80.27 7.71 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 123.613 0.765 . . . . 0.0 109.928 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.34 174.41 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 124.357 3.371 . . . . 0.0 111.792 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -113.36 135.43 53.87 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -142.99 147.62 35.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 122.212 0.205 . . . . 0.0 110.717 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -142.31 164.47 30.07 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 124.801 1.24 . . . . 0.0 109.504 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.78 16.85 74.66 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.969 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.9 -29.03 68.08 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.036 0.918 . . . . 0.0 111.152 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.4 m -81.92 6.08 17.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.097 0.559 . . . . 0.0 112.092 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.61 -15.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.684 0.394 . . . . 0.0 111.923 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -123.29 -18.39 6.29 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 m -139.12 -18.27 1.02 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -177.49 39.63 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.7 tp -58.41 -27.57 64.41 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.21 0.604 . . . . 0.0 111.825 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -61.66 -34.21 75.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.238 -0.289 . . . . 0.0 111.246 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.77 -28.2 30.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.226 0.466 . . . . 0.0 110.981 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.16 -31.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -78.8 -33.51 46.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -77.57 -22.44 50.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.312 0.245 . . . . 0.0 111.334 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -84.43 -32.78 23.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.845 0.293 . . . . 0.0 111.179 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.8 m -77.79 -22.63 49.85 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.411 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.34 6.07 42.17 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.866 0.467 . . . . 0.0 111.821 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.5 p -127.86 165.45 20.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.29 131.08 42.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.139 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -142.78 167.13 22.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.678 0.791 . . . . 0.0 109.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.68 123.69 26.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.2 -160.15 36.24 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.61 -14.4 45.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.01 -11.82 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 122.594 0.358 . . . . 0.0 111.881 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.89 45.54 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -76.59 140.22 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.082 0.941 . . . . 0.0 111.55 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.96 169.23 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.516 0.726 . . . . 0.0 110.733 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -138.29 151.05 47.24 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.95 -172.41 2.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.326 0.512 . . . . 0.0 111.635 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -102.48 -35.95 8.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -153.95 -175.92 5.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.98 168.43 26.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 112.078 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.96 163.83 39.75 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.894 0.878 . . . . 0.0 109.539 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.8 m -93.72 142.41 27.39 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.2 p -137.67 -178.52 5.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.458 0.703 . . . . 0.0 111.008 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 -176.97 52.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.01 134.24 56.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt 50.86 20.13 0.73 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.981 0.912 . . . . 0.0 113.229 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.38 76.64 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.229 0.468 . . . . 0.0 112.345 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.9 p -75.53 8.76 2.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 155.84 42.0 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.588 0.631 . . . . 0.0 110.085 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.7 t -112.52 138.83 48.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.303 0.641 . . . . 0.0 110.159 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 m -141.32 145.8 35.92 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.008 0.523 . . . . 0.0 110.025 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.914 0.388 . . . . 0.0 111.42 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mm -112.4 143.18 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.798 0.839 . . . . 0.0 110.047 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -71.01 156.06 92.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 0.0 111.068 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 162.83 91.44 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 O-C-N 121.883 0.412 . . . . 0.0 111.387 -1.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.7 m -136.08 69.69 63.35 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.591 0.757 . . . . 0.0 109.772 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.66 161.77 30.74 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.383 2.722 . . . . 0.0 111.074 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.17 161.37 28.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.693 0.397 . . . . 0.0 111.681 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.62 -1.181 . . . . 0.0 110.146 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -142.99 157.54 44.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.525 0.73 . . . . 0.0 109.991 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.07 81.87 9.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.357 0.663 . . . . 0.0 110.217 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.94 178.46 7.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.365 3.377 . . . . 0.0 111.231 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -117.41 133.38 56.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.563 0.745 . . . . 0.0 109.246 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -142.79 142.82 31.96 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.657 0.383 . . . . 0.0 110.043 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -142.81 164.76 29.23 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.386 1.074 . . . . 0.0 109.207 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.79 18.7 77.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.489 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.28 -14.41 55.74 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.522 0.661 . . . . 0.0 112.332 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.04 -3.25 41.74 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.062 0.392 . . . . 0.0 111.635 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.24 -27.62 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 O-C-N 121.909 -0.494 . . . . 0.0 111.549 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -154.44 -26.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -83.8 -20.38 33.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.151 0.432 . . . . 0.0 111.992 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.22 170.44 45.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.104 0.859 . . . . 0.0 112.408 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.6 -28.17 68.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.846 0.459 . . . . 0.0 111.078 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -62.0 -32.5 72.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.212 -0.305 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.35 45.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.068 -0.395 . . . . 0.0 110.501 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.2 t -74.05 -30.9 62.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -77.44 -28.96 52.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.615 0.366 . . . . 0.0 111.051 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.56 -30.66 41.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.999 0.187 . . . . 0.0 110.899 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -76.34 -32.5 58.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.756 0.253 . . . . 0.0 111.187 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 98.9 m -76.48 -28.48 56.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.322 -0.371 . . . . 0.0 111.575 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -85.17 -20.53 30.09 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.365 0.529 . . . . 0.0 111.769 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -94.34 166.19 12.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.8 m -75.95 136.55 40.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.581 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -144.61 170.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -75.19 140.61 43.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.135 0.174 . . . . 0.0 111.407 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.63 -170.58 16.68 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.58 -14.42 48.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.53 -18.38 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.867 0.467 . . . . 0.0 111.149 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.99 176.8 44.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -75.17 144.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.612 0.706 . . . . 0.0 111.548 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.79 171.7 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.25 1.02 . . . . 0.0 110.463 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -141.66 153.07 44.47 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.7 m -123.83 -175.26 3.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 111.491 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -103.81 -29.58 10.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -155.92 -177.51 6.63 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.446 0.566 . . . . 0.0 109.756 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.0 170.03 22.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.273 0.558 . . . . 0.0 111.785 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -152.65 165.76 34.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.399 1.08 . . . . 0.0 109.028 173.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.0 t -107.99 141.51 39.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -130.6 179.73 5.77 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.586 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 168.63 45.06 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.83 132.09 47.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.47 -0.429 . . . . 0.0 110.295 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt 52.53 14.71 0.42 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.427 1.091 . . . . 0.0 112.749 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.73 102.0 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.99 0.805 . . . . 0.0 111.521 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 p -144.82 4.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.877 0.471 . . . . 0.0 111.551 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.3 m -134.05 152.25 51.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.603 0.361 . . . . 0.0 110.216 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.78 138.13 47.56 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.171 0.589 . . . . 0.0 110.271 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.1 m -139.45 140.96 37.45 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.88 164.12 12.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.377 0.271 . . . . 0.0 111.043 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.84 143.03 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 124.055 0.942 . . . . 0.0 110.448 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -73.55 157.05 88.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 122.939 0.496 . . . . 0.0 111.105 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.72 164.01 88.44 Favored 'Cis proline' 0 N--CA 1.455 -0.784 0 O-C-N 121.87 0.405 . . . . 0.0 111.575 -2.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 95.1 m -134.67 70.63 71.5 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 124.1 0.96 . . . . 0.0 109.906 177.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.73 167.28 15.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.248 3.299 . . . . 0.0 112.018 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -69.45 163.25 25.71 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.276 0.63 . . . . 0.0 111.557 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.525 175.735 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.043 0.449 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -77.3 1.2 19.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.928 0.491 . . . . 0.0 110.813 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.1 p -152.7 86.84 4.18 Favored Pre-proline 0 N--CA 1.452 -0.342 0 C-N-CA 123.337 0.655 . . . . 0.0 110.469 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.34 -179.08 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.428 3.418 . . . . 0.0 110.581 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -125.32 122.41 36.77 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 122.804 0.441 . . . . 0.0 110.15 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -144.74 139.02 27.6 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.963 0.905 . . . . 0.0 109.431 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -137.77 -12.08 1.52 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.687 0.395 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.55 12.22 70.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.584 0.611 . . . . 0.0 112.581 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.77 -25.61 63.22 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.668 0.734 . . . . 0.0 112.609 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.9 t -86.39 10.14 15.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.16 0.436 . . . . 0.0 111.811 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -17.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 123.024 0.529 . . . . 0.0 111.252 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.3 p -120.59 -17.11 8.15 Favored 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 m -140.51 -19.51 0.85 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 -173.68 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.344 0.497 . . . . 0.0 112.069 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.38 -26.6 68.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.161 0.584 . . . . 0.0 111.751 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -63.45 -36.17 82.86 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.759 -0.588 . . . . 0.0 110.664 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.6 36.3 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.002 0.365 . . . . 0.0 110.703 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 t -68.62 -30.86 69.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -79.08 -35.46 42.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.259 -0.276 . . . . 0.0 110.691 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -19.57 60.92 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.918 0.136 . . . . 0.0 111.031 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.49 -33.35 21.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.447 0.299 . . . . 0.0 110.675 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.36 -26.49 46.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.554 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -87.13 8.02 25.57 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 122.865 0.466 . . . . 0.0 111.305 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -130.89 167.23 19.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.539 1.136 . . . . 0.0 108.347 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.3 m -73.2 133.82 44.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.047 -0.408 . . . . 0.0 110.41 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.95 170.91 15.66 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.887 0.875 . . . . 0.0 109.554 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -73.54 140.38 46.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.234 0.214 . . . . 0.0 111.14 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.81 -168.1 14.76 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -86.63 -17.09 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.86 -16.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.852 0.461 . . . . 0.0 110.907 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.79 48.07 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.6 m -80.29 142.18 34.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.833 0.816 . . . . 0.0 110.895 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.22 169.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.782 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -138.44 150.5 46.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.422 1.089 . . . . 0.0 108.16 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.9 m -128.18 -172.49 2.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.242 0.617 . . . . 0.0 111.212 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.2 m -107.54 -29.85 8.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -154.16 -178.97 7.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.729 0.695 . . . . 0.0 109.799 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 168.1 26.97 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.281 0.562 . . . . 0.0 112.348 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -153.93 168.09 27.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.992 1.317 . . . . 0.0 108.757 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.4 m -105.0 146.29 29.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -132.79 179.59 6.07 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.476 0.71 . . . . 0.0 111.0 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 176.37 28.6 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -68.89 -18.01 64.06 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.37 13.3 3.51 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.074 0.55 . . . . 0.0 111.667 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.68 17.7 78.27 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.909 -0.477 . . . . 0.0 111.909 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.6 p -83.15 9.55 10.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 113.009 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.9 m -125.65 150.82 47.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.0 t -102.66 141.69 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.484 0.714 . . . . 0.0 110.125 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.5 m -143.66 147.36 34.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.719 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -101.22 164.45 11.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.97 143.97 20.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.065 0.946 . . . . 0.0 109.632 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -72.46 156.09 90.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 122.832 0.453 . . . . 0.0 110.691 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.66 166.08 83.91 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 122.041 0.495 . . . . 0.0 111.441 -1.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.58 70.31 45.17 Favored Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 123.491 0.716 . . . . 0.0 110.069 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.9 163.43 22.18 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.798 2.998 . . . . 0.0 111.733 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -76.35 161.99 28.25 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.07 179.711 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.116 0.484 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -150.01 157.54 43.25 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.517 0.727 . . . . 0.0 110.275 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p -149.07 77.56 9.1 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.11 174.91 11.64 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 124.232 3.288 . . . . 0.0 111.57 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -111.15 134.63 52.6 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.306 0.642 . . . . 0.0 109.696 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -143.95 142.75 30.91 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.958 0.503 . . . . 0.0 110.023 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -142.09 163.69 32.18 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.062 0.945 . . . . 0.0 109.512 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.68 17.95 75.36 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.389 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.41 -27.31 67.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.754 0.777 . . . . 0.0 111.405 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.63 4.37 16.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.047 0.539 . . . . 0.0 112.192 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -14.8 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 122.889 0.476 . . . . 0.0 111.62 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -121.48 -19.6 6.88 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 m -140.71 -19.36 0.83 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.34 -173.47 34.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.565 0.602 . . . . 0.0 111.761 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -59.82 -28.08 67.17 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.014 0.526 . . . . 0.0 111.933 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -60.7 -36.2 78.22 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 122.052 -0.405 . . . . 0.0 110.988 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.1 27.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.067 0.394 . . . . 0.0 110.792 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.5 t -68.05 -31.47 71.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -80.12 -36.96 34.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.231 -0.293 . . . . 0.0 110.999 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.74 -18.65 61.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.927 0.142 . . . . 0.0 111.325 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -87.64 -35.69 17.88 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 117.871 0.305 . . . . 0.0 110.574 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.5 m -75.48 -28.4 59.2 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.84 3.26 34.5 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.391 . . . . 0.0 111.97 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -126.01 163.73 22.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.9 m -71.12 133.3 46.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.137 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -145.08 167.33 22.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 124.78 28.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.379 -0.201 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.79 -158.55 34.51 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 123.752 0.692 . . . . 0.0 111.389 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.67 -20.25 31.56 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.496 -0.414 . . . . 0.0 112.093 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.32 -12.39 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.58 0.352 . . . . 0.0 111.651 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.8 175.4 46.51 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.5 m -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.019 0.909 . . . . 0.0 111.875 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -142.9 167.86 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.032 0.933 . . . . 0.0 110.745 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -139.71 144.1 37.37 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.4 -173.69 2.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.133 0.424 . . . . 0.0 111.47 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -103.4 -35.85 8.22 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -152.7 -176.36 5.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.47 168.25 27.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 111.647 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -153.62 163.39 40.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.876 0.87 . . . . 0.0 109.321 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.54 142.57 27.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.4 p -132.34 -179.71 5.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 111.122 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.92 177.06 30.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.37 -18.78 63.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 112.002 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.35 14.52 3.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.069 0.547 . . . . 0.0 111.387 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.13 15.69 78.63 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -80.62 8.33 8.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.6 m -125.26 155.34 40.29 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 122.914 0.486 . . . . 0.0 110.075 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -114.34 139.36 49.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.584 0.754 . . . . 0.0 110.063 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -142.95 144.5 32.39 Favored 'General case' 0 C--O 1.228 -0.058 0 C-N-CA 122.921 0.488 . . . . 0.0 109.919 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.27 162.23 13.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.964 0.412 . . . . 0.0 111.274 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.64 145.62 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 123.918 0.887 . . . . 0.0 110.127 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -73.59 156.18 88.79 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.061 0.544 . . . . 0.0 111.609 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.57 165.37 85.84 Favored 'Cis proline' 0 N--CA 1.451 -1.004 0 CA-C-N 118.188 0.388 . . . . 0.0 111.288 -2.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.0 m -137.14 67.45 55.16 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.729 0.812 . . . . 0.0 110.287 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.69 168.84 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.961 3.107 . . . . 0.0 112.052 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -70.64 165.01 23.77 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.549 0.739 . . . . 0.0 111.661 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 176.88 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.77 2.61 19.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.183 0.593 . . . . 0.0 111.019 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.87 83.76 6.13 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.323 0.649 . . . . 0.0 110.534 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.93 175.48 11.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.842 3.028 . . . . 0.0 111.098 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -117.23 127.8 54.45 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -141.52 146.01 35.85 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.266 0.627 . . . . 0.0 110.157 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -143.14 165.52 27.2 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 109.354 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.71 17.33 74.91 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.594 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.21 -23.19 65.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.555 0.678 . . . . 0.0 112.033 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.64 3.67 15.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.723 0.409 . . . . 0.0 111.594 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.6 -27.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 122.879 0.472 . . . . 0.0 111.088 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.5 p -87.63 -15.18 38.01 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 122.09 -0.381 . . . . 0.0 111.789 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -154.21 -40.25 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.352 0.261 . . . . 0.0 111.283 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.15 -167.73 16.41 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.96 -27.88 65.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.874 0.47 . . . . 0.0 111.715 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 m -61.7 -40.43 95.0 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.288 -0.257 . . . . 0.0 111.291 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -28.05 41.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.895 -0.503 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.7 -32.53 71.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -80.03 -36.18 36.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.16 -0.337 . . . . 0.0 110.949 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -71.6 -21.78 61.81 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.167 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -87.51 -31.88 19.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.633 0.373 . . . . 0.0 111.315 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.02 -27.5 54.6 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.584 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -83.96 -14.76 50.05 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.541 0.609 . . . . 0.0 111.652 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.8 p -101.02 168.44 9.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -78.38 139.51 38.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.611 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -145.8 170.58 16.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 109.394 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -72.91 139.27 46.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.465 0.174 . . . . 0.0 111.001 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.92 -172.79 16.4 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.176 0.893 . . . . 0.0 111.0 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -83.69 -12.68 55.56 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.87 -17.68 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 110.987 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.06 -179.77 45.2 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.4 m -78.02 141.59 38.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.739 0.769 . . . . 0.0 111.041 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.06 163.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.759 0.823 . . . . 0.0 110.8 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -135.43 147.24 48.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.91 -174.3 2.67 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.995 0.518 . . . . 0.0 111.117 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 -30.24 10.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.77 -177.97 6.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.289 0.495 . . . . 0.0 109.856 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 168.46 26.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 111.842 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -153.18 165.83 34.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.788 0.835 . . . . 0.0 109.434 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.3 m -98.64 143.03 29.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -131.99 179.46 6.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.714 0.806 . . . . 0.0 110.801 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.17 176.05 30.35 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -69.48 -18.15 63.68 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.805 0.442 . . . . 0.0 112.05 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.33 13.45 3.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.011 0.524 . . . . 0.0 111.451 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.07 16.68 78.47 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -81.26 7.96 10.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.6 m -125.79 154.16 42.98 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 122.896 0.478 . . . . 0.0 110.304 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 t -111.71 140.57 46.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.484 0.713 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.8 m -143.51 143.74 31.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.433 0.693 . . . . 0.0 109.582 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.9 162.82 13.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.033 0.445 . . . . 0.0 111.189 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -107.34 142.0 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 123.714 0.806 . . . . 0.0 109.801 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.25 156.03 89.52 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 122.59 0.356 . . . . 0.0 110.974 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.03 168.61 76.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 118.265 0.416 . . . . 0.0 111.739 -1.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.74 69.11 37.31 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.641 0.777 . . . . 0.0 109.725 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.77 171.7 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.064 3.176 . . . . 0.0 112.268 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -66.75 169.82 7.38 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.666 0.786 . . . . 0.0 110.529 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.222 -1.37 . . . . 0.0 111.655 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.4 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.16 176.62 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.529 3.486 . . . . 0.0 111.921 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 m -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.186 0.594 . . . . 0.0 109.828 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.39 132.43 22.97 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.24 -10.72 1.69 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.907 0.483 . . . . 0.0 111.988 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.28 13.43 61.86 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 123.656 0.646 . . . . 0.0 112.427 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.53 -17.16 64.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.875 0.838 . . . . 0.0 112.643 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.4 m -94.46 3.33 55.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.081 0.4 . . . . 0.0 111.742 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.32 -29.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-N 118.19 0.45 . . . . 0.0 111.476 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 t -156.12 -26.41 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -79.49 -20.01 48.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.085 -0.384 . . . . 0.0 111.817 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.86 172.48 48.38 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.809 0.719 . . . . 0.0 112.99 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.13 -28.65 69.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.94 0.496 . . . . 0.0 110.852 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -63.07 -33.7 76.0 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.064 -0.398 . . . . 0.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.21 -33.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.6 t -69.73 -30.89 68.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -79.04 -31.26 44.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.888 0.475 . . . . 0.0 110.744 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.56 -30.64 52.76 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.072 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -76.73 -34.42 58.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.841 0.291 . . . . 0.0 110.609 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.7 m -74.39 -24.31 59.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.326 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -89.3 -8.78 52.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.321 0.51 . . . . 0.0 111.397 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -102.99 165.43 11.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 109.303 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.77 125.07 25.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -142.71 169.53 17.41 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.838 0.455 . . . . 0.0 109.997 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpt85 -73.97 126.8 31.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.247 0.219 . . . . 0.0 110.737 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.76 -159.97 33.85 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -82.54 -21.3 35.4 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.94 -10.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.682 0.393 . . . . 0.0 111.74 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.48 171.79 44.52 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.0 m -73.8 142.49 46.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.89 0.845 . . . . 0.0 111.423 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.36 167.86 3.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.409 1.083 . . . . 0.0 110.205 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -136.24 149.88 48.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.61 -173.1 2.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.888 0.475 . . . . 0.0 111.648 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -98.53 -36.89 9.77 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.03 -174.81 4.99 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.043 -0.41 . . . . 0.0 109.993 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.67 167.15 31.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.866 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.46 163.67 39.84 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.012 0.925 . . . . 0.0 109.146 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.7 m -94.98 143.65 26.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -135.9 -179.34 5.6 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.902 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.48 173.41 25.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -69.74 -19.77 63.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.974 0.51 . . . . 0.0 111.755 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.78 14.01 4.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.209 0.604 . . . . 0.0 111.177 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 15.31 78.61 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.6 p -82.82 13.57 3.79 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.883 0.873 . . . . 0.0 113.094 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -130.88 150.18 52.16 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.906 -0.496 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.9 t -107.18 143.78 34.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.915 0.886 . . . . 0.0 109.422 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.4 m -144.3 145.96 32.31 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.063 0.545 . . . . 0.0 109.941 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.16 163.94 12.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.783 0.433 . . . . 0.0 111.631 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.91 134.86 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.595 0.758 . . . . 0.0 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -70.02 159.62 83.58 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.017 0.527 . . . . 0.0 110.799 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -64.9 162.82 64.19 Favored 'Cis proline' 0 N--CA 1.459 -0.509 0 CA-C-N 118.692 0.568 . . . . 0.0 113.259 -2.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 96.7 m -140.82 69.46 29.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 110.265 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.11 168.83 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.158 3.239 . . . . 0.0 112.041 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.26 164.25 23.2 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.898 0.479 . . . . 0.0 111.444 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.586 178.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.506 0.193 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.64 177.68 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.053 3.169 . . . . 0.0 110.345 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -125.85 128.86 48.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.549 0.34 . . . . 0.0 110.13 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -141.14 134.74 30.05 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.885 0.874 . . . . 0.0 109.143 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -138.78 163.08 33.13 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.7 0.8 . . . . 0.0 109.213 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 15.87 76.65 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.17 -25.26 63.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.435 0.617 . . . . 0.0 111.409 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -76.28 2.61 12.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.884 0.474 . . . . 0.0 111.715 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -124.84 -24.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 122.869 0.468 . . . . 0.0 111.238 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -98.9 -21.14 16.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -146.71 -22.05 0.42 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -178.02 26.0 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -58.82 -28.01 65.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.185 0.594 . . . . 0.0 111.68 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.6 m -61.34 -34.85 75.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.025 -0.422 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.52 -31.99 28.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.848 0.294 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.1 t -67.22 -31.85 72.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -79.17 -36.65 40.02 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.187 -0.321 . . . . 0.0 110.768 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -69.99 -22.6 63.12 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.913 -0.089 . . . . 0.0 110.976 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -82.17 -35.83 27.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.671 0.214 . . . . 0.0 110.832 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.11 -24.61 54.96 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.455 0.302 . . . . 0.0 111.616 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.04 6.34 22.46 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.377 0.671 . . . . 0.0 111.226 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -133.29 169.8 16.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.84 131.82 39.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -145.11 171.13 14.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.71 0.404 . . . . 0.0 110.364 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -78.35 137.1 37.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.16 -170.9 17.12 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -88.69 -11.42 45.25 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.3 t -129.83 -16.46 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.031 0.532 . . . . 0.0 111.081 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.11 44.6 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.5 m -82.24 139.55 34.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.203 -0.587 . . . . 0.0 111.058 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.31 168.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.274 0.63 . . . . 0.0 111.639 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -139.06 143.24 38.28 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -127.2 -175.32 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.499 0.591 . . . . 0.0 112.289 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -100.59 -35.03 9.65 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -154.46 -175.11 5.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.82 167.35 30.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.26 165.18 37.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.964 0.906 . . . . 0.0 109.356 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.7 m -95.35 143.53 26.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.3 p -135.8 179.57 6.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.117 0.567 . . . . 0.0 111.105 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.56 179.68 49.77 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.8 136.87 57.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.4 mt 52.22 16.66 0.6 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.921 0.888 . . . . 0.0 113.229 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.7 75.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.972 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -74.81 3.1 8.64 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.193 0.997 . . . . 0.0 113.613 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 48.6 m -121.8 155.71 34.73 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.538 0.608 . . . . 0.0 110.256 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.4 t -112.49 139.3 48.19 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.577 0.751 . . . . 0.0 109.959 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.7 m -142.41 146.1 34.52 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.346 0.658 . . . . 0.0 109.846 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.02 165.02 11.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.986 0.514 . . . . 0.0 111.48 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.75 145.32 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 110.408 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -70.4 156.06 92.48 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.915 0.486 . . . . 0.0 110.852 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.97 162.64 91.82 Favored 'Cis proline' 0 N--CA 1.454 -0.847 0 CA-C-N 118.274 0.419 . . . . 0.0 111.146 -2.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.8 m -137.65 68.99 52.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 109.942 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.83 167.44 13.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.936 3.091 . . . . 0.0 112.094 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.37 164.2 26.72 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.293 0.637 . . . . 0.0 111.802 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.991 176.334 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.318 0.104 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.77 171.47 18.16 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.975 3.117 . . . . 0.0 109.955 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.2 m -118.59 120.74 38.36 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -136.09 137.16 40.79 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 123.796 0.838 . . . . 0.0 109.407 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -139.94 162.49 35.05 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.09 17.31 78.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.51 -24.24 63.48 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.484 0.642 . . . . 0.0 111.918 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.4 m -76.53 2.87 12.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.075 0.55 . . . . 0.0 111.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.73 -25.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 122.737 0.415 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -95.21 -21.16 18.65 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.017 -0.427 . . . . 0.0 111.968 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -146.27 -21.84 0.44 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -177.43 25.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.31 -29.26 65.75 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 m -62.59 -34.22 76.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 111.141 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.59 -30.39 32.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.94 -0.475 . . . . 0.0 110.583 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.86 -30.77 69.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -81.0 -30.24 35.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.489 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.62 -22.29 43.84 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.505 -0.122 . . . . 0.0 111.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.55 -35.95 24.37 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.252 -0.28 . . . . 0.0 110.782 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.4 m -73.98 -26.14 60.3 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.462 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -88.61 8.98 25.73 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.959 0.345 . . . . 0.0 111.494 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -127.97 164.93 21.25 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.888 0.875 . . . . 0.0 108.993 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.6 t -69.7 127.09 31.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -143.49 168.16 20.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.792 0.437 . . . . 0.0 110.538 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.54 133.8 37.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.567 0.347 . . . . 0.0 111.037 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.86 -163.48 23.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -86.84 -11.36 51.06 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.77 -11.92 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.627 0.371 . . . . 0.0 111.893 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.75 177.57 47.46 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.0 m -86.94 139.91 30.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.663 0.731 . . . . 0.0 111.45 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.31 166.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.377 0.671 . . . . 0.0 110.611 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -135.01 148.3 49.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.8 m -126.88 -174.01 3.03 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.971 0.351 . . . . 0.0 111.755 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -100.5 -33.39 10.36 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.28 -175.14 5.28 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.46 167.62 29.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.61 164.99 37.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.981 0.912 . . . . 0.0 109.501 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.8 142.6 27.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.4 p -137.26 -177.88 4.97 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.732 0.813 . . . . 0.0 110.981 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.76 -175.91 53.16 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.8 134.27 56.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 51.18 18.89 0.64 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.102 0.961 . . . . 0.0 113.275 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 22.23 77.25 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.334 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -75.42 7.61 3.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -125.31 153.23 43.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.423 0.556 . . . . 0.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.9 t -108.9 138.94 44.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.538 0.735 . . . . 0.0 110.146 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.0 m -141.0 147.17 38.27 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 123.008 0.523 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -100.87 162.88 12.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.121 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.71 141.01 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.793 0.837 . . . . 0.0 110.035 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -68.86 155.35 93.52 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.159 0.583 . . . . 0.0 111.088 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.52 164.49 87.09 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 118.23 0.403 . . . . 0.0 111.351 -1.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.2 m -139.11 68.32 41.03 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.509 0.724 . . . . 0.0 110.192 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.77 164.08 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.675 2.916 . . . . 0.0 111.874 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.54 160.77 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.896 0.478 . . . . 0.0 111.43 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.702 -178.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.17 178.34 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.921 3.081 . . . . 0.0 110.731 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -122.6 128.57 50.86 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.846 0.458 . . . . 0.0 110.157 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -143.62 144.91 32.11 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.699 0.799 . . . . 0.0 109.16 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.6 mmm180 -133.27 -23.88 1.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 17.4 58.63 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.75 0.69 . . . . 0.0 113.604 -173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.72 -25.76 63.25 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.971 0.886 . . . . 0.0 112.623 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.9 m -79.53 4.65 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 111.936 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.63 -25.41 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.111 0.565 . . . . 0.0 111.181 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.5 p -89.11 -15.58 33.56 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -154.73 -36.61 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.689 0.396 . . . . 0.0 111.384 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -165.36 13.03 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.4 -27.6 67.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.479 -0.424 . . . . 0.0 111.751 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -62.81 -39.63 94.88 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.772 -0.58 . . . . 0.0 111.0 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -28.77 48.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.181 0.446 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.33 -32.83 70.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -78.56 -31.99 47.59 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.443 0.297 . . . . 0.0 110.8 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -77.14 -20.17 55.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.483 -0.136 . . . . 0.0 110.838 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -86.24 -31.43 21.69 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.638 0.375 . . . . 0.0 110.875 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.4 m -80.16 -29.89 38.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.259 -0.401 . . . . 0.0 111.925 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.51 -15.71 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.54 0.609 . . . . 0.0 111.036 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -102.99 169.64 8.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -77.69 141.44 39.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -146.54 171.97 14.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.132 0.973 . . . . 0.0 109.609 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -73.43 139.36 45.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.589 0.233 . . . . 0.0 111.271 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.5 -169.34 15.27 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.908 0.766 . . . . 0.0 111.199 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.68 -14.82 36.41 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.771 0.429 . . . . 0.0 112.015 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.2 -8.12 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 122.813 0.445 . . . . 0.0 111.616 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.93 179.26 42.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.72 140.31 34.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.579 0.69 . . . . 0.0 110.881 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.84 163.41 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.497 0.719 . . . . 0.0 110.989 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -133.68 147.34 51.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.22 -173.27 2.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.79 0.436 . . . . 0.0 111.568 -172.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -99.97 -35.75 9.62 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -154.13 -174.5 4.99 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.48 26.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.38 165.12 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.474 1.11 . . . . 0.0 109.508 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 100.0 m -99.03 144.8 27.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -136.95 -178.88 5.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.953 0.901 . . . . 0.0 111.106 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.65 -178.45 25.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.01 -22.89 67.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.047 0.539 . . . . 0.0 112.014 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -144.36 20.8 1.72 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.815 0.279 . . . . 0.0 111.676 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.68 17.78 79.57 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -81.29 7.1 12.28 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.4 m -128.02 153.27 46.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.811 0.444 . . . . 0.0 110.273 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 t -105.39 141.88 36.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.335 0.654 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 m -142.4 146.04 34.46 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.195 0.598 . . . . 0.0 110.101 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.94 162.96 12.52 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.886 0.474 . . . . 0.0 111.256 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -111.69 138.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.426 0.69 . . . . 0.0 110.007 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -67.46 156.1 89.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.22 0.608 . . . . 0.0 111.027 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.71 167.95 78.77 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 O-C-N 121.97 0.458 . . . . 0.0 111.382 -1.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 88.5 m -139.97 67.64 34.49 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.627 0.771 . . . . 0.0 110.063 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.61 170.88 14.17 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.317 3.345 . . . . 0.0 112.082 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -66.11 169.74 6.6 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.597 0.759 . . . . 0.0 110.715 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.17 -1.395 . . . . 0.0 111.363 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.275 0.083 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.52 173.11 15.06 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.428 2.752 . . . . 0.0 110.162 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.3 m -120.51 123.92 44.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.5 0.32 . . . . 0.0 110.197 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -143.77 138.63 28.91 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -138.87 -15.0 1.18 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.202 0.601 . . . . 0.0 111.716 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.1 13.21 62.05 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.554 0.597 . . . . 0.0 112.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.06 -17.35 63.29 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.683 0.741 . . . . 0.0 112.499 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.42 2.69 52.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.152 0.433 . . . . 0.0 111.95 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.11 -30.08 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 118.226 0.467 . . . . 0.0 111.603 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -155.45 -26.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -79.98 -19.75 47.13 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.137 -0.352 . . . . 0.0 111.591 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.69 171.34 47.65 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.942 0.782 . . . . 0.0 112.609 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.57 -28.25 68.32 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.831 0.452 . . . . 0.0 111.097 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -62.46 -33.08 74.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.865 0.302 . . . . 0.0 110.564 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -33.58 42.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.031 -0.418 . . . . 0.0 110.384 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.86 -29.67 68.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -79.43 -30.83 42.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.716 0.407 . . . . 0.0 111.079 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -77.53 -19.27 56.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.092 0.157 . . . . 0.0 111.128 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -87.43 -31.61 19.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.581 0.352 . . . . 0.0 111.108 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.7 m -80.37 -23.84 40.21 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -88.05 9.49 22.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.845 0.293 . . . . 0.0 111.117 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -132.8 170.53 15.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.222 1.009 . . . . 0.0 108.449 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.8 133.5 43.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.769 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -146.88 169.24 19.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.409 0.684 . . . . 0.0 110.019 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -75.08 139.48 42.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.058 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.48 -170.82 16.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.73 -13.27 54.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.02 -18.13 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 122.695 0.398 . . . . 0.0 111.25 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.94 179.58 47.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -82.95 141.56 32.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.915 0.857 . . . . 0.0 111.242 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -146.94 170.01 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.449 0.7 . . . . 0.0 110.829 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -136.15 146.02 46.45 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -126.29 -172.24 2.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.09 0.405 . . . . 0.0 112.062 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 t -103.37 -36.93 7.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.75 -174.87 4.99 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.89 167.85 28.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.19 164.85 37.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.418 1.087 . . . . 0.0 109.206 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.86 145.01 26.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -139.29 -178.52 5.4 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.526 0.73 . . . . 0.0 111.176 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.77 174.28 41.96 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.37 143.44 57.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 tp 54.5 11.73 0.45 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.72 0.808 . . . . 0.0 112.53 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.12 76.31 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.37 -0.684 . . . . 0.0 112.924 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -76.19 9.88 2.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.589 1.194 . . . . 0.0 114.184 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.3 m -127.37 152.31 47.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.65 0.659 . . . . 0.0 110.671 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 t -111.27 139.61 46.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.5 m -140.54 148.34 40.88 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 123.659 0.784 . . . . 0.0 109.783 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.54 164.46 11.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.821 0.448 . . . . 0.0 111.652 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.75 142.99 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 123.906 0.883 . . . . 0.0 110.113 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.11 156.48 91.74 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 122.898 0.479 . . . . 0.0 110.964 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.57 163.03 90.74 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 O-C-N 121.901 0.422 . . . . 0.0 111.347 -1.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.15 68.85 48.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.767 0.827 . . . . 0.0 110.38 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -62.6 159.97 34.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.464 2.776 . . . . 0.0 111.614 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -74.57 159.44 32.16 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.883 0.473 . . . . 0.0 112.025 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.259 -1.353 . . . . 0.0 109.952 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.83 -0.063 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.79 174.33 12.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.699 2.932 . . . . 0.0 110.392 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 m -122.06 134.63 54.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.337 0.025 0 C-N-CA 123.379 0.672 . . . . 0.0 110.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -143.31 162.44 35.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.639 1.176 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.11 13.84 70.42 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.777 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.5 mt -58.62 -26.33 63.6 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 117.83 0.815 . . . . 0.0 111.974 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -85.75 7.31 24.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.4 -24.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 122.843 0.457 . . . . 0.0 110.978 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -103.62 -18.79 14.59 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 m -143.07 -19.76 0.64 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.35 -176.65 32.93 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 tp -59.14 -27.35 65.55 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.297 0.639 . . . . 0.0 111.791 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.166 -0.334 . . . . 0.0 111.214 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.46 31.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.057 -0.402 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -69.47 -31.58 69.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -78.27 -36.3 46.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.555 0.342 . . . . 0.0 110.87 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.83 -23.93 61.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.899 0.124 . . . . 0.0 110.783 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -81.31 -34.72 31.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.881 0.31 . . . . 0.0 110.656 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -77.49 -28.09 52.07 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.561 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -85.83 4.24 38.02 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.793 0.437 . . . . 0.0 111.462 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -123.98 165.7 16.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -72.22 134.09 45.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.001 -0.437 . . . . 0.0 110.034 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.04 170.18 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.187 0.595 . . . . 0.0 110.449 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -72.57 137.36 46.16 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.44 -163.24 22.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.02 -17.43 25.08 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.42 -0.459 . . . . 0.0 112.135 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.79 -4.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.93 0.492 . . . . 0.0 111.898 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.71 -147.11 5.83 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.0 m -125.92 140.88 52.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.132 0.466 . . . . 0.0 110.797 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.47 170.26 6.32 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.049 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.38 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.84 150.4 45.97 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 124.841 1.256 . . . . 0.0 107.83 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -127.82 -174.09 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.181 0.446 . . . . 0.0 111.506 -175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -105.96 -28.15 10.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -156.94 -178.06 7.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.656 0.662 . . . . 0.0 109.772 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.64 168.37 25.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.35 170.15 21.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.423 1.089 . . . . 0.0 108.721 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.1 m -109.02 145.69 35.16 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.9 p -133.47 -178.25 4.91 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.381 0.672 . . . . 0.0 110.979 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.73 -176.65 26.33 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -66.61 -22.02 66.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.899 0.479 . . . . 0.0 112.23 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -144.44 20.74 1.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.853 0.297 . . . . 0.0 111.306 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.07 19.75 79.69 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 121.971 -0.456 . . . . 0.0 112.177 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -82.03 3.0 28.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.802 0.801 . . . . 0.0 112.973 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.8 m -119.15 153.21 35.23 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.092 0.557 . . . . 0.0 109.777 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.6 t -110.17 136.86 48.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.007 0.523 . . . . 0.0 110.33 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -139.94 147.23 40.23 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 109.861 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.86 164.95 11.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.584 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.0 mm -112.88 145.48 18.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 123.907 0.883 . . . . 0.0 110.292 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -72.94 155.64 90.35 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.866 0.466 . . . . 0.0 110.825 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.19 164.58 87.41 Favored 'Cis proline' 0 N--CA 1.455 -0.769 0 CA-C-N 118.321 0.436 . . . . 0.0 111.42 -1.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -137.42 69.66 54.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 123.505 0.722 . . . . 0.0 110.329 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.3 163.39 26.58 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.901 3.067 . . . . 0.0 111.76 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -74.76 160.58 30.54 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.498 0.719 . . . . 0.0 111.672 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.859 179.527 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.02 177.67 8.45 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.315 3.343 . . . . 0.0 110.915 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -118.19 137.59 52.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -142.39 147.31 36.0 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.657 0.383 . . . . 0.0 110.902 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -141.9 163.42 32.94 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.802 1.241 . . . . 0.0 109.047 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.85 16.79 72.72 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.395 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.54 -28.41 68.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.884 0.842 . . . . 0.0 111.462 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.1 m -81.31 5.56 16.92 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.21 -13.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.768 0.427 . . . . 0.0 111.54 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -126.19 -16.58 5.46 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 m -140.39 -19.15 0.87 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.55 -175.94 39.44 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.95 -27.83 65.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.055 0.542 . . . . 0.0 112.003 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -61.11 -36.49 79.85 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.873 0.306 . . . . 0.0 111.143 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.04 -29.22 35.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.995 0.361 . . . . 0.0 110.648 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 t -70.22 -31.03 68.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -80.64 -33.52 35.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.552 0.341 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.8 -28.81 61.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -78.21 -33.34 50.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.709 0.231 . . . . 0.0 110.855 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.97 -28.4 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.534 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.81 -20.18 36.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.56 0.618 . . . . 0.0 111.105 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 m -90.85 163.49 14.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.61 134.55 42.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -144.04 169.83 17.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.055 0.542 . . . . 0.0 110.042 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -73.77 140.16 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.343 0.257 . . . . 0.0 111.192 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.77 -166.48 14.77 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.94 -17.27 31.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.781 0.432 . . . . 0.0 112.156 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.81 -10.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.754 0.422 . . . . 0.0 111.685 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.08 47.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.3 m -83.86 140.78 31.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.674 0.737 . . . . 0.0 111.286 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -145.15 169.65 7.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -140.77 154.01 46.09 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -127.36 -173.81 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.889 0.476 . . . . 0.0 111.44 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -98.33 -39.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -150.18 -175.06 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.592 0.757 . . . . 0.0 110.201 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.92 167.54 30.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 112.059 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.47 164.22 38.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.959 0.904 . . . . 0.0 109.216 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.9 m -94.57 142.2 27.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -135.2 -176.34 4.23 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.443 0.697 . . . . 0.0 111.027 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.21 -177.27 28.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -67.42 -21.88 65.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.736 0.414 . . . . 0.0 112.093 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -145.17 22.97 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.68 17.59 80.05 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.885 -0.509 . . . . 0.0 111.978 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 p -81.64 6.62 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.8 m -126.98 158.15 37.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.94 0.496 . . . . 0.0 109.952 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.6 t -115.36 138.17 51.27 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.313 0.645 . . . . 0.0 109.977 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.0 m -140.53 146.24 37.86 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.559 0.744 . . . . 0.0 109.981 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -98.7 164.79 12.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.844 0.458 . . . . 0.0 111.388 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.28 146.06 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.231 1.013 . . . . 0.0 109.937 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -76.27 155.34 84.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.39 0.276 . . . . 0.0 111.056 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.43 165.26 86.2 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 CA-C-N 118.257 0.413 . . . . 0.0 111.649 -0.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 76.2 m -135.9 70.46 64.18 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.674 0.79 . . . . 0.0 109.96 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.41 162.44 27.28 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.841 3.027 . . . . 0.0 111.877 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -74.15 160.14 31.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.878 0.471 . . . . 0.0 111.625 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.316 -1.326 . . . . 0.0 109.723 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 120.679 0.276 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 175.21 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.112 3.208 . . . . 0.0 111.183 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -118.61 119.96 36.03 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -144.71 135.81 25.08 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.403 0.681 . . . . 0.0 109.279 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -131.99 -14.92 3.04 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.202 0.601 . . . . 0.0 111.225 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.75 11.16 67.37 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.632 0.634 . . . . 0.0 112.531 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.99 -25.63 65.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.719 0.76 . . . . 0.0 112.288 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.82 3.6 16.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.567 0.347 . . . . 0.0 111.908 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.75 -25.63 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 122.99 0.516 . . . . 0.0 110.835 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -89.96 -15.25 32.37 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -155.04 -37.91 0.09 Allowed 'General case' 0 C--O 1.23 0.079 0 C-N-CA 122.53 0.332 . . . . 0.0 111.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.16 -165.65 13.64 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.02 -26.95 66.5 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.735 0.414 . . . . 0.0 111.591 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -62.67 -39.19 93.17 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 121.913 -0.492 . . . . 0.0 111.277 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.45 -29.98 42.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.328 0.513 . . . . 0.0 110.863 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.74 -32.35 72.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -78.49 -35.9 45.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.196 -0.315 . . . . 0.0 110.653 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.38 -17.02 62.43 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.72 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -90.71 -30.78 16.89 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.186 0.594 . . . . 0.0 111.258 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.33 -21.37 39.24 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.035 -0.416 . . . . 0.0 110.749 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -86.13 4.08 39.9 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.511 0.724 . . . . 0.0 111.35 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.2 p -131.62 169.61 15.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.088 0.955 . . . . 0.0 108.841 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -75.15 134.67 41.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.58 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -145.73 169.99 17.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.837 0.855 . . . . 0.0 109.891 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -73.32 139.54 46.11 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 122.44 -0.163 . . . . 0.0 111.16 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.8 -166.8 14.38 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.367 0.984 . . . . 0.0 111.031 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.25 -13.05 53.65 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.0 -10.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.645 0.378 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.05 179.98 45.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -80.92 142.52 33.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.616 0.708 . . . . 0.0 111.279 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 m -145.08 169.27 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.843 0.857 . . . . 0.0 110.8 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.97 151.76 49.38 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -130.91 -175.25 3.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 112.024 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.9 p -97.07 -36.91 10.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -154.45 -174.78 5.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.023 0.529 . . . . 0.0 109.609 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 166.94 30.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.426 0.632 . . . . 0.0 112.518 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.25 165.82 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.9 0.88 . . . . 0.0 109.246 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.39 143.9 29.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -137.15 -178.64 5.3 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.881 0.872 . . . . 0.0 111.212 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.94 -176.7 23.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.05 -23.02 66.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.144 0.578 . . . . 0.0 111.854 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.96 20.9 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.26 -0.275 . . . . 0.0 111.24 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.39 17.82 80.08 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.7 p -82.62 7.9 13.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.7 m -127.78 151.5 48.94 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.838 0.455 . . . . 0.0 110.381 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -104.35 140.21 38.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.525 0.73 . . . . 0.0 110.655 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -141.45 147.76 38.42 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.686 0.795 . . . . 0.0 110.046 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.98 162.97 12.5 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.874 0.369 . . . . 0.0 111.247 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.2 147.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.698 0.799 . . . . 0.0 110.315 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -75.42 154.5 85.9 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.794 0.438 . . . . 0.0 111.109 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.74 164.47 88.13 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 O-C-N 121.819 0.378 . . . . 0.0 111.715 -1.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 63.5 m -136.48 70.8 60.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.736 0.815 . . . . 0.0 110.192 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.19 160.65 29.72 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.649 2.9 . . . . 0.0 111.438 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.08 160.38 29.1 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.895 0.478 . . . . 0.0 111.95 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.188 -179.638 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.87 175.59 10.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.518 3.479 . . . . 0.0 111.523 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -112.86 121.95 46.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.132 0.573 . . . . 0.0 110.004 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -139.97 137.62 34.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.079 0.952 . . . . 0.0 109.315 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.92 -11.87 1.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.397 0.679 . . . . 0.0 111.352 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.43 10.4 74.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.416 0.531 . . . . 0.0 112.482 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.04 -24.9 64.92 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 117.431 0.615 . . . . 0.0 112.39 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.1 m -77.35 2.34 16.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.37 -23.74 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 122.827 0.451 . . . . 0.0 111.394 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.1 p -97.27 -21.36 17.3 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.322 0.51 . . . . 0.0 112.207 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.4 m -145.93 -22.18 0.45 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 -177.46 25.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.46 -29.51 69.09 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.177 0.591 . . . . 0.0 111.665 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -62.02 -34.93 77.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.004 -0.435 . . . . 0.0 111.142 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -30.51 38.99 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.072 -0.393 . . . . 0.0 110.13 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.7 t -68.78 -31.67 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -78.9 -32.36 45.73 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.896 0.478 . . . . 0.0 111.035 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -78.03 -24.13 47.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.246 0.218 . . . . 0.0 111.353 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -81.71 -35.86 29.3 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 122.185 -0.322 . . . . 0.0 110.896 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.8 m -74.92 -24.18 58.46 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.734 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.62 13.99 14.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.891 0.476 . . . . 0.0 111.167 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -134.01 168.36 18.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.824 0.85 . . . . 0.0 109.098 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -73.31 123.22 23.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -140.2 164.36 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.049 0.54 . . . . 0.0 109.859 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -73.54 134.99 43.93 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.269 -0.269 . . . . 0.0 110.583 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.0 -152.78 25.0 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.02 -19.24 27.43 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.89 -10.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.969 0.508 . . . . 0.0 112.112 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.19 173.04 45.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.4 m -79.81 141.26 36.39 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 117.582 0.691 . . . . 0.0 111.458 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.62 169.05 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 110.163 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -136.87 151.6 49.28 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.649 1.18 . . . . 0.0 108.088 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.7 m -128.04 -173.44 2.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.993 0.361 . . . . 0.0 111.83 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 t -99.01 -36.43 9.72 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.9 -175.22 5.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.54 167.14 31.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.931 0.396 . . . . 0.0 111.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.47 165.33 36.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.787 0.835 . . . . 0.0 109.667 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -99.1 140.7 32.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.6 p -137.68 -178.41 5.23 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.652 0.781 . . . . 0.0 110.752 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.76 -172.65 16.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -66.81 -23.03 66.0 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 111.781 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -146.78 21.71 1.28 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 111.294 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.83 79.13 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 112.085 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -81.65 7.03 13.35 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -129.83 145.57 51.58 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.689 0.677 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -95.37 141.74 28.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.652 0.781 . . . . 0.0 110.291 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.7 m -143.63 145.19 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.212 0.605 . . . . 0.0 109.991 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.87 164.61 12.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 111.422 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.24 136.48 53.07 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.061 0 C-N-CA 123.964 0.905 . . . . 0.0 109.763 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.81 159.01 86.74 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 122.989 0.516 . . . . 0.0 111.185 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.57 161.57 65.89 Favored 'Cis proline' 0 N--CA 1.459 -0.535 0 CA-C-N 118.741 0.586 . . . . 0.0 113.073 -2.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.82 71.33 36.21 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.54 165.06 23.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.62 2.88 . . . . 0.0 111.583 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.47 164.65 25.25 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.072 -178.844 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 178.09 7.93 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.288 3.325 . . . . 0.0 110.619 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -123.01 122.87 39.57 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.759 0.424 . . . . 0.0 110.151 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.58 130.65 20.65 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.474 0.709 . . . . 0.0 109.233 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -126.76 -15.11 5.53 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.373 0.669 . . . . 0.0 111.452 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.52 11.1 59.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.733 0.683 . . . . 0.0 112.839 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 -17.33 64.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.527 0.664 . . . . 0.0 112.177 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.3 m -96.96 2.36 51.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.16 0.436 . . . . 0.0 112.046 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.54 -29.92 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.06 0.391 . . . . 0.0 111.478 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -154.48 -26.95 0.12 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -80.09 -20.42 45.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.199 -0.313 . . . . 0.0 111.766 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.05 171.9 48.29 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.12 0.867 . . . . 0.0 112.386 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.57 -28.74 68.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.164 0.585 . . . . 0.0 111.147 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -61.7 -33.8 74.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.153 -0.342 . . . . 0.0 110.722 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.75 -31.26 40.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.232 -0.293 . . . . 0.0 110.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.9 t -71.34 -29.66 65.25 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -79.23 -33.48 43.66 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 122.194 -0.316 . . . . 0.0 110.935 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -22.88 59.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.207 0.203 . . . . 0.0 110.76 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -82.76 -32.51 27.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.893 0.477 . . . . 0.0 110.743 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -80.38 -25.17 39.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.431 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -86.15 9.36 17.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.783 0.433 . . . . 0.0 111.059 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -131.13 170.26 14.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.1 m -78.13 132.69 37.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -145.02 170.63 15.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.583 0.753 . . . . 0.0 109.726 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -74.48 140.07 44.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.166 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.69 -169.55 15.24 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -86.37 -12.5 49.08 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.16 -10.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.811 0.445 . . . . 0.0 111.854 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.1 44.08 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.72 140.84 34.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.496 0.648 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.7 168.62 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.101 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -138.48 148.77 44.72 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 107.703 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -128.58 -171.68 2.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.038 0.381 . . . . 0.0 111.906 -172.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.2 t -103.46 -39.4 6.77 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -146.67 -175.43 4.79 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.574 0.75 . . . . 0.0 110.416 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 168.09 28.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.83 165.54 35.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.323 1.049 . . . . 0.0 109.539 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.25 143.01 30.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.5 p -138.62 -176.64 4.55 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.681 0.792 . . . . 0.0 110.943 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.93 178.18 25.58 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.65 -20.57 66.02 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.11 0.564 . . . . 0.0 111.968 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -141.54 18.38 2.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.661 0.267 . . . . 0.0 111.329 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.67 80.61 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.1 p -83.21 10.46 8.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.982 0.913 . . . . 0.0 113.09 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 m -126.14 151.77 46.83 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.368 0.531 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -108.71 140.19 42.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.501 0.72 . . . . 0.0 109.769 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.5 m -140.89 147.19 38.51 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.297 0.639 . . . . 0.0 110.071 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.59 165.97 10.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mm -116.8 142.3 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 124.202 1.001 . . . . 0.0 110.516 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -67.76 156.43 89.17 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 122.894 0.477 . . . . 0.0 111.224 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 162.43 91.73 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 O-C-N 121.761 0.348 . . . . 0.0 111.337 -1.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -137.51 68.9 53.61 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.826 0.851 . . . . 0.0 110.499 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.91 164.66 21.13 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.718 2.945 . . . . 0.0 111.189 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.17 167.07 22.38 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.462 0.649 . . . . 0.0 112.085 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.087 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.536 0.431 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.6 177.21 8.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.219 3.279 . . . . 0.0 111.497 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -115.89 130.98 57.06 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 109.825 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.07 142.28 31.5 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.7 mmm180 -131.13 -23.53 2.43 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.73 17.0 58.07 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.358 0.504 . . . . 0.0 113.59 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.04 -24.71 59.44 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.884 0.842 . . . . 0.0 112.747 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.83 6.92 19.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.393 0.542 . . . . 0.0 111.843 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.32 -25.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.514 0.726 . . . . 0.0 110.374 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -89.05 -15.49 33.9 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.97 -0.457 . . . . 0.0 111.423 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -153.61 -38.91 0.1 Allowed 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.632 0.253 . . . . 0.0 111.062 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.81 -167.92 15.12 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.82 -27.15 66.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.635 0.374 . . . . 0.0 111.327 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -60.91 -41.24 95.75 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 122.07 -0.394 . . . . 0.0 111.283 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.75 -28.62 44.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.998 -0.439 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.1 -32.69 72.27 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -79.13 -36.25 40.84 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 122.369 0.268 . . . . 0.0 110.776 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -73.3 -17.73 61.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.0 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -89.79 -30.99 17.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.601 0.361 . . . . 0.0 111.108 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.3 m -77.87 -25.14 48.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.545 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -88.93 8.32 29.98 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.949 0.5 . . . . 0.0 111.351 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p -130.58 169.28 15.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 108.593 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.5 m -74.82 131.62 40.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.754 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.58 167.07 23.41 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.985 0.914 . . . . 0.0 109.162 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.53 124.31 26.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 -158.29 34.4 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.11 -21.18 36.85 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.59 -10.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.794 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 173.61 45.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -76.06 140.24 41.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.042 0.921 . . . . 0.0 111.482 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.93 169.7 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 124.233 1.013 . . . . 0.0 110.691 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -137.68 149.96 46.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.7 m -129.22 -172.31 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.159 0.436 . . . . 0.0 111.501 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -103.3 -37.52 7.62 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -151.15 -176.13 5.43 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.17 168.34 26.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.87 168.58 25.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.915 1.286 . . . . 0.0 108.657 173.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.17 148.6 25.58 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.193 -0.317 . . . . 0.0 110.622 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -135.12 179.96 5.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.548 0.739 . . . . 0.0 110.796 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 177.22 29.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.03 -19.69 63.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.746 0.419 . . . . 0.0 111.947 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.42 13.93 3.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.066 0.546 . . . . 0.0 111.658 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.06 16.23 78.5 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.287 -0.325 . . . . 0.0 112.287 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.6 p -80.49 6.13 13.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.681 0.792 . . . . 0.0 113.072 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.6 m -122.81 154.39 38.29 Favored 'General case' 0 CA--C 1.526 0.022 0 C-N-CA 122.95 0.5 . . . . 0.0 110.139 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.7 t -107.35 141.39 38.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.585 0.754 . . . . 0.0 110.566 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -142.34 147.15 35.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.395 0.678 . . . . 0.0 109.971 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.6 m -101.53 164.55 11.7 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.872 0.368 . . . . 0.0 111.512 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.98 143.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -70.23 156.28 92.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 122.92 0.488 . . . . 0.0 110.868 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.84 162.87 91.26 Favored 'Cis proline' 0 N--CA 1.451 -1.012 0 O-C-N 121.959 0.452 . . . . 0.0 111.378 -1.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.8 m -136.94 69.25 57.83 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.562 0.745 . . . . 0.0 110.367 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.09 162.96 24.25 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.587 2.858 . . . . 0.0 111.623 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -76.61 159.98 29.81 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.869 0.468 . . . . 0.0 111.592 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.99 178.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 p . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.9 174.22 12.71 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.872 3.048 . . . . 0.0 110.962 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.8 m -115.87 121.47 42.47 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.0 138.78 30.27 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 123.741 0.816 . . . . 0.0 109.211 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.19 -16.18 1.08 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.673 0.389 . . . . 0.0 111.7 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.24 11.45 71.01 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.586 0.613 . . . . 0.0 112.491 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.0 -27.05 63.16 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.53 0.665 . . . . 0.0 112.395 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.0 t -74.94 -6.09 47.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.666 0.386 . . . . 0.0 111.536 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.01 -22.76 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.166 -0.334 . . . . 0.0 111.319 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 p -98.69 -21.16 16.56 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -144.93 -22.66 0.5 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.56 179.68 23.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.92 -27.84 68.49 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.221 0.608 . . . . 0.0 111.787 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -63.09 -33.79 76.2 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.976 -0.453 . . . . 0.0 110.857 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.09 -30.25 43.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.891 -0.506 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.69 -31.0 67.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.48 -29.07 46.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.344 0.258 . . . . 0.0 110.959 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.71 -16.48 51.06 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.067 0.147 . . . . 0.0 111.005 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -87.39 -33.59 19.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.074 -0.391 . . . . 0.0 110.967 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.59 -26.36 45.42 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.195 -0.316 . . . . 0.0 111.815 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -87.16 9.75 19.01 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.116 0.416 . . . . 0.0 111.28 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -133.18 166.78 21.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.484 1.113 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.8 m -72.48 133.45 44.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.551 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -145.64 169.63 18.07 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.591 0.756 . . . . 0.0 109.766 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -74.3 136.72 42.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.217 0.207 . . . . 0.0 111.079 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 -159.61 19.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.123 0.868 . . . . 0.0 111.098 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.79 -18.32 33.27 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.28 -11.37 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 122.569 0.348 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.99 178.61 48.61 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -81.48 142.84 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.64 0.72 . . . . 0.0 111.328 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -146.48 169.48 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.698 0.799 . . . . 0.0 110.418 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.7 150.27 47.19 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.1 m -130.16 -174.61 3.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.059 0.391 . . . . 0.0 111.462 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 -27.54 11.95 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.05 -177.31 6.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.693 0.678 . . . . 0.0 109.814 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.08 169.5 22.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.64 168.95 24.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.665 1.186 . . . . 0.0 109.037 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.7 t -110.93 142.56 42.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -132.42 173.15 11.59 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.026 -175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.82 177.77 15.31 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -72.2 -20.61 61.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.877 0.339 . . . . 0.0 111.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.12 9.94 3.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.082 0.953 . . . . 0.0 110.709 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.12 83.87 0.24 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -140.29 4.91 2.04 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.2 m -132.81 147.68 52.31 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.314 0.506 . . . . 0.0 110.323 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.3 t -94.01 137.95 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.084 0.554 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -138.01 145.17 41.53 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.414 0.686 . . . . 0.0 109.555 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.42 162.7 12.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 143.86 18.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.726 0.81 . . . . 0.0 110.049 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -72.7 155.16 91.1 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 122.888 0.475 . . . . 0.0 110.99 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.61 165.43 85.62 Favored 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.605 0.538 . . . . 0.0 111.249 -0.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.61 69.8 38.13 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.051 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.8 161.67 28.07 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.785 2.99 . . . . 0.0 111.322 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -76.5 161.42 28.64 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.851 0.358 . . . . 0.0 111.642 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.283 -1.342 . . . . 0.0 109.916 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 177.14 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 124.786 3.657 . . . . 0.0 111.487 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m -108.62 125.86 52.32 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.379 0.672 . . . . 0.0 109.576 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -138.88 133.31 31.77 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.45 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -130.88 -16.97 3.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.5 67.82 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.339 0.495 . . . . 0.0 112.879 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.16 -27.46 68.41 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 117.564 0.682 . . . . 0.0 112.01 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.7 m -80.24 5.33 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.09 -24.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 122.613 0.365 . . . . 0.0 111.497 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -100.09 -15.65 18.12 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.7 t -149.86 -35.07 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.04 -164.53 12.03 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.97 -27.15 66.59 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.948 0.499 . . . . 0.0 111.794 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 m -62.39 -40.76 97.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.86 -0.525 . . . . 0.0 111.125 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.09 46.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.411 0.55 . . . . 0.0 110.626 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -68.0 -33.28 74.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -78.7 -35.93 44.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.261 0.224 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -72.43 -17.47 61.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.942 -0.117 . . . . 0.0 111.17 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -90.05 -32.04 16.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.578 0.351 . . . . 0.0 110.79 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.39 -25.65 42.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.574 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -85.89 5.2 34.0 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.3 0.5 . . . . 0.0 111.249 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.9 m -127.73 165.97 19.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.57 1.148 . . . . 0.0 107.946 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.43 137.33 39.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.806 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -146.18 167.92 22.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.351 1.06 . . . . 0.0 108.834 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -73.87 134.31 43.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.154 -0.342 . . . . 0.0 110.635 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.69 -152.24 24.94 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -88.64 -17.95 29.0 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.766 0.427 . . . . 0.0 112.135 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.75 -12.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.687 0.395 . . . . 0.0 112.051 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 175.37 47.59 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -78.03 142.58 38.13 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.425 0.612 . . . . 0.0 111.602 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.09 165.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 124.006 0.922 . . . . 0.0 110.621 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -132.96 144.51 50.17 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 124.763 1.225 . . . . 0.0 107.946 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.53 -172.47 2.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.613 0.365 . . . . 0.0 111.335 -172.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 t -103.48 -36.6 7.92 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.41 -177.3 5.99 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.24 167.95 28.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -154.25 164.53 38.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.083 0.953 . . . . 0.0 109.548 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.7 m -96.44 143.26 27.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -137.89 -177.4 4.8 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.662 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.29 -179.07 48.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -65.7 138.92 58.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.533 . . . . 0.0 109.946 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp 52.92 17.21 0.83 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.078 0.951 . . . . 0.0 112.483 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.87 77.35 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.92 -0.488 . . . . 0.0 112.164 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -76.19 10.06 2.19 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 153.29 48.46 Favored 'General case' 0 C--O 1.228 -0.069 0 CA-C-N 118.501 0.591 . . . . 0.0 110.355 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 t -108.98 141.37 41.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.684 0.794 . . . . 0.0 110.021 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.6 m -142.42 146.76 35.2 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.158 0.583 . . . . 0.0 109.727 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.1 m -100.46 164.41 11.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.787 0.435 . . . . 0.0 111.327 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.41 142.53 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.172 0.989 . . . . 0.0 110.237 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -70.78 155.77 92.92 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.215 0.606 . . . . 0.0 111.267 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.09 165.33 86.2 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 118.176 0.384 . . . . 0.0 111.529 -1.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.59 67.76 44.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.762 0.825 . . . . 0.0 110.388 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.66 167.66 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.013 3.142 . . . . 0.0 111.286 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -78.47 172.69 13.28 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.882 0.473 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.241 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.588 0.232 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 174.01 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.132 3.221 . . . . 0.0 111.328 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -111.43 126.72 55.24 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.897 0.479 . . . . 0.0 109.868 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -139.82 135.23 32.78 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -140.25 161.87 36.64 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.686 0.795 . . . . 0.0 109.433 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.89 15.35 78.26 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.436 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.98 -23.27 63.48 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 117.665 0.733 . . . . 0.0 111.687 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.1 m -74.43 0.72 13.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.811 0.444 . . . . 0.0 111.831 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 -23.19 2.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.042 0.383 . . . . 0.0 111.416 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -97.94 -20.1 17.65 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -149.94 -24.1 0.26 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.09 178.51 22.07 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.31 -28.05 67.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.661 0.385 . . . . 0.0 111.857 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -61.46 -33.29 73.5 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.881 -0.512 . . . . 0.0 110.88 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.15 -30.4 49.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.959 -0.463 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.43 -29.07 46.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.402 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.16 -34.06 72.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -74.4 -28.95 61.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.255 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -78.81 -35.02 44.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.1 m -75.49 -30.59 59.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.642 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -81.68 -15.99 52.72 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.493 0.588 . . . . 0.0 111.623 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -99.83 170.49 8.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -80.18 139.38 36.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.192 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -147.37 170.19 17.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.146 0.578 . . . . 0.0 109.923 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 tpt85 -74.27 122.05 22.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.72 -160.89 36.96 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.01 -17.44 37.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.928 0.364 . . . . 0.0 111.918 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.7 -11.56 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.39 177.22 48.37 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.09 137.34 35.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.666 0.733 . . . . 0.0 111.82 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.07 166.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 C-N-CA 123.708 0.803 . . . . 0.0 110.562 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -134.07 149.48 51.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.3 -170.12 2.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.084 0.554 . . . . 0.0 111.23 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -104.67 -35.73 7.7 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.68 -175.14 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.8 163.77 39.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.938 -0.476 . . . . 0.0 111.868 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -151.64 160.36 43.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.673 0.789 . . . . 0.0 109.545 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -91.1 140.71 29.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -131.52 178.8 6.46 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.939 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.78 173.49 30.6 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.07 -18.97 61.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.277 -0.543 . . . . 0.0 111.987 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 14.03 3.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.417 0.687 . . . . 0.0 111.352 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 16.01 78.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 122.037 -0.414 . . . . 0.0 112.072 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -78.38 4.83 11.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.48 0.712 . . . . 0.0 112.554 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 m -133.85 162.59 31.6 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t -130.17 158.12 40.57 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.183 -0.323 . . . . 0.0 110.892 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -143.03 136.57 28.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.727 0.811 . . . . 0.0 109.361 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -87.37 159.43 18.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.749 0.309 . . . . 0.0 110.351 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -106.75 140.15 25.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.372 0.669 . . . . 0.0 110.32 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -68.08 155.37 92.19 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.469 0.708 . . . . 0.0 110.928 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.95 166.09 83.83 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 -0.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 72.4 m -138.04 66.88 47.65 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 110.372 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.81 165.91 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.887 3.058 . . . . 0.0 111.504 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -75.71 167.88 21.05 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.937 0.495 . . . . 0.0 110.564 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.16 -1.4 . . . . 0.0 111.562 -178.669 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 177.58 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.36 3.373 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -118.36 135.7 54.17 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -140.71 146.51 37.89 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.086 0.554 . . . . 0.0 110.1 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -142.09 161.97 36.66 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.701 1.2 . . . . 0.0 108.815 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.67 14.31 72.44 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.749 -0.473 . . . . 0.0 112.98 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.9 -26.18 61.83 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.823 0.811 . . . . 0.0 111.604 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.2 t -75.67 -4.18 38.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.648 0.379 . . . . 0.0 111.88 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.29 -27.24 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.565 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.91 -21.09 20.78 Favored 'General case' 0 N--CA 1.458 -0.048 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -145.86 -22.4 0.46 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.03 178.96 24.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.11 -27.94 64.17 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.023 0.529 . . . . 0.0 111.704 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -62.32 -32.71 73.5 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.022 -0.424 . . . . 0.0 111.246 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.18 -29.77 34.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.952 -0.467 . . . . 0.0 110.717 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.0 -31.84 69.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -78.17 -31.32 49.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.806 0.443 . . . . 0.0 111.098 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.19 -23.02 44.15 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.301 0.241 . . . . 0.0 111.238 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -82.29 -33.01 29.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.933 0.333 . . . . 0.0 111.245 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.6 m -76.91 -23.42 52.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.448 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.17 5.85 42.8 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.791 0.436 . . . . 0.0 111.69 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -126.99 166.76 16.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.8 m -72.66 131.82 42.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.102 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -142.95 170.14 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 109.464 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -75.1 139.28 42.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.369 -0.207 . . . . 0.0 111.193 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.74 -168.08 15.79 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -17.44 37.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.828 0.451 . . . . 0.0 112.206 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.5 -10.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.86 0.464 . . . . 0.0 111.708 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.09 178.76 45.2 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.5 m -80.99 142.29 33.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.88 168.54 7.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.524 0.73 . . . . 0.0 110.773 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.09 150.65 45.95 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.7 m -127.53 -173.81 3.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.184 0.447 . . . . 0.0 111.487 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 m -104.92 -30.55 9.75 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -155.19 -177.36 6.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.449 0.568 . . . . 0.0 109.6 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.95 170.18 21.03 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.139 0.495 . . . . 0.0 112.257 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -151.84 166.36 31.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.34 1.056 . . . . 0.0 109.213 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.3 t -106.5 139.75 40.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -137.08 -171.53 2.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.809 0.844 . . . . 0.0 111.03 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.37 173.74 26.11 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.75 -21.02 63.48 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.973 0.509 . . . . 0.0 111.772 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -144.9 24.81 1.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.684 0.22 . . . . 0.0 111.393 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.68 32.38 57.38 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.7 p -101.29 12.21 37.88 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -133.05 154.02 50.94 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.517 0.327 . . . . 0.0 110.762 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -116.9 139.43 50.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.795 0.838 . . . . 0.0 109.489 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -139.34 143.98 38.03 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.126 0.57 . . . . 0.0 109.783 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -100.86 164.68 11.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.659 0.384 . . . . 0.0 111.515 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.31 145.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.791 0.836 . . . . 0.0 110.399 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.42 155.74 89.4 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.973 0.509 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.9 162.96 91.12 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 118.49 0.497 . . . . 0.0 111.687 -1.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.3 m -136.56 69.8 60.08 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.698 0.799 . . . . 0.0 109.976 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.62 162.82 26.47 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.054 3.17 . . . . 0.0 111.507 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -75.38 161.33 29.35 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.966 0.506 . . . . 0.0 111.471 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.013 179.561 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.34 174.41 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 124.357 3.371 . . . . 0.0 111.792 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -113.36 135.43 53.87 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -142.99 147.62 35.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 122.212 0.205 . . . . 0.0 110.717 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -142.31 164.47 30.07 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 124.801 1.24 . . . . 0.0 109.504 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.78 16.85 74.66 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.969 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.9 -29.03 68.08 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.036 0.918 . . . . 0.0 111.152 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.4 m -81.92 6.08 17.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.097 0.559 . . . . 0.0 112.092 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.61 -15.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.684 0.394 . . . . 0.0 111.923 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -123.29 -18.39 6.29 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 m -139.12 -18.27 1.02 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -177.49 39.63 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.7 tp -58.41 -27.57 64.41 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.21 0.604 . . . . 0.0 111.825 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -61.66 -34.21 75.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.238 -0.289 . . . . 0.0 111.246 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.77 -28.2 30.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.226 0.466 . . . . 0.0 110.981 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.16 -31.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -78.8 -33.51 46.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -77.57 -22.44 50.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.312 0.245 . . . . 0.0 111.334 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -84.43 -32.78 23.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.845 0.293 . . . . 0.0 111.179 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.8 m -77.79 -22.63 49.85 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.411 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.34 6.07 42.17 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.866 0.467 . . . . 0.0 111.821 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.5 p -127.86 165.45 20.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.29 131.08 42.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.139 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -142.78 167.13 22.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.678 0.791 . . . . 0.0 109.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.68 123.69 26.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.2 -160.15 36.24 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.61 -14.4 45.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.01 -11.82 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 122.594 0.358 . . . . 0.0 111.881 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.89 45.54 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -76.59 140.22 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.082 0.941 . . . . 0.0 111.55 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.96 169.23 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.516 0.726 . . . . 0.0 110.733 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -138.29 151.05 47.24 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.95 -172.41 2.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.326 0.512 . . . . 0.0 111.635 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -102.48 -35.95 8.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -153.95 -175.92 5.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.98 168.43 26.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 112.078 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.96 163.83 39.75 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.894 0.878 . . . . 0.0 109.539 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.8 m -93.72 142.41 27.39 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.2 p -137.67 -178.52 5.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.458 0.703 . . . . 0.0 111.008 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 -176.97 52.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.01 134.24 56.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt 50.86 20.13 0.73 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.981 0.912 . . . . 0.0 113.229 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.38 76.64 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.229 0.468 . . . . 0.0 112.345 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.9 p -75.53 8.76 2.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 155.84 42.0 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.588 0.631 . . . . 0.0 110.085 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.7 t -112.52 138.83 48.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.303 0.641 . . . . 0.0 110.159 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 m -141.32 145.8 35.92 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.008 0.523 . . . . 0.0 110.025 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.914 0.388 . . . . 0.0 111.42 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mm -112.4 143.18 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.798 0.839 . . . . 0.0 110.047 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -71.01 156.06 92.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 0.0 111.068 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 162.83 91.44 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 O-C-N 121.883 0.412 . . . . 0.0 111.387 -1.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.7 m -136.08 69.69 63.35 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.591 0.757 . . . . 0.0 109.772 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.66 161.77 30.74 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.383 2.722 . . . . 0.0 111.074 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.17 161.37 28.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.693 0.397 . . . . 0.0 111.681 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.62 -1.181 . . . . 0.0 110.146 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.94 178.46 7.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.365 3.377 . . . . 0.0 111.231 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -117.41 133.38 56.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.563 0.745 . . . . 0.0 109.246 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -142.79 142.82 31.96 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.657 0.383 . . . . 0.0 110.043 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -142.81 164.76 29.23 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.386 1.074 . . . . 0.0 109.207 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.79 18.7 77.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.489 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.28 -14.41 55.74 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.522 0.661 . . . . 0.0 112.332 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.04 -3.25 41.74 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.062 0.392 . . . . 0.0 111.635 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.24 -27.62 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 O-C-N 121.909 -0.494 . . . . 0.0 111.549 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -154.44 -26.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -83.8 -20.38 33.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.151 0.432 . . . . 0.0 111.992 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.22 170.44 45.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.104 0.859 . . . . 0.0 112.408 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.6 -28.17 68.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.846 0.459 . . . . 0.0 111.078 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -62.0 -32.5 72.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.212 -0.305 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.35 45.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.068 -0.395 . . . . 0.0 110.501 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.2 t -74.05 -30.9 62.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -77.44 -28.96 52.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.615 0.366 . . . . 0.0 111.051 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.56 -30.66 41.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.999 0.187 . . . . 0.0 110.899 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -76.34 -32.5 58.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.756 0.253 . . . . 0.0 111.187 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 98.9 m -76.48 -28.48 56.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.322 -0.371 . . . . 0.0 111.575 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -85.17 -20.53 30.09 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.365 0.529 . . . . 0.0 111.769 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -94.34 166.19 12.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.8 m -75.95 136.55 40.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.581 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -144.61 170.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -75.19 140.61 43.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.135 0.174 . . . . 0.0 111.407 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.63 -170.58 16.68 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.58 -14.42 48.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.53 -18.38 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.867 0.467 . . . . 0.0 111.149 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.99 176.8 44.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -75.17 144.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.612 0.706 . . . . 0.0 111.548 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.79 171.7 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.25 1.02 . . . . 0.0 110.463 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -141.66 153.07 44.47 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.7 m -123.83 -175.26 3.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 111.491 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -103.81 -29.58 10.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -155.92 -177.51 6.63 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.446 0.566 . . . . 0.0 109.756 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.0 170.03 22.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.273 0.558 . . . . 0.0 111.785 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.65 165.76 34.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.399 1.08 . . . . 0.0 109.028 173.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.0 t -107.99 141.51 39.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -130.6 179.73 5.77 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.586 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 168.63 45.06 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.83 132.09 47.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.47 -0.429 . . . . 0.0 110.295 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt 52.53 14.71 0.42 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.427 1.091 . . . . 0.0 112.749 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.73 102.0 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.99 0.805 . . . . 0.0 111.521 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 p -144.82 4.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.877 0.471 . . . . 0.0 111.551 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.3 m -134.05 152.25 51.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.603 0.361 . . . . 0.0 110.216 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.78 138.13 47.56 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.171 0.589 . . . . 0.0 110.271 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.1 m -139.45 140.96 37.45 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.88 164.12 12.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.377 0.271 . . . . 0.0 111.043 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.84 143.03 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 124.055 0.942 . . . . 0.0 110.448 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -73.55 157.05 88.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 122.939 0.496 . . . . 0.0 111.105 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.72 164.01 88.44 Favored 'Cis proline' 0 N--CA 1.455 -0.784 0 O-C-N 121.87 0.405 . . . . 0.0 111.575 -2.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 95.1 m -134.67 70.63 71.5 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 124.1 0.96 . . . . 0.0 109.906 177.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.73 167.28 15.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.248 3.299 . . . . 0.0 112.018 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -69.45 163.25 25.71 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.276 0.63 . . . . 0.0 111.557 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.525 175.735 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.34 -179.08 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.428 3.418 . . . . 0.0 110.581 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -125.32 122.41 36.77 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 122.804 0.441 . . . . 0.0 110.15 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -144.74 139.02 27.6 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.963 0.905 . . . . 0.0 109.431 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -137.77 -12.08 1.52 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.687 0.395 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.55 12.22 70.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.584 0.611 . . . . 0.0 112.581 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.77 -25.61 63.22 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.668 0.734 . . . . 0.0 112.609 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.9 t -86.39 10.14 15.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.16 0.436 . . . . 0.0 111.811 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -17.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 123.024 0.529 . . . . 0.0 111.252 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.3 p -120.59 -17.11 8.15 Favored 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 m -140.51 -19.51 0.85 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 -173.68 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.344 0.497 . . . . 0.0 112.069 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.38 -26.6 68.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.161 0.584 . . . . 0.0 111.751 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -63.45 -36.17 82.86 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.759 -0.588 . . . . 0.0 110.664 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.6 36.3 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.002 0.365 . . . . 0.0 110.703 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 t -68.62 -30.86 69.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -79.08 -35.46 42.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.259 -0.276 . . . . 0.0 110.691 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -19.57 60.92 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.918 0.136 . . . . 0.0 111.031 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.49 -33.35 21.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.447 0.299 . . . . 0.0 110.675 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.36 -26.49 46.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.554 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -87.13 8.02 25.57 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 122.865 0.466 . . . . 0.0 111.305 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -130.89 167.23 19.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.539 1.136 . . . . 0.0 108.347 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.3 m -73.2 133.82 44.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.047 -0.408 . . . . 0.0 110.41 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.95 170.91 15.66 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.887 0.875 . . . . 0.0 109.554 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -73.54 140.38 46.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.234 0.214 . . . . 0.0 111.14 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.81 -168.1 14.76 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -86.63 -17.09 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.86 -16.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.852 0.461 . . . . 0.0 110.907 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.79 48.07 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.6 m -80.29 142.18 34.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.833 0.816 . . . . 0.0 110.895 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.22 169.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.782 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -138.44 150.5 46.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.422 1.089 . . . . 0.0 108.16 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.9 m -128.18 -172.49 2.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.242 0.617 . . . . 0.0 111.212 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.2 m -107.54 -29.85 8.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -154.16 -178.97 7.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.729 0.695 . . . . 0.0 109.799 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 168.1 26.97 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.281 0.562 . . . . 0.0 112.348 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.93 168.09 27.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.992 1.317 . . . . 0.0 108.757 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.4 m -105.0 146.29 29.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -132.79 179.59 6.07 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.476 0.71 . . . . 0.0 111.0 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 176.37 28.6 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -68.89 -18.01 64.06 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.37 13.3 3.51 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.074 0.55 . . . . 0.0 111.667 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.68 17.7 78.27 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.909 -0.477 . . . . 0.0 111.909 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.6 p -83.15 9.55 10.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 113.009 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.9 m -125.65 150.82 47.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.0 t -102.66 141.69 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.484 0.714 . . . . 0.0 110.125 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.5 m -143.66 147.36 34.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.719 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -101.22 164.45 11.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.97 143.97 20.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.065 0.946 . . . . 0.0 109.632 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -72.46 156.09 90.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 122.832 0.453 . . . . 0.0 110.691 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.66 166.08 83.91 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 122.041 0.495 . . . . 0.0 111.441 -1.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.58 70.31 45.17 Favored Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 123.491 0.716 . . . . 0.0 110.069 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.9 163.43 22.18 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.798 2.998 . . . . 0.0 111.733 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -76.35 161.99 28.25 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.07 179.711 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.11 174.91 11.64 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 124.232 3.288 . . . . 0.0 111.57 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -111.15 134.63 52.6 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.306 0.642 . . . . 0.0 109.696 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -143.95 142.75 30.91 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.958 0.503 . . . . 0.0 110.023 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -142.09 163.69 32.18 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.062 0.945 . . . . 0.0 109.512 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.68 17.95 75.36 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.389 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.41 -27.31 67.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.754 0.777 . . . . 0.0 111.405 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.63 4.37 16.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.047 0.539 . . . . 0.0 112.192 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -14.8 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 122.889 0.476 . . . . 0.0 111.62 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -121.48 -19.6 6.88 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 m -140.71 -19.36 0.83 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.34 -173.47 34.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.565 0.602 . . . . 0.0 111.761 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -59.82 -28.08 67.17 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.014 0.526 . . . . 0.0 111.933 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -60.7 -36.2 78.22 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 122.052 -0.405 . . . . 0.0 110.988 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.1 27.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.067 0.394 . . . . 0.0 110.792 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.5 t -68.05 -31.47 71.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -80.12 -36.96 34.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.231 -0.293 . . . . 0.0 110.999 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.74 -18.65 61.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.927 0.142 . . . . 0.0 111.325 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -87.64 -35.69 17.88 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 117.871 0.305 . . . . 0.0 110.574 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.5 m -75.48 -28.4 59.2 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.84 3.26 34.5 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.391 . . . . 0.0 111.97 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -126.01 163.73 22.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.9 m -71.12 133.3 46.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.137 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -145.08 167.33 22.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 124.78 28.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.379 -0.201 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.79 -158.55 34.51 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 123.752 0.692 . . . . 0.0 111.389 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.67 -20.25 31.56 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.496 -0.414 . . . . 0.0 112.093 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.32 -12.39 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.58 0.352 . . . . 0.0 111.651 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.8 175.4 46.51 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.5 m -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.019 0.909 . . . . 0.0 111.875 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -142.9 167.86 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.032 0.933 . . . . 0.0 110.745 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -139.71 144.1 37.37 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.4 -173.69 2.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.133 0.424 . . . . 0.0 111.47 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -103.4 -35.85 8.22 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -152.7 -176.36 5.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.47 168.25 27.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 111.647 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -153.62 163.39 40.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.876 0.87 . . . . 0.0 109.321 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.54 142.57 27.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.4 p -132.34 -179.71 5.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 111.122 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.92 177.06 30.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.37 -18.78 63.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 112.002 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.35 14.52 3.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.069 0.547 . . . . 0.0 111.387 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.13 15.69 78.63 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -80.62 8.33 8.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.6 m -125.26 155.34 40.29 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 122.914 0.486 . . . . 0.0 110.075 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -114.34 139.36 49.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.584 0.754 . . . . 0.0 110.063 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -142.95 144.5 32.39 Favored 'General case' 0 C--O 1.228 -0.058 0 C-N-CA 122.921 0.488 . . . . 0.0 109.919 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.27 162.23 13.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.964 0.412 . . . . 0.0 111.274 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.64 145.62 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 123.918 0.887 . . . . 0.0 110.127 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -73.59 156.18 88.79 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.061 0.544 . . . . 0.0 111.609 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.57 165.37 85.84 Favored 'Cis proline' 0 N--CA 1.451 -1.004 0 CA-C-N 118.188 0.388 . . . . 0.0 111.288 -2.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.0 m -137.14 67.45 55.16 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.729 0.812 . . . . 0.0 110.287 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.69 168.84 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.961 3.107 . . . . 0.0 112.052 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -70.64 165.01 23.77 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.549 0.739 . . . . 0.0 111.661 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 176.88 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.741 0.305 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.93 175.48 11.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.842 3.028 . . . . 0.0 111.098 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -117.23 127.8 54.45 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -141.52 146.01 35.85 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.266 0.627 . . . . 0.0 110.157 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -143.14 165.52 27.2 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 109.354 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.71 17.33 74.91 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.594 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.21 -23.19 65.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.555 0.678 . . . . 0.0 112.033 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.64 3.67 15.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.723 0.409 . . . . 0.0 111.594 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.6 -27.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 122.879 0.472 . . . . 0.0 111.088 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.5 p -87.63 -15.18 38.01 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 122.09 -0.381 . . . . 0.0 111.789 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -154.21 -40.25 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.352 0.261 . . . . 0.0 111.283 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.15 -167.73 16.41 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.96 -27.88 65.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.874 0.47 . . . . 0.0 111.715 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 m -61.7 -40.43 95.0 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.288 -0.257 . . . . 0.0 111.291 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -28.05 41.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.895 -0.503 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.7 -32.53 71.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -80.03 -36.18 36.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.16 -0.337 . . . . 0.0 110.949 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -71.6 -21.78 61.81 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.167 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -87.51 -31.88 19.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.633 0.373 . . . . 0.0 111.315 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.02 -27.5 54.6 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.584 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -83.96 -14.76 50.05 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.541 0.609 . . . . 0.0 111.652 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.8 p -101.02 168.44 9.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -78.38 139.51 38.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.611 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -145.8 170.58 16.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 109.394 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -72.91 139.27 46.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.465 0.174 . . . . 0.0 111.001 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.92 -172.79 16.4 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.176 0.893 . . . . 0.0 111.0 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -83.69 -12.68 55.56 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.87 -17.68 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 110.987 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.06 -179.77 45.2 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.4 m -78.02 141.59 38.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.739 0.769 . . . . 0.0 111.041 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.06 163.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.759 0.823 . . . . 0.0 110.8 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -135.43 147.24 48.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.91 -174.3 2.67 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.995 0.518 . . . . 0.0 111.117 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 -30.24 10.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.77 -177.97 6.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.289 0.495 . . . . 0.0 109.856 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 168.46 26.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 111.842 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.18 165.83 34.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.788 0.835 . . . . 0.0 109.434 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.3 m -98.64 143.03 29.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -131.99 179.46 6.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.714 0.806 . . . . 0.0 110.801 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.17 176.05 30.35 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -69.48 -18.15 63.68 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.805 0.442 . . . . 0.0 112.05 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.33 13.45 3.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.011 0.524 . . . . 0.0 111.451 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.07 16.68 78.47 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -81.26 7.96 10.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.6 m -125.79 154.16 42.98 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 122.896 0.478 . . . . 0.0 110.304 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 t -111.71 140.57 46.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.484 0.713 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.8 m -143.51 143.74 31.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.433 0.693 . . . . 0.0 109.582 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.9 162.82 13.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.033 0.445 . . . . 0.0 111.189 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -107.34 142.0 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 123.714 0.806 . . . . 0.0 109.801 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.25 156.03 89.52 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 122.59 0.356 . . . . 0.0 110.974 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.03 168.61 76.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 118.265 0.416 . . . . 0.0 111.739 -1.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.74 69.11 37.31 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.641 0.777 . . . . 0.0 109.725 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.77 171.7 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.064 3.176 . . . . 0.0 112.268 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -66.75 169.82 7.38 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.666 0.786 . . . . 0.0 110.529 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.222 -1.37 . . . . 0.0 111.655 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.565 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -78.84 -6.01 54.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.589 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.4 p -149.43 74.53 9.69 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.802 0.841 . . . . 0.0 110.006 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.16 176.62 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 124.529 3.486 . . . . 0.0 111.921 -176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.0 m -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.186 0.594 . . . . 0.0 109.828 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -143.39 132.43 22.97 Favored 'General case' 0 C--O 1.23 0.043 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.24 -10.72 1.69 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 122.907 0.483 . . . . 0.0 111.988 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.28 13.43 61.86 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 123.656 0.646 . . . . 0.0 112.427 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.53 -17.16 64.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.875 0.838 . . . . 0.0 112.643 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 87.4 m -94.46 3.33 55.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.081 0.4 . . . . 0.0 111.742 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.32 -29.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 CA-C-N 118.19 0.45 . . . . 0.0 111.476 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 t -156.12 -26.41 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.8 m -79.49 -20.01 48.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.085 -0.384 . . . . 0.0 111.817 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.86 172.48 48.38 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 123.809 0.719 . . . . 0.0 112.99 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.6 tp -62.13 -28.65 69.79 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.94 0.496 . . . . 0.0 110.852 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -63.07 -33.7 76.0 Favored 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 122.064 -0.398 . . . . 0.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.21 -33.09 50.17 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.6 t -69.73 -30.89 68.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -79.04 -31.26 44.5 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.888 0.475 . . . . 0.0 110.744 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -77.56 -30.64 52.76 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.072 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -76.73 -34.42 58.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.841 0.291 . . . . 0.0 110.609 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 67.7 m -74.39 -24.31 59.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.326 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -89.3 -8.78 52.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.321 0.51 . . . . 0.0 111.397 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 m -102.99 165.43 11.03 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 109.303 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.1 t -70.77 125.07 25.82 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -142.71 169.53 17.41 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 122.838 0.455 . . . . 0.0 109.997 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.7 tpt85 -73.97 126.8 31.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.247 0.219 . . . . 0.0 110.737 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.76 -159.97 33.85 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -82.54 -21.3 35.4 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -136.94 -10.7 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 122.682 0.393 . . . . 0.0 111.74 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.48 171.79 44.52 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.0 m -73.8 142.49 46.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 117.89 0.845 . . . . 0.0 111.423 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -148.36 167.86 3.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 124.409 1.083 . . . . 0.0 110.205 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -136.24 149.88 48.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.3 m -123.61 -173.1 2.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.888 0.475 . . . . 0.0 111.648 -170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -98.53 -36.89 9.77 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -152.03 -174.81 4.99 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.043 -0.41 . . . . 0.0 109.993 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.67 167.15 31.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.945 0.402 . . . . 0.0 111.866 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.46 163.67 39.84 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.012 0.925 . . . . 0.0 109.146 173.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.7 m -94.98 143.65 26.31 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -135.9 -179.34 5.6 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.73 0.812 . . . . 0.0 110.902 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.48 173.41 25.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -69.74 -19.77 63.52 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.974 0.51 . . . . 0.0 111.755 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -133.78 14.01 4.01 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.209 0.604 . . . . 0.0 111.177 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.08 15.31 78.61 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.6 p -82.82 13.57 3.79 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.883 0.873 . . . . 0.0 113.094 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -130.88 150.18 52.16 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 121.906 -0.496 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.9 t -107.18 143.78 34.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.915 0.886 . . . . 0.0 109.422 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.4 m -144.3 145.96 32.31 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.063 0.545 . . . . 0.0 109.941 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -100.16 163.94 12.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.783 0.433 . . . . 0.0 111.631 -177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.91 134.86 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.595 0.758 . . . . 0.0 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -70.02 159.62 83.58 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 123.017 0.527 . . . . 0.0 110.799 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -64.9 162.82 64.19 Favored 'Cis proline' 0 N--CA 1.459 -0.509 0 CA-C-N 118.692 0.568 . . . . 0.0 113.259 -2.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 96.7 m -140.82 69.46 29.96 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.015 0.926 . . . . 0.0 110.265 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -65.11 168.83 13.14 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.158 3.239 . . . . 0.0 112.041 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -69.26 164.25 23.2 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 122.898 0.479 . . . . 0.0 111.444 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.586 178.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -80.9 12.99 2.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.072 0.549 . . . . 0.0 111.399 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.21 87.63 4.91 Favored Pre-proline 0 N--CA 1.451 -0.383 0 C-N-CA 123.225 0.61 . . . . 0.0 110.614 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.64 177.68 7.71 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.053 3.169 . . . . 0.0 110.345 173.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 m -125.85 128.86 48.28 Favored 'General case' 0 CA--C 1.522 -0.124 0 C-N-CA 122.549 0.34 . . . . 0.0 110.13 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -141.14 134.74 30.05 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 123.885 0.874 . . . . 0.0 109.143 175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -138.78 163.08 33.13 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.7 0.8 . . . . 0.0 109.213 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.09 15.87 76.65 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.17 -25.26 63.78 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.435 0.617 . . . . 0.0 111.409 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 94.8 m -76.28 2.61 12.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.884 0.474 . . . . 0.0 111.715 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -124.84 -24.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 122.869 0.468 . . . . 0.0 111.238 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 p -98.9 -21.14 16.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.3 m -146.71 -22.05 0.42 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.63 -178.02 26.0 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -58.82 -28.01 65.62 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.185 0.594 . . . . 0.0 111.68 -177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.6 m -61.34 -34.85 75.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.025 -0.422 . . . . 0.0 110.589 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.52 -31.99 28.93 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.848 0.294 . . . . 0.0 110.582 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 35.1 t -67.22 -31.85 72.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -79.17 -36.65 40.02 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.187 -0.321 . . . . 0.0 110.768 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -69.99 -22.6 63.12 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.913 -0.089 . . . . 0.0 110.976 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -82.17 -35.83 27.99 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 117.671 0.214 . . . . 0.0 110.832 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.1 m -76.11 -24.61 54.96 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.455 0.302 . . . . 0.0 111.616 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -84.04 6.34 22.46 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.377 0.671 . . . . 0.0 111.226 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -133.29 169.8 16.38 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.7 m -75.84 131.82 39.96 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -145.11 171.13 14.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.71 0.404 . . . . 0.0 110.364 -177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -78.35 137.1 37.87 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.166 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.16 -170.9 17.12 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -88.69 -11.42 45.25 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.3 t -129.83 -16.46 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 123.031 0.532 . . . . 0.0 111.081 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 172.94 -179.11 44.6 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 88.5 m -82.24 139.55 34.17 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 122.203 -0.587 . . . . 0.0 111.058 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.31 168.17 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.274 0.63 . . . . 0.0 111.639 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -139.06 143.24 38.28 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.8 m -127.2 -175.32 3.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.499 0.591 . . . . 0.0 112.289 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -100.59 -35.03 9.65 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -154.46 -175.11 5.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.82 167.35 30.53 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.26 165.18 37.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.964 0.906 . . . . 0.0 109.356 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.7 m -95.35 143.53 26.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.3 p -135.8 179.57 6.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.117 0.567 . . . . 0.0 111.105 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.56 179.68 49.77 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.8 136.87 57.76 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 89.4 mt 52.22 16.66 0.6 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.921 0.888 . . . . 0.0 113.229 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.7 75.22 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.972 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.8 p -74.81 3.1 8.64 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.193 0.997 . . . . 0.0 113.613 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 48.6 m -121.8 155.71 34.73 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 118.538 0.608 . . . . 0.0 110.256 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.4 t -112.49 139.3 48.19 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.577 0.751 . . . . 0.0 109.959 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.7 m -142.41 146.1 34.52 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 123.346 0.658 . . . . 0.0 109.846 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.4 m -99.02 165.02 11.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.986 0.514 . . . . 0.0 111.48 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.75 145.32 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.611 0.764 . . . . 0.0 110.408 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -70.4 156.06 92.48 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 122.915 0.486 . . . . 0.0 110.852 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.97 162.64 91.82 Favored 'Cis proline' 0 N--CA 1.454 -0.847 0 CA-C-N 118.274 0.419 . . . . 0.0 111.146 -2.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.8 m -137.65 68.99 52.67 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 109.942 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.83 167.44 13.8 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.936 3.091 . . . . 0.0 112.094 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 mmt85 -72.37 164.2 26.72 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.293 0.637 . . . . 0.0 111.802 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 51.3 t . . . . . 0 C--O 1.249 1.062 0 CA-C-O 117.354 -1.308 . . . . 0.0 109.991 176.334 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 111.114 0.042 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -139.44 17.31 2.56 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.574 0.75 . . . . 0.0 111.266 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p -147.16 93.41 4.72 Favored Pre-proline 0 N--CA 1.453 -0.304 0 C-N-CA 122.667 0.387 . . . . 0.0 110.84 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.77 171.47 18.16 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.975 3.117 . . . . 0.0 109.955 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.2 m -118.59 120.74 38.36 Favored 'General case' 0 CA--C 1.523 -0.073 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -136.09 137.16 40.79 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 123.796 0.838 . . . . 0.0 109.407 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.3 mmt-85 -139.94 162.49 35.05 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.952 0.901 . . . . 0.0 109.619 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.09 17.31 78.61 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.51 -24.24 63.48 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 117.484 0.642 . . . . 0.0 111.918 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.4 m -76.53 2.87 12.63 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.075 0.55 . . . . 0.0 111.907 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.73 -25.8 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 122.737 0.415 . . . . 0.0 111.282 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.5 p -95.21 -21.16 18.65 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.017 -0.427 . . . . 0.0 111.968 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -146.27 -21.84 0.44 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.08 -177.43 25.2 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.31 -29.26 65.75 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.8 m -62.59 -34.22 76.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 122.238 -0.289 . . . . 0.0 111.141 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.59 -30.39 32.98 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 121.94 -0.475 . . . . 0.0 110.583 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.86 -30.77 69.36 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -81.0 -30.24 35.04 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.015 0.526 . . . . 0.0 111.489 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -79.62 -22.29 43.84 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.505 -0.122 . . . . 0.0 111.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -83.55 -35.95 24.37 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 122.252 -0.28 . . . . 0.0 110.782 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.4 m -73.98 -26.14 60.3 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.462 177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -88.61 8.98 25.73 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 117.959 0.345 . . . . 0.0 111.494 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.9 m -127.97 164.93 21.25 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.888 0.875 . . . . 0.0 108.993 175.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.6 t -69.7 127.09 31.72 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -143.49 168.16 20.49 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.792 0.437 . . . . 0.0 110.538 -177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -78.54 133.8 37.32 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.567 0.347 . . . . 0.0 111.037 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -105.86 -163.48 23.17 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -86.84 -11.36 51.06 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.5 p -139.77 -11.92 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 122.627 0.371 . . . . 0.0 111.893 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 178.75 177.57 47.46 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.0 m -86.94 139.91 30.14 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.663 0.731 . . . . 0.0 111.45 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.31 166.62 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 123.377 0.671 . . . . 0.0 110.611 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -135.01 148.3 49.92 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.8 m -126.88 -174.01 3.03 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 117.971 0.351 . . . . 0.0 111.755 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.9 t -100.5 -33.39 10.36 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -155.28 -175.14 5.28 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.46 167.62 29.44 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.976 0.417 . . . . 0.0 112.117 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -154.61 164.99 37.89 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.981 0.912 . . . . 0.0 109.501 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.7 m -95.8 142.6 27.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.4 p -137.26 -177.88 4.97 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.732 0.813 . . . . 0.0 110.981 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.76 -175.91 53.16 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.8 134.27 56.0 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 51.18 18.89 0.64 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.102 0.961 . . . . 0.0 113.275 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.11 22.23 77.25 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.814 -0.437 . . . . 0.0 112.334 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.5 p -75.42 7.61 3.44 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.9 m -125.31 153.23 43.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.423 0.556 . . . . 0.0 110.371 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.9 t -108.9 138.94 44.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.538 0.735 . . . . 0.0 110.146 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.0 m -141.0 147.17 38.27 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 123.008 0.523 . . . . 0.0 109.999 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.8 m -100.87 162.88 12.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.991 0.424 . . . . 0.0 111.121 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.71 141.01 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.793 0.837 . . . . 0.0 110.035 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -68.86 155.35 93.52 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 123.159 0.583 . . . . 0.0 111.088 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.52 164.49 87.09 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 118.23 0.403 . . . . 0.0 111.351 -1.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.2 m -139.11 68.32 41.03 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 123.509 0.724 . . . . 0.0 110.192 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.77 164.08 25.55 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.675 2.916 . . . . 0.0 111.874 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -75.54 160.77 29.8 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.896 0.478 . . . . 0.0 111.43 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.702 -178.785 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -80.12 6.98 10.16 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.128 0.571 . . . . 0.0 110.826 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p -150.59 84.68 5.48 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 123.682 0.793 . . . . 0.0 110.602 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.17 178.34 7.61 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.921 3.081 . . . . 0.0 110.731 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -122.6 128.57 50.86 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 122.846 0.458 . . . . 0.0 110.157 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -143.62 144.91 32.11 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.699 0.799 . . . . 0.0 109.16 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.6 mmm180 -133.27 -23.88 1.88 Allowed 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 17.4 58.63 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.75 0.69 . . . . 0.0 113.604 -173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.6 mt -58.72 -25.76 63.25 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.971 0.886 . . . . 0.0 112.623 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.9 m -79.53 4.65 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.025 0.375 . . . . 0.0 111.936 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -126.63 -25.41 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 123.111 0.565 . . . . 0.0 111.181 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.5 p -89.11 -15.58 33.56 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 t -154.73 -36.61 0.09 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.689 0.396 . . . . 0.0 111.384 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.98 -165.36 13.03 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.4 -27.6 67.57 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.479 -0.424 . . . . 0.0 111.751 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 m -62.81 -39.63 94.88 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.772 -0.58 . . . . 0.0 111.0 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -28.77 48.25 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 118.181 0.446 . . . . 0.0 110.6 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.33 -32.83 70.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -78.56 -31.99 47.59 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.443 0.297 . . . . 0.0 110.8 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -77.14 -20.17 55.93 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 122.483 -0.136 . . . . 0.0 110.838 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -86.24 -31.43 21.69 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.638 0.375 . . . . 0.0 110.875 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.4 m -80.16 -29.89 38.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 119.259 -0.401 . . . . 0.0 111.925 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -81.51 -15.71 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.54 0.609 . . . . 0.0 111.036 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.8 m -102.99 169.64 8.44 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.7 t -77.69 141.44 39.36 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.129 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -146.54 171.97 14.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.132 0.973 . . . . 0.0 109.609 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -73.43 139.36 45.79 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.589 0.233 . . . . 0.0 111.271 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.5 -169.34 15.27 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.908 0.766 . . . . 0.0 111.199 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -88.68 -14.82 36.41 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.771 0.429 . . . . 0.0 112.015 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.2 -8.12 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 122.813 0.445 . . . . 0.0 111.616 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 171.93 179.26 42.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.1 m -81.72 140.31 34.37 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.579 0.69 . . . . 0.0 110.881 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -144.84 163.41 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.497 0.719 . . . . 0.0 110.989 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -133.68 147.34 51.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.22 -173.27 2.42 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.79 0.436 . . . . 0.0 111.568 -172.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -99.97 -35.75 9.62 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -154.13 -174.5 4.99 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.59 168.48 26.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.38 165.12 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.474 1.11 . . . . 0.0 109.508 173.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 100.0 m -99.03 144.8 27.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -136.95 -178.88 5.39 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.953 0.901 . . . . 0.0 111.106 -175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.65 -178.45 25.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.01 -22.89 67.07 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.047 0.539 . . . . 0.0 112.014 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -144.36 20.8 1.72 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 117.815 0.279 . . . . 0.0 111.676 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.68 17.78 79.57 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -81.29 7.1 12.28 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.4 m -128.02 153.27 46.95 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.811 0.444 . . . . 0.0 110.273 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.6 t -105.39 141.88 36.12 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.335 0.654 . . . . 0.0 110.441 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.6 m -142.4 146.04 34.46 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.195 0.598 . . . . 0.0 110.101 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -101.94 162.96 12.52 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.886 0.474 . . . . 0.0 111.256 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -111.69 138.63 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.426 0.69 . . . . 0.0 110.007 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -67.46 156.1 89.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.22 0.608 . . . . 0.0 111.027 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.71 167.95 78.77 Favored 'Cis proline' 0 N--CA 1.455 -0.791 0 O-C-N 121.97 0.458 . . . . 0.0 111.382 -1.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 88.5 m -139.97 67.64 34.49 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 123.627 0.771 . . . . 0.0 110.063 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.61 170.88 14.17 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 124.317 3.345 . . . . 0.0 112.082 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -66.11 169.74 6.6 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 123.597 0.759 . . . . 0.0 110.715 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.17 -1.395 . . . . 0.0 111.363 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.63 10.84 6.62 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.23 0.612 . . . . 0.0 111.705 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.8 p -154.13 93.25 2.96 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 123.063 0.545 . . . . 0.0 110.957 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.52 173.11 15.06 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.428 2.752 . . . . 0.0 110.162 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.3 m -120.51 123.92 44.11 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.5 0.32 . . . . 0.0 110.197 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -143.77 138.63 28.91 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.7 mmt-85 -138.87 -15.0 1.18 Allowed 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.202 0.601 . . . . 0.0 111.716 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.1 13.21 62.05 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 123.554 0.597 . . . . 0.0 112.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.06 -17.35 63.29 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.683 0.741 . . . . 0.0 112.499 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.42 2.69 52.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.152 0.433 . . . . 0.0 111.95 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.0 t -85.11 -30.08 6.64 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 118.226 0.467 . . . . 0.0 111.603 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.6 t -155.45 -26.23 0.11 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -79.98 -19.75 47.13 Favored 'General case' 0 C--O 1.231 0.1 0 O-C-N 122.137 -0.352 . . . . 0.0 111.591 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.69 171.34 47.65 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 123.942 0.782 . . . . 0.0 112.609 174.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.0 tp -60.57 -28.25 68.32 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 122.831 0.452 . . . . 0.0 111.097 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.7 m -62.46 -33.08 74.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.865 0.302 . . . . 0.0 110.564 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -33.58 42.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 122.031 -0.418 . . . . 0.0 110.384 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.6 t -68.86 -29.67 68.03 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -79.43 -30.83 42.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.716 0.407 . . . . 0.0 111.079 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -77.53 -19.27 56.05 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.092 0.157 . . . . 0.0 111.128 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -87.43 -31.61 19.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.581 0.352 . . . . 0.0 111.108 177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.7 m -80.37 -23.84 40.21 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 177.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -88.05 9.49 22.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.845 0.293 . . . . 0.0 111.117 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.7 p -132.8 170.53 15.15 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.222 1.009 . . . . 0.0 108.449 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.5 m -73.8 133.5 43.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.769 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -146.88 169.24 19.55 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.409 0.684 . . . . 0.0 110.019 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -75.08 139.48 42.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.058 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.48 -170.82 16.27 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.73 -13.27 54.39 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.9 t -131.02 -18.13 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 122.695 0.398 . . . . 0.0 111.25 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.94 179.58 47.41 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.4 m -82.95 141.56 32.05 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.915 0.857 . . . . 0.0 111.242 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -146.94 170.01 4.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.449 0.7 . . . . 0.0 110.829 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -136.15 146.02 46.45 Favored 'General case' 0 C--O 1.227 -0.122 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.0 m -126.29 -172.24 2.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.09 0.405 . . . . 0.0 112.062 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 t -103.37 -36.93 7.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -173.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -151.75 -174.87 4.99 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.89 167.85 28.32 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -154.19 164.85 37.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.418 1.087 . . . . 0.0 109.206 173.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.0 m -96.86 145.01 26.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.4 p -139.29 -178.52 5.4 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 123.526 0.73 . . . . 0.0 111.176 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.77 174.28 41.96 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.37 143.44 57.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 tp 54.5 11.73 0.45 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.72 0.808 . . . . 0.0 112.53 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.44 22.12 76.31 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-O 119.37 -0.684 . . . . 0.0 112.924 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.5 p -76.19 9.88 2.29 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.589 1.194 . . . . 0.0 114.184 -174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.3 m -127.37 152.31 47.66 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.65 0.659 . . . . 0.0 110.671 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.7 t -111.27 139.61 46.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.987 0.915 . . . . 0.0 110.257 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 82.5 m -140.54 148.34 40.88 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 123.659 0.784 . . . . 0.0 109.783 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.54 164.46 11.64 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.821 0.448 . . . . 0.0 111.652 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.75 142.99 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 123.906 0.883 . . . . 0.0 110.113 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -70.11 156.48 91.74 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 122.898 0.479 . . . . 0.0 110.964 -178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.57 163.03 90.74 Favored 'Cis proline' 0 N--CA 1.455 -0.786 0 O-C-N 121.901 0.422 . . . . 0.0 111.347 -1.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.15 68.85 48.75 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 123.767 0.827 . . . . 0.0 110.38 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -62.6 159.97 34.36 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.464 2.776 . . . . 0.0 111.614 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -74.57 159.44 32.16 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.883 0.473 . . . . 0.0 112.025 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.259 -1.353 . . . . 0.0 109.952 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.164 0.507 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -70.6 -22.2 62.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.352 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.2 p -160.07 88.56 1.88 Allowed Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 122.486 0.314 . . . . 0.0 110.83 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.79 174.33 12.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.699 2.932 . . . . 0.0 110.392 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.8 m -122.06 134.63 54.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.8 mmt-85 -142.28 147.3 36.2 Favored 'General case' 0 C--N 1.337 0.025 0 C-N-CA 123.379 0.672 . . . . 0.0 110.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -143.31 162.44 35.67 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.639 1.176 . . . . 0.0 109.206 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.11 13.84 70.42 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.777 176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 98.5 mt -58.62 -26.33 63.6 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 117.83 0.815 . . . . 0.0 111.974 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 t -85.75 7.31 24.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.1 t -123.4 -24.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 C-N-CA 122.843 0.457 . . . . 0.0 110.978 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -103.62 -18.79 14.59 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.6 m -143.07 -19.76 0.64 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.35 -176.65 32.93 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.2 tp -59.14 -27.35 65.55 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.297 0.639 . . . . 0.0 111.791 -176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.166 -0.334 . . . . 0.0 111.214 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.46 31.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 122.057 -0.402 . . . . 0.0 110.582 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -69.47 -31.58 69.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 59.4 ttt-85 -78.27 -36.3 46.93 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.555 0.342 . . . . 0.0 110.87 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -71.83 -23.93 61.62 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.899 0.124 . . . . 0.0 110.783 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -81.31 -34.72 31.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.881 0.31 . . . . 0.0 110.656 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 87.7 m -77.49 -28.09 52.07 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.561 178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.4 mtp-105 -85.83 4.24 38.02 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 122.793 0.437 . . . . 0.0 111.462 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m -123.98 165.7 16.98 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.4 m -72.22 134.09 45.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 122.001 -0.437 . . . . 0.0 110.034 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.04 170.18 16.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.187 0.595 . . . . 0.0 110.449 -177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -72.57 137.36 46.16 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.237 0.215 . . . . 0.0 110.789 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.44 -163.24 22.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -92.02 -17.43 25.08 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.42 -0.459 . . . . 0.0 112.135 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.79 -4.13 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 122.93 0.492 . . . . 0.0 111.898 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -173.71 -147.11 5.83 Favored Glycine 0 CA--C 1.521 0.421 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.0 m -125.92 140.88 52.28 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.132 0.466 . . . . 0.0 110.797 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.47 170.26 6.32 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.049 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.38 -173.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -138.84 150.4 45.97 Favored 'General case' 0 C--N 1.335 -0.046 0 C-N-CA 124.841 1.256 . . . . 0.0 107.83 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -127.82 -174.09 3.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.181 0.446 . . . . 0.0 111.506 -175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -105.96 -28.15 10.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -156.94 -178.06 7.08 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.656 0.662 . . . . 0.0 109.772 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.64 168.37 25.85 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.35 170.15 21.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.423 1.089 . . . . 0.0 108.721 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.1 m -109.02 145.69 35.16 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.9 p -133.47 -178.25 4.91 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 123.381 0.672 . . . . 0.0 110.979 -175.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.73 -176.65 26.33 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -66.61 -22.02 66.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.899 0.479 . . . . 0.0 112.23 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -144.44 20.74 1.7 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.853 0.297 . . . . 0.0 111.306 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.07 19.75 79.69 Favored Glycine 0 CA--C 1.526 0.751 0 O-C-N 121.971 -0.456 . . . . 0.0 112.177 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.1 p -82.03 3.0 28.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.802 0.801 . . . . 0.0 112.973 -175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.8 m -119.15 153.21 35.23 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.092 0.557 . . . . 0.0 109.777 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 32.6 t -110.17 136.86 48.72 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.007 0.523 . . . . 0.0 110.33 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -139.94 147.23 40.23 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.545 0.738 . . . . 0.0 109.861 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.1 m -100.86 164.95 11.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.584 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.0 mm -112.88 145.48 18.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 123.907 0.883 . . . . 0.0 110.292 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -72.94 155.64 90.35 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.866 0.466 . . . . 0.0 110.825 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.19 164.58 87.41 Favored 'Cis proline' 0 N--CA 1.455 -0.769 0 CA-C-N 118.321 0.436 . . . . 0.0 111.42 -1.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -137.42 69.66 54.09 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 123.505 0.722 . . . . 0.0 110.329 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -64.3 163.39 26.58 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.901 3.067 . . . . 0.0 111.76 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -74.76 160.58 30.54 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.498 0.719 . . . . 0.0 111.672 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.538 -1.22 . . . . 0.0 109.859 179.527 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.679 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -82.83 10.48 7.64 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.946 0.498 . . . . 0.0 110.876 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 p -148.15 84.64 6.71 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 123.009 0.523 . . . . 0.0 110.365 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.02 177.67 8.45 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.315 3.343 . . . . 0.0 110.915 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.4 m -118.19 137.59 52.89 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -142.39 147.31 36.0 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 122.657 0.383 . . . . 0.0 110.902 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -141.9 163.42 32.94 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.802 1.241 . . . . 0.0 109.047 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.85 16.79 72.72 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 120.0 -0.334 . . . . 0.0 113.395 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.54 -28.41 68.4 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.884 0.842 . . . . 0.0 111.462 -177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.1 m -81.31 5.56 16.92 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 t -121.21 -13.74 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 122.768 0.427 . . . . 0.0 111.54 -176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -126.19 -16.58 5.46 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 m -140.39 -19.15 0.87 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.55 -175.94 39.44 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.95 -27.83 65.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.055 0.542 . . . . 0.0 112.003 -176.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -61.11 -36.49 79.85 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.873 0.306 . . . . 0.0 111.143 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.04 -29.22 35.1 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 117.995 0.361 . . . . 0.0 110.648 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.5 t -70.22 -31.03 68.27 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -80.64 -33.52 35.64 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.552 0.341 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.8 -28.81 61.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -78.21 -33.34 50.03 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 117.709 0.231 . . . . 0.0 110.855 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.9 m -74.97 -28.4 60.55 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.534 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -82.81 -20.18 36.25 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.56 0.618 . . . . 0.0 111.105 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.2 m -90.85 163.49 14.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 173.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 58.7 m -74.61 134.55 42.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -144.04 169.83 17.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.055 0.542 . . . . 0.0 110.042 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -73.77 140.16 45.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.343 0.257 . . . . 0.0 111.192 -176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -115.77 -166.48 14.77 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -87.94 -17.27 31.69 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.781 0.432 . . . . 0.0 112.156 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.81 -10.5 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.754 0.422 . . . . 0.0 111.685 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.08 47.41 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.3 m -83.86 140.78 31.78 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.674 0.737 . . . . 0.0 111.286 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.9 m -145.15 169.65 7.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.85 -175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -140.77 154.01 46.09 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.1 m -127.36 -173.81 3.0 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.889 0.476 . . . . 0.0 111.44 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p -98.33 -39.61 8.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -150.18 -175.06 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.592 0.757 . . . . 0.0 110.201 -175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.92 167.54 30.09 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.958 0.409 . . . . 0.0 112.059 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.47 164.22 38.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.959 0.904 . . . . 0.0 109.216 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 71.9 m -94.57 142.2 27.71 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.9 p -135.2 -176.34 4.23 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.443 0.697 . . . . 0.0 111.027 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.21 -177.27 28.59 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -67.42 -21.88 65.55 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.736 0.414 . . . . 0.0 112.093 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.8 tp -145.17 22.97 1.52 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.68 17.59 80.05 Favored Glycine 0 CA--C 1.527 0.823 0 O-C-N 121.885 -0.509 . . . . 0.0 111.978 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 p -81.64 6.62 14.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.8 m -126.98 158.15 37.64 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.94 0.496 . . . . 0.0 109.952 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.6 t -115.36 138.17 51.27 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.313 0.645 . . . . 0.0 109.977 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.0 m -140.53 146.24 37.86 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.559 0.744 . . . . 0.0 109.981 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.0 m -98.7 164.79 12.09 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.844 0.458 . . . . 0.0 111.388 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.5 mm -112.28 146.06 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.231 1.013 . . . . 0.0 109.937 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -76.27 155.34 84.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 122.39 0.276 . . . . 0.0 111.056 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.43 165.26 86.2 Favored 'Cis proline' 0 N--CA 1.456 -0.694 0 CA-C-N 118.257 0.413 . . . . 0.0 111.649 -0.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 76.2 m -135.9 70.46 64.18 Favored Pre-proline 0 N--CA 1.453 -0.276 0 C-N-CA 123.674 0.79 . . . . 0.0 109.96 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.41 162.44 27.28 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.841 3.027 . . . . 0.0 111.877 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -74.15 160.14 31.6 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.878 0.471 . . . . 0.0 111.625 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.316 -1.326 . . . . 0.0 109.723 179.097 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -79.58 8.59 6.17 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.759 0.424 . . . . 0.0 111.174 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.0 84.88 5.24 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 123.555 0.742 . . . . 0.0 110.436 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -73.43 175.21 10.94 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.112 3.208 . . . . 0.0 111.183 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -118.61 119.96 36.03 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.6 mmt-85 -144.71 135.81 25.08 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.403 0.681 . . . . 0.0 109.279 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -131.99 -14.92 3.04 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.202 0.601 . . . . 0.0 111.225 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.75 11.16 67.37 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.632 0.634 . . . . 0.0 112.531 -177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.99 -25.63 65.4 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 117.719 0.76 . . . . 0.0 112.288 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.82 3.6 16.31 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.567 0.347 . . . . 0.0 111.908 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.75 -25.63 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 122.99 0.516 . . . . 0.0 110.835 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.3 p -89.96 -15.25 32.37 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.7 t -155.04 -37.91 0.09 Allowed 'General case' 0 C--O 1.23 0.079 0 C-N-CA 122.53 0.332 . . . . 0.0 111.48 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.16 -165.65 13.64 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.02 -26.95 66.5 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.735 0.414 . . . . 0.0 111.591 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.9 m -62.67 -39.19 93.17 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 121.913 -0.492 . . . . 0.0 111.277 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.45 -29.98 42.02 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.328 0.513 . . . . 0.0 110.863 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.1 t -68.74 -32.35 72.06 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.5 ttt-85 -78.49 -35.9 45.88 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.196 -0.315 . . . . 0.0 110.653 178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.38 -17.02 62.43 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.861 -0.154 . . . . 0.0 110.72 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -90.71 -30.78 16.89 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.186 0.594 . . . . 0.0 111.258 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 93.3 m -81.33 -21.37 39.24 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.035 -0.416 . . . . 0.0 110.749 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -86.13 4.08 39.9 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.511 0.724 . . . . 0.0 111.35 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.2 p -131.62 169.61 15.9 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.088 0.955 . . . . 0.0 108.841 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.1 m -75.15 134.67 41.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.58 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -145.73 169.99 17.39 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.837 0.855 . . . . 0.0 109.891 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 -73.32 139.54 46.11 Favored 'General case' 0 C--N 1.333 -0.133 0 O-C-N 122.44 -0.163 . . . . 0.0 111.16 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.8 -166.8 14.38 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.367 0.984 . . . . 0.0 111.031 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -84.25 -13.05 53.65 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -137.0 -10.16 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 122.645 0.378 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.05 179.98 45.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.5 m -80.92 142.52 33.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.616 0.708 . . . . 0.0 111.279 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.0 m -145.08 169.27 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.843 0.857 . . . . 0.0 110.8 -176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -136.97 151.76 49.38 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -130.91 -175.25 3.61 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.173 0.511 . . . . 0.0 112.024 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.9 p -97.07 -36.91 10.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -154.45 -174.78 5.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.023 0.529 . . . . 0.0 109.609 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 166.94 30.84 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.426 0.632 . . . . 0.0 112.518 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -154.25 165.82 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.9 0.88 . . . . 0.0 109.246 173.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.5 m -99.39 143.9 29.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -137.15 -178.64 5.3 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.881 0.872 . . . . 0.0 111.212 -175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.94 -176.7 23.96 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -66.05 -23.02 66.46 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.144 0.578 . . . . 0.0 111.854 -177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.2 tp -143.96 20.9 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.26 -0.275 . . . . 0.0 111.24 -177.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.39 17.82 80.08 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.7 p -82.62 7.9 13.42 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.7 m -127.78 151.5 48.94 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.838 0.455 . . . . 0.0 110.381 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.2 t -104.35 140.21 38.22 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.525 0.73 . . . . 0.0 110.655 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 100.0 m -141.45 147.76 38.42 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.686 0.795 . . . . 0.0 110.046 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -101.98 162.97 12.5 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.874 0.369 . . . . 0.0 111.247 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -108.2 147.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.698 0.799 . . . . 0.0 110.315 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -75.42 154.5 85.9 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 122.794 0.438 . . . . 0.0 111.109 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.74 164.47 88.13 Favored 'Cis proline' 0 N--CA 1.453 -0.857 0 O-C-N 121.819 0.378 . . . . 0.0 111.715 -1.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 63.5 m -136.48 70.8 60.11 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 123.736 0.815 . . . . 0.0 110.192 178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -62.19 160.65 29.72 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.649 2.9 . . . . 0.0 111.438 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -77.08 160.38 29.1 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.895 0.478 . . . . 0.0 111.95 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.4 t . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.188 -179.638 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -143.54 154.37 43.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.819 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 p -147.63 80.68 8.9 Favored Pre-proline 0 N--CA 1.451 -0.411 0 C-N-CA 122.985 0.514 . . . . 0.0 110.07 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.87 175.59 10.99 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 124.518 3.479 . . . . 0.0 111.523 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -112.86 121.95 46.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.132 0.573 . . . . 0.0 110.004 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -139.97 137.62 34.87 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 124.079 0.952 . . . . 0.0 109.315 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -137.92 -11.87 1.5 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.397 0.679 . . . . 0.0 111.352 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.43 10.4 74.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.416 0.531 . . . . 0.0 112.482 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 83.2 mt -60.04 -24.9 64.92 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 117.431 0.615 . . . . 0.0 112.39 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.1 m -77.35 2.34 16.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.37 -23.74 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 122.827 0.451 . . . . 0.0 111.394 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.1 p -97.27 -21.36 17.3 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.322 0.51 . . . . 0.0 112.207 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.4 m -145.93 -22.18 0.45 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.21 -177.46 25.07 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.46 -29.51 69.09 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.177 0.591 . . . . 0.0 111.665 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.1 m -62.02 -34.93 77.12 Favored 'General case' 0 N--CA 1.456 -0.156 0 O-C-N 122.004 -0.435 . . . . 0.0 111.142 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -30.51 38.99 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.072 -0.393 . . . . 0.0 110.13 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.7 t -68.78 -31.67 70.86 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -78.9 -32.36 45.73 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.896 0.478 . . . . 0.0 111.035 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -78.03 -24.13 47.93 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.246 0.218 . . . . 0.0 111.353 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -81.71 -35.86 29.3 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 122.185 -0.322 . . . . 0.0 110.896 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.8 m -74.92 -24.18 58.46 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.734 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -90.62 13.99 14.51 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.891 0.476 . . . . 0.0 111.167 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -134.01 168.36 18.93 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.824 0.85 . . . . 0.0 109.098 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -73.31 123.22 23.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -140.2 164.36 30.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.049 0.54 . . . . 0.0 109.859 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -73.54 134.99 43.93 Favored 'General case' 0 C--N 1.332 -0.166 0 O-C-N 122.269 -0.269 . . . . 0.0 110.583 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.0 -152.78 25.0 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.02 -19.24 27.43 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.89 -10.82 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.969 0.508 . . . . 0.0 112.112 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.19 173.04 45.94 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.4 m -79.81 141.26 36.39 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 117.582 0.691 . . . . 0.0 111.458 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -145.62 169.05 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 110.163 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -136.87 151.6 49.28 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.649 1.18 . . . . 0.0 108.088 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.7 m -128.04 -173.44 2.94 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.993 0.361 . . . . 0.0 111.83 -173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.9 t -99.01 -36.43 9.72 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -152.9 -175.22 5.22 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.54 167.14 31.09 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.931 0.396 . . . . 0.0 111.731 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -155.47 165.33 36.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.787 0.835 . . . . 0.0 109.667 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -99.1 140.7 32.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.6 p -137.68 -178.41 5.23 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.652 0.781 . . . . 0.0 110.752 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.76 -172.65 16.78 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -66.81 -23.03 66.0 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.671 0.388 . . . . 0.0 111.781 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.4 tp -146.78 21.71 1.28 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 111.294 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.13 18.83 79.13 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 112.085 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.0 p -81.65 7.03 13.35 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -174.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.0 m -129.83 145.57 51.58 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.689 0.677 . . . . 0.0 110.313 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 t -95.37 141.74 28.58 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.652 0.781 . . . . 0.0 110.291 178.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.7 m -143.63 145.19 32.29 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.212 0.605 . . . . 0.0 109.991 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.87 164.61 12.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 122.833 0.453 . . . . 0.0 111.422 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.24 136.48 53.07 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.061 0 C-N-CA 123.964 0.905 . . . . 0.0 109.763 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -70.81 159.01 86.74 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 122.989 0.516 . . . . 0.0 111.185 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -64.57 161.57 65.89 Favored 'Cis proline' 0 N--CA 1.459 -0.535 0 CA-C-N 118.741 0.586 . . . . 0.0 113.073 -2.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.8 m -139.82 71.33 36.21 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 110.301 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -65.54 165.06 23.98 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.62 2.88 . . . . 0.0 111.583 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -77.47 164.65 25.25 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.792 -1.575 . . . . 0.0 111.072 -178.844 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.934 0.397 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -78.31 6.91 7.28 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.618 0.367 . . . . 0.0 110.883 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.8 p -152.05 87.3 4.33 Favored Pre-proline 0 N--CA 1.453 -0.319 0 C-N-CA 123.284 0.633 . . . . 0.0 110.482 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -76.18 178.09 7.93 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 124.288 3.325 . . . . 0.0 110.619 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -123.01 122.87 39.57 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 122.759 0.424 . . . . 0.0 110.151 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.58 130.65 20.65 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.474 0.709 . . . . 0.0 109.233 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -126.76 -15.11 5.53 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.373 0.669 . . . . 0.0 111.452 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.52 11.1 59.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.733 0.683 . . . . 0.0 112.839 -176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.85 -17.33 64.17 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.527 0.664 . . . . 0.0 112.177 -175.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.3 m -96.96 2.36 51.47 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.16 0.436 . . . . 0.0 112.046 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.3 t -86.54 -29.92 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.06 0.391 . . . . 0.0 111.478 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -154.48 -26.95 0.12 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -80.09 -20.42 45.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 O-C-N 122.199 -0.313 . . . . 0.0 111.766 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.05 171.9 48.29 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.12 0.867 . . . . 0.0 112.386 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.4 tp -60.57 -28.74 68.7 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.164 0.585 . . . . 0.0 111.147 -176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.7 m -61.7 -33.8 74.65 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.153 -0.342 . . . . 0.0 110.722 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.75 -31.26 40.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 122.232 -0.293 . . . . 0.0 110.417 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 39.9 t -71.34 -29.66 65.25 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -79.23 -33.48 43.66 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 122.194 -0.316 . . . . 0.0 110.935 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -73.99 -22.88 59.44 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.207 0.203 . . . . 0.0 110.76 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -82.76 -32.51 27.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.893 0.477 . . . . 0.0 110.743 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -80.38 -25.17 39.26 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 119.467 -0.301 . . . . 0.0 111.431 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -86.15 9.36 17.68 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.783 0.433 . . . . 0.0 111.059 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -131.13 170.26 14.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.1 m -78.13 132.69 37.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.386 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -145.02 170.63 15.8 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.583 0.753 . . . . 0.0 109.726 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -74.48 140.07 44.32 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.166 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.69 -169.55 15.24 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -86.37 -12.5 49.08 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.16 -10.88 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.811 0.445 . . . . 0.0 111.854 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.1 44.08 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.72 140.84 34.07 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 117.496 0.648 . . . . 0.0 110.869 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.7 168.62 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.101 -175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -138.48 148.77 44.72 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.795 1.238 . . . . 0.0 107.703 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -128.58 -171.68 2.52 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.038 0.381 . . . . 0.0 111.906 -172.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.2 t -103.46 -39.4 6.77 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 -146.67 -175.43 4.79 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.574 0.75 . . . . 0.0 110.416 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.83 168.09 28.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.83 165.54 35.73 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.323 1.049 . . . . 0.0 109.539 172.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.25 143.01 30.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.5 p -138.62 -176.64 4.55 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 123.681 0.792 . . . . 0.0 110.943 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.93 178.18 25.58 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -66.65 -20.57 66.02 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.11 0.564 . . . . 0.0 111.968 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.4 tp -141.54 18.38 2.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.661 0.267 . . . . 0.0 111.329 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.33 14.67 80.61 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 112.143 -0.383 . . . . 0.0 112.143 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.1 p -83.21 10.46 8.32 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.982 0.913 . . . . 0.0 113.09 -175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.4 m -126.14 151.77 46.83 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.368 0.531 . . . . 0.0 110.324 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -108.71 140.19 42.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.501 0.72 . . . . 0.0 109.769 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 92.5 m -140.89 147.19 38.51 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 123.297 0.639 . . . . 0.0 110.071 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.5 m -101.59 165.97 10.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.94 0.4 . . . . 0.0 111.936 -177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mm -116.8 142.3 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 124.202 1.001 . . . . 0.0 110.516 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -67.76 156.43 89.17 Favored Pre-proline 0 CA--C 1.532 0.253 0 C-N-CA 122.894 0.477 . . . . 0.0 111.224 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.07 162.43 91.73 Favored 'Cis proline' 0 N--CA 1.456 -0.687 0 O-C-N 121.761 0.348 . . . . 0.0 111.337 -1.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.4 m -137.51 68.9 53.61 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.826 0.851 . . . . 0.0 110.499 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.91 164.66 21.13 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.718 2.945 . . . . 0.0 111.189 177.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -77.17 167.07 22.38 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.462 0.649 . . . . 0.0 112.085 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.73 -1.128 . . . . 0.0 110.087 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -143.47 157.66 44.27 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.826 0.85 . . . . 0.0 109.825 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.1 p -145.8 79.59 11.04 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.185 0.594 . . . . 0.0 110.232 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -74.6 177.21 8.73 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.219 3.279 . . . . 0.0 111.497 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.1 m -115.89 130.98 57.06 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 122.949 0.5 . . . . 0.0 109.825 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.07 142.28 31.5 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 7' ' ' ARG . 12.7 mmm180 -131.13 -23.53 2.43 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.73 17.0 58.07 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.358 0.504 . . . . 0.0 113.59 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.04 -24.71 59.44 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 117.884 0.842 . . . . 0.0 112.747 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -83.83 6.92 19.65 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.393 0.542 . . . . 0.0 111.843 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 t -126.32 -25.54 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.161 0 C-N-CA 123.514 0.726 . . . . 0.0 110.374 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.2 p -89.05 -15.49 33.9 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.97 -0.457 . . . . 0.0 111.423 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -153.61 -38.91 0.1 Allowed 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.632 0.253 . . . . 0.0 111.062 177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 122.81 -167.92 15.12 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.2 tp -59.82 -27.15 66.36 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.635 0.374 . . . . 0.0 111.327 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 m -60.91 -41.24 95.75 Favored 'General case' 0 N--CA 1.457 -0.082 0 O-C-N 122.07 -0.394 . . . . 0.0 111.283 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.75 -28.62 44.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.998 -0.439 . . . . 0.0 110.741 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.1 -32.69 72.27 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt-85 -79.13 -36.25 40.84 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 122.369 0.268 . . . . 0.0 110.776 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -73.3 -17.73 61.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.46 -0.305 . . . . 0.0 111.0 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -89.79 -30.99 17.61 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.601 0.361 . . . . 0.0 111.108 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.3 m -77.87 -25.14 48.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 119.489 -0.291 . . . . 0.0 111.545 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -88.93 8.32 29.98 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.949 0.5 . . . . 0.0 111.351 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p -130.58 169.28 15.8 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 108.593 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.5 m -74.82 131.62 40.91 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.754 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -144.58 167.07 23.41 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.985 0.914 . . . . 0.0 109.162 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.53 124.31 26.97 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.44 -158.29 34.4 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.11 -21.18 36.85 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.0 p -137.59 -10.24 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 122.688 0.395 . . . . 0.0 111.794 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.42 173.61 45.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -76.06 140.24 41.8 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.042 0.921 . . . . 0.0 111.482 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.5 m -143.93 169.7 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 C-N-CA 124.233 1.013 . . . . 0.0 110.691 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -137.68 149.96 46.96 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 60.7 m -129.22 -172.31 2.7 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.159 0.436 . . . . 0.0 111.501 -173.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -103.3 -37.52 7.62 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -151.15 -176.13 5.43 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -176.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.17 168.34 26.27 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.87 168.58 25.88 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.915 1.286 . . . . 0.0 108.657 173.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.17 148.6 25.58 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.193 -0.317 . . . . 0.0 110.622 176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 74.6 p -135.12 179.96 5.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 123.548 0.739 . . . . 0.0 110.796 -175.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 177.22 29.83 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.03 -19.69 63.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.746 0.419 . . . . 0.0 111.947 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.7 mt -134.42 13.93 3.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.066 0.546 . . . . 0.0 111.658 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.06 16.23 78.5 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 112.287 -0.325 . . . . 0.0 112.287 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.6 p -80.49 6.13 13.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.681 0.792 . . . . 0.0 113.072 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.6 m -122.81 154.39 38.29 Favored 'General case' 0 CA--C 1.526 0.022 0 C-N-CA 122.95 0.5 . . . . 0.0 110.139 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 34.7 t -107.35 141.39 38.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.585 0.754 . . . . 0.0 110.566 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -142.34 147.15 35.84 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.395 0.678 . . . . 0.0 109.971 177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.6 m -101.53 164.55 11.7 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.872 0.368 . . . . 0.0 111.512 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.5 mm -112.98 143.31 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.289 1.035 . . . . 0.0 110.324 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -70.23 156.28 92.1 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 122.92 0.488 . . . . 0.0 110.868 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.84 162.87 91.26 Favored 'Cis proline' 0 N--CA 1.451 -1.012 0 O-C-N 121.959 0.452 . . . . 0.0 111.378 -1.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.8 m -136.94 69.25 57.83 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 123.562 0.745 . . . . 0.0 110.367 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.09 162.96 24.25 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.587 2.858 . . . . 0.0 111.623 178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -76.61 159.98 29.81 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 122.869 0.468 . . . . 0.0 111.592 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 C--O 1.252 1.232 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.99 178.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.467 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -80.79 5.66 15.26 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.125 0.57 . . . . 0.0 111.246 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 p -150.18 84.92 5.6 Favored Pre-proline 0 CA--C 1.532 0.275 0 C-N-CA 123.189 0.596 . . . . 0.0 110.11 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.9 174.22 12.71 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.872 3.048 . . . . 0.0 110.962 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.8 m -115.87 121.47 42.47 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -143.0 138.78 30.27 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 123.741 0.816 . . . . 0.0 109.211 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -139.19 -16.18 1.08 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.673 0.389 . . . . 0.0 111.7 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.24 11.45 71.01 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.586 0.613 . . . . 0.0 112.491 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.0 -27.05 63.16 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.53 0.665 . . . . 0.0 112.395 -174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.0 t -74.94 -6.09 47.33 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.666 0.386 . . . . 0.0 111.536 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.01 -22.76 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.166 -0.334 . . . . 0.0 111.319 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 p -98.69 -21.16 16.56 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 m -144.93 -22.66 0.5 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.56 179.68 23.75 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.92 -27.84 68.49 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.221 0.608 . . . . 0.0 111.787 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 m -63.09 -33.79 76.2 Favored 'General case' 0 C--N 1.333 -0.147 0 O-C-N 121.976 -0.453 . . . . 0.0 110.857 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.09 -30.25 43.78 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.891 -0.506 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.69 -31.0 67.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -78.48 -29.07 46.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.344 0.258 . . . . 0.0 110.959 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -81.71 -16.48 51.06 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.067 0.147 . . . . 0.0 111.005 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -87.39 -33.59 19.07 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 122.074 -0.391 . . . . 0.0 110.967 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.59 -26.36 45.42 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.195 -0.316 . . . . 0.0 111.815 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -87.16 9.75 19.01 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.116 0.416 . . . . 0.0 111.28 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -133.18 166.78 21.66 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.484 1.113 . . . . 0.0 108.178 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.8 m -72.48 133.45 44.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.551 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -145.64 169.63 18.07 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.591 0.756 . . . . 0.0 109.766 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -74.3 136.72 42.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.217 0.207 . . . . 0.0 111.079 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -109.15 -159.61 19.04 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.123 0.868 . . . . 0.0 111.098 177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -85.79 -18.32 33.27 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.28 -11.37 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 122.569 0.348 . . . . 0.0 111.898 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -179.99 178.61 48.61 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.0 m -81.48 142.84 32.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.64 0.72 . . . . 0.0 111.328 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -146.48 169.48 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 C-N-CA 123.698 0.799 . . . . 0.0 110.418 -176.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -137.7 150.27 47.19 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.1 m -130.16 -174.61 3.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.059 0.391 . . . . 0.0 111.462 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 70.7 m -104.26 -27.54 11.95 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -157.05 -177.31 6.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.693 0.678 . . . . 0.0 109.814 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.08 169.5 22.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -153.64 168.95 24.52 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.665 1.186 . . . . 0.0 109.037 173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.7 t -110.93 142.56 42.86 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.1 p -132.42 173.15 11.59 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 123.408 0.683 . . . . 0.0 111.026 -175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.82 177.77 15.31 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -72.2 -20.61 61.54 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.877 0.339 . . . . 0.0 111.385 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -137.12 9.94 3.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.082 0.953 . . . . 0.0 110.709 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.12 83.87 0.24 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.0 p -140.29 4.91 2.04 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.2 m -132.81 147.68 52.31 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.314 0.506 . . . . 0.0 110.323 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.3 t -94.01 137.95 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.084 0.554 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.4 m -138.01 145.17 41.53 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.414 0.686 . . . . 0.0 109.555 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -102.42 162.7 12.71 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.799 0.333 . . . . 0.0 111.658 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.27 143.86 18.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 C-N-CA 123.726 0.81 . . . . 0.0 110.049 -177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -72.7 155.16 91.1 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 122.888 0.475 . . . . 0.0 110.99 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.61 165.43 85.62 Favored 'Cis proline' 0 N--CA 1.456 -0.721 0 CA-C-N 118.605 0.538 . . . . 0.0 111.249 -0.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 66.7 m -139.61 69.8 38.13 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 123.495 0.718 . . . . 0.0 110.051 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -62.8 161.67 28.07 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.785 2.99 . . . . 0.0 111.322 178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -76.5 161.42 28.64 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 120.851 0.358 . . . . 0.0 111.642 -176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.6 t . . . . . 0 C--O 1.251 1.175 0 CA-C-O 117.283 -1.342 . . . . 0.0 109.916 -179.372 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -80.27 7.55 9.27 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.032 0.533 . . . . 0.0 110.709 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 8.5 p -145.56 72.32 14.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.701 0.8 . . . . 0.0 109.958 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.21 177.14 9.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 124.786 3.657 . . . . 0.0 111.487 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m -108.62 125.86 52.32 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.379 0.672 . . . . 0.0 109.576 178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -138.88 133.31 31.77 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.432 0.693 . . . . 0.0 109.45 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -130.88 -16.97 3.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.5 67.82 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.339 0.495 . . . . 0.0 112.879 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 88.7 mt -61.16 -27.46 68.41 Favored 'General case' 0 N--CA 1.458 -0.054 0 CA-C-N 117.564 0.682 . . . . 0.0 112.01 -175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 88.7 m -80.24 5.33 14.91 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.3 t -123.09 -24.45 2.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 122.613 0.365 . . . . 0.0 111.497 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -100.09 -15.65 18.12 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.7 t -149.86 -35.07 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.04 -164.53 12.03 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.97 -27.15 66.59 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.948 0.499 . . . . 0.0 111.794 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.8 m -62.39 -40.76 97.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.86 -0.525 . . . . 0.0 111.125 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.62 -30.09 46.3 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.411 0.55 . . . . 0.0 110.626 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 41.2 t -68.0 -33.28 74.32 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -78.7 -35.93 44.24 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.261 0.224 . . . . 0.0 110.79 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -72.43 -17.47 61.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.942 -0.117 . . . . 0.0 111.17 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -90.05 -32.04 16.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 122.578 0.351 . . . . 0.0 110.79 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 89.3 m -79.39 -25.65 42.11 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.574 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.4 mtp85 -85.89 5.2 34.0 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.3 0.5 . . . . 0.0 111.249 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.9 m -127.73 165.97 19.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.57 1.148 . . . . 0.0 107.946 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.1 t -76.43 137.33 39.64 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.806 -177.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -146.18 167.92 22.28 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.351 1.06 . . . . 0.0 108.834 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -73.87 134.31 43.25 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.154 -0.342 . . . . 0.0 110.635 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.69 -152.24 24.94 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.166 -0.774 . . . . 0.0 111.166 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -88.64 -17.95 29.0 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.766 0.427 . . . . 0.0 112.135 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.75 -12.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 122.687 0.395 . . . . 0.0 112.051 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -177.32 175.37 47.59 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -78.03 142.58 38.13 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.425 0.612 . . . . 0.0 111.602 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -146.09 165.16 9.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.05 0 C-N-CA 124.006 0.922 . . . . 0.0 110.621 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -132.96 144.51 50.17 Favored 'General case' 0 CA--C 1.523 -0.092 0 C-N-CA 124.763 1.225 . . . . 0.0 107.946 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.53 -172.47 2.56 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.613 0.365 . . . . 0.0 111.335 -172.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.2 t -103.48 -36.6 7.92 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -151.41 -177.3 5.99 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.24 167.95 28.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -154.25 164.53 38.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.083 0.953 . . . . 0.0 109.548 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.7 m -96.44 143.26 27.64 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.2 p -137.89 -177.4 4.8 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.662 -175.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.29 -179.07 48.75 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -65.7 138.92 58.29 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 122.293 -0.533 . . . . 0.0 109.946 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp 52.92 17.21 0.83 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.078 0.951 . . . . 0.0 112.483 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.87 77.35 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.92 -0.488 . . . . 0.0 112.164 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -76.19 10.06 2.19 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.5 m -129.88 153.29 48.46 Favored 'General case' 0 C--O 1.228 -0.069 0 CA-C-N 118.501 0.591 . . . . 0.0 110.355 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.0 t -108.98 141.37 41.18 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.684 0.794 . . . . 0.0 110.021 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 90.6 m -142.42 146.76 35.2 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 123.158 0.583 . . . . 0.0 109.727 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.1 m -100.46 164.41 11.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.787 0.435 . . . . 0.0 111.327 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.41 142.53 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.172 0.989 . . . . 0.0 110.237 -177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -70.78 155.77 92.92 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 123.215 0.606 . . . . 0.0 111.267 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.09 165.33 86.2 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 CA-C-N 118.176 0.384 . . . . 0.0 111.529 -1.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 74.4 m -138.59 67.76 44.42 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 123.762 0.825 . . . . 0.0 110.388 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.66 167.66 18.62 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.013 3.142 . . . . 0.0 111.286 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -78.47 172.69 13.28 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 122.882 0.473 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 16.7 p . . . . . 0 C--O 1.252 1.208 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.241 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 59.15 0.77 0.19 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 113.079 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.0 p -152.35 74.08 7.46 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 123.546 0.739 . . . . 0.0 110.606 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 174.01 12.93 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 124.132 3.221 . . . . 0.0 111.328 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -111.43 126.72 55.24 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 122.897 0.479 . . . . 0.0 109.868 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.2 mmt-85 -139.82 135.23 32.78 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 176.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -140.25 161.87 36.64 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.686 0.795 . . . . 0.0 109.433 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.89 15.35 78.26 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.999 -0.334 . . . . 0.0 112.436 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -59.98 -23.27 63.48 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 117.665 0.733 . . . . 0.0 111.687 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 78.1 m -74.43 0.72 13.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.811 0.444 . . . . 0.0 111.831 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.0 t -125.58 -23.19 2.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 CA-C-N 118.042 0.383 . . . . 0.0 111.416 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 77.0 p -97.94 -20.1 17.65 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -149.94 -24.1 0.26 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.09 178.51 22.07 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.31 -28.05 67.8 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.661 0.385 . . . . 0.0 111.857 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -61.46 -33.29 73.5 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.881 -0.512 . . . . 0.0 110.88 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.15 -30.4 49.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.959 -0.463 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 42.0 t -78.43 -29.07 46.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.402 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.16 -34.06 72.55 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -74.4 -28.95 61.31 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.255 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -78.81 -35.02 44.87 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.1 m -75.49 -30.59 59.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.642 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.2 mtp85 -81.68 -15.99 52.72 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.493 0.588 . . . . 0.0 111.623 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.3 t -99.83 170.49 8.5 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 172.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.1 t -80.18 139.38 36.79 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.192 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -147.37 170.19 17.86 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.146 0.578 . . . . 0.0 109.923 -176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.0 tpt85 -74.27 122.05 22.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.72 -160.89 36.96 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -85.01 -17.44 37.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.928 0.364 . . . . 0.0 111.918 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.7 -11.56 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.39 177.22 48.37 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.09 137.34 35.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.666 0.733 . . . . 0.0 111.82 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -148.07 166.17 4.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.065 0 C-N-CA 123.708 0.803 . . . . 0.0 110.562 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -134.07 149.48 51.14 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.3 -170.12 2.06 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.084 0.554 . . . . 0.0 111.23 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.0 t -104.67 -35.73 7.7 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -152.68 -175.14 5.17 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.8 163.77 39.79 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.938 -0.476 . . . . 0.0 111.868 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -151.64 160.36 43.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.673 0.789 . . . . 0.0 109.545 172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 73.4 m -91.1 140.71 29.57 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.6 p -131.52 178.8 6.46 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 123.446 0.699 . . . . 0.0 110.939 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.78 173.49 30.6 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -73.07 -18.97 61.26 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 122.277 -0.543 . . . . 0.0 111.987 -176.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 14.03 3.59 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.417 0.687 . . . . 0.0 111.352 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 16.01 78.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 122.037 -0.414 . . . . 0.0 112.072 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -78.38 4.83 11.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.48 0.712 . . . . 0.0 112.554 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 m -133.85 162.59 31.6 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t -130.17 158.12 40.57 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.183 -0.323 . . . . 0.0 110.892 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -143.03 136.57 28.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.727 0.811 . . . . 0.0 109.361 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -87.37 159.43 18.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.749 0.309 . . . . 0.0 110.351 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.5 mm -106.75 140.15 25.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 123.372 0.669 . . . . 0.0 110.32 -176.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -68.08 155.37 92.19 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.469 0.708 . . . . 0.0 110.928 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.95 166.09 83.83 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 N-CA-C 111.134 -0.372 . . . . 0.0 111.134 -0.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 72.4 m -138.04 66.88 47.65 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.573 0.749 . . . . 0.0 110.372 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.81 165.91 26.22 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.887 3.058 . . . . 0.0 111.504 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -75.71 167.88 21.05 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 122.937 0.495 . . . . 0.0 110.564 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.16 -1.4 . . . . 0.0 111.562 -178.669 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -78.19 -0.88 30.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.874 0.47 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.0 p -146.14 83.27 8.64 Favored Pre-proline 0 N--CA 1.454 -0.241 0 C-N-CA 123.433 0.693 . . . . 0.0 110.324 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 177.58 8.47 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.36 3.373 . . . . 0.0 111.489 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.8 m -118.36 135.7 54.17 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -140.71 146.51 37.89 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 123.086 0.554 . . . . 0.0 110.1 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -142.09 161.97 36.66 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.701 1.2 . . . . 0.0 108.815 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.67 14.31 72.44 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 119.749 -0.473 . . . . 0.0 112.98 176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 96.3 mt -57.9 -26.18 61.83 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 117.823 0.811 . . . . 0.0 111.604 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 37.2 t -75.67 -4.18 38.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.648 0.379 . . . . 0.0 111.88 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.29 -27.24 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.565 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.0 p -91.91 -21.09 20.78 Favored 'General case' 0 N--CA 1.458 -0.048 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.9 m -145.86 -22.4 0.46 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 105.03 178.96 24.33 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.6 tp -58.11 -27.94 64.17 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.023 0.529 . . . . 0.0 111.704 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.4 m -62.32 -32.71 73.5 Favored 'General case' 0 C--N 1.334 -0.102 0 O-C-N 122.022 -0.424 . . . . 0.0 111.246 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.18 -29.77 34.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.952 -0.467 . . . . 0.0 110.717 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.4 t -70.0 -31.84 69.72 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -78.17 -31.32 49.55 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.806 0.443 . . . . 0.0 111.098 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -79.19 -23.02 44.15 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 122.301 0.241 . . . . 0.0 111.238 177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -82.29 -33.01 29.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.933 0.333 . . . . 0.0 111.245 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 91.6 m -76.91 -23.42 52.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.448 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.17 5.85 42.8 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.791 0.436 . . . . 0.0 111.69 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.9 p -126.99 166.76 16.94 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.8 m -72.66 131.82 42.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.102 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -142.95 170.14 16.25 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 109.464 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -75.1 139.28 42.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 122.369 -0.207 . . . . 0.0 111.193 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.74 -168.08 15.79 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.93 -17.44 37.74 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.828 0.451 . . . . 0.0 112.206 -177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.5 -10.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 122.86 0.464 . . . . 0.0 111.708 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.09 178.76 45.2 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 94.5 m -80.99 142.29 33.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.88 168.54 7.29 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.524 0.73 . . . . 0.0 110.773 -176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -139.09 150.65 45.95 Favored 'General case' 0 C--O 1.227 -0.079 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.7 m -127.53 -173.81 3.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.184 0.447 . . . . 0.0 111.487 -174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.7 m -104.92 -30.55 9.75 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -155.19 -177.36 6.48 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.449 0.568 . . . . 0.0 109.6 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.95 170.18 21.03 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.139 0.495 . . . . 0.0 112.257 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -151.84 166.36 31.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.34 1.056 . . . . 0.0 109.213 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.3 t -106.5 139.75 40.47 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -137.08 -171.53 2.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.809 0.844 . . . . 0.0 111.03 -174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.37 173.74 26.11 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -69.75 -21.02 63.48 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.973 0.509 . . . . 0.0 111.772 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -144.9 24.81 1.47 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 117.684 0.22 . . . . 0.0 111.393 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.68 32.38 57.38 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.7 p -101.29 12.21 37.88 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 m -133.05 154.02 50.94 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.517 0.327 . . . . 0.0 110.762 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.1 t -116.9 139.43 50.64 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.795 0.838 . . . . 0.0 109.489 178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 85.5 m -139.34 143.98 38.03 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.126 0.57 . . . . 0.0 109.783 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -100.86 164.68 11.72 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.659 0.384 . . . . 0.0 111.515 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.3 mm -113.31 145.09 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 C-N-CA 123.791 0.836 . . . . 0.0 110.399 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -73.42 155.74 89.4 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 122.973 0.509 . . . . 0.0 110.634 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.9 162.96 91.12 Favored 'Cis proline' 0 N--CA 1.455 -0.748 0 CA-C-N 118.49 0.497 . . . . 0.0 111.687 -1.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 67.3 m -136.56 69.8 60.08 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 123.698 0.799 . . . . 0.0 109.976 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -63.62 162.82 26.47 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.054 3.17 . . . . 0.0 111.507 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -75.38 161.33 29.35 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.966 0.506 . . . . 0.0 111.471 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.253 1.24 0 CA-C-O 117.395 -1.288 . . . . 0.0 110.013 179.561 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -75.91 1.06 16.15 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.13 0.572 . . . . 0.0 110.889 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p -149.5 80.27 7.71 Favored Pre-proline 0 N--CA 1.453 -0.296 0 C-N-CA 123.613 0.765 . . . . 0.0 109.928 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -73.34 174.41 12.17 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 124.357 3.371 . . . . 0.0 111.792 -178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.5 m -113.36 135.43 53.87 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -142.99 147.62 35.46 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 122.212 0.205 . . . . 0.0 110.717 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -142.31 164.47 30.07 Favored 'General case' 0 N--CA 1.461 0.087 0 C-N-CA 124.801 1.24 . . . . 0.0 109.504 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.78 16.85 74.66 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.867 -0.407 . . . . 0.0 112.969 176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.9 -29.03 68.08 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.036 0.918 . . . . 0.0 111.152 -177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.4 m -81.92 6.08 17.0 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.097 0.559 . . . . 0.0 112.092 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.7 t -122.61 -15.74 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.684 0.394 . . . . 0.0 111.923 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 t -123.29 -18.39 6.29 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.4 m -139.12 -18.27 1.02 Allowed 'General case' 0 N--CA 1.457 -0.084 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -177.49 39.63 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.7 tp -58.41 -27.57 64.41 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.21 0.604 . . . . 0.0 111.825 -176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -61.66 -34.21 75.31 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.238 -0.289 . . . . 0.0 111.246 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.77 -28.2 30.5 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.226 0.466 . . . . 0.0 110.981 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.16 -31.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -78.8 -33.51 46.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.795 0.438 . . . . 0.0 110.873 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -77.57 -22.44 50.97 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.312 0.245 . . . . 0.0 111.334 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -84.43 -32.78 23.9 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.845 0.293 . . . . 0.0 111.179 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.8 m -77.79 -22.63 49.85 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.411 176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -89.34 6.07 42.17 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 122.866 0.467 . . . . 0.0 111.821 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 91.5 p -127.86 165.45 20.14 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.3 m -72.29 131.08 42.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.139 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -142.78 167.13 22.81 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.678 0.791 . . . . 0.0 109.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.68 123.69 26.99 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.2 -160.15 36.24 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.61 -14.4 45.78 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -137.01 -11.82 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 122.594 0.358 . . . . 0.0 111.881 -178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.04 176.89 45.54 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.3 m -76.59 140.22 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.082 0.941 . . . . 0.0 111.55 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.5 m -144.96 169.23 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.516 0.726 . . . . 0.0 110.733 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -138.29 151.05 47.24 Favored 'General case' 0 N--CA 1.458 -0.073 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.4 m -129.95 -172.41 2.77 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.326 0.512 . . . . 0.0 111.635 -173.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.0 t -102.48 -35.95 8.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -153.95 -175.92 5.61 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.98 168.43 26.44 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 112.078 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -154.96 163.83 39.75 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.894 0.878 . . . . 0.0 109.539 173.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.8 m -93.72 142.41 27.39 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.2 p -137.67 -178.52 5.28 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.458 0.703 . . . . 0.0 111.008 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.74 -176.97 52.29 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -62.01 134.24 56.38 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.6 mt 50.86 20.13 0.73 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.981 0.912 . . . . 0.0 113.229 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.38 76.64 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.229 0.468 . . . . 0.0 112.345 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.9 p -75.53 8.76 2.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 39.3 m -126.68 155.84 42.0 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.588 0.631 . . . . 0.0 110.085 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.7 t -112.52 138.83 48.71 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.303 0.641 . . . . 0.0 110.159 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.6 m -141.32 145.8 35.92 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.008 0.523 . . . . 0.0 110.025 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.7 m -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.914 0.388 . . . . 0.0 111.42 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.4 mm -112.4 143.18 22.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 123.798 0.839 . . . . 0.0 110.047 -177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -71.01 156.06 92.53 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 0.0 111.068 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 162.83 91.44 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 O-C-N 121.883 0.412 . . . . 0.0 111.387 -1.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 65.7 m -136.08 69.69 63.35 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.591 0.757 . . . . 0.0 109.772 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.66 161.77 30.74 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.383 2.722 . . . . 0.0 111.074 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -77.17 161.37 28.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.693 0.397 . . . . 0.0 111.681 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.252 1.192 0 CA-C-O 117.62 -1.181 . . . . 0.0 110.146 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -142.99 157.54 44.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.525 0.73 . . . . 0.0 109.991 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.07 81.87 9.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.357 0.663 . . . . 0.0 110.217 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.94 178.46 7.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.365 3.377 . . . . 0.0 111.231 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -117.41 133.38 56.03 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.563 0.745 . . . . 0.0 109.246 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -142.79 142.82 31.96 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.657 0.383 . . . . 0.0 110.043 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -142.81 164.76 29.23 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.386 1.074 . . . . 0.0 109.207 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.79 18.7 77.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 120.036 -0.313 . . . . 0.0 112.489 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.28 -14.41 55.74 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.522 0.661 . . . . 0.0 112.332 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.7 t -97.04 -3.25 41.74 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.062 0.392 . . . . 0.0 111.635 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.24 -27.62 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 O-C-N 121.909 -0.494 . . . . 0.0 111.549 -176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 t -154.44 -26.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -83.8 -20.38 33.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.151 0.432 . . . . 0.0 111.992 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.22 170.44 45.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.104 0.859 . . . . 0.0 112.408 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.6 -28.17 68.3 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.846 0.459 . . . . 0.0 111.078 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.7 m -62.0 -32.5 72.98 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 122.212 -0.305 . . . . 0.0 110.988 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.35 45.76 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.068 -0.395 . . . . 0.0 110.501 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 33.2 t -74.05 -30.9 62.64 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -77.44 -28.96 52.68 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 122.615 0.366 . . . . 0.0 111.051 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -79.56 -30.66 41.75 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.999 0.187 . . . . 0.0 110.899 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -76.34 -32.5 58.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 117.756 0.253 . . . . 0.0 111.187 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 98.9 m -76.48 -28.48 56.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 119.322 -0.371 . . . . 0.0 111.575 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -85.17 -20.53 30.09 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.365 0.529 . . . . 0.0 111.769 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.3 p -94.34 166.19 12.21 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 172.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 55.8 m -75.95 136.55 40.05 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.581 -177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -144.61 170.52 15.91 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.848 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.7 tpp85 -75.19 140.61 43.42 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.135 0.174 . . . . 0.0 111.407 -177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -114.63 -170.58 16.68 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -84.58 -14.42 48.88 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -130.53 -18.38 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 122.867 0.467 . . . . 0.0 111.149 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 175.99 176.8 44.5 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -75.17 144.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.612 0.706 . . . . 0.0 111.548 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.79 171.7 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.25 1.02 . . . . 0.0 110.463 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -141.66 153.07 44.47 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.7 m -123.83 -175.26 3.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.753 0.421 . . . . 0.0 111.491 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 71.8 m -103.81 -29.58 10.92 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -155.92 -177.51 6.63 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.446 0.566 . . . . 0.0 109.756 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.0 170.03 22.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.273 0.558 . . . . 0.0 111.785 -177.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -152.65 165.76 34.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.399 1.08 . . . . 0.0 109.028 173.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.0 t -107.99 141.51 39.53 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.6 p -130.6 179.73 5.77 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.815 0.846 . . . . 0.0 110.586 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 168.63 45.06 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.83 132.09 47.84 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 122.47 -0.429 . . . . 0.0 110.295 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.3 mt 52.53 14.71 0.42 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.427 1.091 . . . . 0.0 112.749 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.73 102.0 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.99 0.805 . . . . 0.0 111.521 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.2 p -144.82 4.89 1.14 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.877 0.471 . . . . 0.0 111.551 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.3 m -134.05 152.25 51.76 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 122.603 0.361 . . . . 0.0 110.216 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 40.1 t -110.78 138.13 47.56 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.171 0.589 . . . . 0.0 110.271 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 89.1 m -139.45 140.96 37.45 Favored 'General case' 0 CA--C 1.526 0.053 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.3 m -99.88 164.12 12.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.377 0.271 . . . . 0.0 111.043 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 47.6 mm -114.84 143.03 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 124.055 0.942 . . . . 0.0 110.448 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -73.55 157.05 88.25 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 122.939 0.496 . . . . 0.0 111.105 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -73.72 164.01 88.44 Favored 'Cis proline' 0 N--CA 1.455 -0.784 0 O-C-N 121.87 0.405 . . . . 0.0 111.575 -2.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 95.1 m -134.67 70.63 71.5 Favored Pre-proline 0 N--CA 1.451 -0.384 0 C-N-CA 124.1 0.96 . . . . 0.0 109.906 177.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -64.73 167.28 15.81 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.248 3.299 . . . . 0.0 112.018 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -69.45 163.25 25.71 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.276 0.63 . . . . 0.0 111.557 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.649 -1.167 . . . . 0.0 109.525 175.735 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.043 0.449 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -77.3 1.2 19.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.928 0.491 . . . . 0.0 110.813 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.1 p -152.7 86.84 4.18 Favored Pre-proline 0 N--CA 1.452 -0.342 0 C-N-CA 123.337 0.655 . . . . 0.0 110.469 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -76.34 -179.08 4.93 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 124.428 3.418 . . . . 0.0 110.581 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -125.32 122.41 36.77 Favored 'General case' 0 CA--C 1.527 0.065 0 C-N-CA 122.804 0.441 . . . . 0.0 110.15 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -144.74 139.02 27.6 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.963 0.905 . . . . 0.0 109.431 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 -137.77 -12.08 1.52 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.687 0.395 . . . . 0.0 111.761 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.55 12.22 70.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 123.584 0.611 . . . . 0.0 112.581 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 86.5 mt -58.77 -25.61 63.22 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.668 0.734 . . . . 0.0 112.609 -174.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.9 t -86.39 10.14 15.91 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.16 0.436 . . . . 0.0 111.811 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -120.94 -17.68 5.81 Favored 'Isoleucine or valine' 0 C--N 1.343 0.31 0 C-N-CA 123.024 0.529 . . . . 0.0 111.252 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.3 p -120.59 -17.11 8.15 Favored 'General case' 0 N--CA 1.46 0.065 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 m -140.51 -19.51 0.85 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.06 -173.68 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 123.344 0.497 . . . . 0.0 112.069 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.3 tp -62.38 -26.6 68.55 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.161 0.584 . . . . 0.0 111.751 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 62.5 m -63.45 -36.17 82.86 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 121.759 -0.588 . . . . 0.0 110.664 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.71 -30.6 36.3 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.002 0.365 . . . . 0.0 110.703 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 25.7 t -68.62 -30.86 69.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -79.08 -35.46 42.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.259 -0.276 . . . . 0.0 110.691 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -73.46 -19.57 60.92 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 122.918 0.136 . . . . 0.0 111.031 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -85.49 -33.35 21.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.447 0.299 . . . . 0.0 110.675 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 95.7 m -78.36 -26.49 46.68 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 119.576 -0.25 . . . . 0.0 111.554 177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -87.13 8.02 25.57 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 122.865 0.466 . . . . 0.0 111.305 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -130.89 167.23 19.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.539 1.136 . . . . 0.0 108.347 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.3 m -73.2 133.82 44.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 122.047 -0.408 . . . . 0.0 110.41 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -145.95 170.91 15.66 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.887 0.875 . . . . 0.0 109.554 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -73.54 140.38 46.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.234 0.214 . . . . 0.0 111.14 -177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.81 -168.1 14.76 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -86.63 -17.09 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -176.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -129.86 -16.95 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.852 0.461 . . . . 0.0 110.907 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 177.56 -179.79 48.07 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 87.6 m -80.29 142.18 34.79 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.833 0.816 . . . . 0.0 110.895 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.22 169.23 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.782 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -138.44 150.5 46.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 124.422 1.089 . . . . 0.0 108.16 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.9 m -128.18 -172.49 2.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.242 0.617 . . . . 0.0 111.212 -174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.2 m -107.54 -29.85 8.96 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -154.16 -178.97 7.47 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.729 0.695 . . . . 0.0 109.799 -176.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.01 168.1 26.97 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.281 0.562 . . . . 0.0 112.348 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -153.93 168.09 27.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.992 1.317 . . . . 0.0 108.757 173.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.4 m -105.0 146.29 29.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -132.79 179.59 6.07 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.476 0.71 . . . . 0.0 111.0 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.49 176.37 28.6 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -68.89 -18.01 64.06 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.37 13.3 3.51 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.074 0.55 . . . . 0.0 111.667 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.68 17.7 78.27 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.909 -0.477 . . . . 0.0 111.909 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.6 p -83.15 9.55 10.24 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 113.009 -174.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 77.9 m -125.65 150.82 47.28 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 36.0 t -102.66 141.69 35.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.484 0.714 . . . . 0.0 110.125 178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 96.5 m -143.66 147.36 34.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.299 0.639 . . . . 0.0 109.719 177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.8 m -101.22 164.45 11.78 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.469 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.0 mm -111.97 143.97 20.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.138 0 C-N-CA 124.065 0.946 . . . . 0.0 109.632 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -72.46 156.09 90.62 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 122.832 0.453 . . . . 0.0 110.691 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.66 166.08 83.91 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 122.041 0.495 . . . . 0.0 111.441 -1.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.8 m -138.58 70.31 45.17 Favored Pre-proline 0 C--O 1.233 0.232 0 C-N-CA 123.491 0.716 . . . . 0.0 110.069 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.9 163.43 22.18 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.798 2.998 . . . . 0.0 111.733 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.6 mtm-85 -76.35 161.99 28.25 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.834 0.453 . . . . 0.0 111.74 -176.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.463 -1.256 . . . . 0.0 110.07 179.711 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.116 0.484 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -150.01 157.54 43.25 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.517 0.727 . . . . 0.0 110.275 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.9 p -149.07 77.56 9.1 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.807 0.443 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.11 174.91 11.64 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 124.232 3.288 . . . . 0.0 111.57 -178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 m -111.15 134.63 52.6 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 123.306 0.642 . . . . 0.0 109.696 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -143.95 142.75 30.91 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.958 0.503 . . . . 0.0 110.023 177.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -142.09 163.69 32.18 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.062 0.945 . . . . 0.0 109.512 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.68 17.95 75.36 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.843 -0.421 . . . . 0.0 112.389 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.41 -27.31 67.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.754 0.777 . . . . 0.0 111.405 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 93.4 m -79.63 4.37 16.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.047 0.539 . . . . 0.0 112.192 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.48 -14.8 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 122.889 0.476 . . . . 0.0 111.62 -178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -121.48 -19.6 6.88 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 m -140.71 -19.36 0.83 Allowed 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.34 -173.47 34.24 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 123.565 0.602 . . . . 0.0 111.761 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.5 tp -59.82 -28.08 67.17 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.014 0.526 . . . . 0.0 111.933 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -60.7 -36.2 78.22 Favored 'General case' 0 C--O 1.226 -0.166 0 O-C-N 122.052 -0.405 . . . . 0.0 110.988 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.29 -30.1 27.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.067 0.394 . . . . 0.0 110.792 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 44.5 t -68.05 -31.47 71.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -80.12 -36.96 34.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 122.231 -0.293 . . . . 0.0 110.999 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -72.74 -18.65 61.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 122.927 0.142 . . . . 0.0 111.325 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -87.64 -35.69 17.88 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 117.871 0.305 . . . . 0.0 110.574 177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.5 m -75.48 -28.4 59.2 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -83.84 3.26 34.5 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 122.676 0.391 . . . . 0.0 111.97 178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.6 m -126.01 163.73 22.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.9 m -71.12 133.3 46.12 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.137 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -145.08 167.33 22.97 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.61 124.78 28.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.379 -0.201 . . . . 0.0 110.48 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.79 -158.55 34.51 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 123.752 0.692 . . . . 0.0 111.389 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -84.67 -20.25 31.56 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.496 -0.414 . . . . 0.0 112.093 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.2 p -134.32 -12.39 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 122.58 0.352 . . . . 0.0 111.651 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 179.8 175.4 46.51 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.5 m -74.29 141.78 45.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.019 0.909 . . . . 0.0 111.875 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -142.9 167.86 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.032 0.933 . . . . 0.0 110.745 -177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -139.71 144.1 37.37 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.2 m -125.4 -173.69 2.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.133 0.424 . . . . 0.0 111.47 -174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -103.4 -35.85 8.22 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -174.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -152.7 -176.36 5.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.47 168.25 27.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.305 0.574 . . . . 0.0 111.647 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -153.62 163.39 40.07 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.876 0.87 . . . . 0.0 109.321 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.1 m -94.54 142.57 27.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.4 p -132.34 -179.71 5.6 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.435 0.694 . . . . 0.0 111.122 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.92 177.06 30.74 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -70.37 -18.78 63.06 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.01 0.524 . . . . 0.0 112.002 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -135.35 14.52 3.49 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.069 0.547 . . . . 0.0 111.387 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.13 15.69 78.63 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.1 p -80.62 8.33 8.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.6 m -125.26 155.34 40.29 Favored 'General case' 0 N--CA 1.46 0.067 0 C-N-CA 122.914 0.486 . . . . 0.0 110.075 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.2 t -114.34 139.36 49.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.584 0.754 . . . . 0.0 110.063 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 95.6 m -142.95 144.5 32.39 Favored 'General case' 0 C--O 1.228 -0.058 0 C-N-CA 122.921 0.488 . . . . 0.0 109.919 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.3 m -97.27 162.23 13.44 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.964 0.412 . . . . 0.0 111.274 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.64 145.62 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 123.918 0.887 . . . . 0.0 110.127 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.7 p-10 -73.59 156.18 88.79 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.061 0.544 . . . . 0.0 111.609 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.57 165.37 85.84 Favored 'Cis proline' 0 N--CA 1.451 -1.004 0 CA-C-N 118.188 0.388 . . . . 0.0 111.288 -2.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 68.0 m -137.14 67.45 55.16 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.729 0.812 . . . . 0.0 110.287 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.69 168.84 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.961 3.107 . . . . 0.0 112.052 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -70.64 165.01 23.77 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.549 0.739 . . . . 0.0 111.661 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 176.88 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.77 2.61 19.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.183 0.593 . . . . 0.0 111.019 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 4.8 p -149.87 83.76 6.13 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 123.323 0.649 . . . . 0.0 110.534 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.93 175.48 11.16 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.842 3.028 . . . . 0.0 111.098 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.1 m -117.23 127.8 54.45 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -141.52 146.01 35.85 Favored 'General case' 0 CA--C 1.523 -0.083 0 C-N-CA 123.266 0.627 . . . . 0.0 110.157 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -143.14 165.52 27.2 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.116 0.966 . . . . 0.0 109.354 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.71 17.33 74.91 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-O 120.019 -0.323 . . . . 0.0 112.594 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.21 -23.19 65.43 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.555 0.678 . . . . 0.0 112.033 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.64 3.67 15.7 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.723 0.409 . . . . 0.0 111.594 178.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.6 -27.13 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 122.879 0.472 . . . . 0.0 111.088 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.5 p -87.63 -15.18 38.01 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 122.09 -0.381 . . . . 0.0 111.789 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.0 t -154.21 -40.25 0.09 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 122.352 0.261 . . . . 0.0 111.283 176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.15 -167.73 16.41 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.4 tp -58.96 -27.88 65.77 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.874 0.47 . . . . 0.0 111.715 -177.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.4 m -61.7 -40.43 95.0 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 122.288 -0.257 . . . . 0.0 111.291 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -28.05 41.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.895 -0.503 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.7 -32.53 71.17 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -80.03 -36.18 36.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.16 -0.337 . . . . 0.0 110.949 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -71.6 -21.78 61.81 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 119.626 -0.226 . . . . 0.0 111.167 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -87.51 -31.88 19.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.633 0.373 . . . . 0.0 111.315 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.02 -27.5 54.6 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.584 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -83.96 -14.76 50.05 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.541 0.609 . . . . 0.0 111.652 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.8 p -101.02 168.44 9.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -78.38 139.51 38.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.611 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -145.8 170.58 16.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.737 0.815 . . . . 0.0 109.394 -176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -72.91 139.27 46.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.465 0.174 . . . . 0.0 111.001 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -116.92 -172.79 16.4 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.176 0.893 . . . . 0.0 111.0 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -83.69 -12.68 55.56 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.87 -17.68 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.222 0.609 . . . . 0.0 110.987 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.06 -179.77 45.2 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 96.4 m -78.02 141.59 38.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 117.739 0.769 . . . . 0.0 111.041 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.06 163.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 123.759 0.823 . . . . 0.0 110.8 -176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -135.43 147.24 48.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.5 m -118.91 -174.3 2.67 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.995 0.518 . . . . 0.0 111.117 -173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -103.37 -30.24 10.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -155.77 -177.97 6.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.289 0.495 . . . . 0.0 109.856 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 168.46 26.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.712 0.405 . . . . 0.0 111.842 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -153.18 165.83 34.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.788 0.835 . . . . 0.0 109.434 173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 76.3 m -98.64 143.03 29.48 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -131.99 179.46 6.08 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 123.714 0.806 . . . . 0.0 110.801 -175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.17 176.05 30.35 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -69.48 -18.15 63.68 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.805 0.442 . . . . 0.0 112.05 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 96.4 mt -135.33 13.45 3.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.011 0.524 . . . . 0.0 111.451 -177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.07 16.68 78.47 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.2 p -81.26 7.96 10.15 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 44.6 m -125.79 154.16 42.98 Favored 'General case' 0 C--N 1.335 -0.056 0 C-N-CA 122.896 0.478 . . . . 0.0 110.304 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.9 t -111.71 140.57 46.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.484 0.713 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.8 m -143.51 143.74 31.68 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 123.433 0.693 . . . . 0.0 109.582 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -96.9 162.82 13.23 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.033 0.445 . . . . 0.0 111.189 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.2 mm -107.34 142.0 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 123.714 0.806 . . . . 0.0 109.801 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.25 156.03 89.52 Favored Pre-proline 0 CA--C 1.532 0.282 0 C-N-CA 122.59 0.356 . . . . 0.0 110.974 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -77.03 168.61 76.6 Favored 'Cis proline' 0 N--CA 1.452 -0.918 0 CA-C-N 118.265 0.416 . . . . 0.0 111.739 -1.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 84.5 m -139.74 69.11 37.31 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.641 0.777 . . . . 0.0 109.725 178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.77 171.7 12.91 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 124.064 3.176 . . . . 0.0 112.268 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 88.8 mmt-85 -66.75 169.82 7.38 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.666 0.786 . . . . 0.0 110.529 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 117.222 -1.37 . . . . 0.0 111.655 179.47 . . . . . . . . 0 0 . 1 stop_ save_